<SEC-DOCUMENT>0001493152-20-001399.txt : 20200130
<SEC-HEADER>0001493152-20-001399.hdr.sgml : 20200130
<ACCEPTANCE-DATETIME>20200130172714
ACCESSION NUMBER:		0001493152-20-001399
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20200127
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200130
DATE AS OF CHANGE:		20200130

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SIGMA LABS, INC.
		CENTRAL INDEX KEY:			0000788611
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS MANUFACTURING INDUSTRIES [3990]
		IRS NUMBER:				820404220
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38015
		FILM NUMBER:		20562418

	BUSINESS ADDRESS:	
		STREET 1:		3900 PASEO DEL SOL
		CITY:			SANTE FE
		STATE:			NM
		ZIP:			87507
		BUSINESS PHONE:		(505) 438-2576

	MAIL ADDRESS:	
		STREET 1:		3900 PASEO DEL SOL
		CITY:			SANTE FE
		STATE:			NM
		ZIP:			87507

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FRAMEWAVES INC
		DATE OF NAME CHANGE:	20010130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MESSIDOR LTD
		DATE OF NAME CHANGE:	20010122
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 13 OR 15(D) OF THE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
of report (Date of earliest event reported): January 27, 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<DIV STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SIGMA
                                         LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38015</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27-1865814</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction <BR>
    of incorporation or organization)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
    <BR>
    File Number)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer<BR>
    &nbsp;Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3900
Paseo del Sol</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Santa
Fe, New Mexico 87507</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of Principal Executive Offices) (Zip Code)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s
telephone number, including area code: (505) 438-2576</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former
name or former address, if changed since last report</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin: 0">Written communications pursuant to Rule 425 under
                                         the Securities Act (17 CFR 230.425)</P>


</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin: 0">Soliciting material pursuant to Rule 14a-12 under
                                         the Exchange Act (17 CFR 240.14a-12)</P>


</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin: 0">Pre-commencement communications pursuant to Rule
                                         14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>


</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin: 0">Pre-commencement communications pursuant to Rule
                                         13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>


</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 18%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock, par value $0.001 per share</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SGLB</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    NASDAQ Stock Market LLC</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to Purchase Common Stock, par value $0.001 per share</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SGLBW</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    NASDAQ Stock Market LLC</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;&thinsp;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;&thinsp;240.12b-2 of this chapter). Emerging growth
company [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
[&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
1.01</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin: 0"><B>Entry
                                         into a Material Definitive Agreement.</B></P>


</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference
is made to the Current Report on Form 8-K of Sigma Labs, Inc. (the &ldquo;Company&rdquo;) filed with the Securities and Exchange
Commission on January 27, 2020 (the &ldquo;Prior 8-K&rdquo;). As described in the Prior 8-K, on January 27, 2020 the Company entered
into a Securities Purchase Agreement with certain institutional investors (the &ldquo;Institutional Investors&rdquo;) pursuant
to which the Company agreed to sell to each Institutional Investor shares of the Company&rsquo;s Series D Convertible Preferred
Stock (the &ldquo;Series D Preferred Stock&rdquo;), warrants to purchase the Company&rsquo;s Common Stock (the &ldquo;Institutional
Common Warrants&rdquo;) and warrants to purchase the Series D Preferred Stock (the &ldquo;Preferred Warrants&rdquo;) for a total
gross purchase price of $1,600,000. The Series D Preferred Stock, the Institutional Common Warrants and the Preferred Warrants
each contain a cashless exercise feature that may be applied upon the happening of specified events. The Prior 8-K also disclosed
that on January 27, 2020, the Company entered into a Securities Purchase Agreement with the Company&rsquo;s largest shareholder
and certain of its directors (the &ldquo;Other Investors&rdquo;) pursuant to which the Company agreed to issue and sell to each
Other Investors shares of the Company&rsquo;s Series E Convertible Preferred Stock (the &ldquo;Series E Preferred Stock&rdquo;),
and Class A warrants to purchase the Company&rsquo;s Common Stock (the &ldquo;Class A Warrants&rdquo;) for a total gross purchase
price of $500,000. The offerings of the securities as described in the Prior 8-K are hereafter referred to as the &ldquo;Private
Placements.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the Private Placements, on January 27, 2020, the Company also entered into a Placement Agency Agreement (&ldquo;Placement Agreement&rdquo;)
with Dawson James Securities, Inc. (&ldquo;Dawson&rdquo;) pursuant to which the Company engaged Dawson as to its exclusive placement
agent in connection with, inter alia, the Private Placements. Under the Placement Agreement, the Company agreed to pay Dawson
8% of the gross proceeds from the Private Placements as well as from the exercise through June 30, 2020 of the Preferred Warrants.
The Company has also agreed to issue to Dawson warrants to purchase shares of Common Stock equal to 8% of the aggregate number
of shares issuable upon conversion of the shares of the Series D Preferred Stock (&ldquo;Preferred Shares&rdquo;) as well as 8%
of the number of common shares that would be issuable upon conversion of the Preferred Shares arising from any exercise
of the Preferred Warrants on or before June 30, 2020 at the initial conversion price of the Series D Preferred Stock without regard
to any price protection provisions. The Warrants to be issued to Dawson will be exercisable six months from issuance at a price
per share of $1.13, will contain a cashless exercise feature, and a term of five years from the date they are exercisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing summary of the Placement Agreement does not purport to be complete and is qualified in its entirety by the terms and
conditions set forth in the form attached hereto as Exhibit 10.9 which is incorporated by reference herein in its entirety.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-size: 10pt"><B>Item 3.02</B></FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Unregistered
                                         Sales of Equity Securities.</B></FONT></P>


</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference
is made to the disclosure in Item 1.01 which is incorporated herein by reference. The Private Placements were consummated on
January 28, 2020. In connection therewith, the Company issued 1,640 shares of Series D Preferred, Institutional Common
Warrants to purchase an aggregate of 7,796,000 shares of Common Stock, Preferred Warrants to purchase an aggregate of
6,156 additional Series D Preferred Stock, 333.33 shares of the Series E Preferred Stock and Class A Warrants to purchase an
aggregate of 485,438 shares of Common Stock. For purposes of determining the total number of shares of Common Stock
issuable to the Other Investors upon the conversion of the Series E Preferred Stock issued on January 28, 2020, the Company
used the consolidated bid price on January 24, 2020 of $0.90 (i.e., a conversion price of $1.03). The Company also issued
warrants to a prior investor to purchase an aggregate of 350,000 shares of its Common Stock as consideration for obtaining a
waiver from the investor. From the Private Placements, the Company received gross proceeds of $2,100,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company paid Dawson a placement commission of $168,000 and issued Placement Agreement Warrants to purchase an aggregate
of 170,035 shares of the Company&rsquo;s Common Stock.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Placements were effected pursuant to an exemption from the registration requirements of the Securities Act of 1933, as
amended, pursuant to Section 4(a)(2) thereof and Rule 506 promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-size: 10pt"><B>Item 5.03 </B></FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amendments
                                         to Articles of Incorporation; Change in Fiscal Year</B></FONT></P>


</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 28, 2020, the Company filed with the Nevada Secretary of State the Certificate of Designations for the Series D Preferred
Stock and the Certificate of Designations for the Series E Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-size: 10pt"><B>Item 9.01</B></FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
                                         Statements and Exhibits.</B></FONT></P>


</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 90%; border-collapse: collapse; margin-left: 0.5in">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><U>Exhibits</U></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attached
as Exhibits 10.2, 10.4, 10.5, 10.7 and 10.8 are the final form of the documents previously filed in the Prior Form 8-K and should
replace the corresponding exhibits from the Prior Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Designations (Series D Convertible Preferred Stock)</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-4.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Institutional Common Warrant</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-5.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Preferred Warrant</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-7.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Designations (Series E Convertible Preferred Stock)</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><A HREF="ex10-8.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Class A Warrant</FONT></A></P>


</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">10.9</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-9.htm">Private Placement Agreement</A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    January 30, 2020</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SIGMA LABS, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"></TD>
    <TD STYLE="width: 5%">By:
</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    JOHN RICE</I></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    Rice</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>ex10-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-2_001.jpg" ALT="" STYLE="height: 867; width: 670">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-2_002.jpg" ALT="" STYLE="height: 867; width: 670">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF DESIGNATIONS OF<BR>
SERIES D CONVERTIBLE PREFERRED STOCK OF<BR>
SIGMA LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
John Rice, hereby certify that I am the Chief Executive Officer of Sigma Labs, Inc (the &ldquo;<B>Company</B>&rdquo;), a corporation
organized and existing under the D Chapter 78 of the Nevada Revised Statues (the &ldquo;<B>NRS</B>&rdquo;), and further do hereby
certify:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
pursuant to the authority expressly conferred upon the Board of Directors of the Company (the &ldquo;<B>Board</B>&rdquo;) by the
Company&rsquo;s Articles of Incorporation, as amended (the &ldquo;<B>Articles of Incorporation</B>&rdquo;), and Section 78.195
of Chapter 78 of the NRS, the Board on January 24, 2020 adopted the following resolution determining it desirable and in the best
interests of the Company and its shareholders for the Company to create a series of Seven Thousand, Seven Hundred and Ninety Six
(7,796) shares of preferred stock designated as &ldquo;<B>Series D Convertible Preferred Stock</B>&rdquo;, none of which shares
have been issued:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RESOLVED,
that pursuant to the authority vested in the Board this Company, in accordance with the provisions of the Articles of Incorporation,
a series of preferred stock, par value $0.001 per share, of the Company be and hereby is created, and that the designation and
number of shares thereof and the voting and other powers, preferences and relative, participating, optional or other rights of
the shares of such series and the qualifications, limitations and restrictions thereof are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERMS
OF SERIES D CONVERTIBLE PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Designation and Number of Shares</U>. There shall hereby be created and established a series of preferred stock of the Company
designated as &ldquo;Series D Convertible Preferred Stock&rdquo; (the &ldquo;<B>Preferred Shares</B>&rdquo;). The authorized number
of Preferred Shares shall be 7,796 shares. Each Preferred Share shall have a par value of $0.001. Capitalized terms not defined
herein shall have the meaning as set forth in Section 31 below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Ranking</U>. Except to the extent that the holders of at least a majority of the outstanding Preferred Shares (the &ldquo;<B>Required
Holders</B>&rdquo;) expressly consent to the creation of Parity Stock (as defined below) or Senior Preferred Stock (as defined
below) in accordance with Section 16, all shares of capital stock of the Company (including the Series E Preferred Stock to be
issued on or prior to the Initial Issuance Date (as defined below)) shall be junior in rank to all Preferred Shares with respect
to the preferences as to dividends, distributions and payments upon the liquidation, dissolution and winding up of the Company
(such junior stock is referred to herein collectively as &ldquo;<B>Junior Stock</B>&rdquo;). The rights of all such shares of
capital stock of the Company shall be subject to the rights, powers, preferences and privileges of the Preferred Shares. Without
limiting any other provision of this Certificate of Designations, without the prior express consent of the Required Holders, voting
separate as a single class, the Company shall not hereafter authorize or issue any additional or other shares of capital stock
that is (i) of senior rank to the Preferred Shares in respect of the preferences as to dividends, distributions and payments upon
the liquidation, dissolution and winding up of the Company (collectively, the &ldquo;<B>Senior Preferred Stock</B>&rdquo;), (ii)
of pari passu rank to the Preferred Shares in respect of the preferences as to dividends, distributions and payments upon the
liquidation, dissolution and winding up of the Company (collectively, the &ldquo;<B>Parity Stock</B>&rdquo;) or (iii) any Junior
Stock having a maturity date or any other date requiring redemption or repayment of such shares of Junior Stock prior to such
time as no Preferred Shares remain outstanding. In the event of the merger or consolidation of the Company with or into another
corporation, the Preferred Shares shall maintain their relative rights, powers, designations, privileges and preferences provided
for herein and no such merger or consolidation shall result inconsistent therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Dividends</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From and after January 28, 2020 (the &ldquo;<B>Initial Issuance Date</B>&rdquo;), each holder of a Preferred Share (each, a &ldquo;<B>Holder</B>&rdquo;
and collectively, the &ldquo;<B>Holders</B>&rdquo;) shall be entitled to receive dividends (&ldquo;<B>Dividends</B>&rdquo;), which
Dividends shall be computed on the basis of a 360-day year and twelve 30-day months and shall increase the Stated Value of the
Preferred Shares on each Dividend Date (each, a &ldquo;<B>Capitalized Dividend</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Prior to the capitalization of Dividends on an Dividend Date, Dividends on the Preferred Shares shall accrue at the Dividend Rate
and be payable by way of inclusion of the Dividends in the Conversion Amount on each Conversion Date in accordance with Section
4(c)(i) or upon any redemption in accordance with Section 11 or upon any required payment upon any Bankruptcy Triggering Event.
From and after the occurrence and during the continuance of any Triggering Event, the Dividend Rate shall automatically be increased
to fifteen percent (15.0%) per annum (the &ldquo;<B>Default Rate</B>&rdquo;). In the event that such Triggering Event is subsequently
cured (and no other Triggering Event then exists), the adjustment referred to in the preceding sentence shall cease to be effective
as of the calendar day immediately following the date of such cure; provided that the Dividends as calculated and unpaid at such
increased rate during the continuance of such Triggering Event shall continue to apply to the extent relating to the days after
the occurrence of such Triggering Event through and including the date of such cure of such Triggering Event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Conversion</U>. At any time after the Initial Issuance Date, each Preferred Share shall be convertible into validly issued,
fully paid and non-assessable shares of Common Stock (as defined below), on the terms and conditions set forth in this Section
4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Holder&rsquo;s Conversion Right</U>. Subject to the provisions of Section 4(d), at any time or times on or after the Initial
Issuance Date, each Holder shall be entitled to convert any portion of the outstanding Preferred Shares held by such Holder into
validly issued, fully paid and non-assessable shares of Common Stock in accordance with Section 4(c) at the Conversion Rate (as
defined below). The Company shall not issue any fraction of a share of Common Stock upon any conversion. If the issuance would
result in the issuance of a fraction of a share of Common Stock, the Company shall round such fraction of a share of Common Stock
up to the nearest whole share. The Company shall pay any and all transfer, stamp, issuance and similar taxes, costs and expenses
(including, without limitation, fees and expenses of the Transfer Agent (as defined below)) that may be payable with respect to
the issuance and delivery of Common Stock upon conversion of any Preferred Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Conversion Rate</U>. The number of shares of Common Stock issuable upon conversion of any Preferred Share pursuant to Section
4(a) shall be determined by dividing (x) the Conversion Amount of such Preferred Share by (y) the Conversion Price (the &ldquo;<B>Conversion
Rate</B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&ldquo;<B>Conversion Amount</B>&rdquo; means, with respect to each Preferred Share, as of the applicable date of determination,
the sum of (A) the Stated Value thereof plus (B) the Additional Amount thereon, plus (C) any accrued and unpaid Late Charges (as
defined below in Section 24(c)) with respect to such Stated Value and Additional Amount as of such date of determination, plus
(D) the Make-Whole Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
&ldquo;<B>Conversion Price</B>&rdquo; means, with respect to each Preferred Share, as of any Conversion Date or other date of
determination, $1.00, subject to adjustment as provided herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Mechanics of Conversion</U>. The conversion of each Preferred Share shall be conducted in the following manner:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Optional Conversion</U>. To convert a Preferred Share into shares of Common Stock on any date (a &ldquo;<B>Conversion Date</B>&rdquo;),
a Holder shall deliver (whether via facsimile, electronic mail or otherwise), for receipt on or prior to 11:59 p.m., New York
time, on such date, a copy of an executed notice of conversion of the share(s) of Preferred Shares subject to such conversion
in the form attached hereto as <B><U>Exhibit I</U></B> (the &ldquo;<B>Conversion Notice</B>&rdquo;) to the Company. If required
by Section 4(c)(iii), within two (2) Trading Days following a conversion of any such Preferred Shares as aforesaid, such Holder
shall surrender to a nationally recognized overnight delivery service for delivery to the Company the original certificates, if
any, representing the Preferred Shares (the &ldquo;<B>Preferred Share Certificates</B>&rdquo;) so converted as aforesaid (or an
indemnification undertaking with respect to the Preferred Shares in the case of its loss, theft or destruction as contemplated
by Section 18(b)). On the date of receipt of a Conversion Notice, the Company shall transmit by facsimile or electronic mail an
acknowledgment of confirmation and representation as to whether such shares of Common Stock may then be resold pursuant to Rule
144 or an effective and available registration statement, in the form attached hereto as <B><U>Exhibit II</U></B>, of receipt
of such Conversion Notice to such Holder and the Company&rsquo;s transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;), which
confirmation shall constitute an instruction to the Transfer Agent to process such Conversion Notice in accordance with the terms
herein. On or before the second (2nd) Trading Day following each date on which the Company has received a Conversion Notice (or
such earlier date as required pursuant to the 1934 Act or other applicable law, rule or regulation for the settlement of a trade
initiated on the applicable Conversion Date of such shares of Common Stock issuable pursuant to such Conversion Notice) (the &ldquo;<B>Share
Delivery Deadline</B>&rdquo;), the Company shall (1) provided that the Transfer Agent is participating in The Depository Trust
Company&rsquo;s (&ldquo;<B>DTC</B>&rdquo;) Fast Automated Securities Transfer Program and such shares of Common Stock are eligible
to be resold pursuant to Rule 144 or an effective registration statement, credit such aggregate number of shares of Common Stock
to which such Holder shall be entitled pursuant to such conversion to such Holder&rsquo;s or its designee&rsquo;s balance account
with DTC through its Deposit/Withdrawal at Custodian system, or (2) if the Transfer Agent is not participating in the DTC Fast
Automated Securities Transfer Program or such shares of Common Stock are not eligible to be resold pursuant to Rule 144 or an
effective registration statement, upon the request of such Holder, issue and deliver (via reputable overnight courier) to the
address as specified in such Conversion Notice, a certificate, registered in the name of such Holder or its designee, for the
number of shares of Common Stock to which such Holder shall be entitled. If the number of Preferred Shares represented by the
Preferred Share Certificate(s) submitted for conversion pursuant to Section 4(c)(iii) is greater than the number of Preferred
Shares being converted, then the Company shall, as soon as practicable and in no event later than two (2) Trading Days after receipt
of the Preferred Share Certificate(s) and at its own expense, issue and deliver to such Holder (or its designee) a new Preferred
Share Certificate (in accordance with Section 18(d)) representing the number of Preferred Shares not converted. The Person or
Persons entitled to receive the shares of Common Stock issuable upon a conversion of Preferred Shares shall be treated for all
purposes as the record holder or holders of such shares of Common Stock on the Conversion Date. Notwithstanding anything to the
contrary contained in this Certificate of Designations or the Registration Rights Agreement, after the effective date of a Registration
Statement (as defined in the Registration Rights Agreement) and prior to a Holder&rsquo;s receipt of the notice of a Grace Period
(as defined in the Registration Rights Agreement), the Company shall cause the Transfer Agent to deliver unlegended shares of
Common Stock to such Holder (or its designee) in connection with any sale of Registrable Securities (as defined in the Registration
Rights Agreement) with respect to which such Holder has entered into a contract for sale, and delivered a copy of the prospectus
included as part of the particular Registration Statement to the extent applicable, and for which such Holder has not yet settled.
Notwithstanding the foregoing, prior to the earlier to occur of (x) the Share Increase Shareholder Approval Date (as defined in
the Securities Purchase Agreement) and (y) the Shareholder Meeting Deadline (as defined in the Securities Purchase Agreement),
no Holder shall be permitted to convert Preferred Shares hereunder (or exercise Common Warrants of such Holder, as applicable)
to the extent that after such conversion such Holder shall have received, whether upon conversion of Preferred Shares and/or exercise
of Common Warrants, as applicable, more than such Holder&rsquo;s Authorized Share Allocation (as defined below). For the avoidance
of doubt, no ink original Conversion Notices, other notices or medallion guarantees will be required by any Holder to convert
any Preferred Shares or for such Holder take any other action in connection herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Company&rsquo;s Failure to Timely Convert</U>. If the Company shall fail, for any reason or for no reason, on or prior to the
applicable Share Delivery Deadline, either (I) if the Transfer Agent is not participating in the DTC Fast Automated Securities
Transfer Program or the applicable shares are not eligible to be resold pursuant to Rule 144 or an effective registration statement,
to issue and deliver to such Holder (or its designee) a certificate for the number of shares of Common Stock to which such Holder
is entitled and register such shares of Common Stock on the Company&rsquo;s share register or, if the Transfer Agent is participating
in the DTC Fast Automated Securities Transfer Program and such shares are eligible to be resold pursuant to Rule 144 or an effective
registration statement, to credit such Holder&rsquo;s or its designee&rsquo;s balance account with DTC for such number of shares
of Common Stock to which such Holder is entitled upon such Holder&rsquo;s conversion of any Conversion Amount (as the case may
be) or (II) if an effective Registration Statement covering the resale of the applicable shares of Common Stock that are the subject
of the Conversion Notice (the &ldquo;<B>Unavailable Conversion Shares</B>&rdquo;) is not available for the resale of such Unavailable
Conversion Shares (solely to the extent such Unavailable Conversion Shares were ever available pursuant to such Registration Statement)
and the Company fails to promptly, but in no event later than as required pursuant to the Registration Rights Agreement (x) notify
such Holder and (y) deliver the shares of Common Stock electronically without any restrictive legend by crediting such aggregate
number of shares of Common Stock to which such Holder is entitled pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s
balance account with DTC through its Deposit/Withdrawal At Custodian system (the event described in the immediately foregoing
clause (II) is hereinafter referred as a &ldquo;<B>Notice Failure</B>&rdquo; and together with the event described in clause (I)
above, a &ldquo;<B>Conversion Failure</B>&rdquo;), then, in addition to all other remedies available to such Holder, (X) the Company
shall pay in cash to such Holder on each day after the Share Delivery Deadline that the issuance of such shares of Common Stock
is not timed effected an amount equal to 2% of the product of (A) the sum of the number of shares of Common Stock not issued to
such Holder on or prior to the Share Delivery Deadline and to which such Holder is entitled, multiplied by (B) any trading price
of the Common Stock selected by such Holder in writing as in effect at any time during the period beginning on the applicable
Conversion Date and ending on the applicable Share Delivery Deadline, and (Y) such Holder, upon written notice to the Company,
may void its Conversion Notice with respect to, and retain or have returned, as the case may be, all, or any portion, of such
Preferred Shares that has not been converted pursuant to such Conversion Notice; provided that the voiding of an Conversion Notice
shall not affect the Company&rsquo;s obligations to make any payments which have accrued prior to the date of such notice pursuant
to this Section 4(c)(ii) or otherwise. In addition to the foregoing, if on or prior to the Share Delivery Deadline either (A)
the Transfer Agent is not participating in the DTC Fast Automated Securities Transfer Program or such Warrant Common Shares are
not eligible to be resold pursuant to Rule 144 or an effective registration statement, the Company shall fail to issue and deliver
to such Holder (or its designee) a certificate and register such shares of Common Stock on the Company&rsquo;s share register
or, if the Transfer Agent is participating in the DTC Fast Automated Securities Transfer Program and such Warrant Common Shares
are eligible to be resold pursuant to Rule 144 or an effective registration statement, the Transfer Agent shall fail to credit
the balance account of such Holder or such Holder&rsquo;s designee, as applicable, with DTC for the number of shares of Common
Stock to which such Holder is entitled upon such Holder&rsquo;s conversion hereunder or pursuant to the Company&rsquo;s obligation
pursuant to clause (ii) below or (B) a Notice Failure occurs, and if on or after such Share Delivery Deadline such Holder purchases
(in an open market transaction or otherwise) shares of Common Stock corresponding to all or any portion of the number of shares
of Common Stock issuable upon such conversion that such Holder is entitled to receive from the Company and has not received from
the Company in connection with such Conversion Failure or Notice Failure, as applicable (a &ldquo;<B>Buy-In</B>&rdquo;), then,
in addition to all other remedies available to such Holder, the Company shall, within two (2) Business Days after receipt of such
Holder&rsquo;s request and in such Holder&rsquo;s discretion, either: (I) pay cash to such Holder in an amount equal to such Holder&rsquo;s
total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock
so purchased (including, without limitation, by any other Person in respect, or on behalf, of such Holder) (the &ldquo;<B>Buy-In
Price</B>&rdquo;), at which point the Company&rsquo;s obligation to so issue and deliver such certificate (and to issue such shares
of Common Stock) or credit to the balance account of such Holder or such Holder&rsquo;s designee, as applicable, with DTC for
the number of shares of Common Stock to which such Holder is entitled upon such Holder&rsquo;s conversion hereunder (as the case
may be) (and to issue such shares of Common Stock) shall terminate, or (II) promptly honor its obligation to so issue and deliver
to such Holder a certificate or certificates representing such shares of Common Stock or credit the balance account of such Holder
or such Holder&rsquo;s designee, as applicable, with DTC for the number of shares of Common Stock to which such Holder is entitled
upon such Holder&rsquo;s conversion hereunder (as the case may be) and pay cash to such Holder in an amount equal to the excess
(if any) of the Buy-In Price over the product of (x) such number of shares of Common Stock multiplied by (y) the lowest Closing
Sale Price of the Common Stock on any Trading Day during the period commencing on the date of the applicable Conversion Notice
and ending on the date of such issuance and payment under this clause (II) (the &ldquo;<B>Buy-In Payment Amount</B>&rdquo;). Nothing
herein shall limit the Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity, including,
without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely
deliver certificates representing shares of Common Stock (or to electronically deliver such shares of Common Stock) upon the conversion
of Preferred Shares as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<U>Registration; Book-Entry</U>. At the time of issuance of any Preferred Shares hereunder, the applicable Holder may, by written
request (including by electronic-mail) to the Company, elect to receive such Preferred Shares in the form of one or more Preferred
Share Certificates or in Book-Entry form. The Company (or the Transfer Agent, as custodian for the Preferred Shares) shall maintain
a register (the &ldquo;<B>Register</B>&rdquo;) for the recordation of the names and addresses of the Holders of each Preferred
Share and the Stated Value of the Preferred Shares and whether the Preferred Shares are held by such Holder in Preferred Share
Certificates or in Book-Entry form (the &ldquo;<B>Registered Preferred Shares</B>&rdquo;). The entries in the Register shall be
conclusive and binding for all purposes absent manifest error. The Company and each Holder of the Preferred Shares shall treat
each Person whose name is recorded in the Register as the owner of a Preferred Share for all purposes (including, without limitation,
the right to receive payments and Dividends hereunder) notwithstanding notice to the contrary. A Registered Preferred Share may
be assigned, transferred or sold only by registration of such assignment or sale on the Register. Upon its receipt of a written
request to assign, transfer or sell one or more Registered Preferred Shares by such Holder thereof, the Company shall record the
information contained therein in the Register and issue one or more new Registered Preferred Shares in the same aggregate Stated
Value as the Stated Value of the surrendered Registered Preferred Shares to the designated assignee or transferee pursuant to
Section 18, provided that if the Company does not so record an assignment, transfer or sale (as the case may be) of such Registered
Preferred Shares within two (2) Business Days of such a request, then the Register shall be automatically deemed updated to reflect
such assignment, transfer or sale (as the case may be). Notwithstanding anything to the contrary set forth in this Section 4,
following conversion of any Preferred Shares in accordance with the terms hereof, the applicable Holder shall not be required
to physically surrender such Preferred Shares held in the form of a Preferred Share Certificate to the Company unless (A) the
full or remaining number of Preferred Shares represented by the applicable Preferred Share Certificate are being converted (in
which event such certificate(s) shall be delivered to the Company as contemplated by this Section 4(c)(iii)) or (B) such Holder
has provided the Company with prior written notice (which notice may be included in a Conversion Notice) requesting reissuance
of Preferred Shares upon physical surrender of the applicable Preferred Share Certificate. Each Holder and the Company shall maintain
records showing the Stated Value, Dividends and Late Charges converted and/or paid (as the case may be) and the dates of such
conversions and/or payments (as the case may be) or shall use such other method, reasonably satisfactory to such Holder and the
Company, so as not to require physical surrender of a Preferred Share Certificate upon conversion. If the Company does not update
the Register to record such Stated Value, Dividends and Late Charges converted and/or paid (as the case may be) and the dates
of such conversions and/or payments (as the case may be) within two (2) Business Days of such occurrence, then the Register shall
be automatically deemed updated to reflect such occurrence. In the event of any dispute or discrepancy, such records of such Holder
establishing the number of Preferred Shares to which the record holder is entitled shall be controlling and determinative in the
absence of manifest error. A Holder and any transferee or assignee, by acceptance of a certificate, acknowledge and agree that,
by reason of the provisions of this paragraph, following conversion of any Preferred Shares, the number of Preferred Shares represented
by such certificate may be less than the number of Preferred Shares stated on the face thereof. Each Preferred Share Certificate
shall bear the following legend:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in 0pt 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANY
TRANSFEREE OR ASSIGNEE OF THIS CERTIFICATE SHOULD CAREFULLY REVIEW THE TERMS OF THE CORPORATION&rsquo;S CERTIFICATE OF DESIGNATIONS
RELATING TO THE SHARES OF SERIES D PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE, INCLUDING SECTION 4(c)(iii) THEREOF. THE NUMBER
OF SHARES OF SERIES D PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE MAY BE LESS THAN THE NUMBER OF SHARES OF SERIES D PREFERRED
STOCK STATED ON THE FACE HEREOF PURSUANT TO SECTION 4(c)(iii) OF THE CERTIFICATE OF DESIGNATIONS RELATING TO THE SHARES OF SERIES
D PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<U>Pro Rata Conversion; Disputes</U>. In the event that the Company receives a Conversion Notice from more than one Holder for
the same Conversion Date and the Company can convert some, but not all, of such Preferred Shares submitted for conversion, the
Company shall convert from each Holder electing to have Preferred Shares converted on such date a pro rata amount of such Holder&rsquo;s
Preferred Shares submitted for conversion on such date based on the number of Preferred Shares submitted for conversion on such
date by such Holder relative to the aggregate number of Preferred Shares submitted for conversion on such date. In the event of
a dispute as to the number of shares of Common Stock issuable to a Holder in connection with a conversion of Preferred Shares,
the Company shall issue to such Holder the number of shares of Common Stock not in dispute and resolve such dispute in accordance
with Section 23.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Limitation on Beneficial Ownership</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Beneficial Ownership</U>. The Company shall not effect the conversion of any of the Preferred Shares held by a Holder, and
such Holder shall not have the right to convert any of the Preferred Shares held by such Holder pursuant to the terms and conditions
of this Certificate of Designations and any such conversion shall be null and void and treated as if never made, to the extent
that after giving effect to such conversion, such Holder together with the other Attribution Parties collectively would beneficially
own in excess of 4.99% (the &ldquo;<B>Maximum Percentage</B>&rdquo;) of the shares of Common Stock outstanding immediately after
giving effect to such conversion. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially
owned by such Holder and the other Attribution Parties shall include the number of shares of Common Stock held by such Holder
and all other Attribution Parties plus the number of shares of Common Stock issuable upon conversion of the Preferred Shares with
respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock which would be issuable
upon (A) conversion of the remaining, nonconverted Preferred Shares beneficially owned by such Holder or any of the other Attribution
Parties and (B) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including,
without limitation, any convertible notes, convertible preferred stock or warrants, including the Preferred Shares, the Preferred
Warrants and the Common Warrants) beneficially owned by such Holder or any other Attribution Party subject to a limitation on
conversion or exercise analogous to the limitation contained in this Section 4(d)(i). For purposes of this Section 4(d)(i), beneficial
ownership shall be calculated in accordance with Section 13(d) of the 1934 Act. For purposes of determining the number of outstanding
shares of Common Stock a Holder may acquire upon the conversion of such Preferred Shares without exceeding the Maximum Percentage,
such Holder may rely on the number of outstanding shares of Common Stock as reflected in (x) the Company&rsquo;s most recent Annual
Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the SEC, as the case
may be, (y) a more recent public announcement by the Company or (z) any other written notice by the Company or the Transfer Agent,
if any, setting forth the number of shares of Common Stock outstanding (the &ldquo;<B>Reported Outstanding Share Number</B>&rdquo;).
If the Company receives a Conversion Notice from a Holder at a time when the actual number of outstanding shares of Common Stock
is less than the Reported Outstanding Share Number, the Company shall notify such Holder in writing of the number of shares of
Common Stock then outstanding and, to the extent that such Conversion Notice would otherwise cause such Holder&rsquo;s beneficial
ownership, as determined pursuant to this Section 4(d)(i), to exceed the Maximum Percentage, such Holder must notify the Company
of a reduced number of shares of Common Stock to be purchased pursuant to such Conversion Notice. For any reason at any time,
upon the written or oral request of any Holder, the Company shall within one (1) Business Day confirm orally and in writing or
by electronic mail to such Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including
such Preferred Shares, by such Holder and any other Attribution Party since the date as of which the Reported Outstanding Share
Number was reported. In the event that the issuance of shares of Common Stock to a Holder upon conversion of such Preferred Shares
results in such Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum
Percentage of the number of outstanding shares of Common Stock (as determined under Section 13(d) of the 1934 Act), the number
of shares so issued by which such Holder&rsquo;s and the other Attribution Parties&rsquo; aggregate beneficial ownership exceeds
the Maximum Percentage (the &ldquo;<B>Excess Shares</B>&rdquo;) shall be deemed null and void and shall be cancelled ab initio,
and such Holder shall not have the power to vote or to transfer the Excess Shares. Upon delivery of a written notice to the Company,
any Holder may from time to time increase (with such increase not effective until the sixty-first (61<SUP>st</SUP>) day after
delivery of such notice) or decrease the Maximum Percentage of such Holder to any other percentage not in excess of 9.99% as specified
in such notice; provided that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61<SUP>st</SUP>)
day after such notice is delivered to the Company and (ii) any such increase or decrease will apply only to such Holder and the
other Attribution Parties and not to any other Holder that is not an Attribution Party of such Holder. For purposes of clarity,
the shares of Common Stock issuable to a Holder pursuant to the terms of this Certificate of Designations in excess of the Maximum
Percentage shall not be deemed to be beneficially owned by such Holder for any purpose including for purposes of Section 13(d)
or Rule 16a-1(a)(1) of the 1934 Act. No prior inability to convert such Preferred Shares pursuant to this paragraph shall have
any effect on the applicability of the provisions of this paragraph with respect to any subsequent determination of convertibility.
The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms
of this Section 4(d)(i) to the extent necessary to correct this paragraph (or any portion of this paragraph) which may be defective
or inconsistent with the intended beneficial ownership limitation contained in this Section 4(d)(i) or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The limitation contained in this paragraph may not be waived
and shall apply to a successor holder of such Preferred Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Principal Market Regulation</U>. The Company shall not issue any shares of Common Stock upon conversion of any Preferred Shares
or otherwise pursuant to the terms of this Certificate of Designations if the issuance of such shares of Common Stock would exceed
the aggregate number of shares of Common Stock which the Company may issue upon conversion of the Preferred Shares without breaching
the Company&rsquo;s obligations under the rules and regulations the listing rules of the Principal Market (the number of shares
which may be issued without violating such rules and regulations, including rules related to the aggregate offerings under NASDAQ
Listing Rule 5635(d), the &ldquo;<B>Exchange Cap</B>&rdquo;), except that such limitation shall not apply in the event that the
Company (A) obtains the approval of its shareholders as required by the applicable rules and regulations of the Principal Market
for issuances of shares of Common Stock in excess of such amount or (B) obtains a written opinion from outside counsel to the
Company that such approval is not required, which opinion shall be reasonably satisfactory to the Required Holders. Until such
approval or such written opinion is obtained, no Holder shall be issued in the aggregate, upon conversion of any Preferred Shares
in an amount greater than the product of (i) the Exchange Cap as of the Initial Issuance Date multiplied by (ii) the quotient
of (1) the aggregate number of Preferred Shares issued to such Holder on the Initial Issuance Date divided by (2) the aggregate
number of Preferred Shares issued to the Holders on the Initial Issuance Date (with respect to each Holder, the &ldquo;<B>Exchange
Cap Allocation</B>&rdquo;). In the event that any Holder shall sell or otherwise transfer any of such Holder&rsquo;s Preferred
Shares, the transferee shall be allocated a pro rata portion of such Holder&rsquo;s Exchange Cap Allocation with respect to such
portion of such Preferred Shares so transferred, and the restrictions of the prior sentence shall apply to such transferee with
respect to the portion of the Exchange Cap Allocation so allocated to such transferee. Upon conversion in full of a holder&rsquo;s
Preferred Shares, the difference (if any) between such holder&rsquo;s Exchange Cap Allocation and the number of shares of Common
Stock actually issued to such holder upon such holder&rsquo;s conversion in full of such Preferred Shares shall be allocated,
to the respective Exchange Cap Allocations of the remaining holders of Preferred Shares on a pro rata basis in proportion to the
shares of Common Stock underlying the Preferred Shares then held by each such holder of Preferred Shares. In the event that after
the Shareholder Meeting Deadline (as defined in the Securities Purchase Agreement) the Company is prohibited from issuing any
shares of Common Stock pursuant to this Section 4(d)(ii)(the &ldquo;<B>Exchange Cap Shares</B>&rdquo;) to a Holder, the Company
shall pay cash to such Holder in exchange for the redemption of such number of Preferred Shares held by such Holder that are not
convertible into such Exchange Cap Shares at a price equal to the sum of (i) the product of (x) such number of Exchange Cap Shares
and (y) the greatest Closing Sale Price of the Common Stock on any Trading Day during the period commencing on the date such Holder
delivers the applicable Conversion Notice with respect to such Exchange Cap Shares to the Company and ending on the date of such
issuance and payment under this Section 4(d)(ii) and (ii) to the extent of any Buy-In related thereto, any Buy-In Payment Amount,
any brokerage commissions and other out-of-pocket expenses, if any, of such Holder incurred in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Right of Alternate Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>General</U>. Subject to Section 4(d), at any time, such Holder may, at such Holder&rsquo;s option, by delivery of a Conversion
Notice to the Company (the date of any such Conversion Notice, each an &ldquo;<B>Alternate Conversion Date</B>&rdquo;), convert
all, or any number of Preferred Shares (such Conversion Amount of the Preferred Shares to be converted pursuant to this Section
4(e)(ii), each, an &ldquo;<B>Alternate Conversion Amount</B>&rdquo;) into shares of Common Stock at the Alternate Conversion Price
(each an &ldquo;<B>Alternate Conversion</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Mechanics of Alternate Conversion</U>. On any Alternate Conversion Date, a Holder may voluntarily convert any Alternate Conversion
Amount of Preferred Shares pursuant to Section 4(c) (with &ldquo;Alternate Conversion Price&rdquo; replacing &ldquo;Conversion
Price&rdquo; for all purposes hereunder with respect to such Alternate Conversion and, if such Conversion Notice is delivered
during a Triggering Event Redemption Right Period (as defined below), with &ldquo;Redemption Premium of the Conversion Amount&rdquo;
replacing &ldquo;Conversion Amount&rdquo; in clause (x) of the definition of Conversion Rate above with respect to such Alternate
Conversion) by designating in the Conversion Notice delivered pursuant to this Section 4(e) of this Certificate of Designations
that such Holder is electing to use the Alternate Conversion Price for such conversion; provided that in the event of the Conversion
Floor Price Condition, on the applicable Alternate Conversion Date the Company shall also deliver to the Holder the applicable
Alternate Conversion Floor Amount. Notwithstanding anything to the contrary in this Section 4(e), but subject to Section 4(d),
until the Company delivers shares of Common Stock representing the applicable Alternate Conversion Amount of Preferred Shares
to such Holder, such Preferred Shares may be converted by such Holder into shares of Common Stock pursuant to Section 4(c) without
regard to this Section 4(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Triggering Event Redemptions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Triggering Event</U>. Each of the following events shall constitute a &ldquo;<B>Triggering Event</B>&rdquo; and each of the
events in clauses (x), (xi) and (xii) shall constitute a &ldquo;<B>Bankruptcy Triggering Event</B>&rdquo;:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the failure of the applicable Registration Statement (as defined in the Registration Rights Agreement) to be filed with the SEC
on or prior to the date that is five (5) days after the applicable Filing Deadline (as defined in the Registration Rights Agreement)
or the failure of the applicable Registration Statement to be declared effective by the SEC on or prior to the date that is five
(5) days after the applicable Effectiveness Deadline (as defined in the Registration Rights Agreement);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
while the applicable Registration Statement is required to be maintained effective pursuant to the terms of the Registration Rights
Agreement, the effectiveness of the applicable Registration Statement lapses for any reason (including, without limitation, the
issuance of a stop order) or such Registration Statement (or the prospectus contained therein) is unavailable to any holder of
Registrable Securities (as defined in the Registration Rights Agreement) for sale of all of such holder&rsquo;s Registrable Securities
in accordance with the terms of the Registration Rights Agreement, and such lapse or unavailability continues for a period of
five (5) consecutive days or for more than an aggregate of ten (10) days in any 365-day period (excluding days during an Allowable
Grace Period (as defined in the Registration Rights Agreement));</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the suspension from trading or the failure of the Common Stock to be trading or listed (as applicable) on an Eligible Market for
a period of five (5) consecutive Trading Days;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the Company&rsquo;s (A) failure to cure a Conversion Failure (as defined herein) or a Delivery Failure (as defined in the Common
Warrants) by delivery of the required number of shares of Common Stock within five (5) Trading Days after the applicable Conversion
Date or exercise date (as the case may be) or (B) notice, written or oral, to any holder of Preferred Shares, Preferred Warrants
or Common Warrants, including, without limitation, by way of public announcement or through any of its agents, at any time, of
its intention not to comply, as required, with a request for exercise of any Common Warrants for Warrant Common Shares in accordance
with the provisions of the Common Warrants or a request for conversion of any Preferred Shares into shares of Common Stock that
is requested in accordance with the provisions of this Certificate of Designations, other than pursuant to Section 4(d) hereof
or a request for conversion of any Preferred Warrants into Preferred Shares that is requested in accordance with the provisions
of this Certificate of Designations;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
except to the extent the Company is in compliance with Section 10(b) below, at any time after the earlier to occur of (x) the
Share Increase Shareholder Approval Date and (y) the Shareholder Meeting Deadline, and following the tenth (10<SUP>th</SUP>) consecutive
day that a Holder&rsquo;s Authorized Share Allocation (as defined in Section 10(a) below) is less than the sum of (A) 200% of
the number of shares of Common Stock that such Holder would be entitled to receive upon a conversion, in full, of all of the Preferred
Shares then held by such Holder at the Alternate Conversion Price then in effect (without regard to any limitations on conversion
set forth in this Certificate of Designations) (B) 100% of the number of Preferred Shares that such Holder would be entitled to
receive upon exercise, in full, of all of such Holder&rsquo;s Preferred Warrants and (C) 150% of the number of shares of Common
Stock that such Holder would then be entitled to receive upon exercise in full of all of such Holder&rsquo;s Common Warrants (without
regard to any limitations on exercise set forth in the Common Warrants);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
the Company&rsquo;s failure to capitalize any Dividend on any Dividend Date (whether or not declared by the Board);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
the Company&rsquo;s failure to pay any amount when and as due under this Certificate of Designations (including, without limitation,
the Company&rsquo;s failure to pay any redemption payments or amounts hereunder), the Securities Purchase Agreement or any other
Transaction Document or any other agreement, document, certificate or other instrument delivered in connection with the transactions
contemplated hereby and thereby (in each case, whether or not permitted pursuant to the NRS), solely to the extent such failure
remains uncured for a period of at least five (5) Trading Days;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
the Company fails to remove any restrictive legend on any certificate or any shares of Common Stock issued to the applicable Holder
upon conversion or exercise (as the case may be) of any Securities (as defined in the Securities Purchase Agreement) acquired
by such Holder under the Securities Purchase Agreement as and when required by such Securities or the Securities Purchase Agreement,
unless otherwise then prohibited by applicable federal securities laws, and any such failure remains uncured for at least five
(5) days;;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
the occurrence of any default under, redemption of or acceleration prior to maturity of at least an aggregate of $$125,000 of
Indebtedness (as defined in the Securities Purchase Agreement) of the Company or any of its Subsidiaries;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings for the relief of debtors shall be instituted
by or against the Company or any Subsidiary and, if instituted against the Company or any Subsidiary by a third party, shall not
be dismissed within thirty (30) days of their initiation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)
the commencement by the Company or any Subsidiary of a voluntary case or proceeding under any applicable federal, state or foreign
bankruptcy, insolvency, reorganization or other similar law or of any other case or proceeding to be adjudicated a bankrupt or
insolvent, or the consent by it to the entry of a decree, order, judgment or other similar document in respect of the Company
or any Subsidiary in an involuntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency,
reorganization or other similar law or to the commencement of any bankruptcy or insolvency case or proceeding against it, or the
filing by it of a petition or answer or consent seeking reorganization or relief under any applicable federal, state or foreign
law, or the consent by it to the filing of such petition or to the appointment of or taking possession by a custodian, receiver,
liquidator, assignee, trustee, sequestrator or other similar official of the Company or any Subsidiary or of any substantial part
of its property, or the making by it of an assignment for the benefit of creditors, or the execution of a composition of debts,
or the occurrence of any other similar federal, state or foreign proceeding, or the admission by it in writing of its inability
to pay its debts generally as they become due, the taking of corporate action by the Company or any Subsidiary in furtherance
of any such action or the taking of any action by any Person to commence a Uniform Commercial Code foreclosure sale or any other
similar action under federal, state or foreign law;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)
the entry by a court of (i) a decree, order, judgment or other similar document in respect of the Company or any Subsidiary of
a voluntary or involuntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization
or other similar law or (ii) a decree, order, judgment or other similar document adjudging the Company or any Subsidiary as bankrupt
or insolvent, or approving as properly filed a petition seeking liquidation, reorganization, arrangement, adjustment or composition
of or in respect of the Company or any Subsidiary under any applicable federal, state or foreign law or (iii) a decree, order,
judgment or other similar document appointing a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar
official of the Company or any Subsidiary or of any substantial part of its property, or ordering the winding up or liquidation
of its affairs, and the continuance of any such decree, order, judgment or other similar document or any such other decree, order,
judgment or other similar document unstayed and in effect for a period of thirty (30) consecutive days;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)
a final judgment or judgments for the payment of money aggregating in excess of $$125,000 are rendered against the Company and/or
any of its Subsidiaries and which judgments are not, within thirty (30) days after the entry thereof, bonded, discharged, settled
or stayed pending appeal, or are not discharged within thirty (30) days after the expiration of such stay; provided, however,
any judgment which is covered by insurance or an indemnity from a credit worthy party shall not be included in calculating the
$$125,000 amount set forth above so long as the Company provides each Holder a written statement from such insurer or indemnity
provider (which written statement shall be reasonably satisfactory to each Holder) to the effect that such judgment is covered
by insurance or an indemnity and the Company or such Subsidiary (as the case may be) will receive the proceeds of such insurance
or indemnity within thirty (30) days of the issuance of such judgment;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)
the Company and/or any Subsidiary, individually or in the aggregate, either (i) fails to pay, when due, or within any applicable
grace period, any payment with respect to any Indebtedness in excess of $$125,000 due to any third party (other than, with respect
to unsecured Indebtedness only, payments contested by the Company and/or such Subsidiary (as the case may be) in good faith by
proper proceedings and with respect to which adequate reserves have been set aside for the payment thereof in accordance with
GAAP) or is otherwise in breach or violation of any agreement for monies owed or owing in an amount in excess of $$125,000, which
breach or violation permits the other party thereto to declare a default or otherwise accelerate amounts due thereunder, or (ii)
suffer to exist any other circumstance or event that would, with or without the passage of time or the giving of notice, result
in a default or event of default under any agreement binding the Company or any Subsidiary, which default or event of default
would or is likely to have a material adverse effect on the business, assets, operations (including results thereof), liabilities,
properties, condition (including financial condition) or prospects of the Company or any of its Subsidiaries, individually or
in the aggregate;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xv)
other than as specifically set forth in another clause of this Section 5(a), the Company or any Subsidiary breaches any representation
or warranty in any material respect (other than the representations or warranties subject to material adverse effect on materiality
limitation, which may not be breached in any respect) or any covenant or other term or condition of any Transaction Document,
except, in the case of a breach of a covenant or other term or condition that is curable, only if such breach remains uncured
for a period of five (5) consecutive Trading Days;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvi)
a false or inaccurate certification (including a false or inaccurate deemed certification) by the Company as to whether any Triggering
Event has occurred;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvii)
if neither John Rice or Mark Ruport is the chief executive officer of the Company and a qualified replacement, acceptable to the
Holder, in its sole discretion, is not appointed in either case within fifteen (15) Business Days;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xviii)
any breach or failure in any respect by the Company or any Subsidiary to comply with any provision of Section 13(m) of this Certificate
of Designations;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xix)
any Material Adverse Effect (as defined in the Securities Purchase Agreement) occurs; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xx)
any provision of any Transaction Document shall at any time for any reason (other than pursuant to the express terms thereof)
cease to be valid and binding on or enforceable against the parties thereto, or the validity or enforceability thereof shall be
contested, directly or indirectly, by the Company or any Subsidiary, or a proceeding shall be commenced by the Company or any
Subsidiary or any governmental authority having jurisdiction over any of them, seeking to establish the invalidity or unenforceability
thereof or the Company or any of its Subsidiaries shall deny in writing that it has any liability or obligation purported to be
created under one or more Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Notice of a Triggering Event; Redemption Right</U>. Upon the occurrence of a Triggering Event with respect to the Preferred
Shares, the Company shall within one (1) Business Day deliver written notice thereof via facsimile or electronic mail and overnight
courier (with next day delivery specified) (an &ldquo;<B>Triggering Event Notice</B>&rdquo;) to each Holder. At any time after
the earlier of a Holder&rsquo;s receipt of a Triggering Event Notice and such Holder becoming aware of a Triggering Event (such
earlier date, the &ldquo;<B>Triggering Event Right Commencement Date</B>&rdquo;) and ending (such ending date, the &ldquo;<B>Triggering
Event Right Expiration Date</B>&rdquo;, and each such period, an &ldquo;<B>Triggering Event Redemption Right Period</B>&rdquo;)
on the sixtieth (60<SUP>th</SUP>) Trading Day after the later of (x) the date such Triggering Event is cured and (y) such Holder&rsquo;s
receipt of a Triggering Event Notice that includes (I) a reasonable description of the applicable Triggering Event, (II) a certification
as to whether, in the opinion of the Company, such Triggering Event is capable of being cured and, if applicable, a reasonable
description of any existing plans of the Company to cure such Triggering Event and (III) a certification as to the date the Triggering
Event occurred and, if cured on or prior to the date of such Triggering Event Notice, the applicable Triggering Event Right Expiration
Date, such Holder may require the Company to redeem (regardless of whether such Triggering Event has been cured on or prior to
the Triggering Event Right Expiration Date) all or any of the Preferred Shares by delivering written notice thereof (the &ldquo;<B>Triggering
Event Redemption Notice</B>&rdquo;) to the Company, which Triggering Event Redemption Notice shall indicate the number of the
Preferred Shares such Holder is electing to redeem. Each of the Preferred Shares subject to redemption by the Company pursuant
to this Section 5(b) shall be redeemed by the Company at a price equal to the greater of (i) the product of (A) the Conversion
Amount to be redeemed multiplied by (B) the Redemption Premium and (ii) the product of (X) the Conversion Rate (with &ldquo;Alternate
Conversion Price&rdquo; replacing &ldquo;Conversion Price&rdquo; for all purposes hereunder with respect thereto and with &ldquo;Redemption
Premium of the Conversion Amount&rdquo; replacing &ldquo;Conversion Amount&rdquo; in clause (x) of the definition of Conversion
Rate above with respect thereto) with respect to the Conversion Amount in effect at such time as such Holder delivers a Triggering
Event Redemption Notice multiplied by (Y) the product of (1) the Redemption Premium multiplied by (2) the greatest Closing Sale
Price of the Common Stock on any Trading Day during the period commencing on the date immediately preceding such Triggering Event
and ending on the date the Company makes the entire payment required to be made under this Section 5(b) (the &ldquo;<B>Triggering
Event Redemption Price</B>&rdquo;). Redemptions required by this Section 5(b) shall be made in accordance with the provisions
of Section 11. To the extent redemptions required by this Section 5(b) are deemed or determined by a court of competent jurisdiction
to be prepayments of the Preferred Shares by the Company, such redemptions shall be deemed to be voluntary prepayments. Notwithstanding
anything to the contrary in this Section 5(b), but subject to Section 4(d), until the Triggering Event Redemption Price (together
with any Late Charges thereon) is paid in full, the Conversion Amount submitted for redemption under this Section 5(b) (together
with any Late Charges thereon) may be converted, in whole or in part, by such Holder into Common Stock pursuant to the terms of
this Certificate of Designations. In the event of the Company&rsquo;s redemption of any of the Preferred Shares under this Section
5(b), a Holder&rsquo;s damages would be uncertain and difficult to estimate because of the parties&rsquo; inability to predict
future interest rates and the uncertainty of the availability of a suitable substitute investment opportunity for such Holder.
Accordingly, any redemption premium due under this Section 5(b) is intended by the parties to be, and shall be deemed, a reasonable
estimate of such Holder&rsquo;s actual loss of its investment opportunity and not as a penalty. Any redemption upon a Triggering
Event shall not constitute an election of remedies by the applicable Holder or any other Holder, and all other rights and remedies
of each Holder shall be preserved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Mandatory Redemption upon Bankruptcy Triggering Event</U>. Notwithstanding anything to the contrary herein, and notwithstanding
any conversion that is then required or in process, upon any Bankruptcy Triggering Event, the Company shall immediately redeem,
in cash, each of the Preferred Shares then outstanding at a redemption price equal to the applicable Triggering Event Redemption
Price (calculated as if such Holder shall have delivered the Triggering Event Redemption Notice immediately prior to the occurrence
of such Bankruptcy Triggering Event), without the requirement for any notice or demand or other action by any Holder or any other
person or entity, provided that a Holder may, in its sole discretion, waive such right to receive payment upon a Bankruptcy Triggering
Event, in whole or in part, and any such waiver shall not affect any other rights of such Holder or any other Holder hereunder,
including any other rights in respect of such Bankruptcy Triggering Event, any right to conversion, and any right to payment of
such Triggering Event Redemption Price or any other Redemption Price, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Rights Upon Fundamental Transactions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Assumption</U>. The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity assumes
in writing all of the obligations of the Company under this Certificate of Designations and the other Transaction Documents in
accordance with the provisions of this Section 6(a) pursuant to written agreements in form and substance satisfactory to the Required
Holders and approved by the Required Holders prior to such Fundamental Transaction, including agreements to deliver to each holder
of Preferred Shares in exchange for such Preferred Shares a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Certificate of Designations, including, without limitation, having a stated
value and dividend rate equal to the stated value and dividend rate of the Preferred Shares held by the Holders and having similar
ranking to the Preferred Shares, and satisfactory to the Required Holders and (ii) the Successor Entity (including its Parent
Entity) is a publicly traded corporation whose shares of common stock are quoted on or listed for trading on an Eligible Market.
Upon the occurrence of any Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from
and after the date of such Fundamental Transaction, the provisions of this Certificate of Designations and the other Transaction
Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and
power of the Company and shall assume all of the obligations of the Company under this Certificate of Designations and the other
Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein and therein. In addition
to the foregoing, upon consummation of a Fundamental Transaction, the Successor Entity shall deliver to each Holder confirmation
that there shall be issued upon conversion or redemption of the Preferred Shares at any time after the consummation of such Fundamental
Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets or other property (except such items still
issuable under Sections 7 and 15, which shall continue to be receivable thereafter)) issuable upon the conversion or redemption
of the Preferred Shares prior to such Fundamental Transaction, such shares of the publicly traded common stock (or their equivalent)
of the Successor Entity (including its Parent Entity) which each Holder would have been entitled to receive upon the happening
of such Fundamental Transaction had all the Preferred Shares held by each Holder been converted immediately prior to such Fundamental
Transaction (without regard to any limitations on the conversion of the Preferred Shares contained in this Certificate of Designations),
as adjusted in accordance with the provisions of this Certificate of Designations. Notwithstanding the foregoing, such Holder
may elect, at its sole option, by delivery of written notice to the Company to waive this Section 6(a) to permit the Fundamental
Transaction without the assumption of the Preferred Shares. The provisions of this Section 6 shall apply similarly and equally
to successive Fundamental Transactions and shall be applied without regard to any limitations on the conversion or redemption
of the Preferred Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Notice of a Change of Control Redemption Right</U>. No sooner than twenty (20) Trading Days nor later than ten (10) Trading
Days prior to the consummation of a Change of Control (the &ldquo;<B>Change of Control Date</B>&rdquo;), but not prior to the
public announcement of such Change of Control, the Company shall deliver written notice thereof via facsimile or electronic mail
and overnight courier to each Holder (a &ldquo;<B>Change of Control Notice</B>&rdquo;). At any time during the period beginning
after a Holder&rsquo;s receipt of a Change of Control Notice or such Holder becoming aware of a Change of Control if a Change
of Control Notice is not delivered to such Holder in accordance with the immediately preceding sentence (as applicable) and ending
on twenty (20) Trading Days after the later of (A) the date of consummation of such Change of Control or (B) the date of receipt
of such Change of Control Notice or (C) the date of the announcement of such Change of Control, such Holder may require the Company
to redeem all or any portion of such Holder&rsquo;s Preferred Shares by delivering written notice thereof (&ldquo;<B>Change of
Control Redemption Notice</B>&rdquo;) to the Company, which Change of Control Redemption Notice shall indicate the number of Preferred
Shares such Holder is electing to have the Company redeem. Each Preferred Share subject to redemption pursuant to this Section
6(b) shall be redeemed by the Company in cash at a price equal to the greatest of (i) the product of (w) the Change of Control
Redemption Premium multiplied by (y) the Conversion Amount of the Preferred Shares being redeemed, (ii) the product of (x) the
Change of Control Redemption Premium multiplied by (y) the product of (A) the Conversion Amount of the Preferred Shares being
redeemed multiplied by (B) the quotient determined by dividing (I) the greatest Closing Sale Price of the shares of Common Stock
during the period beginning on the date immediately preceding the earlier to occur of (1) the consummation of the applicable Change
of Control and (2) the public announcement of such Change of Control and ending on the date such Holder delivers the Change of
Control Redemption Notice by (II) the Conversion Price then in effect and (iii) the product of (y) the Change of Control Redemption
Premium multiplied by (z) the product of (A) the Conversion Amount of the Preferred Shares being redeemed multiplied by (B) the
quotient of (I) the aggregate cash consideration and the aggregate cash value of any non-cash consideration per share of Common
Stock to be paid to such holders of the shares of Common Stock upon consummation of such Change of Control (any such non-cash
consideration constituting publicly-traded securities shall be valued at the highest of the Closing Sale Price of such securities
as of the Trading Day immediately prior to the consummation of such Change of Control, the Closing Sale Price of such securities
on the Trading Day immediately following the public announcement of such proposed Change of Control and the Closing Sale Price
of such securities on the Trading Day immediately prior to the public announcement of such proposed Change of Control) divided
by (II) the Conversion Price then in effect (the &ldquo;<B>Change of Control Redemption Price</B>&rdquo;). Redemptions required
by this Section 6(b) shall have priority to payments to all other shareholders of the Company in connection with such Change of
Control. To the extent redemptions required by this Section 6(b) are deemed or determined by a court of competent jurisdiction
to be prepayments of the Preferred Shares by the Company, such redemptions shall be deemed to be voluntary prepayments. Notwithstanding
anything to the contrary in this Section 6(b), but subject to Section 4(d), until the applicable Change of Control Redemption
Price (together with any Late Charges thereon) is paid in full to the applicable Holder, the Preferred Shares submitted by such
Holder for redemption under this Section 6(b) may be converted, in whole or in part, by such Holder into Common Stock pursuant
to Section 4(c) or in the event the Conversion Date is after the consummation of such Change of Control, stock or equity interests
of the Successor Entity substantially equivalent to the Company&rsquo;s shares of Common Stock pursuant to Section 4(c). In the
event of the Company&rsquo;s redemption of any of the Preferred Shares under this Section 6(b), such Holder&rsquo;s damages would
be uncertain and difficult to estimate because of the parties&rsquo; inability to predict future interest rates and the uncertainty
of the availability of a suitable substitute investment opportunity for a Holder. Accordingly, any redemption premium due under
this Section 6(b) is intended by the parties to be, and shall be deemed, a reasonable estimate of such Holder&rsquo;s actual loss
of its investment opportunity and not as a penalty. The Company shall make payment of the applicable Change of Control Redemption
Price concurrently with the consummation of such Change of Control if a Change of Control Redemption Notice is received prior
to the consummation of such Change of Control and within two (2) Trading Days after the Company&rsquo;s receipt of such notice
otherwise (the &ldquo;<B>Change of Control Redemption Date</B>&rdquo;). Redemptions required by this Section 6 shall be made in
accordance with the provisions of Section 11.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Rights Upon Issuance of Purchase Rights and Other Corporate Events</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Purchase Rights</U>. In addition to any adjustments pursuant to Section 8 and Section 15 below, if at any time the Company
grants, issues or sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property
pro rata to all or substantially all of the record holders of any class of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;),
then each Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights
which such Holder could have acquired if such Holder had held the number of shares of Common Stock acquirable upon complete conversion
of all the Preferred Shares (without taking into account any limitations or restrictions on the convertibility of the Preferred
Shares and assuming for such purpose that all the Preferred Shares were converted at the Alternate Conversion Price as of the
applicable record date) held by such Holder immediately prior to the date on which a record is taken for the grant, issuance or
sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock
are to be determined for the grant, issue or sale of such Purchase Rights, provided, however, to the extent that such Holder&rsquo;s
right to participate in any such Purchase Right would result in such Holder and the other Attribution Parties exceeding the Maximum
Percentage, then such Holder shall not be entitled to participate in such Purchase Right to such extent of the Maximum Percentage
(and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Purchase Right (and beneficial
ownership) to such extent of any such excess) and such Purchase Right to such extent shall be held in abeyance (and, if such Purchase
Right has an expiration date, maturity date or other similar provision, such term shall be extended by such number of days held
in abeyance, if applicable) for the benefit of such Holder until such time or times, if ever, as its right thereto would not result
in such Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or times such Holder shall be
granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or on any subsequent Purchase
Right held similarly in abeyance (and, if such Purchase Right has an expiration date, maturity date or other similar provision,
such term shall be extended by such number of days held in abeyance, if applicable)) to the same extent as if there had been no
such limitation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Other Corporate Events</U>. In addition to and not in substitution for any other rights hereunder, prior to the consummation
of any Fundamental Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities or other
assets with respect to or in exchange for shares of Common Stock (a &ldquo;<B>Corporate Event</B>&rdquo;), the Company shall make
appropriate provision to ensure that each Holder will thereafter have the right, at such Holder&rsquo;s option, to receive upon
a conversion of all the Preferred Shares held by such Holder (i) in addition to the shares of Common Stock receivable upon such
conversion, such securities or other assets to which such Holder would have been entitled with respect to such shares of Common
Stock had such shares of Common Stock been held by such Holder upon the consummation of such Corporate Event (without taking into
account any limitations or restrictions on the convertibility of the Preferred Shares set forth in this Certificate of Designations)
or (ii) in lieu of the shares of Common Stock otherwise receivable upon such conversion, such securities or other assets received
by the holders of shares of Common Stock in connection with the consummation of such Corporate Event in such amounts as such Holder
would have been entitled to receive had the Preferred Shares held by such Holder initially been issued with conversion rights
for the form of such consideration (as opposed to shares of Common Stock) at a conversion rate for such consideration commensurate
with the Conversion Rate. Provision made pursuant the preceding sentence shall be in a form and substance satisfactory to the
Required Holders. The provisions of this Section 7 shall apply similarly and equally to successive Corporate Events and shall
be applied without regard to any limitations on the conversion or redemption of the Preferred Shares set forth in this Certificate
of Designations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Rights Upon Issuance of Other Securities</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Adjustment of Conversion Price upon Issuance of Common Stock</U>. If and whenever on or after the Subscription Date the Company
grants, issues or sells (or enter into any agreement to grant, issue or sell), or in accordance with this Section 8(a) is deemed
to have issued or sold, any shares of Common Stock (including the issuance or sale of shares of Common Stock owned or held by
or for the account of the Company, but excluding any Excluded Securities issued or sold or deemed to have been issued or sold)
for a consideration per share (the &ldquo;<B>New Issuance Price</B>&rdquo;) less than a price equal to the Conversion Price in
effect immediately prior to such issuance or sale or deemed issuance or sale (such Conversion Price then in effect is referred
to herein as the &ldquo;<B>Applicable Price</B>&rdquo;) (the foregoing a &ldquo;<B>Dilutive Issuance</B>&rdquo;), then, immediately
after such Dilutive Issuance, the Conversion Price then in effect shall be reduced to an amount equal to the New Issuance Price.
For all purposes of the foregoing (including, without limitation, determining the adjusted Conversion Price and the New Issuance
Price under this Section 8(a)), the following shall be applicable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Issuance of Options</U>. If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue
or sell) any Options and the lowest price per share for which one share of Common Stock is at any time issuable upon the exercise
of any such Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option
or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed
to be outstanding and to have been issued and sold by the Company at the time of the granting or sale of such Option for such
price per share. For purposes of this Section 8(a)(i), the &ldquo;lowest price per share for which one share of Common Stock is
at any time issuable upon the exercise of any such Option or upon conversion, exercise or exchange of any Convertible Securities
issuable upon exercise of any such Option or otherwise pursuant to the terms thereof&rdquo; shall be equal to (1) the lower of
(x) the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any one share
of Common Stock upon the granting, issuance or sale of such Option, upon exercise of such Option and upon conversion, exercise
or exchange of any Convertible Security issuable upon exercise of such Option or otherwise pursuant to the terms thereof and (y)
the lowest exercise price set forth in such Option for which one share of Common Stock is issuable (or may become issuable assuming
all possible market conditions) upon the exercise of any such Options or upon conversion, exercise or exchange of any Convertible
Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof minus (2) the sum of all amounts
paid or payable to the holder of such Option (or any other Person) with respect to nay one share of Common Stock upon the granting,
issuance or sale of such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Convertible Security
issuable upon exercise of such Option or otherwise pursuant to the terms thereof plus the value of any other consideration consisting
of cash, debt forgiveness, assets or any other property received or receivable by, or benefit conferred on, the holder of such
Option (or any other Person). Except as contemplated below, no further adjustment of the Conversion Price shall be made upon the
actual issuance of such shares of Common Stock or of such Convertible Securities upon the exercise of such Options or otherwise
pursuant to the terms thereof or upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange
of such Convertible Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Issuance of Convertible Securities</U>. If the Company in any manner issues or sells (or enters in to any agreement to issue
or sell) any Convertible Securities and the lowest price per share for which one share of Common Stock is at any time issuable
(or may become issuable assuming all possible market conditions) upon the conversion, exercise or exchange thereof or otherwise
pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding
and to have been issued and sold by the Company at the time of the issuance or sale of such Convertible Securities for such price
per share. For purposes of this Section 8(a)(ii), the &ldquo;lowest price per share for which one share of Common Stock is at
any time issuable (or may become issuable assuming all possible market conditions) upon the conversion, exercise or exchange thereof
or otherwise pursuant to the terms thereof&rdquo; shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration
(if any) received or receivable by the Company with respect to one share of Common Stock upon the issuance or sale of the Convertible
Security and upon conversion, exercise or exchange of such Convertible Security or otherwise pursuant to the terms thereof and
(y) the lowest conversion price set forth in such Convertible Security for which one share of Common Stock is issuable (or may
become issuable assuming all possible market conditions) upon conversion, exercise or exchange thereof or otherwise pursuant to
the terms thereof minus (2) the sum of all amounts paid or payable to the holder of such Convertible Security (or any other Person)
with respect to any one share of Common Stock upon the issuance or sale of such Convertible Security plus the value of any other
consideration received or receivable consisting of cash, debt forgiveness, assets or other property by, or benefit conferred on,
the holder of such Convertible Security (or any other Person). Except as contemplated below, no further adjustment of the Conversion
Price shall be made upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible
Securities or otherwise pursuant to the terms thereof, and if any such issuance or sale of such Convertible Securities is made
upon exercise of any Options for which adjustment of the Conversion Price has been or is to be made pursuant to other provisions
of this Section 8(a), except as contemplated below, no further adjustment of the Conversion Price shall be made by reason of such
issuance or sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<U>Change in Option Price or Rate of Conversion</U>. If the purchase or exercise price provided for in any Options, the additional
consideration, if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at
which any Convertible Securities are convertible into or exercisable or exchangeable for shares of Common Stock increases or decreases
at any time (other than proportional changes in conversion or exercise prices, as applicable, in connection with an event referred
to in Section 8(b) below), the Conversion Price in effect at the time of such increase or decrease shall be adjusted to the Conversion
Price which would have been in effect at such time had such Options or Convertible Securities provided for such increased or decreased
purchase price, additional consideration or increased or decreased conversion rate (as the case may be) at the time initially
granted, issued or sold. For purposes of this Section 8(a)(iii), if the terms of any Option or Convertible Security that was outstanding
as of the Subscription Date are increased or decreased in the manner described in the immediately preceding sentence, then such
Option or Convertible Security and the shares of Common Stock deemed issuable upon exercise, conversion or exchange thereof shall
be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 8(a) shall be
made if such adjustment would result in an increase of the Conversion Price then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<U>Calculation of Consideration Received</U>. If any Option and/or Convertible Security and/or Adjustment Right is issued in connection
with the issuance or sale or deemed issuance or sale of any other securities of the Company (as determined by the Required Holders,
the &ldquo;<B>Primary Security</B>&rdquo;, and such Option and/or Convertible Security and/or Adjustment Right, the &ldquo;<B>Secondary
Securities</B>&rdquo;), together comprising one integrated transaction (or one or more transactions if such issuances or sales
or deemed issuances or sales of securities of the Company either (A) have at least one investor or purchaser in common, (B) are
consummated in reasonable proximity to each other and/or (C) are consummated under the same plan of financing), the consideration
per share of Common Stock with respect to such Primary Security shall be deemed to be equal to the difference of (x) the lowest
price per share for which one share of Common Stock was issued (or was deemed to be issued pursuant to Section 8(a)(i) or 8(a)(ii)
above, as applicable) in such integrated transaction solely with respect to such Primary Security, minus (y) with respect to such
Secondary Securities, the sum of (A) the Black Scholes Consideration Value of each such Option, if any, (B) the fair market value
(as determined by the Required Holders in good faith) or the Black Scholes Consideration Value, as applicable, of such Adjustment
Right, if any, and (C) the fair market value (as determined by the Required Holder) of such Convertible Security, if any, in each
case, as determined on a per share basis in accordance with this Section 8(a)(iv). If any shares of Common Stock, Options or Convertible
Securities are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor (for the purpose
of determining the consideration paid for such Common Stock, Option or Convertible Security, but not for the purpose of the calculation
of the Black Scholes Consideration Value) will be deemed to be the net amount of consideration received by the Company therefor.
If any shares of Common Stock, Options or Convertible Securities are issued or sold for a consideration other than cash, the amount
of such consideration received by the Company (for the purpose of determining the consideration paid for such Common Stock, Option
or Convertible Security, but not for the purpose of the calculation of the Black Scholes Consideration Value), will be the fair
value of such consideration, except where such consideration consists of publicly traded securities, in which case the amount
of consideration received by the Company for such securities will be the arithmetic average of the VWAPs of such security for
each of the five (5) Trading Days immediately preceding the date of receipt. If any shares of Common Stock, Options or Convertible
Securities are issued to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving
entity, the amount of consideration therefor (for the purpose of determining the consideration paid for such Common Stock, Option
or Convertible Security, but not for the purpose of the calculation of the Black Scholes Consideration Value), will be deemed
to be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such shares
of Common Stock, Options or Convertible Securities (as the case may be). The fair value of any consideration other than cash or
publicly traded securities will be determined jointly by the Company and the Required Holders. If such parties are unable to reach
agreement within ten (10) days after the occurrence of an event requiring valuation (the &ldquo;<B>Valuation Event</B>&rdquo;),
the fair value of such consideration will be determined within five (5) Trading Days after the tenth (10<SUP>th</SUP>) day following
such Valuation Event by an independent, reputable appraiser jointly selected by the Company and the Required Holders. The determination
of such appraiser shall be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser
shall be borne by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Record Date</U>. If the Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A)
to receive a dividend or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B) to
subscribe for or purchase shares of Common Stock, Options or Convertible Securities, then such record date will be deemed to be
the date of the issuance or sale of the shares of Common Stock deemed to have been issued or sold upon the declaration of such
dividend or the making of such other distribution or the date of the granting of such right of subscription or purchase (as the
case may be).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Adjustment of Conversion Price upon Subdivision or Combination of Common Stock</U>. Without limiting any provision of Section
6 or Section 8(a), if the Company at any time on or after the Subscription Date subdivides (by any stock split, stock dividend,
stock combination, recapitalization or other similar transaction) one or more classes of its outstanding shares of Common Stock
into a greater number of shares, the Conversion Price in effect immediately prior to such subdivision will be proportionately
reduced. Without limiting any provision of Section 6 or Section 8(a), if the Company at any time on or after the Subscription
Date combines (by any stock split, stock dividend, stock combination, recapitalization or other similar transaction) one or more
classes of its outstanding shares of Common Stock into a smaller number of shares, the Conversion Price in effect immediately
prior to such combination will be proportionately increased. Any adjustment pursuant to this Section 8(b) shall become effective
immediately after the effective date of such subdivision or combination. If any event requiring an adjustment under this Section
8(b) occurs during the period that a Conversion Price is calculated hereunder, then the calculation of such Conversion Price shall
be adjusted appropriately to reflect such event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Holder&rsquo;s Right of Adjusted Conversion Price</U>. In addition to and not in limitation of the other provisions of this
Section 8(b), if the Company in any manner issues or sells or enters into (whether initially or pursuant to any subsequent amendment
thereof) any agreement to issue or sell, any Common Stock, Options or Convertible Securities (any such securities, &ldquo;<B>Variable
Price Securities</B>&rdquo;) after the Subscription Date that are issuable pursuant to such agreement or convertible into or exchangeable
or exercisable for shares of Common Stock at a price which varies or may vary with the market price of the shares of Common Stock,
including by way of one or more reset(s) to a fixed price, but exclusive of such formulations reflecting customary anti-dilution
provisions (such as share splits, share combinations, share dividends and similar transactions) (each of the formulations for
such variable price being herein referred to as, the &ldquo;<B>Variable Price</B>&rdquo;), the Company shall provide written notice
thereof via facsimile or electronic mail and overnight courier to each Holder on the date of such agreement and/or the issuance
of such shares of Common Stock, Convertible Securities or Options, as applicable. From and after the date the Company enters into
such agreement or issues any such Variable Price Securities, each Holder shall have the right, but not the obligation, in its
sole discretion to substitute the Variable Price for the Conversion Price upon conversion of the Preferred Shares by designating
in the Conversion Notice delivered upon any conversion of Preferred Shares that solely for purposes of such conversion such Holder
is relying on the Variable Price rather than the Conversion Price then in effect. A Holder&rsquo;s election to rely on a Variable
Price for a particular conversion of Preferred Shares shall not obligate such Holder to rely on a Variable Price for any future
conversions of Preferred Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Stock Combination Event Adjustments</U>. If at any time and from time to time on or after the Subscription Date there occurs
any stock split, stock dividend, stock combination recapitalization or other similar transaction involving the Common Stock (each,
a &ldquo;<B>Stock Combination Event</B>&rdquo;, and such date thereof, the &ldquo;<B>Stock Combination Event Date</B>&rdquo;)
and the Event Market Price is less than the Conversion Price then in effect (after giving effect to the adjustment in Section
8(b) above), then on the sixteenth (16th) Trading Day immediately following such Stock Combination Event Date, the Conversion
Price then in effect on such sixteenth (16th) Trading Day (after giving effect to the adjustment in Section 88(b) above) shall
be reduced (but in no event increased) to the Event Market Price. For the avoidance of doubt, if the adjustment in the immediately
preceding sentence would otherwise result in an increase in the Conversion Price hereunder, no adjustment shall be made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Other Events</U>. In the event that the Company (or any Subsidiary) shall take any action to which the provisions hereof are
not strictly applicable, or, if applicable, would not operate to protect any Holder from dilution (other than with respect to
Excluded Securities) or if any event occurs of the type contemplated by the provisions of this Section 8 but not expressly provided
for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other
rights with equity features), then the Board shall in good faith determine and implement an appropriate adjustment in the Conversion
Price so as to protect the rights of such Holder, provided that no such adjustment pursuant to this Section 8(b) will increase
the Conversion Price as otherwise determined pursuant to this Section 8, provided further that if such Holder does not accept
such adjustments as appropriately protecting its interests hereunder against such dilution, then the Board and such Holder shall
agree, in good faith, upon an independent investment bank of nationally recognized standing to make such appropriate adjustments,
whose determination shall be final and binding absent manifest error and whose fees and expenses shall be borne by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Calculations</U>. All calculations under this Section 8 shall be made by rounding to the nearest cent or the nearest 1/100<SUP>th
</SUP>of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned
or held by or for the account of the Company, and the disposition of any such shares shall be considered an issue or sale of Common
Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Voluntary Adjustment by Company</U>. Subject to the rules and regulations of the Principal Market, the Company may at any time
any Preferred Shares remain outstanding, with the prior written consent of the Required Holders, reduce the then current Conversion
Price to any amount and for any period of time deemed appropriate by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Noncircumvention</U>. The Company hereby covenants and agrees that the Company will not, by amendment of its Articles of Incorporation,
Bylaws (as defined in the Securities Purchase Agreement) or through any reorganization, transfer of assets, consolidation, merger,
scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance
or performance of any of the terms of this Certificate of Designations, and will at all times in good faith carry out all the
provisions of this Certificate of Designations and take all action as may be required to protect the rights of the Holders hereunder.
Without limiting the generality of the foregoing or any other provision of this Certificate of Designations or the other Transaction
Documents, the Company (a) shall not increase the par value of any shares of Common Stock receivable upon the conversion of any
Preferred Shares above the Conversion Price then in effect, (b) shall take all such actions as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and non-assessable shares of Common Stock upon the conversion
of Preferred Shares and (c) shall, so long as any Preferred Shares are outstanding, take all action necessary to reserve and keep
available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting the conversion of the
Preferred Shares, the maximum number of shares of Common Stock as shall from time to time be necessary to effect the conversion
of the Preferred Shares then outstanding (without regard to any limitations on conversion contained herein). Notwithstanding anything
herein to the contrary, if after the sixty (60) calendar day anniversary of the Initial Issuance Date, each Holder is not permitted
to convert such Holder&rsquo;s Preferred Shares in full for any reason (other than pursuant to restrictions set forth in Section
4(d)(i) hereof), the Company shall use its reasonable best efforts to promptly remedy such failure, including, without limitation,
obtaining such consents or approvals as necessary to effect such conversion into shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Reservation</U>. So long as any Preferred Shares remain outstanding, the Company shall (i) on or prior to the Share Increase
Shareholder Approval Date (as defined in the Securities Purchase Agreement), reserve 3,852,879 shares of Common Stock (the &ldquo;<B>Initial
Reserve Amount</B>&rdquo;) for issuance pursuant to this Certificate of Designations (and/or the Common Warrants, as designated
from time to time in writing by a Holder with respect to such Holder&rsquo;s Authorized Share Allocation (as defined below) and
not with respect to any other Holder&rsquo;s Authorized Share Allocation) and (ii) after the Share Increase Shareholder Approval
Date, at all times reserve at least 200% of the number of shares of Common Stock as shall from time to time be necessary to effect
the conversion, including without limitation, Alternate Conversions of all of the Preferred Shares then outstanding (without regard
to any limitations on conversions) (the &ldquo;<B>Subsequent Reserve Amount</B>&rdquo;, and together with the Initial Reserve
Amount, as applicable, the &ldquo;<B>Required Reserve Amount</B>&rdquo;). The Required Reserve Amount (including, without limitation,
each increase in the number of shares so reserved) shall be allocated pro rata among the Holders based on the number of the Preferred
Shares held by each Holder on the Initial Issuance Date or increase in the number of reserved shares, as the case may be (the
&ldquo;<B>Authorized Share Allocation</B>&rdquo;). In the event that a Holder shall sell or otherwise transfer any of such Holder&rsquo;s
Preferred Shares, each transferee shall be allocated a pro rata portion of such Holder&rsquo;s Authorized Share Allocation. Any
shares of Common Stock reserved and allocated to any Person which ceases to hold any Preferred Shares shall be allocated to the
remaining Holders of Preferred Shares, pro rata based on the number of the Preferred Shares then held by the Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Insufficient Authorized Shares</U>. If, notwithstanding Section 10(a) and not in limitation thereof, at any time while any
of the Preferred Shares remain outstanding the Company does not have a sufficient number of authorized and unreserved shares of
Common Stock to satisfy its obligation to reserve for issuance upon conversion of the Preferred Shares at least a number of shares
of Common Stock equal to the Required Reserve Amount (an &ldquo;<B>Authorized Share Failure</B>&rdquo;), then the Company shall
immediately take all action necessary to increase the Company&rsquo;s authorized shares of Common Stock to an amount sufficient
to allow the Company to reserve the Required Reserve Amount for the Preferred Shares then outstanding (or deemed outstanding pursuant
to Section 10(a) above). Without limiting the generality of the foregoing sentence, as soon as practicable after the date of the
occurrence of an Authorized Share Failure, but in no event later than ninety (90) days after the occurrence of such Authorized
Share Failure, the Company shall hold a meeting of its shareholders for the approval of an increase in the number of authorized
shares of Common Stock. In connection with such meeting, the Company shall provide each shareholder with a proxy statement and
shall use its reasonable best efforts to solicit its shareholders&rsquo; approval of such increase in authorized shares of Common
Stock and to cause its board of directors to recommend to the shareholders that they approve such proposal (or, if a majority
of the voting power then in effect of the capital stock of the Company consents to such increase, in lieu of such proxy statement,
deliver to the shareholders of the Company an information statement that has been filed with (and either approved by or not subject
to comments from) the SEC with respect thereto). In the event that the Company is prohibited from issuing shares of Common Stock
to a Holder upon any conversion due to the failure by the Company to have sufficient shares of Common Stock available out of the
authorized but unissued shares of Common Stock (such unavailable number of shares of Common Stock, the &ldquo;<B>Authorized Failure
Shares</B>&rdquo;), in lieu of delivering such Authorized Failure Shares to such Holder, the Company shall pay cash in exchange
for the redemption of such portion of the Conversion Amount of the Preferred Shares convertible into such Authorized Failure Shares
at a price equal to the sum of (i) the product of (x) such number of Authorized Failure Shares and (y) the greatest Closing Sale
Price of the Common Stock on any Trading Day during the period commencing on the date such Holder delivers the applicable Conversion
Notice with respect to such Authorized Failure Shares to the Company and ending on the date of such issuance and payment under
this Section 10(a); and (ii) to the extent such Holder purchases (in an open market transaction or otherwise) shares of Common
Stock to deliver in satisfaction of a sale by such Holder of Authorized Failure Shares, any brokerage commissions and other out-of-pocket
expenses, if any, of such Holder incurred in connection therewith. Nothing contained in Section 10(a) or this Section 10(b) shall
limit any obligations of the Company under any provision of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>Redemptions.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>General</U>. If a Holder has submitted a Triggering Event Redemption Notice in accordance with Section 5(b), the Company shall
deliver the applicable Triggering Event Redemption Price to such Holder in cash within five (5) Business Days after the Company&rsquo;s
receipt of such Holder&rsquo;s Triggering Event Redemption Notice. If a Holder has submitted a Change of Control Redemption Notice
in accordance with Section 6(b), the Company shall deliver the applicable Change of Control Redemption Price to such Holder in
cash concurrently with the consummation of such Change of Control if such notice is received prior to the consummation of such
Change of Control and within five (5) Business Days after the Company&rsquo;s receipt of such notice otherwise. Notwithstanding
anything herein to the contrary, in connection with any redemption hereunder at a time a Holder is entitled to receive a cash
payment under any of the other Transaction Documents, at the option of such Holder delivered in writing to the Company, the applicable
Redemption Price hereunder shall be increased by the amount of such cash payment owed to such Holder under such other Transaction
Document and, upon payment in full or conversion in accordance herewith, shall satisfy the Company&rsquo;s payment obligation
under such other Transaction Document. In the event of a redemption of less than all of the Preferred Shares, the Company shall
promptly cause to be issued and delivered to such Holder a new Preferred Share Certificate (in accordance with Section 18) (or
evidence of the creation of a new Book-Entry) representing the number of Preferred Shares which have not been redeemed. In the
event that the Company does not pay the applicable Redemption Price to a Holder within the time period required for any reason
(including, without limitation, to the extent such payment is prohibited pursuant to the NRS), at any time thereafter and until
the Company pays such unpaid Redemption Price in full, such Holder shall have the option, in lieu of redemption, to require the
Company to promptly return to such Holder all or any of the Preferred Shares that were submitted for redemption and for which
the applicable Redemption Price (together with any Late Charges thereon) has not been paid. Upon the Company&rsquo;s receipt of
such notice, (x) the applicable Redemption Notice shall be null and void with respect to such Preferred Shares, (y) the Company
shall immediately return the applicable Preferred Share Certificate, or issue a new Preferred Share Certificate (in accordance
with Section 18(d)), to such Holder (unless the Preferred Shares are held in Book-Entry form, in which case the Company shall
deliver evidence to such Holder that a Book-Entry for such Preferred Shares then exists), and in each case the Additional Amount
of such Preferred Shares shall be increased by an amount equal to the difference between (1) the applicable Redemption Price (as
the case may be, and as adjusted pursuant to this Section 11, if applicable) minus (2) the Stated Value portion of the Conversion
Amount submitted for redemption and (z) the Conversion Price of such Preferred Shares shall be automatically adjusted with respect
to each conversion effected thereafter by such Holder to the lowest of (A) the Conversion Price as in effect on the date on which
the applicable Redemption Notice is voided, (B) the greater of (x) the Floor Price and (y) 75% of the lowest Closing Bid Price
of the Common Stock during the period beginning on and including the date on which the applicable Redemption Notice is delivered
to the Company and ending on and including the date on which the applicable Redemption Notice is voided and (C) the greater of
(x) the Floor Price and (y) 75% of the quotient of (I) the sum of the five (5) lowest VWAPs of the Common Stock during the twenty
(20) consecutive Trading Day period ending and including the applicable Conversion Date divided by (II) five (5) (it being understood
and agreed that all such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination
or other similar transaction during such period); provided that in the event of the Conversion Floor Price Condition, on the applicable
Conversion Date in connection herewith the Company shall also deliver to the Holder the applicable Redemption Conversion Floor
Amount in cash on the applicable Conversion Date. A Holder&rsquo;s delivery of a notice voiding a Redemption Notice and exercise
of its rights following such notice shall not affect the Company&rsquo;s obligations to make any payments of Late Charges which
have accrued prior to the date of such notice with respect to the Preferred Shares subject to such notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Redemption by Multiple Holders</U>. Upon the Company&rsquo;s receipt of a Redemption Notice from any Holder for redemption
or repayment as a result of an event or occurrence substantially similar to the events or occurrences described in Section 5(b)
or Section 6(b), the Company shall immediately, but no later than one (1) Business Day of its receipt thereof, forward to each
other Holder by facsimile or electronic mail a copy of such notice. If the Company receives one or more Redemption Notices, during
the seven (7) Business Day period beginning on and including the date which is two (2) Business Days prior to the Company&rsquo;s
receipt of the initial Redemption Notice and ending on and including the date which is two (2) Business Days after the Company&rsquo;s
receipt of the initial Redemption Notice and the Company is unable to redeem all of the Conversion Amount of such Preferred Shares
designated in such initial Redemption Notice and such other Redemption Notices received during such seven (7) Business Day period,
then the Company shall redeem a pro rata amount from each Holder based on the Stated Value of the Preferred Shares submitted for
redemption pursuant to such Redemption Notices received by the Company during such seven (7) Business Day period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<U>Voting Rights</U>. Holders of Preferred Shares shall have no voting rights, except as required by law (including without limitation,
the NRS) and as expressly provided in this Certificate of Designations. To the extent that under the NRS the vote of the holders
of the Preferred Shares, voting separately as a class or series, as applicable, is required to authorize a given action of the
Company, the affirmative vote or consent of the Required Holders of the shares of the Preferred Shares, voting together in the
aggregate and not in separate series unless required under the NRS, represented at a duly held meeting at which a quorum is presented
or by written consent of the Required Holders (except as otherwise may be required under the NRS), voting together in the aggregate
and not in separate series unless required under the NRS, shall constitute the approval of such action by both the class or the
series, as applicable. Subject to Section 4(d)(i), to the extent that under the NRS holders of the Preferred Shares are entitled
to vote on a matter with holders of shares of Common Stock, voting together as one class, each Preferred Share shall entitle the
holder thereof to cast that number of votes per share as is equal to the number of shares of Common Stock into which it is then
convertible (subject to the ownership limitations specified in Section 4(d)(i) hereof) using the record date for determining the
stockholders of the Company eligible to vote on such matters as the date as of which the Conversion Price is calculated. Holders
of the Preferred Shares shall be entitled to written notice of all stockholder meetings or written consents (and copies of proxy
materials and other information sent to stockholders) with respect to which they would be entitled to vote, which notice would
be provided pursuant to the Company&rsquo;s bylaws and the NRS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<U>Covenants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Incurrence of Indebtedness</U>. So long as the Minimum Ownership Condition (as defined in the Securities Purchase Agreement)
exists, the Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, incur or guarantee,
assume or suffer to exist any Indebtedness (other than Permitted Indebtedness).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Existence of Liens</U>. So long as the Minimum Ownership Condition exists, the Company shall not, and the Company shall cause
each of its Subsidiaries to not, directly or indirectly, allow or suffer to exist any mortgage, lien, pledge, charge, security
interest or other encumbrance upon or in any property or assets (including accounts and contract rights) owned by the Company
or any of its Subsidiaries (collectively, &ldquo;<B>Liens</B>&rdquo;) other than Permitted Liens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Restricted Payments</U>. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly,
redeem, defease, repurchase, repay or make any payments in respect of, by the payment of cash or cash equivalents (in whole or
in part, whether by way of open market purchases, tender offers, private transactions or otherwise), all or any portion of any
Indebtedness (other than any amounts payable pursuant to this Certificate of Designations) whether by way of payment in respect
of principal of (or premium, if any) or interest on, such Indebtedness if at the time such payment is due or is otherwise made
or, after giving effect to such payment, (i) an event constituting a Triggering Event has occurred and is continuing or (ii) an
event that with the passage of time and without being cured would constitute a Triggering Event has occurred and is continuing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Restriction on Redemption and Cash Dividends</U>. The Company shall not, and the Company shall cause each of its Subsidiaries
to not, directly or indirectly, redeem, repurchase or declare or pay any cash dividend or distribution on any of its capital stock
(other than as required by the Certificate of Designations).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Restriction on Transfer of Assets</U>. The Company shall not, and the Company shall cause each of its Subsidiaries to not,
directly or indirectly, sell, lease, license, assign, transfer, spin-off, split-off, close, convey or otherwise dispose of any
assets or rights of the Company or any Subsidiary owned or hereafter acquired whether in a single transaction or a series of related
transactions, other than (i) sales, leases, licenses, assignments, transfers, conveyances and other dispositions of such assets
or rights by the Company and its Subsidiaries in the ordinary course of business consistent with its past practice and (ii) sales
of inventory and product in the ordinary course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Maturity of Indebtedness</U>. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly
or indirectly, permit any Indebtedness of the Company or any of its Subsidiaries to mature or accelerate prior to the third anniversary
of the Initial Issuance Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Change in Nature of Business</U>. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly
or indirectly, engage in any material line of business substantially different from those lines of business conducted by or publicly
contemplated to be conducted by the Company and each of its Subsidiaries on the Subscription Date or any business substantially
related or incidental thereto. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or
indirectly, modify its or their corporate structure or purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Preservation of Existence, Etc</U>. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain
and preserve, its existence, rights and privileges, and become or remain, and cause each of its Subsidiaries to become or remain,
duly qualified and in good standing in each jurisdiction in which the character of the properties owned or leased by it or in
which the transaction of its business makes such qualification necessary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Maintenance of Properties, Etc</U>. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain
and preserve, all of its properties which are necessary or useful in the proper conduct of its business in good working order
and condition, ordinary wear and tear excepted, and comply, and cause each of its Subsidiaries to comply, at all times with the
provisions of all leases to which it is a party as lessee or under which it occupies property, so as to prevent any loss or forfeiture
thereof or thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Maintenance of Intellectual Property</U>. The Company will, and will cause each of its Subsidiaries to, take all action necessary
or advisable to maintain all of the Intellectual Property Rights of the Company and/or any of its Subsidiaries that are necessary
or material to the conduct of its business in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Maintenance of Insurance</U>. The Company shall maintain, and cause each of its Subsidiaries to maintain, insurance with responsible
and reputable insurance companies or associations (including, without limitation, comprehensive general liability, hazard, rent
and business interruption insurance) with respect to its properties (including all real properties leased or owned by it) and
business, in such amounts and covering such risks as is required by any governmental authority having jurisdiction with respect
thereto or as is carried generally in accordance with sound business practice by companies in similar businesses similarly situated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Transactions with Affiliates</U>. Other than the Insider Financing (as defined in the Securities Purchase Agreement) and the
transactions described on <U>Schedule 13(l)</U> attached hereto, the Company shall not, nor shall it permit any of its Subsidiaries
to, enter into, renew, extend or be a party to, any transaction or series of related transactions (including, without limitation,
the purchase, sale, lease, transfer or exchange of property or assets of any kind or the rendering of services of any kind) with
any affiliate, except transactions in the ordinary course of business in a manner and to an extent consistent with past practice
and necessary or desirable for the prudent operation of its business, for fair consideration and on terms no less favorable to
it or its Subsidiaries than would be obtainable in a comparable arm&rsquo;s length transaction with a Person that is not an affiliate
thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Restricted Issuances</U>. The Company shall not, directly or indirectly, without the prior written consent of the Required
Holders, (i) issue any Preferred Shares (other than as contemplated by the Securities Purchase Agreement and this Certificate
of Designations) or (ii) issue any other securities that would cause a breach or default under this Certificate of Designations,
the Preferred Warrants or the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Independent Investigation</U>. At the request of any Holder either (x) at any time when a Triggering Event has occurred and
is continuing, (y) upon the occurrence of an event that with the passage of time or giving of notice would constitute a Triggering
Event or (z) at any time such Holder reasonably believes a Triggering Event may have occurred or be continuing, the Company shall
hire an independent, reputable investment bank selected by the Company and approved by such Holder to investigate as to whether
any breach of the Certificate of Designations has occurred (the &ldquo;<B>Independent Investigator</B>&rdquo;). If the Independent
Investigator determines that such breach of the Certificate of Designations has occurred, the Independent Investigator shall notify
the Company of such breach and the Company shall deliver written notice to each Holder of such breach. In connection with such
investigation, the Independent Investigator may, during normal business hours, inspect all contracts, books, records, personnel,
offices and other facilities and properties of the Company and its Subsidiaries and, to the extent available to the Company after
the Company uses reasonable efforts to obtain them, the records of its legal advisors and accountants (including the accountants&rsquo;
work papers) and any books of account, records, reports and other papers not contractually required of the Company to be confidential
or secret, or subject to attorney-client or other evidentiary privilege, and the Independent Investigator may make such copies
and inspections thereof as the Independent Investigator may reasonably request. The Company shall furnish the Independent Investigator
with such financial and operating data and other information with respect to the business and properties of the Company as the
Independent Investigator may reasonably request. The Company shall permit the Independent Investigator to discuss the affairs,
finances and accounts of the Company with, and to make proposals and furnish advice with respect thereto to, the Company&rsquo;s
officers, directors, key employees and independent public accountants or any of them (and by this provision the Company authorizes
said accountants to discuss with such Independent Investigator the finances and affairs of the Company and any Subsidiaries),
all at such reasonable times, upon reasonable notice, and as often as may be reasonably requested.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<U>Liquidation, Dissolution, Winding-Up</U>. In the event of a Liquidation Event, the Holders shall be entitled to receive in
cash out of the assets of the Company, whether from capital or from earnings available for distribution to its shareholders (the
&ldquo;<B>Liquidation Funds</B>&rdquo;), before any amount shall be paid to the holders of any of shares of Junior Stock, but
pari passu with any Parity Stock then outstanding, an amount per Preferred Share equal to the greater of (A) 125% of the Conversion
Amount of such Preferred Share on the date of such payment and (B) the amount per share such Holder would receive if such Holder
converted such Preferred Share into Common Stock immediately prior to the date of such payment, provided that if the Liquidation
Funds are insufficient to pay the full amount due to the Holders and holders of shares of Parity Stock, then each Holder and each
holder of Parity Stock shall receive a percentage of the Liquidation Funds equal to the full amount of Liquidation Funds payable
to such Holder and such holder of Parity Stock as a liquidation preference, in accordance with their respective certificate of
designations (or equivalent), as a percentage of the full amount of Liquidation Funds payable to all holders of Preferred Shares
and all holders of shares of Parity Stock. To the extent necessary, the Company shall cause such actions to be taken by each of
its Subsidiaries so as to enable, to the maximum extent permitted by law, the proceeds of a Liquidation Event to be distributed
to the Holders in accordance with this Section 14. All the preferential amounts to be paid to the Holders under this Section 14
shall be paid or set apart for payment before the payment or setting apart for payment of any amount for, or the distribution
of any Liquidation Funds of the Company to the holders of shares of Junior Stock in connection with a Liquidation Event as to
which this Section 14 applies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<U>Distribution of Assets</U>. In addition to any adjustments pursuant to Section 7(a) and Section 8, if the Company shall declare
or make any dividend or other distributions of its assets (or rights to acquire its assets) to any or all holders of shares of
Common Stock, by way of return of capital or otherwise (including without limitation, any distribution of cash, stock or other
securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement
or other similar transaction) (the &ldquo;<B>Distributions</B>&rdquo;), then each Holder, as holders of Preferred Shares, will
be entitled to such Distributions as if such Holder had held the number of shares of Common Stock acquirable upon complete conversion
of the Preferred Shares (without taking into account any limitations or restrictions on the convertibility of the Preferred Shares
and assuming for such purpose that the Preferred Share was converted at the Alternate Conversion Price as of the applicable record
date) immediately prior to the date on which a record is taken for such Distribution or, if no such record is taken, the date
as of which the record holders of Common Stock are to be determined for such Distributions (<U>provided</U>, <U>however</U>, that
to the extent that such Holder&rsquo;s right to participate in any such Distribution would result in such Holder and the other
Attribution Parties exceeding the Maximum Percentage, then such Holder shall not be entitled to participate in such Distribution
to such extent of the Maximum Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as
a result of such Distribution (and beneficial ownership) to such extent of any such excess) and the portion of such Distribution
shall be held in abeyance for the benefit of such Holder until such time or times as its right thereto would not result in such
Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or times, if any, such Holder shall be
granted such Distribution (and any Distributions declared or made on such initial Distribution or on any subsequent Distribution
held similarly in abeyance) to the same extent as if there had been no such limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.
<U>Vote to Change the Terms of or Issue Preferred Shares</U>. In addition to any other rights provided by law, except where the
vote or written consent of the holders of a greater number of shares is required by law or by another provision of the Articles
of Incorporation, without first obtaining the affirmative vote at a meeting duly called for such purpose or the written consent
without a meeting of the Required Holders, voting together as a single class, the Company shall not: (a) amend or repeal any provision
of, or add any provision to, its Articles of Incorporation or bylaws, or file any certificate of designations or articles of amendment
of any series of shares of preferred stock, if such action would adversely alter or change in any respect the preferences, rights,
privileges or powers, or restrictions provided for the benefit of the Preferred Shares hereunder, regardless of whether any such
action shall be by means of amendment to the Articles of Incorporation or by merger, consolidation or otherwise; (b) increase
or decrease (other than by conversion) the authorized number of Preferred Shares; (c) without limiting any provision of Section
2, create or authorize (by reclassification or otherwise) any new class or series of Senior Preferred Stock or Parity Stock; (d)
purchase, repurchase or redeem any shares of Junior Stock (other than pursuant to the terms of the Company&rsquo;s equity incentive
plans and options and other equity awards granted under such plans (that have in good faith been approved by the Board)); (e)
without limiting any provision of Section 2, pay dividends or make any other distribution on any shares of any Junior Stock; (f)
issue any Preferred Shares other than as contemplated hereby or pursuant to the Securities Purchase Agreement; or (g) without
limiting any provision of Section 9, whether or not prohibited by the terms of the Preferred Shares, circumvent a right of the
Preferred Shares hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.
<U>Transfer of Preferred Shares</U>. A Holder may transfer some or all of its Preferred Shares without the consent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.
<U>Reissuance of Preferred Share Certificates and Book Entries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Transfer</U>. If any Preferred Shares are to be transferred, the applicable Holder shall surrender the applicable Preferred
Share Certificate to the Company (or, if the Preferred Shares are held in Book-Entry form, a written instruction letter to the
Company), whereupon the Company will forthwith issue and deliver upon the order of such Holder a new Preferred Share Certificate
(in accordance with Section 18(d)) (or evidence of the transfer of such Book-Entry), registered as such Holder may request, representing
the outstanding number of Preferred Shares being transferred by such Holder and, if less than the entire outstanding number of
Preferred Shares is being transferred, a new Preferred Share Certificate (in accordance with Section 18(d)) to such Holder representing
the outstanding number of Preferred Shares not being transferred (or evidence of such remaining Preferred Shares in a Book-Entry
for such Holder). Such Holder and any assignee, by acceptance of the Preferred Share Certificate or evidence of Book-Entry issuance,
as applicable, acknowledge and agree that, by reason of the provisions of Section 4(c)(i) following conversion or redemption of
any of the Preferred Shares, the outstanding number of Preferred Shares represented by the Preferred Shares may be less than the
number of Preferred Shares stated on the face of the Preferred Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Lost, Stolen or Mutilated Preferred Share Certificate</U>. Upon receipt by the Company of evidence reasonably satisfactory
to the Company of the loss, theft, destruction or mutilation of a Preferred Share Certificate (as to which a written certification
and the indemnification contemplated below shall suffice as such evidence), and, in the case of loss, theft or destruction, of
any indemnification undertaking by the applicable Holder to the Company in customary and reasonable form and, in the case of mutilation,
upon surrender and cancellation of such Preferred Share Certificate, the Company shall execute and deliver to such Holder a new
Preferred Share Certificate (in accordance with Section 18(d)) representing the applicable outstanding number of Preferred Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Preferred Share Certificate and Book-Entries Exchangeable for Different Denominations and Forms</U>. Each Preferred Share Certificate
is exchangeable, upon the surrender hereof by the applicable Holder at the principal office of the Company, for a new Preferred
Share Certificate or Preferred Share Certificate(s) or new Book-Entry (in accordance with Section 18(d)) representing, in the
aggregate, the outstanding number of the Preferred Shares in the original Preferred Share Certificate, and each such new Preferred
Share Certificate and/or new Book-Entry, as applicable, will represent such portion of such outstanding number of Preferred Shares
from the original Preferred Share Certificate as is designated in writing by such Holder at the time of such surrender. Each Book-Entry
may be exchanged into one or more new Preferred Share Certificates or split by the applicable Holder by delivery of a written
notice to the Company into two or more new Book-Entries (in accordance with Section 18(d)) representing, in the aggregate, the
outstanding number of the Preferred Shares in the original Book-Entry, and each such new Book-Entry and/or new Preferred Share
Certificate, as applicable, will represent such portion of such outstanding number of Preferred Shares from the original Book-Entry
as is designated in writing by such Holder at the time of such surrender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Issuance of New Preferred Share Certificate or Book-Entry</U>. Whenever the Company is required to issue a new Preferred Share
Certificate or a new Book-Entry pursuant to the terms of this Certificate of Designations, such new Preferred Share Certificate
or new Book-Entry (i) shall represent, as indicated on the face of such Preferred Share Certificate or in such Book-Entry, as
applicable, the number of Preferred Shares remaining outstanding (or in the case of a new Preferred Share Certificate or new Book-Entry
being issued pursuant to Section 18(a) or Section 18(c), the number of Preferred Shares designated by such Holder) which, when
added to the number of Preferred Shares represented by the other new Preferred Share Certificates or other new Book-Entry, as
applicable, issued in connection with such issuance, does not exceed the number of Preferred Shares remaining outstanding under
the original Preferred Share Certificate or original Book-Entry, as applicable, immediately prior to such issuance of new Preferred
Share Certificate or new Book-Entry, as applicable, and (ii) shall have an issuance date, as indicated on the face of such new
Preferred Share Certificate or in such new Book-Entry, as applicable, which is the same as the issuance date of the original Preferred
Share Certificate or in such original Book-Entry, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.
<U>Remedies, Characterizations, Other Obligations, Breaches and Injunctive Relief. </U>The remedies provided in this Certificate
of Designations shall be cumulative and in addition to all other remedies available under this Certificate of Designations and
any of the other Transaction Documents, at law or in equity (including a decree of specific performance and/or other injunctive
relief), and nothing herein shall limit any Holder&rsquo;s right to pursue actual and consequential damages for any failure by
the Company to comply with the terms of this Certificate of Designations. The Company covenants to each Holder that there shall
be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein
with respect to payments, conversion and the like (and the computation thereof) shall be the amounts to be received by a Holder
and shall not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof).
No failure on the part of a Holder to exercise, and no delay in exercising, any right, power or remedy hereunder shall operate
as a waiver thereof; nor shall any single or partial exercise by such Holder of any right, power or remedy preclude any other
or further exercise thereof or the exercise of any other right, power or remedy. In addition, the exercise of any right or remedy
of any Holder at law or equity or under Preferred Shares or any of the documents shall not be deemed to be an election of such
Holder&rsquo;s rights or remedies under such documents or at law or equity. The Company acknowledges that a breach by it of its
obligations hereunder will cause irreparable harm to the Holders and that the remedy at law for any such breach may be inadequate.
The Company therefore agrees that, in the event of any such breach or threatened breach, each Holder shall be entitled, in addition
to all other available remedies, to specific performance and/or temporary, preliminary and permanent injunctive or other equitable
relief from any court of competent jurisdiction in any such case without the necessity of proving actual damages and without posting
a bond or other security. The Company shall provide all information and documentation to a Holder that is requested by such Holder
to enable such Holder to confirm the Company&rsquo;s compliance with the terms and conditions of this Certificate of Designations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.
<U>Payment of Collection, Enforcement and Other Costs</U>. If (a) any Preferred Shares are placed in the hands of an attorney
for collection or enforcement or is collected or enforced through any legal proceeding or a Holder otherwise takes action to collect
amounts due under this Certificate of Designations with respect to the Preferred Shares or to enforce the provisions of this Certificate
of Designations or (b) there occurs any bankruptcy, reorganization, receivership of the Company or other proceedings affecting
Company creditors&rsquo; rights and involving a claim under this Certificate of Designations, then the Company shall pay the costs
incurred by such Holder for such collection, enforcement or action or in connection with such bankruptcy, reorganization, receivership
or other proceeding, including, without limitation, attorneys&rsquo; fees and disbursements. The Company expressly acknowledges
and agrees that no amounts due under this Certificate of Designations with respect to any Preferred Shares shall be affected,
or limited, by the fact that the purchase price paid for each Preferred Share was less than the original Stated Value thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.
<U>Construction; Headings</U>. This Certificate of Designations shall be deemed to be jointly drafted by the Company and the Holders
and shall not be construed against any such Person as the drafter hereof. The headings of this Certificate of Designations are
for convenience of reference and shall not form part of, or affect the interpretation of, this Certificate of Designations. Unless
the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular
and plural forms thereof. The terms &ldquo;including,&rdquo; &ldquo;includes,&rdquo; &ldquo;include&rdquo; and words of like import
shall be construed broadly as if followed by the words &ldquo;without limitation.&rdquo; The terms &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo;
&ldquo;hereof&rdquo; and words of like import refer to this entire Certificate of Designations instead of just the provision in
which they are found. Unless expressly indicated otherwise, all section references are to sections of this Certificate of Designations.
Terms used in this Certificate of Designations and not otherwise defined herein, but defined in the other Transaction Documents,
shall have the meanings ascribed to such terms on the Initial Issuance Date in such other Transaction Documents unless otherwise
consented to in writing by the Required Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.
<U>Failure or Indulgence Not Waiver</U>. No failure or delay on the part of a Holder in the exercise of any power, right or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude
other or further exercise thereof or of any other right, power or privilege. No waiver shall be effective unless it is in writing
and signed by an authorized representative of the waiving party. This Certificate of Designations shall be deemed to be jointly
drafted by the Company and all Holders and shall not be construed against any Person as the drafter hereof. Notwithstanding the
foregoing, nothing contained in this Section 22 shall permit any waiver of any provision of Section 4(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.
<U>Dispute Resolution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Submission to Dispute Resolution.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
In the case of a dispute relating to a Closing Bid Price, a Closing Sale Price, a Conversion Price, a Black Scholes Consideration
Value, an Alternate Conversion Price, an Alternate Conversion Floor Amount, a Redemption Conversion Floor Amount, a VWAP or a
fair market value or the arithmetic calculation of a Conversion Rate, or the applicable Redemption Price (as the case may be)
(including, without limitation, a dispute relating to the determination of any of the foregoing), the Company or the applicable
Holder (as the case may be) shall submit the dispute to the other party via facsimile or electronic mail (A) if by the Company,
within two (2) Business Days after the occurrence of the circumstances giving rise to such dispute or (B) if by such Holder at
any time after such Holder learned of the circumstances giving rise to such dispute. If such Holder and the Company are unable
to promptly resolve such dispute relating to such Closing Bid Price, such Closing Sale Price, such Conversion Price, such Black
Scholes Consideration Value, such Alternate Conversion Price, such Alternate Conversion Floor Amount, such Redemption Conversion
Floor Amount, such VWAP or such fair market value, or the arithmetic calculation of such Conversion Rate or such applicable Redemption
Price (as the case may be), at any time after the second (2<SUP>nd</SUP>) Business Day following such initial notice by the Company
or such Holder (as the case may be) of such dispute to the Company or such Holder (as the case may be), then such Holder may,
at its sole option, select an independent, reputable investment bank to resolve such dispute.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Such Holder and the Company shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered
in accordance with the first sentence of this Section 23 and (B) written documentation supporting its position with respect to
such dispute, in each case, no later than 5:00 p.m. (New York time) by the fifth (5<SUP>th</SUP>) Business Day immediately following
the date on which such Holder selected such investment bank (the &ldquo;<B>Dispute Submission Deadline</B>&rdquo;) (the documents
referred to in the immediately preceding clauses (A) and (B) are collectively referred to herein as the &ldquo;<B>Required Dispute
Documentation</B>&rdquo;) (it being understood and agreed that if either such Holder or the Company fails to so deliver all of
the Required Dispute Documentation by the Dispute Submission Deadline, then the party who fails to so submit all of the Required
Dispute Documentation shall no longer be entitled to (and hereby waives its right to) deliver or submit any written documentation
or other support to such investment bank with respect to such dispute and such investment bank shall resolve such dispute based
solely on the Required Dispute Documentation that was delivered to such investment bank prior to the Dispute Submission Deadline).
Unless otherwise agreed to in writing by both the Company and such Holder or otherwise requested by such investment bank, neither
the Company nor such Holder shall be entitled to deliver or submit any written documentation or other support to such investment
bank in connection with such dispute (other than the Required Dispute Documentation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The Company and such Holder shall cause such investment bank to determine the resolution of such dispute and notify the Company
and such Holder of such resolution no later than ten (10) Business Days immediately following the Dispute Submission Deadline.
The fees and expenses of such investment bank shall be borne solely by the Company, and such investment bank&rsquo;s resolution
of such dispute shall be final and binding upon all parties absent manifest error.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Miscellaneous</U>. The Company expressly acknowledges and agrees that (i) this Section 23 constitutes an agreement to arbitrate
between the Company and each Holder (and constitutes an arbitration agreement) under &sect; 7501, et seq. of the New York Civil
Practice Law and Rules (&ldquo;<B>CPLR</B>&rdquo;) and that any Holder is authorized to apply for an order to compel arbitration
pursuant to CPLR &sect; 7503(a) in order to compel compliance with this Section 23, (ii) a dispute relating to a Conversion Price
includes, without limitation, disputes as to (A) whether an issuance or sale or deemed issuance or sale of Common Stock occurred
under Section 8(a), (B) the consideration per share at which an issuance or deemed issuance of Common Stock occurred, (C) whether
any issuance or sale or deemed issuance or sale of Common Stock was an issuance or sale or deemed issuance or sale of Excluded
Securities, (D) whether an agreement, instrument, security or the like constitutes and Option or Convertible Security and (E)
whether a Dilutive Issuance occurred, (iii) the terms of this Certificate of Designations and each other applicable Transaction
Document shall serve as the basis for the selected investment bank&rsquo;s resolution of the applicable dispute, such investment
bank shall be entitled (and is hereby expressly authorized) to make all findings, determinations and the like that such investment
bank determines are required to be made by such investment bank in connection with its resolution of such dispute and in resolving
such dispute such investment bank shall apply such findings, determinations and the like to the terms of this Certificate of Designations
and any other applicable Transaction Documents, (iv) the applicable Holder (and only such Holder with respect to disputes solely
relating to such Holder), in its sole discretion, shall have the right to submit any dispute described in this Section 23 to any
state or federal court sitting in The City of New York, Borough of Manhattan in lieu of utilizing the procedures set forth in
this Section 23 and (v) nothing in this Section 23 shall limit such Holder from obtaining any injunctive relief or other equitable
remedies (including, without limitation, with respect to any matters described in this Section 23).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.
<U>Notices; Currency; Payments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Notices</U>. The Company shall provide each Holder of Preferred Shares with prompt written notice of all actions taken pursuant
to the terms of this Certificate of Designations, including in reasonable detail a description of such action and the reason therefor.
Whenever notice is required to be given under this Certificate of Designations, unless otherwise provided herein, such notice
must be in writing and shall be given in accordance with Section 9(f) of the Securities Purchase Agreement. The Company shall
provide each Holder with prompt written notice of all actions taken pursuant to this Certificate of Designations, including in
reasonable detail a description of such action and the reason therefore. Without limiting the generality of the foregoing, the
Company shall give written notice to each Holder (i) immediately upon any adjustment of the Conversion Price, setting forth in
reasonable detail, and certifying, the calculation of such adjustment and (ii) at least fifteen (15) days prior to the date on
which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon the Common Stock, (B)
with respect to any grant, issuances, or sales of any Options, Convertible Securities or rights to purchase stock, warrants, securities
or other property to holders of shares of Common Stock or (C) for determining rights to vote with respect to any Fundamental Transaction,
dissolution or liquidation, provided in each case that such information shall be made known to the public prior to or in conjunction
with such notice being provided to such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Currency</U>. All dollar amounts referred to in this Certificate of Designations are in United States Dollars (&ldquo;<B>U.S.
Dollars</B>&rdquo;), and all amounts owing under this Certificate of Designations shall be paid in U.S. Dollars. All amounts denominated
in other currencies (if any) shall be converted into the U.S. Dollar equivalent amount in accordance with the Exchange Rate on
the date of calculation. &ldquo;<B>Exchange Rate</B>&rdquo; means, in relation to any amount of currency to be converted into
U.S. Dollars pursuant to this Certificate of Designations, the U.S. Dollar exchange rate as published in the Wall Street Journal
on the relevant date of calculation (it being understood and agreed that where an amount is calculated with reference to, or over,
a period of time, the date of calculation shall be the final date of such period of time).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Payments</U>. Whenever any payment of cash is to be made by the Company to any Person pursuant to this Certificate of Designations,
unless otherwise expressly set forth herein, such payment shall be made in lawful money of the United States of America by wire
transfer of immediately available funds pursuant to wire transfer instructions that Holder shall provide to the Company in writing
from time to time. Whenever any amount expressed to be due by the terms of this Certificate of Designations is due on any day
which is not a Business Day, the same shall instead be due on the next succeeding day which is a Business Day. Any amount due
under the Transaction Documents which is not paid when due shall result in a late charge being incurred and payable by the Company
in an amount equal to interest on such amount at the rate of fifteen percent (15%) per annum from the date such amount was due
until the same is paid in full (&ldquo;<B>Late Charge</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.
<U>Waiver of Notice</U>. To the extent permitted by law, the Company hereby irrevocably waives demand, notice, presentment, protest
and all other demands and notices in connection with the delivery, acceptance, performance, default or enforcement of this Certificate
of Designations and the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.
<U>Governing Law</U>. This Certificate of Designations shall be construed and enforced in accordance with, and all questions concerning
the construction, validity, interpretation and performance of this Certificate of Designations shall be governed by, the internal
laws of the State of Nevada, without giving effect to any choice of law or conflict of law provision or rule (whether of the State
of Nevada or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of
Nevada. Except as otherwise required by Section 23 above, the Company hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and
agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any
such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or
proceeding is improper. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner
permitted by law. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted
by law. Nothing contained herein (i) shall be deemed or operate to preclude any Holder from bringing suit or taking other legal
action against the Company in any other jurisdiction to collect on the Company&rsquo;s obligations to such Holder, to realize
on any collateral or any other security for such obligations, or to enforce a judgment or other court ruling in favor of such
Holder or (ii) shall limit, or shall be deemed or construed to limit, any provision of Section 23 above. <B>THE COMPANY HEREBY
IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER
OR IN CONNECTION WITH OR ARISING OUT OF THIS CERTIFICATE OF DESIGNATIONS OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.
<U>Judgment Currency</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
If for the purpose of obtaining or enforcing judgment against the Company in any court in any jurisdiction it becomes necessary
to convert into any other currency (such other currency being hereinafter in this Section 27 referred to as the &ldquo;<B>Judgment
Currency</B>&rdquo;) an amount due in U.S. dollars under this Certificate of Designations, the conversion shall be made at the
Exchange Rate prevailing on the Trading Day immediately preceding:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the date actual payment of the amount due, in the case of any proceeding in the courts of New York or in the courts of any other
jurisdiction that will give effect to such conversion being made on such date: or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the date on which the foreign court determines, in the case of any proceeding in the courts of any other jurisdiction (the date
as of which such conversion is made pursuant to this Section 27(a)(ii) being hereinafter referred to as the &ldquo;<B>Judgment
Conversion Date</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If in the case of any proceeding in the court of any jurisdiction referred to in Section 27(a)(ii) above, there is a change in
the Exchange Rate prevailing between the Judgment Conversion Date and the date of actual payment of the amount due, the applicable
party shall pay such adjusted amount as may be necessary to ensure that the amount paid in the Judgment Currency, when converted
at the Exchange Rate prevailing on the date of payment, will produce the amount of US dollars which could have been purchased
with the amount of Judgment Currency stipulated in the judgment or judicial order at the Exchange Rate prevailing on the Judgment
Conversion Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Any amount due from the Company under this provision shall be due as a separate debt and shall not be affected by judgment being
obtained for any other amounts due under or in respect of this Certificate of Designations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.
<U>Severability</U>. If any provision of this Certificate of Designations is prohibited by law or otherwise determined to be invalid
or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable
shall be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability
of such provision shall not affect the validity of the remaining provisions of this Certificate of Designations so long as this
Certificate of Designations as so modified continues to express, without material change, the original intentions of the parties
as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does
not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of
the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace
the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible
to that of the prohibited, invalid or unenforceable provision(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.
<U>Maximum Payments</U>. Without limiting Section 9(d) of the Securities Purchase Agreement, nothing contained herein shall be
deemed to establish or require the payment of a rate of interest or other charges in excess of the maximum permitted by applicable
law. In the event that the rate of interest required to be paid or other charges hereunder exceed the maximum permitted by such
law, any payments in excess of such maximum shall be credited against amounts owed by the Company to the applicable Holder and
thus refunded to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.
<U>Stockholder Matters; Amendment</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Stockholder Matters</U>. Any shareholder action, approval or consent required, desired or otherwise sought by the Company pursuant
to the NRS, the Articles of Incorporation, this Certificate of Designations or otherwise with respect to the issuance of Preferred
Shares may be effected by written consent of the Company&rsquo;s shareholders or at a duly called meeting of the Company&rsquo;s
shareholders, all in accordance with the applicable rules and regulations of the NRS. This provision is intended to comply with
the applicable sections of the NRS permitting shareholder action, approval and consent affected by written consent in lieu of
a meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Amendment</U>. Except for Section 4(d)(i), which may not be amended or waived hereunder, this Certificate of Designations or
any provision hereof may be amended by obtaining the affirmative vote at a meeting duly called for such purpose, or written consent
without a meeting in accordance with the NRS, of the Required Holders, voting separate as a single class, and with such other
shareholder approval, if any, as may then be required pursuant to the NRS and the Articles of Incorporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.
<U>Certain Defined Terms</U>. For purposes of this Certificate of Designations, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<B>1933 Act</B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;<B>1934 Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;<B>Additional Amount</B>&rdquo; means, as of the applicable date of determination, with respect to each Preferred Share,
all declared and unpaid Dividends on such Preferred Share and any other unpaid amounts then due and payable hereunder with respect
to such Preferred Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&ldquo;<B>Adjustment Right</B>&rdquo; means any right granted with respect to any securities issued in connection with, or with
respect to, any issuance or sale (or deemed issuance or sale in accordance with Section 8(a)) of shares of Common Stock (other
than rights of the type described in Section 7(a) hereof) that could result in a decrease in the net consideration received by
the Company in connection with, or with respect to, such securities (including, without limitation, any cash settlement rights,
cash adjustment or other similar rights).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&ldquo;<B>Affiliate</B>&rdquo; or &ldquo;<B>Affiliated</B>&rdquo; means, with respect to any Person, any other Person that directly
or indirectly controls, is controlled by, or is under common control with, such Person, it being understood for purposes of this
definition that &ldquo;control&rdquo; of a Person means the power directly or indirectly either to vote 10% or more of the stock
having ordinary voting power for the election of directors of such Person or direct or cause the direction of the management and
policies of such Person whether by contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&ldquo;<B>Alternate Conversion Floor Amount</B>&rdquo; means an amount in cash, to be delivered by wire transfer of immediately
available funds pursuant to wire instructions delivered to the Company by the Holder in writing, equal to the product obtained
by multiplying (A) the higher of (I) the highest price that the Common Stock trades at on the Trading Day immediately preceding
the relevant Alternate Conversion Date and (II) the applicable Alternate Conversion Price and (B) the difference obtained by subtracting
(I) the number of shares of Common Stock delivered (or to be delivered) to the Holder on the applicable Share Delivery Deadline
with respect to such Alternate Conversion from (II) the quotient obtain by dividing (x) the applicable Conversion Amount that
the Holder has elected to be the subject of the applicable Alternate Conversion, by (y) the applicable Alternate Conversion Price
without giving effect to clause (x) of such definition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&ldquo;<B>Alternate Conversion Price</B>&rdquo; <FONT STYLE="background-color: white">with respect to any Alternate Conversion
that price which shall be the lower of (i) the applicable Conversion Price as in effect on the applicable Conversion Date of the
applicable Alternate Conversion and (ii) the greater of (x) the Floor Price and (y) 85% of the price computed as the quotient
of (I) the sum of the VWAP of the Common Stock for each Trading Day in five (5) consecutive Trading Day period ending and including
the Trading Day immediately preceding the delivery or deemed delivery of the applicable Conversion Notice, divided by (II) five
(5) (such period, the &ldquo;<B>Alternate Conversion Measuring Period</B>&rdquo;). All such determinations to be appropriately
adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately
decreases or increases the Common Stock during such Alternate Conversion Measuring Period.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
&ldquo;<B>Approved Stock Plan</B>&rdquo; means any employee benefit plan which has been approved by the Board prior to or subsequent
to the Subscription Date pursuant to which shares of Common Stock and options to purchase Common Stock may be issued to any employee,
officer, consultant or director for services provided to the Company in their capacity as such.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&ldquo;<B>Attribution Parties</B>&rdquo; means, collectively, the following Persons and entities: (i) any investment vehicle,
including, any funds, feeder funds or managed accounts, currently, or from time to time after the Initial Issuance Date, directly
or indirectly managed or advised by a Holder&rsquo;s investment manager or any of its Affiliates or principals, (ii) any direct
or indirect Affiliates of such Holder or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as
a Group together with such Holder or any of the foregoing and (iv) any other Persons whose beneficial ownership of the Company&rsquo;s
Common Stock would or could be aggregated with such Holder&rsquo;s and the other Attribution Parties for purposes of Section 13(d)
of the 1934 Act. For clarity, the purpose of the foregoing is to subject collectively such Holder and all other Attribution Parties
to the Maximum Percentage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
&ldquo;<B>Black Scholes Consideration Value</B>&rdquo; means the value of the applicable Option, Convertible Security or Adjustment
Right (as the case may be) as of the date of issuance thereof calculated using the Black Scholes Option Pricing Model obtained
from the &ldquo;OV&rdquo; function on Bloomberg utilizing (i) an underlying price per share equal to the Closing Sale Price of
the Common Stock on the Trading Day immediately preceding the public announcement of the execution of definitive documents with
respect to the issuance of such Option, Convertible Security or Adjustment Right (as the case may be), (ii) a risk-free interest
rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of such Option, Convertible Security or
Adjustment Right (as the case may be) as of the date of issuance of such Option, Convertible Security or Adjustment Right (as
the case may be), (iii) a zero cost of borrow and (iv) an expected volatility equal to the greater of 100% and the 100 day volatility
obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately
following the date of issuance of such Option, Convertible Security or Adjustment Right (as the case may be).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
&ldquo;<B>Bloomberg</B>&rdquo; means Bloomberg, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
&ldquo;<B>Book-Entry</B>&rdquo; means each entry on the Register evidencing one or more Preferred Shares held by a Holder in lieu
of a Preferred Share Certificate issuable hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
&ldquo;<B>Business Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City
of New York are authorized or required by law to remain closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
&ldquo;<B>Change of Control</B>&rdquo; means any Fundamental Transaction other than (i) any merger of the Company or any of its,
direct or indirect, wholly-owned Subsidiaries with or into any of the foregoing Persons, (ii) any reorganization, recapitalization
or reclassification of the shares of Common Stock in which holders of the Company&rsquo;s voting power immediately prior to such
reorganization, recapitalization or reclassification continue after such reorganization, recapitalization or reclassification
to hold publicly traded securities and, directly or indirectly, are, in all material respects, the holders of the voting power
of the surviving entity (or entities with the authority or voting power to elect the members of the board of directors (or their
equivalent if other than a corporation) of such entity or entities) after such reorganization, recapitalization or reclassification
or (iii) pursuant to a migratory merger effected solely for the purpose of changing the jurisdiction of incorporation of the Company
or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
&ldquo;<B>Change of Control Redemption Premium</B>&rdquo; means 125%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
&ldquo;<B>Closing Bid Price</B>&rdquo; and &ldquo;<B>Closing Sale Price</B>&rdquo; means, for any security as of any date, the
last closing bid price and last closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg,
or, if the Principal Market begins to operate on an extended hours basis and does not designate the closing bid price or the closing
trade price (as the case may be) then the last bid price or last trade price, respectively, of such security prior to 4:00:00
p.m., New York time, as reported by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading
market for such security, the last closing bid price or last trade price, respectively, of such security on the principal securities
exchange or trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply,
the last closing bid price or last trade price, respectively, of such security in the over-the-counter market on the electronic
bulletin board for such security as reported by Bloomberg, or, if no closing bid price or last trade price, respectively, is reported
for such security by Bloomberg, the average of the bid prices, or the ask prices, respectively, of any market makers for such
security as reported in the &ldquo;pink sheets&rdquo; by OTC Markets Group Inc. (formerly Pink Sheets LLC). If the Closing Bid
Price or the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing
Bid Price or the Closing Sale Price (as the case may be) of such security on such date shall be the fair market value as mutually
determined by the Company and the Required Holder. If the Company and the Required Holders are unable to agree upon the fair market
value of such security, then such dispute shall be resolved in accordance with the procedures in Section 23. All such determinations
shall be appropriately adjusted for any stock splits, stock dividends, stock combinations, recapitalizations or other similar
transactions during such period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
&ldquo;<B>Closing Date</B>&rdquo; shall have the meaning set forth in the Securities Purchase Agreement, which date is the date
the Company initially issued the Preferred Shares, the Preferred Warrants and the Common Warrants pursuant to the terms of the
Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
&ldquo;<B>Common Stock</B>&rdquo; means (i) the Company&rsquo;s shares of common stock, $0.001 par value per share, and (ii) any
capital stock into which such common stock shall have been changed or any share capital resulting from a reclassification of such
common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
&ldquo;<B>Common Warrants</B>&rdquo; has the meaning ascribed to such term in the Securities Purchase Agreement, and shall include
all warrants issued in exchange therefor or replacement thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
&ldquo;<B>Contingent Obligation</B>&rdquo; means, as to any Person, any direct or indirect liability, contingent or otherwise,
of that Person with respect to any Indebtedness, lease, dividend or other obligation of another Person if the primary purpose
or intent of the Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee of such
liability that such liability will be paid or discharged, or that any agreements relating thereto will be complied with, or that
the holders of such liability will be protected (in whole or in part) against loss with respect thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
&ldquo;<B>Conversion Floor Price Condition</B>&rdquo; means that the relevant Alternate Conversion Price or other conversion price
determined pursuant to Section 11(a) hereof, as applicable, is being determined based on clause (x) of such definition or section,
as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
&ldquo;<B>Convertible Securities</B>&rdquo; means any stock or other security (other than Options) that is at any time and under
any circumstances, directly or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the
holder thereof to acquire, any shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
&ldquo;<B>Current Subsidiary</B>&rdquo; means any Person in which the Company on the Subscription Date, directly or indirectly,
(i) owns any of the outstanding capital stock or holds any equity or similar interest of such Person or (ii) controls or operates
all or any part of the business, operations or administration of such Person, and all of the foregoing, collectively, &ldquo;<B>Current
Subsidiaries</B>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
&ldquo;<B>Dividend Date</B>&rdquo; means, with respect to any given calendar month, the first Trading Day of such calendar month,
but with the first Dividend Date commencing on March 1, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
&ldquo;<B>Dividend Rate</B>&rdquo; means nine percent (9%) per annum, as may be adjusted from time to time in accordance with
Section 3(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
&ldquo;<B>Eligible Market</B>&rdquo; means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the
Nasdaq Global Market or the Principal Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
&ldquo;<B>Event Market Price</B>&rdquo; <FONT STYLE="background-color: white">means, with respect to any Stock Combination Event
Date, the quotient determined by dividing (x) the sum of the VWAP of the Common Stock for each of the five (5) Trading Days with
the lowest VWAP of the Common Stock during the fifteen (15) consecutive Trading Day period ending and including the Trading Day
immediately preceding the sixteenth (16th) Trading Day after such Stock Combination Event Date, divided by (y) five (5).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
&ldquo;<B>Excluded Securities</B>&rdquo; means (i) shares of Common Stock or options to purchase Common Stock issued to directors,
consultants, officers or employees of the Company for services rendered to the Company in their capacity as such pursuant to an
Approved Stock Plan (as defined above), provided that (A) all such issuances (taking into account the shares of Common Stock issuable
upon exercise of such options) after the Subscription Date pursuant to this clause (i) do not, in the aggregate, exceed more than
15% of the Common Stock issued and outstanding immediately prior to the Subscription Date, in the aggregate and (B) the exercise
price of any such options is not lowered, none of such options are amended to increase the number of shares issuable thereunder
and none of the terms or conditions of any such options are otherwise materially changed in any manner that adversely affects
any of the Holders; (ii) shares of Common Stock issued upon the conversion or exercise of Convertible Securities (other than options
to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) issued prior to the Subscription
Date, provided that the conversion price of any such Convertible Securities (other than options to purchase Common Stock issued
pursuant to an Approved Stock Plan that are covered by clause (i) above) is not lowered, none of such Convertible Securities (other
than options to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) are amended
to increase the number of shares issuable thereunder and none of the terms or conditions of any such Convertible Securities (other
than options to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) are otherwise
materially changed in any manner that adversely affects any of the Holders; (iii) the shares of Common Stock issuable upon conversion
of the Preferred Shares or otherwise pursuant to the terms of this Certificate of Designations; provided, that the terms of this
Certificate of Designations are not amended, modified or changed on or after the Subscription Date (other than antidilution adjustments
pursuant to the terms thereof in effect as of the Subscription Date), (iv) the Warrant Preferred Shares issuable upon exercise
of the Preferred Warrants; provided, that the terms of the Preferred Warrants are not amended, modified or changed on or after
the Subscription Date (other than antidilution adjustments pursuant to the terms thereof in effect as of the Subscription Date),
(vi) the shares of Common Stock issuable upon exercise of the Common Warrants; provided, that the terms of the Common Warrants
are not amended, modified or changed on or after the Subscription Date (other than antidilution adjustments pursuant to the terms
thereof in effect as of the Subscription Date) and (vii) shares of Common Stock and Common Stock issued upon the conversion or
exercise of Convertible Securities or Options (other than options to purchase Common Stock issued pursuant to an Approved Stock
Plan on or after the date of this Certificate of Designations that are covered by clause (i) above) issued or issuable pursuant
to strategic alliances, strategic mergers and acquisitions, strategic partnerships, strategic license agreements and other similar
transactions, provided that (I) the primary purpose of such issuance is not to raise capital, (II) the purchaser or acquirer of
such shares of Common Stock, Options and/or Convertible Securities in such issuance solely consists of the actual participants
in such strategic transaction or the stockholders, partners, members or Affiliates of the such participants, and (III) to the
extent there are multiple participants in such transaction, the number or amount (as the case may be) of such shares of Common
Stock, Options and/or Convertible Securities issued to such Person by the Company in such transaction shall not be disproportionate
to such Person&rsquo;s actual participation in such strategic transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
&ldquo;<B>Floor Price</B>&rdquo; means $0.18.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
&ldquo;<B>Fundamental Transaction</B>&rdquo; means (A) that the Company shall, directly or indirectly, including through subsidiaries,
Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company
is the surviving corporation) another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially
all of the properties or assets of the Company or any of its &ldquo;significant subsidiaries&rdquo; (as defined in Rule 1-02 of
Regulation S-X) to one or more Subject Entities, or (iii) make, or allow one or more Subject Entities to make, or allow the Company
to be subject to or have its Common Stock be subject to or party to one or more Subject Entities making, a purchase, tender or
exchange offer that is accepted by the holders of at least either (x) 50% of the outstanding shares of Common Stock, (y) 50% of
the outstanding shares of Common Stock calculated as if any shares of Common Stock held by all Subject Entities making or party
to, or Affiliated with any Subject Entities making or party to, such purchase, tender or exchange offer were not outstanding;
or (z) such number of shares of Common Stock such that all Subject Entities making or party to, or Affiliated with any Subject
Entity making or party to, such purchase, tender or exchange offer, become collectively the beneficial owners (as defined in Rule
13d-3 under the 1934 Act) of at least 50% of the outstanding shares of Common Stock, or (iv) consummate a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme
of arrangement) with one or more Subject Entities whereby all such Subject Entities, individually or in the aggregate, acquire,
either (x) at least 50% of the outstanding shares of Common Stock, (y) at least 50% of the outstanding shares of Common Stock
calculated as if any shares of Common Stock held by all the Subject Entities making or party to, or Affiliated with any Subject
Entity making or party to, such stock purchase agreement or other business combination were not outstanding; or (z) such number
of shares of Common Stock such that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under
the 1934 Act) of at least 50% of the outstanding shares of Common Stock, or (v) reorganize, recapitalize or reclassify its Common
Stock, (B) that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or
more related transactions, allow any Subject Entity individually or the Subject Entities in the aggregate to be or become the
&ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, whether through acquisition,
purchase, assignment, conveyance, tender, tender offer, exchange, reduction in outstanding shares of Common Stock, merger, consolidation,
business combination, reorganization, recapitalization, spin-off, scheme of arrangement, reorganization, recapitalization or reclassification
or otherwise in any manner whatsoever, of either (x) at least 50% of the aggregate ordinary voting power represented by issued
and outstanding Common Stock, (y) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common
Stock not held by all such Subject Entities as of the date of this Certificate of Designations calculated as if any shares of
Common Stock held by all such Subject Entities were not outstanding, or (z) a percentage of the aggregate ordinary voting power
represented by issued and outstanding shares of Common Stock or other equity securities of the Company sufficient to allow such
Subject Entities to effect a statutory short form merger or other transaction requiring other shareholders of the Company to surrender
their shares of Common Stock without approval of the shareholders of the Company or (C) directly or indirectly, including through
subsidiaries, Affiliates or otherwise, in one or more related transactions, the issuance of or the entering into any other instrument
or transaction structured in a manner to circumvent, or that circumvents, the intent of this definition in which case this definition
shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this definition to the extent
necessary to correct this definition or any portion of this definition which may be defective or inconsistent with the intended
treatment of such instrument or transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
&ldquo;<B>GAAP</B>&rdquo; means United States generally accepted accounting principles, consistently applied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
&ldquo;<B>Group</B>&rdquo; means a &ldquo;group&rdquo; as that term is used in Section 13(d) of the 1934 Act and as defined in
Rule 13d-5 thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
&ldquo;<B>Holder Pro Rata Amount</B>&rdquo; means, with respect to any Holder, a fraction (i) the numerator of which is the number
of Preferred Shares issued to such Holder pursuant to the Securities Purchase Agreement on the Initial Issuance Date and (ii)
the denominator of which is the number of Preferred Shares issued to all Holders pursuant to the Securities Purchase Agreement
on the Initial Issuance Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
&ldquo;<B>Indebtedness</B>&rdquo; means of any Person means, without duplication (A) all indebtedness for borrowed money, (B)
all obligations issued, undertaken or assumed as the deferred purchase price of property or services, including, without limitation,
&ldquo;capital leases&rdquo; in accordance with United States generally accepted accounting principles consistently applied for
the periods covered thereby (other than trade payables entered into in the ordinary course of business consistent with past practice),
(C) all reimbursement or payment obligations with respect to letters of credit, surety bonds and other similar instruments, (D)
all obligations evidenced by notes, bonds, debentures or similar instruments, including obligations so evidenced incurred in connection
with the acquisition of property, assets or businesses, (E) all indebtedness created or arising under any conditional sale or
other title retention agreement, or incurred as financing, in either case with respect to any property or assets acquired with
the proceeds of such indebtedness (even though the rights and remedies of the seller or bank under such agreement in the event
of default are limited to repossession or sale of such property), (F) all monetary obligations under any leasing or similar arrangement
which, in connection with United States generally accepted accounting principles, consistently applied for the periods covered
thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through (F) above secured by (or for
which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any mortgage, deed of
trust, lien, pledge, charge, security interest or other encumbrance of any nature whatsoever in or upon any property or assets
(including accounts and contract rights) with respect to any asset or property owned by any Person, even though the Person which
owns such assets or property has not assumed or become liable for the payment of such indebtedness, and (H) all Contingent Obligations
in respect of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">(ii)
&ldquo;<B>Intellectual Property Rights</B>&rdquo; means, with respect to the Company and its Subsidiaries, all of their rights
or licenses to use all trademarks, trade names, service marks, service mark registrations, service names, original works of authorship,
patents, patent rights, copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual
property rights and all applications and registrations therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
&ldquo;<B>Liquidation Event</B>&rdquo; means, whether in a single transaction or series of transactions, the voluntary or involuntary
liquidation, dissolution or winding up of the Company or such Subsidiaries the assets of which constitute all or substantially
all of the assets of the business of the Company and its Subsidiaries, taken as a whole.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
&ldquo;<B>Make-Whole Amount</B>&rdquo; means as of any given date, the amount of any Dividend that, but for any conversion hereunder
on such given date, would have accrued with respect to the Conversion Amount being redeemed hereunder at the Dividend Rate then
in effect for the period from such given date through the third (3<SUP>rd</SUP>) anniversary of the Initial Issuance Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
&ldquo;<B>Material Adverse Effect</B>&rdquo; means any material adverse effect on the business, properties, assets, liabilities,
operations, results of operations, condition (financial or otherwise) or prospects of the Company and its Subsidiaries, if any,
individually or taken as a whole, or on the transactions contemplated hereby or on the other Transaction Documents (as defined
below), or by the agreements and instruments to be entered into in connection therewith or on the authority or ability of the
Company to perform its obligations under the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
&ldquo;<B>New Subsidiary</B>&rdquo; means, as of any date of determination, any Person in which the Company after the Subscription
Date, directly or indirectly, (i) owns or acquires any of the outstanding capital stock or holds any equity or similar interest
of such Person or (ii) controls or operates all or any part of the business, operations or administration of such Person, and
all of the foregoing, collectively, &ldquo;<B>New Subsidiaries</B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
&ldquo;<B>Options</B>&rdquo; means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
&ldquo;<B>Parent Entity</B>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person and
whose common stock or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such
Person or Parent Entity, the Person or Parent Entity with the largest public market capitalization as of the date of consummation
of the Fundamental Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
&ldquo;<B>Permitted Indebtedness</B>&rdquo; means (i) Indebtedness set forth on Schedule 3(s) to the Securities Purchase Agreement,
as in effect as of the Subscription Date, (ii) Indebtedness secured by Permitted Liens or unsecured but as described in clauses
(iv) and (v) of the definition of Permitted Liens and (iii) Permitted Senior Indebtedness .</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
&ldquo;<B>Permitted Liens</B>&rdquo; means (i) any Lien for taxes not yet due or delinquent or being contested in good faith by
appropriate proceedings for which adequate reserves have been established in accordance with GAAP, (ii) any statutory Lien arising
in the ordinary course of business by operation of law with respect to a liability that is not yet due or delinquent, (iii) any
Lien created by operation of law, such as materialmen&rsquo;s liens, mechanics&rsquo; liens and other similar liens, arising in
the ordinary course of business with respect to a liability that is not yet due or delinquent or that are being contested in good
faith by appropriate proceedings, (iv) Liens (A) upon or in any equipment acquired or held by the Company or any of its Subsidiaries
to secure the purchase price of such equipment or Indebtedness incurred solely for the purpose of financing the acquisition or
lease of such equipment, or (B) existing on such equipment at the time of its acquisition, provided that the Lien is confined
solely to the property so acquired and improvements thereon, and the proceeds of such equipment, in either case, with respect
to Indebtedness in an aggregate amount not to exceed $250,000, (v) Liens incurred in connection with the extension, renewal or
refinancing of the Indebtedness secured by Liens of the type described in clause (iv) above, provided that any extension, renewal
or replacement Lien shall be limited to the property encumbered by the existing Lien and the principal amount of the Indebtedness
being extended, renewed or refinanced does not increase, (vi) Liens in favor of customs and revenue authorities arising as a matter
of law to secure payments of custom duties in connection with the importation of goods, (vii) Liens arising from judgments, decrees
or attachments in circumstances not constituting a Triggering Event under Section 5(a)(ix) and (viii) Liens with respect to Permitted
Senior Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)
&ldquo;<B>Permitted Senior Indebtedness</B>&rdquo; means the principal of (and premium, if any), interest on, and all fees and
other amounts (including, without limitation, any reasonable out-of-pocket costs, enforcement expenses (including reasonable out-of-pocket
legal fees and disbursements), collateral protection expenses and other reimbursement or indemnity obligations relating thereto)
payable by Company and/or its Subsidiaries under or in connection with any credit facility to be entered into by the Company and/or
its Subsidiaries with one or more financial institutions (and on terms and conditions), in form and substance reasonably satisfactory
to the Required Holders; provided, however, that (i) no Permitted Senior Indebtedness is outstanding during the Restricted Period
(as defined in the Securities Purchase Agreement (or until such earlier time as approved by the Required Holders), (ii) the aggregate
outstanding amount of such Indebtedness permitted hereunder (taking into account the maximum amounts which may be advanced under
the loan documents evidencing such Permitted Senior Indebtedness) does not at any time exceed $2,000,000, (iii) such Permitted
Senior Indebtedness shall not be convertible or exchangeable, directly or indirectly, into Common Stock of the Company and (iv)
no Convertible Securities or Options shall be issued in connection with such Permitted Senior Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)
&ldquo;<B>Person</B>&rdquo; means an individual, a limited liability company, a partnership, a joint venture, a corporation, a
trust, an unincorporated organization, any other entity or a government or any department or agency thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt)
&ldquo;<B>Preferred Warrants</B>&rdquo; has the meaning ascribed to such term in the Securities Purchase Agreement, and shall
include all warrants issued in exchange therefor or replacement thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(uu)
&ldquo;<B>Principal Market</B>&rdquo; means the Nasdaq Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vv)
&ldquo;<B>Redemption Conversion Floor Amount</B>&rdquo; means an amount in cash, to be delivered by wire transfer of immediately
available funds pursuant to wire instructions delivered to the Company by the Holder in writing, equal to the product obtained
by multiplying (A) the higher of (I) the highest price that the Common Stock trades at on the Trading Day immediately preceding
the relevant Conversion Date and (II) the applicable conversion price determined in accordance with Section 11(a) above and (B)
the difference obtained by subtracting (I) the number of shares of Common Stock delivered (or to be delivered) to the Holder on
the applicable Share Delivery Deadline with respect to such conversion from (II) the quotient obtain by dividing (x) the applicable
Conversion Amount that the Holder has elected to be the subject of the applicable conversion, by (y) the applicable conversion
price determined in accordance with Section 11(a) above without giving effect to clause (x) of such definition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ww)
&ldquo;<B>Redemption Notices</B>&rdquo; means, collectively, the Triggering Events Redemption Notices, and the Change of Control
Redemption Notices, and each of the foregoing, individually, a &ldquo;<B>Redemption Notice</B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xx)
&ldquo;<B>Redemption Premium</B>&rdquo; means 125%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(yy)
&ldquo;<B>Redemption Prices</B>&rdquo; means, collectively, any Triggering Event Redemption Price, Change of Control Redemption
Price, and each of the foregoing, individually, a &ldquo;<B>Redemption Price</B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(zz)
&ldquo;<B>Registration Rights Agreement</B>&rdquo; means that certain registration rights agreement, dated as of the Closing Date,
by and among the Company and the initial holders of the Preferred Shares relating to, among other things, the registration of
the resale of the Preferred Shares, the Common Stock issuable upon conversion of the Preferred Shares or otherwise pursuant to
the terms of this Certificate of Designations and exercise of the Common Warrants, as may be amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aaa)
&ldquo;<B>SEC</B>&rdquo; means the United States Securities and Exchange Commission or the successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bbb)
&ldquo;<B>Securities Purchase Agreement</B>&rdquo; means that certain securities purchase agreement by and among the Company and
the initial holders of Preferred Shares, dated as of the Subscription Date, as may be amended from time in accordance with the
terms thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ccc)
&ldquo;<B>Series E Preferred Stock</B>&rdquo; shall mean the Series E Convertible Preferred Stock, par value $0.001, of the Company
as in effect as of the Initial Issuance Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ddd)
&ldquo;<B>Stated Value</B>&rdquo; shall mean, with respect to any given Preferred Share, the sum of (x) $1,000 per Preferred Share,
and (y) the aggregate amount of any Capitalized Dividends per such Preferred Share, in each case, subject to adjustment for stock
splits, stock dividends, recapitalizations, reorganizations, reclassifications, combinations, subdivisions or other similar events
occurring after the Initial Issuance Date with respect to the Preferred Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(eee)
&ldquo;<B>Subscription Date</B>&rdquo; means January 28, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(fff)
&ldquo;<B>Subject Entity</B>&rdquo; means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons
or Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ggg)
&ldquo;<B>Subsidiaries</B>&rdquo; means, as of any date of determination, collectively, all Current Subsidiaries and all New Subsidiaries,
and each of the foregoing, individually, a &ldquo;<B>Subsidiary</B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hhh)
&ldquo;<B>Successor Entity</B>&rdquo; means the Person (or, if so elected by the Required Holders, the Parent Entity) formed by,
resulting from or surviving any Fundamental Transaction or the Person (or, if so elected by the Required Holders, the Parent Entity)
with which such Fundamental Transaction shall have been entered into.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
&ldquo;<B>Trading Day</B>&rdquo; means, as applicable, (x) with respect to all price or trading volume determinations relating
to the Common Stock, any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the
principal trading market for the Common Stock, then on the principal securities exchange or securities market on which the Common
Stock is then traded, provided that &ldquo;Trading Day&rdquo; shall not include any day on which the Common Stock is scheduled
to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during
the final hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing
time of trading on such exchange or market, then during the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise
designated as a Trading Day in writing by the applicable Holder or (y) with respect to all determinations other than price determinations
relating to the Common Stock, any day on which The New York Stock Exchange (or any successor thereto) is open for trading of securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jjj)
&ldquo;<B>Transaction Documents</B>&rdquo; means the Securities Purchase Agreement, this Certificate of Designations, the Preferred
Warrants, the Common Warrants and each of the other agreements and instruments entered into or delivered by the Company or any
of the Holders in connection with the transactions contemplated by the Securities Purchase Agreement, all as may be amended from
time to time in accordance with the terms thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kkk)
&ldquo;<B>VWAP</B>&rdquo; means, for any security as of any date, the dollar volume-weighted average price for such security on
the Principal Market (or, if the Principal Market is not the principal trading market for such security, then on the principal
securities exchange or securities market on which such security is then traded), during the period beginning at 9:30 a.m., New
York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg through its &ldquo;VAP&rdquo; function (set to 09:30
start time and 16:00 end time) or, if the foregoing does not apply, the dollar volume-weighted average price of such security
in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30 a.m., New
York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg, or, if no dollar volume-weighted average price is
reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask
price of any of the market makers for such security as reported in the &ldquo;pink sheets&rdquo; by OTC Markets Group Inc. (formerly
Pink Sheets LLC). If the VWAP cannot be calculated for such security on such date on any of the foregoing bases, the VWAP of such
security on such date shall be the fair market value as mutually determined by the Company and the Required Holders. If the Company
and the Required Holders are unable to agree upon the fair market value of such security, then such dispute shall be resolved
in accordance with the procedures in Section 23. All such determinations shall be appropriately adjusted for any stock dividend,
stock split, stock combination, recapitalization or other similar transaction during such period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(lll)
&ldquo;<B>Warrant Common Shares</B>&rdquo; means, collectively, the shares of Common Stock issuable upon exercise of the Common
Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mmm)
&ldquo;<B>Warrant Preferred Shares</B>&rdquo; means, collectively, the Preferred Shares issuable upon exercise of the Preferred
Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.
<U>Disclosure</U>. Upon receipt or delivery by the Company of any notice in accordance with the terms of this Certificate of Designations,
unless the Company has in good faith determined that the matters relating to such notice do not constitute material, non-public
information relating to the Company or any of its Subsidiaries, the Company shall within one (1) Business Day of such receipt
or prior to (or simultaneous with) such delivery, as applicable, publicly disclose such material, non-public information on a
Current Report on Form 8-K or otherwise. In the event that the Company believes that a notice contains material, non-public information
relating to the Company or any of its Subsidiaries, the Company so shall indicate to such Holder explicitly in writing in such
notice (or immediately upon receipt of notice from such Holder, as applicable), and in the absence of any such written indication
in such notice (or notification from the Company immediately upon receipt of notice from such Holder), such Holder shall be allowed
to presume that all matters relating to such notice do not constitute material, non-public information relating to the Company
or any of its Subsidiaries. If the Company or any of its Subsidiaries provides material non-public information to a Holder that
is not simultaneously filed in a Current Report on Form 8-K and such Holder has not agreed to receive such material non-public
information, the Company hereby covenants and agrees that such Holder shall not have any duty of confidentiality to the Company,
any of its Subsidiaries or any of their respective officers, directors, employees, affiliates or agents with respect to, or a
duty to any of the foregoing not to trade on the basis of, such material non-public information. Nothing contained in this Section
32 shall limit any obligations of the Company, or any rights of any Holder, under Section 4(i) of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* * * *</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Certificate of Designations of Series D Convertible Preferred Stock of Sigma Labs,
Inc to be signed by its Chief Executive Officer on this 27th day of January, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SIGMA LABS, INC.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    John Rice</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    Rice</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
I</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGMA
LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONVERSION
NOTICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference
is made to the Certificate of Designations, Preferences and Rights of the Series D Convertible Preferred Stock of Sigma Labs,
Inc (the &ldquo;<B>Certificate of Designations</B>&rdquo;). In accordance with and pursuant to the Certificate of Designations,
the undersigned hereby elects to convert the number of shares of Series D Convertible Preferred Stock, $[ ] par value per share
(the &ldquo;<B>Preferred Shares</B>&rdquo;), of Sigma Labs, Inc a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), indicated
below into shares of common stock, $0.001 value per share (the &ldquo;<B>Common Stock</B>&rdquo;), of the Company, as of the date
specified below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    of Conversion:</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="5" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
    number of Preferred Shares to be converted</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="5" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="5" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
    Stated Value of such Preferred Shares to be converted:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="5" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="5" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
    accrued and unpaid Dividends and accrued and unpaid Late Charges with respect to such Preferred Shares and such Aggregate
    Dividends to be converted:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="5" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="5" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGGREGATE
    CONVERSION AMOUNT TO BE CONVERTED:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="5" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    confirm the following information:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
    Price:</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="4" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Common Stock to be issued:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="4" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
        If this Conversion Notice is being delivered with respect to an Alternate Conversion, check here if Holder is electing
        to use the following Alternate Conversion Price:____________</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
        issue the Common Stock into which the applicable Preferred Shares are being converted to Holder, or for its benefit, as
        follows:</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
        Check here if requesting delivery as a certificate to the following name and to the following address:</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    to:</FONT></TD>
    <TD COLSPAN="5" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="5" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="5" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="4" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
    Check here if requesting delivery by Deposit/Withdrawal at Custodian as follows: </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC
    Participant:</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC
    Number:</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
    Number:</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 52%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
_____________ __,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Registered Holder</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18.45pt; text-align: justify; text-indent: -18.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 29.5pt; text-align: justify; text-indent: -18.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
ID:_____________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36.7pt; text-align: justify; text-indent: -18.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 29.5pt; text-align: justify; text-indent: -18.7pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Facsimile:___________________</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18.45pt; text-align: justify; text-indent: -18.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18.45pt; text-indent: -18.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail
Address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18.45pt; text-indent: -18.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18.45pt; text-indent: -18.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACKNOWLEDGMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby (a) acknowledges this Conversion Notice, (b) certifies that the above indicated number of shares of Common Stock
[are][are not] eligible to be resold by the Holder either (i) pursuant to Rule 144 (subject to the Holder&rsquo;s execution and
delivery to the Company of a customary 144 representation letter) or (ii) an effective and available registration statement and
(c) hereby directs _________________ to issue the above indicated number of shares of Common Stock in accordance with the Transfer
Agent Instructions dated _____________, 20__ from the Company and acknowledged and agreed to by ________________________.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SIGMA LABS, INC.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 57; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex10-2_001.jpg
<TEXT>
begin 644 ex10-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9]CRKZH&P6'!Y&:VJ "BH+.]MM0MA<6DZ30EF4.AR"58J1^!!'X5/0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%<3\4?#6H^*O#$-EH]W'!J=M=QWENKOM$A3(Q^&[/ID#-=M7.^*M U/6GTN?
M2=872[JPN3.)&MA,) 492A&X<$-SS^H!H XKP9XUG\0>)H_#OC719-.\26]O
M(D#894N8V'[SCH,^6#D$@X.",<U_BY"+?Q7\-4MT"K%JRHB@'C#PX'IVKM[+
MPW?W7B>VU_7Y[&6ZL87ALTLH6C"!\;V<LQ+$XX' 7)ZDYK+\;^ M3\6Z_HVI
MP:W;V(T:87%K&UD92TFY6)=O,''R+P!Z\^@!V,D5EI[WFJ2!8F,0-Q+D_<C#
M$$CV!;_.*\-A\33:-\9]'U^ZU!&L?$ML(IHO-1OLP+$1(P4D*5'E$D]VDYZU
MZ[XFTK6-9T*.QLKRSMY'9#=&6%G25 060 ,"%;&#DGY21WR,7X@_#M/&VB0:
M;;O9:=LE$S3BVWON P%&"O')S^'% '47UC9P-?:L(HTO&L_)>X89Q&FY@,'C
M +,>G/?H*\W^!^G6NH?"BVBN8@Z+J)N!@X/F1R*Z'(]"B_ECI7=MI>M-X+.E
M/J%K+J;6QMVNVA8(V05W;=V<XQWY-9OPX\'7W@;P_)HUS?P7L E,L,D<1C8;
MNH().>>E 'G4VHW^D_'WQU?:;IL]_<Q:*I2*)D7!\NV.26(X&.@R3V!KV/1[
M*&&)[]0?M%^D4UPV>'<1JN<>N% _ 5Q%MX"\1V?Q'U/QC#J>EM+J$1@DM);=
MV41X0!=P8<_NUYQSSQS75>'=(U>QOM0O=8OK2XEN%BBACM(#%'!''NPH!8D\
MN3_G@ \[^(5S-J/QN\&>'KIF?2@$O3!U5Y0TF"PZ' 0#Z,?6M'X^%H/ 5MJ$
M$KPWEGJ,,MO-&=KHV&'!'(ZY_ 5T_C'P3'XEN-.U2TNC8ZWI<HEL[K!9>N2C
MKD;E./K^!(.=K/@S6?&K6%KXKN=/72K67SY+73Q)FX<*0NYF/RJ,DX /U[@
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M^(?!)T%+?2[6:155IH[<A8MIR#& <@Y ZGID'K61JGPZU_5?AI:^#I];LY!
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MV/E YX#KA S=</QF@#UVBHX%*01HSL[*H!=ARW'4U)0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7'>,? \WB^_TN:;55
M@MM-N5N8K86Y82.,??.\9'&.,'!/-=C10!Q?_" ?:/%T?BK4M5DO=7MH3%9
MPA+>#AL'RP=S?>)Y?N?;&OHVA76DV5_OU"*YU.\F::2^>VVEB1A0RAN0H 4
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M1)H(%B$F^10?FD9B2Y.23ZY.<DYK2/AO4KK5K"[U/Q!+<VUH_F_8H[9(HY)
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M>,#US#J_PL.JV'A:W761:R>'546TT-I\S%=NTG+_ .PN?4Y/? ]%HH XC7?
M5UX@\4:3KMWK,0FTEM]I MF?*#9!+,/,R3P.A'05I6?AK4O^$C@U?5M?DOEM
MHW6WM$MUABC=A@O@$EFVY')X#''6NEHH **** "BBB@ HHHH **** "BBB@
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M\W=D@H6W-( 2<<$'%8=EXJU2?[%_94UCIFCZD9(F&B0GSB4VJ5)E (EVE6#
MCJ.3S7.7.D74>H1VY(O[J\C-S;SV[Y%PO&7)SDG[P.X@@Y&"26H GN7GM]<7
M59[1(9)BMTJ74+'ST&P*PVLOF# RQ7&23T!-:S934/[1L=-BCN[]Y+72M)MU
M^ZRE5W$$_*"I89Z ;C@?-39;W4Y=;LH+U)M8UQ1&EE9[=S1QJ<GS.FX< Y=A
MPYQU+5ZYX!^'Z^&D&JZJZW7B&:,I+.K$I$AQ\B _09/4G/:@"_X"\(+X3T+;
M<.9]6N\37]P3G?(<G [!02<8]2>]=7110 4444 %%%% !1110 4444 %%%%
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MO 2'*Y+$ 8/)YYP)[OP#;ZWX>T+3-=F2Y.F72W4K11[5N6 ?A@2<!BP9O7!
MQGCLJ* .$O? >I:G\1-*\77>L6P.G*8X[!;1BFT[@3O,GWL/G.WJ!P<4W5O
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M44 %%%% !1110 4444 %<+J.JV%U\3K)+F]BCMM%M))0"2 ]S+\FT=F98PW
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MA3ZCTI3%&91*8U\P#:'QR!Z9I]% !1110 4444 %%%% !1110 4444 %%%%
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M/'2NRBL;2&T:TBM8([9MVZ%(P$.XDME>G)))]2352#PYHEMI\MA!H^GQV<H
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M"-/';J'>%5A /S,BJ>C84Y/J/0;33+"Q2!+2QMH%MXS%"(HE7RT)!*K@< D
MD#K@5S^I>#H)[B'[-:::UA!"(X+&6 I';ON9FEC*8VLV0"<9XX(RV0#(NM3\
M267AF*YN=0GBG%WYESF"'[1;6;^:D+.H!4G<(F? XPX'2N]MEF6UB6X=7G"
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MW5X'5[G3K*6XB@0_*.<8#G/&X@#DG@ , =!<Z[I-JEJ;F_MT2[ \@LXQ(#@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %<JG@^\M-1U*ZT[Q/J=HFH2M-+!Y<,B1N
M?XH]R?+P/?/4YKJJ* .)U;X9:5J/@NS\)6]W<V&DV^"Z0!"\Q!SEF93SG).,
M9)].*5_ -U+:6.GS>+-6ETRT,(%H8X%$B1XPKLJ!F!P,\UVM% ',>(?!%GKF
MK6FLV]Y=Z7K%J"J7MD5#NG]QPP(=<]B*MV&@74%\+[4-:N]2N(TVP"5$CBB)
M&&8(@ 9CZMG&2!@$YW** .+\.?#U/#VOZMJIUBZO3JY+7T%Q$FR4_-C@ 8QN
M/X'%0Z)\-E\-6^J6>C:[>V^GZ@S.;5XXW6$MP2AQD<<?3'<9KNJ* .#T'X<W
M?AGP_+HND>+-0M[5V9E)@A9D+#G:2N1Z_P L5T5OH!L_"<6@VM],FRW\@W3@
M/(V1@MSQN.2<^];5% '+>!?!4?@729=+M=0FN[1Y#*@F10R,>#R,9!P.WXU<
M\.Z!>:&-2-QK$NHR7MP;DR30JI5RH7'RXRN%4 =@,?3=HH X?P[\/&\+ZKJU
M_IFNW*?VF[RS6[0(85D8DAE7'&W<<#.,<'/%-\)_#&R\+:?J>F'4;C4M,U,'
M[3;7B@Y8C!8$8P2.OT'3%=U10!RO@GP8?!-E+I]OK%W>:>6+0V]RJ_N"3D[6
M S@^AX],<YI67P]:R\?7'C(:U*^HW2>7<1>0HA>/:J[0,[A@(N#N/(YSS7;T
M4 %<KJW@B"\\31^)=+OYM*UE8C!+-"BNEQ'Q\LJ,/FQ@8.0>!Z#'544 <UHW
M@RTT[7KCQ!>W$FI:Y<((VNYE"B-  -D:#A1Q[DY.3S5#1_A\-(\<7OBL:S<W
M%[?(8[B.2)-C)\N ,#(QL7'/;O7:44 %<F/!UY9ZSJ>IZ3XBO+-]2F$MQ \4
M<T0(4+E%(!5L <Y.<<C@8ZRB@#&T/PW:^'=#?3=-=T=R\DERX#/),WWI6[$D
M\XZ< =!63X9\"_\ ",ZWJ.J1:Y>W4FIS&:]CG2/;(W.",*"N"QZ'&,#M77T4
M 8%GX;FMO%MYK[ZQ=3_:8E@^RO&GEQHI)4*0,\%F/7G/-9'_  K>U3Q[+XR@
MUC4(=2F<>;&FSR7C 5?+*[<XPHR<]>>*[:B@#D?&?@"U\;RV?V_5=0MH+-O,
MABM#&H$G/SDLI)/08Z<>]:^LZ++K?AZ72)]1EB6XB,%S-%&@>6-E*L!D$*2#
MU XK7HH X'3_ (9/I/AXZ!IWB[6[;2RC#RHUMP^6.6Q)Y>X#.> <\]:[>QM(
M["PMK.'=Y5O$L2;CD[5  S^53T4 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !3(88[>&.&&-(XHU"(B*
M JJ.  !T I]% !33&AD60HI=05#8Y .,C/O@?D*=10 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ==,L*M'-@$[@#G'!7H>H/8BNJD\2>(="^*&D^']5O[>[L-9MW9#';^6UM*
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M;.HMQ+YD9W="2 I&]L$@C..#TKL:* .(T[P'>Z?K_BC51KB.=>C*M$+0J(2
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M9)ZFG4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<X%>K4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% %==/LD,I6T@4S;O,(C W[NN>.<]\TMQ9
MVMUC[1;0S;>GF(&Q^=3T4 5WL+.2T%H]I UL.D+1@IZ_=QBI8X8H@!'&B *$
M&U0,*.@^@R:?10!76PLTE$JVD"R Y#", Y]<XIPM+871NA;Q"X*[#-L&\KZ9
MZXJ:B@"NEA9QR"1+2!9 <AA& 0?KBI%MX%N&N%AC$S#:T@4;B/0GK4E% #)8
MHYHS'+&LB'JK#(/X5&UC:-$L36L)C3E4,8P/H*GHH B6UMTC6-8(E16W*H0
M ^H'K0EM;QSO.D$2S2</(J ,WU/>I:* (?LEMNW?9XMV[?G8,[O7Z^].^SP[
MG;R8]SMN<[1ECC&3ZG  J2B@"(VT!B\HPQF/.=I48S]*EHHH 8(8@X<1H&&<
M':,C/7\Z:+: 7!N!!&)R,&38-Q'UZ]A^52T4 5+G2M.O)HYKJPM9Y8AB-Y85
M8IWX)'%6Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+(B@$\@$X.!G&?K@UPWC7X<7_BWQ3-J:WL5O"NE&UM2DTB21SB3S$D.T8(#
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M>3C !EM/JGB7Q%+H<]Y=:;]CT>*>5K1RA^U3;@&)!Y";"0IX))SG J"X>_\
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M),_/(5!+-C!VJ,LW3@'OBJ2^%)HO">N:8EU%)?:PUQ+/.\9"!YAM.%!SM5<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS#. =S?= ZCKGVJUHGB.:?P19Z[J\*132Q@LEJ"ZRL6VIY8/)#DJ5'^T.>]
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MEB8,K@]""."* )/+3Y/D7Y.5X^[QCCTX)IU%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7C_TFW1PZHW0X()&#UZGK67/X!\-W.EV&GR6,IAT]@UFXNI1+;D  ;)-V\
M*,9Q\HXX%;4>FVL6F?V?&LB6^PI\LKA\'J=^=V3DDMG))SF@#P6*SN_AUX9L
MO$]JK3^'-?TB"+4K-!_Q[W$D Q,HZ8+=?]\C'W<=OXV\2Z]X;TB+^RY[>(6^
MD"Y2!8?-F9U*ARZGA8E4CY@<YKN4\-Z2GAO_ (1XVIDTKR?L_P!GEE>3]WC
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M 49F8N3@]]Q)SZTS3="TW2"6LK8(Y7;O=VD?;UQN8DX]LXH T:*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BLO5?$.GZ-<6]O=&Z:>X5WCCM;*:Y8JN Q(B1B!\R\G'6
MJ5CXWT+4A:&TEO9$O YMY#IUPJ2[5+$*QC )PK<9R<8&30!T-%4-$UBVU_1K
M75;(2"VN5WQ^8NUL9(Y';I5^@ HHHH ***R]>UVV\.Z<M]=PW$D)FCB/D)N*
MEV"@GD<9(_.@#4HHHH ***JZ;>G4=/ANS:7-H9 3Y%T@21.<?, 3CUZT 6J*
M** "BBL>;Q#!!XLM?#SVMQY]S;/<I/A?**H0",YSNY';O0!L451UG5K70M'N
MM4O"_P!GMD+L(UW,WH%'<DX ]S6;HOB6ZU/4;BPN_#FK:;/"I<O<(AB8?+@"
M16*ECN/ )QM;)% '045A:5XGCU?PU'K5MIU\4>=H?LP13,I68Q$D;L<$%CSP
M >IXK=H **** "BBLC6=;.F3V=G;6;WM_>%S#;I(J95!EW+,< #*CZLON0 :
M]%<?)XYN&M1-9^&-6NGBBB>\MD55GMV?.$V,0688R<<8(.<&NILYY+FQM[B6
MWDMI)8U=H)""T9(R5..,CIQ0!/1110 456U"[-AIUS=K!)<&")I/*C(#/@9P
M,D#/U-1:+J::UH.G:K'&T27MM'<JC')4.H8 _3- %ZBBB@ HK(\4:\/#/AR\
MUE[.:[2U3>\4)4-M[GYB.!^?M6E;3"YM89PNT2(KX],C- $M%%% !1110 45
M!<7EO:O D\JHUQ)Y40/5WP3@>^%)_ U'#=S/=WD<UH\$$!7RYW==LP*Y) !R
M #QSCD'M0!;HKD;#Q?JFHWEAY'A6\;3;\++!?"=-JPGG?(IY4X*D+R3D^E==
M0 445!>7EOI]G+=W<JQ01+N=VZ 4 3T5AP^(Q+XUN?#364D;PV2WBW!<%9$9
MMO ZCD,.?2MR@ HJM<7]K:7-I;3S*DUY(8H$/5V",Y ^BJQ_#W%27-S#9VLM
MS<2+%!$A>1V. J@9)- $M%8(\2-_PGG_  C#6+*#IS7ZW9D&& D5-H7&>K'D
MGL.N>-Z@ HHHH **J/J=E&UX'N$7[&@DN">!$I!;)/3H":G@GCN;>*XA;=%*
M@=&QC((R#S0!)116/?:W)9>)M*TC[&'CU!)C]H\T#88UW8VXYSD=Z -BBBB@
M HK%TK7)=0U_6M+ELA!_9K1!9!-O\T.I8'&!MX XR>M;5 !1110 454U2>]M
MM,N)M.LEO;Q$S%;M*(A(WIN((%6Z "BBB@ HHHH ***J#4[0ZN=+$P-XL'VA
MHAU5"VT$_4YQ]#0!;HHHH **0$$D @XX/M0S!1EB /4T +12$@$ D#/ ]Z4$
M'H<T %%86FZW=7GB[6]'FMHHX=/BMI8I%<LTHE\S.>!C!CZ<_6MN21(D+R.J
M*.K,<"@!U%)N&<9&?2H_M,'E-+YT?EKU?<,#\: ):*89HA#YQD018W;]PVX]
M<^E4K[6]-TZ.UDN;N)5NID@@^<?O'8X 'KZGT - &A1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% ";5W;L#=C&<<XKD_ADG_%L_#A89/V-&!)SR<\_K7531
M^=#)%O=-ZE=R'##(Z@]C6?HN@6'A_25TO34EBLDR(XC,[>6#V5B<@9R>O>@#
MS3PQ>:OH?A;P%<IJC&TOKT:?+8B-&C\MQ*58.5W[@4'.<>WKH6.H>+=?D.MV
M=_8VEK;:I+#-'->G8((Y2AC:(1'YR!G<7SDCH" .LB\#>'X=-TW3TM9Q;:9<
M?:;1/MDW[N7).[._)ZG@Y')]:!X(T)=>?6$MIDN))A<2QI<R"&28=)&B#;"P
MZYQUYZ\T 0_$6>ZL_ .L7ME=S6MU:V[312PM@AE_F*BDGO9/'=G:#4[F&*]T
M2:5X4";8Y4DA"N@8'#8D?@@CIUKI-0L+75-/N+"]A6:UN(VBEC;HRD8(XY'X
M5AVW@+P_:W<5VEO<FZCM&LQ.]Y,TAB;^$MNSQV].V.* .5\-ZEK?]G^!-5NM
M8O;Z35V,-S ZH(]I@DD# *H.04!R2>,]NE;67F\1_#:YUZ;5+K=-?H!;A@(8
MD6]550H!U"J,DG.<\XXKO(/"&B6UKI5M%:R+#I+%K(?:928B?<MD\$CG. <=
M.*J77P]\,W9NQ+93B.[G%Q/#'>SI$\@8-O\ +5PH.0#D"@#GKZ[\0Z_J7B-=
M.U&#3CI-TL4<DMZT0A5423?)%Y9#JV6Y+ $#&!@YT+"/4;_QIK#3^(KR.PM5
MLKJ.&%HQ'@JY9#E>(SCV8]VX&-;4/ WAS5-8BU6[TU6O$"@LLCH)0OW1(H($
M@''W@>..G%:$>@Z;%JE]J26["[OHUBN7\U\2*HPH*YQP,X..,GU- '%>#Y]0
M_MB.RUFYU>VU>:TE9Y#/]HLKP[D/G6['*)@8^3:,!\8XS5>TU/49/!O@Y;^]
MOI+:_N'2_N+:24W+C;(R!3&-^"P7.T# '4 &NTTSPEHVD) EG!<*MO UO!YE
MY-)Y,;8RJ%W.S[HZ8Z"N<\0>#Q!;:+I^D^'XK_1K)I6:T%^\$L+L %9')Z8:
M3*Y')!S0!B7B>)=/\,^>^N:Q#&^OP6]@LQ7S3:-,JKOW)YA)RW#G)&W/I5J\
MU+4?"G_"86D6K7EU' +">&>^E\QK<W,C1R$-CA5"[@,87GCKG7T+P5')I]Q;
M:Q8R0V+3QRVFGOJ<UR8"F3O+EN&).<*2!@'.<UTK^']+DN[ZZDM \M_"L%UN
M=BLJ 8 *DXX!/;/)]30!P.I7&N>"+#5;T:Y#);O9*]O:37,MW+$WFHC3AY#N
M* 2 D<C.#TXJU#I<.F?%;P^8=0O;R.?2KIQ+=W;3[VW199<G"Y&#A<+Z 5U&
ME^"?#>C:?=6-CI426UVABG21FDWIS\F7).WD_*.!D\<U#IW@#PQI6I6NHV>F
ME+NU0QP2/<2OY2G^%0S$ >@[=L4 9GQ9LH[KP+.SR3H4N;4+Y4[QCYKF($D*
M0#@=,YP>1SS5IK>73_B%HEI!J%\UH^F7A:VFN'D7*R0[6)8DLW[QAEB<#@8K
M>UC1-/U^Q-EJ=O\ :+8L',9=E!(.1G:1G!Y^HI6T6P;5;;4VA9KVUA,$4S2N
M2J'J.N#GC).3P/2@#SRV^U1_"N"YM+ZYM98=;E.8'V[U;4G5E;O@JQXS^=6M
M3L-0OO$?C.V&OZO!!!86US;)#<F,12$3GY2!D#*@D#KWS@"NH/@GP^VD'238
ML; S>>8#<2[?,SG=][UY^O/6KC^'=+>XU"X:W<RZC$(;IO.?]Z@! !^;C )Z
M>I]30!Y^=7U'6)/!G]JW5^;&_P!%-W.-*:1)FNML9WN(3NV#<<<;=Q (Z5U_
M@&VUFV\&V/\ PD,UQ)JTJF2X^T2!F4D\+QTX X[$FN<\0>"9/[9T[[%X;LM4
MTFSLOL]K%)J,EM):/EB2&Y)4C8OJ,<<5UGA31Y]$T=K:?";YFE6W6X>=;<''
MR+(_S,,@G) Y8X&,4 <I<+)KUGXKU.;6-1L+S2+R:.U:WNVC2W6)%92T8.QP
MW4[P<AL<"EDL8]8\9>$;V_:\AN[S2+B>>.'4+B$(X^S'"JKC:,DY P&QSD@5
MU6H>#]!U2^FO+S3UDFN BW $CJEP$^Z)4!"R =MP-7;C1K"ZU2WU.:%FO+<%
M891(P* XR  <8.!D=\<T </9:)!;^(O'<UM<ZE'*D<>R0:A.2&:W!)PS$$CC
M!(..@QC%10WLNM7O@W0=6O[N.UO=#^V.T5R\,EU<A8^"Z$,<!G; /)P3G%=Q
M'X<TF*74)4LP)-1&V\;>V9QC'S<\\$@>@XJM?>#/#NI:/:Z3>:5#-8VA!MXF
M+?NL=-ISD#VSC'% '&7*>?J^A>#G\03W5@;6Y;[1/.Z27<T<BJ$+Q,C,44MD
M9 )'.2.'?V1=&^\,Z3<>*M0NV9[VWFGMKJ2-G558@'DY=<A=^=W&/6NSU#PA
MX>U31(=&O-(M9=.@QY,&S:(\#'RXP5/)Y'K4R>&M&C;33'I\*?V8"++8"H@!
M&#MQZCKZ]Z 'SVPLO#4EH)IIQ!9F/S9WWR/M3&YF[L<9)[FO/?#L5SI=Y\.I
MX-4U"6/5;'RKF"6=C 0MF'39'G:A!0<@9/.2223Z?<V\5Y:S6TZ;X9D:.1<X
MW*1@CCVK.7PQHJ_V=C3H1_9O_'D,'_1_]ST_P&* . \+PSZW#HWBW_A*_)N)
MYE6]MP\LBRLY*FVV&78A7/!5 1C=[U!;B\TCP9KNM+KFK2S:??7E@AGO9)%2
M'[3LWL"3ET7+!NO'>O0;/P?X=T_7)]:M-'M(=2GR7N$3#9.<D>A.3DC!.>:L
MZ=X?TC2;&>RL-/@@M)V9I857*.6&&)!X.1P?6@#S?Q+IK:7X7\5SVWB6*[L;
M[1GECTY \@&, 3*[RN>5.#C 8D'J*T[?39M/\3>'[>WU74;NUUJQF34+:XNV
M=518@1)&/^6?S,%^7 ^88 KJ]*\&^&]$L[NTT[1;*&WNQBX3R@PE'3:V<Y7D
M\'CD^M26GAZPT6*XFT:P@CO&A*1&1F(&.53))*IG' X]J .)TB*343;^";VY
MO9+K2-0EGN[AKF7S9K<$O$Y?.?G\U01G^%P.G'5^.M2ETGPC=7<4TEN!)!'+
M/&/FAB>5$D<>A",Q![$9[5+X;TW4H'N]4ULVO]JWP19([0'RX8T!V1ACRV"S
ML2>[$#@"MJ>"*YMY+>>-)894*21N,JRD8(([@B@#@->^Q^%]%UN;2-9G7[1'
M:,\33O*EG&TBQO,ISE<HV[[P)V9!ZD97B;3)]+\)>)YK7Q0\D4NFB[AMK$RH
M(67I(LGFN0KC@KG#8)'>O0=,\*Z#HVF7&FZ?I5K!97!)FA5,K)D8.[/7CBH+
M7P5X:LM'N-(MM%M(]/N7#SP!/ED(.1N]<8&,]* .(U?PUI_]L^"Y[NZU&Z^U
MW,KS-<:E,54&U=CL!?"#(S\N/3IQ5S3X4N_$'Q$L+BXN)[&#[,\*27+L(]UO
MO.TD\+DYP#CVQ7;W'A_2+S3;;3KK3K>>RMF1H8)4#HA7A< ^@X'M33X;T9IM
M0F.GPF345"WC$',X'0-ZX' ]!Q0!YZEC'I?A+X<3V-U<P^;>V*RA+F0I,KP\
MAANP1E5QZ8P,9I8TN==U#7KVY\2PZ7?:=J[1Q[E<R6\,;KY:[?-"E9%&<%3N
M+GKTKOG\+:%):6%J^EVQ@T]P]HFSB!AR"OH:6Y\+Z%>:Y#K5SI-I+J4('EW+
MQ NN.ASZCL>H[4 <7--)9^.XKC4(+B:RN]4$=GJ=I>,1'*%*?9YH>RY#<C(S
M@GO6O\4X+:?P%=-=#]W%<VKYWE0#YZ#)/I@FMV+PSHL&K'5(M/B2\:1I3(,\
MNPP7QG&XCC=C..*O7UC::G9365];17-K,NV2*50RL/<&@#SNY\/Z=JGQ8FTU
MWN18KX;C&RWNI(R3]IDZNK!C@YXSCU!P*IV%ZVN>'O!\5S<276H2:0]Q(DMW
M]FA5/W:F>1EY++T4 <[FR1UKT*#POH5K.9[?2+.*8VXM2\<05O) P$R/X< #
M'L/2FMX3\.LEBC:'IY2P)-HAMUVP$G)VC&!SS]>: /+=/:VUMOA5J.J,)97M
MKF*>9YW&1';MRQW=<KDD]<FNW^*UM#<_#C51.JE8Q&X+,5"XD7DD=L$UN-X6
MT![2WM&T:Q:WMIOM$,1@7:DG)+ 8Z\GFM&ZM8+ZTFM;J%)K>9"DD4BY5U(P0
M1W% 'GEUHNGWWQ6M],#S?8E\/2AEANW1SBZ3C>K;\;@>A[8/'%9=A<_;-,\(
MZ-J=_$-.F@O$66Y=W2>:&0(D;$,AXCWD9/)'3(KTB'PSH5M/#/!H]C%-!!]G
MBDC@56CBY^12!D#D\#U-,F\*>'I]'72)-$T\Z:K^8MJ+=1&K?W@H& >3S[GU
MH K^#+<6>@"R&LG5UMI7B6Y,>W@'[@.3NVYQNR>F.H-><ZUJ$<>KI?65_P Q
M^+(K>2\O;H+*3O5)+>-0.(5'!W'D G!SD^PVUK;V5M';6D$4%O$H6.*) JH/
M0 < 5F3>$_#MQ<W-Q/H6FRS73*\\DELC&0C&"21ST% 'GFMZ5H=O!\345;=;
MB:R:5(MQ!)^RB0L!GYOF3=G'4&F:H-&ET_1=-MIH9)%T.2413W(6VA1E0--G
MDM*,84#IDG*]:]2.DZ<;^:^-A;&[GB\B6<Q*7>/^X3C)7VJLGAG08UL531M/
M L"6L_\ 1D_T<DY)3CY>>>.] 'G6@ZO;:O#X-M_$-TCZ;+HA<&YG^2>\78"'
M)X9@A9@"<_,3R0#6B^E:7+J7@K3+;4KJ[T]1?+'*]PV^95 ^7>,%E[<<%0.H
M.:[.;POH%QI$6DRZ-8OIT3AX[4P+Y:L,\A<8SR?S-33:%H]Q=VUW-I5C)<V@
M"V\SVZ%X0.0$8C*X]J /+H]073M!M=/FO%AT:'Q-=V+/<!IHDB#2&*.7YE8I
MN*]6QT!R*FO!;:';Z;IT.LI=:%>Z\BW;0@K;VZE-P@5MS 1EU7*YP V.AKTE
M/#NB1V=S9IHVGK:W3;[B 6J!)FZY=<88\#DT[^PM(_L@Z1_9=G_9I&TVGD+Y
M1&<_<QCKS]: .4\(_P!F6_Q \76^GO:I'MLMD,#* H$1SA1T'(_.FZY+I-U\
M16TGQ+*BV3Z4KV,4\FV%Y#(XF;)P/, \O'4@$D$9-=A8:-I>E9_L_3K2T)14
M)@A5"57H#@=!VIFJZ#I&N+$NK:79WRPMNC%S LFP]\9'&<#ZT <)IOV*[\8:
M+H=S.^HZ%'H?F:<][AUO)5DVL_( D8(%(Z\,6'7-8FCB2ZF\.6VHW$K:='K>
MIZ=93M<L#<67D2JF6SR<C:&ZX48/>O6-3T72]:M4M=4TZTO8$;<D=Q"LBJ<8
MR 1P<$BL#Q+X7GU:_P!!2VL]*?2]-=FDM;D';(C1M%Y80*5 "L2/< 8QS0!P
ME]86^F^'/B#IT5S<_P!CZ;<Q2V+M,=L$K("\:.6YVLP&TG +8ZUO^(GTW4O%
MNKZ;KNI6-E;MIT+V4ETO2,^9YDD3E@%<,5R1S\JUW::+I4>F)IB:;9K81_<M
M1 OE+SGA<8Z\TEUHFDWWV;[7I=E<?92#;^;;H_DD=-F1\N,#I0!Y?KT(\N*]
M=8?$>FQV-I;WC7(\F_ME.2MQ$7&"6#@E3@D@#UQZ-XMNK2R\(ZM<7UQ=V]JE
MJ_FS69Q,@QC*'LWH:GN/#VBW>IQZE<:1837\94I=26R-*I7[N'(R,=N:T64.
MI5@"I&""."* /&M &F'Q)KM@)=-C@N?#L4KVMC,"B,K28!=2-T@7:2P Z^@!
M+OL^FZ5\.?!^I^8\=IJ'V!-7N"6FC*+ ^WS%+;0@D*ANV, YP!7J\>CZ9%&L
M<>G6B(L7DJJP* (\YV 8^[GG'3-2#3[);1K1;.W%L^0T(B&QL]<KC% '->"[
M#2;&]UG^QM4CN[>:2.5X;55%M;R;2"(]O 8[06&>.#QFLN\M]#/QAO(]3@TX
M-<Z'"ZM.J!W<2RJ2I/.=N 2.< >E=U96-IIMJEK8VL%K;I]R&",(B_0#@4Z2
MTMII1++;Q/(%*!V0$A3U&?3VH \,T_0]''P(T[Q +2!]3@%L&O&^9X42\4M@
M_P ("ELXQQUK9\2:I$/%?BR7PW<QRWUSX=A<&T"L\K++(KLA'WF5,=,\X';%
M>L)86<=I):):0+;2 AX1& C C!!7&#D46]C:6A!MK6"$A!&/+C"X0$D+QV!)
M./<T <3X,M_#3:S!J&@ZO%=-)I_DO;VL:*JH&5E:4*,JXY7YN3EO0X?XXN=+
M'B7P]:W_ -C\UTN6C?4G M(UVJ&9D(Q(^#A1N7 +G..O:6]E:VC2M;6T,+3-
MOD,<84NWJ<=33Y((9FC:6*-VC;<A902I]1Z&@#P[1$TG6%^%T=T]M<@-?6LF
M7(WJD;A4;)R1]T;3D$-CD-SJO=:=INE3V,+0IX>M_%ACOT0KY5O 0'"LHX6/
MS=N1TQD$<FO6UM;=0H6"(!22 $'!)W']0#]>:62"&5)$DBC=9!APR@AA[^M
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M8J2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT%U$VW@MM#*<J#P#WZUK:IX=U35M+2VU6'3-928R-=6ER[0Q*S;=GE,$9EV
M, >"=Q/';KZ* ,WP]IT^D>'K#3[FY-S-;PK&\I).XCW/) Z9//%<JO@O4QX=
M?PG))83:$\Y;SF9Q.(3+YAB* ;2>J[MPX_A-=Y10!SD6DZHGCVYUIEL_L4UE
M'9[1,WF (\CA\;,<F3&,]LY[5)XKT6^UJVL!8SP*UK>)</!<@F&X4!AL<#G
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MR_ZQ^>>B\=:[^B@#E(_"^IV3Z\=.U:"-=2O4OHUEM2VQ_P!V'1R'&Y&6/;@
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ME?K.BW$ ?ET#*@!4^A!_E7<T4 4=)TJVT:Q6UMC*PR7DEFD+R2N>KNQY)/\
M^K XJ]110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!SOB77YM*O](TVV
MFM+>XU.9XUN+P%HXPB[B-H92S'@ ;AWYXP9=#O=;DO\ 5+36X;51:M']GGMD
M95G1ER6PQ.#D$8R<8ZG@UG>.IO#$\%MI'BV*W_LV[6203SL56*1"BKA@/D)$
MA^;(QC'.:XJU7Q#=>$?&6DZ+JLVO:7;^2FEW3D.\L9.9X0^,2X3Y0>0=V!Z
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MT@>[U>RA2X7=$[SJ%=?4'.,>_2B[\2Z#83217FM:=;R1())%FN438IP 6R>
M=PQGKFN!\8:D+^]URV6SO[9+O02D,T%B[S7ZE93Y>64K&J9.0P5B7'(XJY9O
MI6I>.=%^V6@F)T/RXC<VCA5DW*< .N%8KGWQ0!V]KKND7UO<W%IJMC<06V?/
MDAN$=8L#)W$'"X'/-6[>X@N[:*YMIHYH)5#QRQL&5U/(((X(/K7":UIEU#XT
MGTRTMR]AXG@#7A5L"#R2JS.>_P \3(@QT;![UVFJPW%QH][!:.$N9+>1(6)Q
MARI"G/UQ0!7M_$.CW5ZMG!J5M)<,S*B+(/G9?O!?[Q'<#I7-R>)+_6O%VKZ%
MHVJ6-K)IT4#()4$AN'8L7!YR JJ!P.K$]A6'I:M?>%?!N@0V5Q!K&D7MJ;J%
MXV'V?R.)7+$;=K+N (//F#&:W_#TT?\ PL?Q4Y@N(_M*VJPRR0.B3")&#[&(
MPVUFP<=": +WB_Q"^@_V5']JM["&^NC!+?W*%HX!L9AGD#+$!020!DGG&*;_
M &S?^'[;5[WQ%=6\VG6D$<]O<V]NR;U(?<"-S988'3 P0<5/XIN;)(X+/5]-
M>\T>Z21;DK:R3B,J RE@BG"\-R>^/>N(T[1+BW\+^--*\/O?77AR33)(],BN
M Q(N&CD#QP[AN9,[/;<2!D[J /0'\4:/!86UW<WT,"7"%HP[<D  M@=2%R,G
MH.]5;_QIHUE?Z):BY2;^URS02QY9/+6-GW[@"",A1C/\6>@-<IJ.I->:GX>-
MOI>HQVLVES*;M-.=KEB=@$ W+B(-U+L,' P0.3G:)#J%AH_PXO+C2=35=+^T
M6]W%]D?S8V:%D7*XSM+8&>!RIS0!Z9-X@TBWOUL9M0@2Y:580C-C]XPRJ9Z!
MB",#J<CU%5H)]77Q;>QSR1/HXME>/_1V0PN,<&0G#[OG/ ^4*,XSSQ=O912W
MEYHVK>'-=N;P:K-=6\JRSI:2AIVECD,BL(U*@@$$9^7 !X%>BZF_EZ5>/Y$E
MQM@<^3']Z3Y3\H]STH J:;XDTC5[HVUA>+-+Y?F@!& 9,XW D8(R1R.M9GB?
MQ-/INLZ+X?TR.-]5U>1PCR<I;Q(NYY&4$%CC@+D9.>>,'&\%1ZC;>(3:*]W>
MZ%%8G['<ZA826]Q:G>H\@LRKY@P">F1L /;-OQ;I-]#XR\-^*K.WENH=/,UO
M>P1*&D$,BX\Q%ZG:>2%RQ' '6@"?4M6U;PKJ6EOJ-]%?Z9J%VEG(YA$4EO*_
MW",'!0G@@C(R#G&:JWOB6ZU+Q?JNA6&K)IG]G6L<HD-J9O,D8N6#*0,J%3^$
MJ<MU/02>(=WB^?2]*LK.^%K%?PW=Y<SVSP1K'$V[8-X4LS,%&%!P,DD<9;I%
MT\'Q)\5W$UEJ26TMO:)#,UE,4D,0EWA#MP<;AC'7/&<T 9\7BBYU'2QK+>*X
M='M_M<L$D,UDKJ4$S)'Y9.#O(3)Y8?,>!BNQU;Q/HNAOLU*_C@8*&;(+>6I.
M SX!V X."V <'T->=ZC!>77P9N=.CTO5/MSZCN%LUE+YF#>^=G&WIL&<]!P.
MO%:T,]UI7BSQ*NI>']1U.PUWRI+22&T\Q)$$(0PRJ>(^X^? .2210!UNH^)]
M%TEU6]OXXMR"0L%9E1#T9B 0J\'DX'!]#6LK!E#*05(R".]><:E;O:Z[J]OJ
M_A[5K^PU2&$01Z8SM",1!'A?:R@#*\,P PW)%=9I^M6T6LQ^&6M+BWNX;%9U
M/EL8&1=JL(Y#][:64'ZCWH J^)O$-S8ZMH^@Z6(CJFJRMM>52R00H,R2$ C)
M P ,\D^U3/;>(++4]-:/4FO[%YBMZDL$:NB^6V&0J%XW[,@@G!Z^N;XMTJ]B
M\4:!XJL;26]_LSSH;JUAQYCPR+C<@/4J0#CN,XK9M=>75)4AL;+455A^\FN;
M.2V$0P>1YJ#<<@< 'KD\4 /'B?1C>):_;D5Y)?(C=E98Y),X\M9"-C/G(V@D
MY!&.*J3>.O#,$DZ2ZO IMYO)G.&(B;C[QQA5Y'S'CWKAAHFH77PXTKP=_9=Y
M%K%G>0 SO$WDQ[)M[7"RXVL"H; SN^;&,U:FM;QM&^)</]EW[2:B\HLU^R/F
M?=;B-2O'(W#\!STH [FU\4Z)>W5U;6^HQ22VL9FEP" $!P6!(PR@\$@D9JE#
MX_\ "MPML\>M0&.Y!,4A#*C$ DC<1@'"G@G/YBLXW @\9Z->)IVH_9(]&G@>
M064AV,SPLJM\N<XC?MZ>M<[H5I=6O@+P/8W.BWWVNPU"-YX39OF$+O!<G!'&
M\'(ZY..AP =_:^*M$O+&[O(=0C\FT<1W!D5D:-CC *L V3D8XYR,9J&7QIX>
M@M+RYN-3C@2R95N4F1XY(2WW=T; , >QQSVKC=9LM3N-3\4W-GI%Y*8M1L+Z
M*,(T7VU8%3>$<C[P*\=SM&,U7UVQ6_\ "?B*XTSPGJ\-UJ%LEN[78>2YN7##
M"X+,0BJ#\S8!R ,T =XGB_0Y;9YX;QYU65H0L%O)*[N!D[$52SC'.5!&.<U4
MNO%&D7BZ%/9^(A!%?7GEPB*$2"[(R&B.5)3GJ>",55UF6\L/$^C^(K;2KV^T
M_P"PS6<L-M%^^@,CQ.K&-L$C]W@CJ*RO$<%W<IX7DM?#T]I&GB!;Z2"" ,R1
MA7#22;.%8L^2,DG//(- '6_\)7HO]JC3A=LT_G?9]RP2&+SL9\OS0NS?_L[L
M^U0Z%>WD_B#Q):7-VUQ#:742P*T:KY2M"CE<@#<,L>3SS7$2V^K2WIDN/#6H
M)-;^(5N4BLT1(!%O'[WA@)78'<S-R.?NXYZWPZ;@>+O%+36=U##/<Q/;RR0E
M4E584C;!_P!Y3UQD$$9'- #/$EWJEOXL\.6-GJDMM:ZG+-#.JQ1L5V1-(&0L
MIP25P<Y&#P!4'@SQ#J>I:WXETN_EAO+;2KB..WU&)-BS;DRR''&Y",''<]!Q
M5?QM81:MXI\,PW6D3W^FVTMP]\/LK2Q*KPLB9&T[CN(^[DC&2.AJ+3=-U;1K
M#5O!QM)FTZ2.5-(OXDS'#%("!%(1\P*$_>P<C!SF@#IK7Q9HEY?06<5Z1-<1
MM+;^9"\:SHO+-&S*%< <Y4G@@]*6S\5:+?W\5E;WA::>-Y82T+JDR*0&9'*A
M7 R/ND]0:XG3M*N=4L+&QE\+WUKK%K:O"^H7\Y>*V8PE"8&,C$ACC 4 8ZX(
M K1TO^V-5T"UT:X\/2Z=J%I8O:37MR$V1$Q% 8'4DMN8(>   #GG&0#HK;Q?
MH5Y<0107VX7#,MO*87$4Y7.1'(5V/T/W2<X.*;9>,_#^HSR0VVHJS1M(LA:)
MT5"@#.&+ !< YY[5RFFZ;J%WX4\*^'I](N;2]TFZM&N79,1(MN02ZN.&W[<
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M-S<B$7AL7F-G*$CF!"[7.WY/F('S8_+FNAOT>33[A([B2W<QL%FCV[D..HW
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M_P#H:]#_ /!C#_\ %4?\)WX/_P"AKT/_ ,&,/_Q5 '045SK>/_!RH6/BK1<
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MO_@HNO7_ *YT =;17)_\+(\.\<ZK_P"">[_^-_YQ31\2?#IQQJPSZZ1=<?\
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MOD1!M)MVO-JY1+E[C9')(!@;MKDG)&0HY YH Z<_#WPJ3G^R(^W_ "UD[?\
M J:/AUX350HT>/ QC][)QC_@59=]JGBG3XIO,2=[9+R EU6![P6Q1C(1&I*D
MAUXP"=N[@E<T6^LZSK4:VVCZ]8FXM])@OA<O #%>22&0<]TC!BP<#=\W;&"
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M (0LKY=6$U]?(NJ2Q2SA)$ #1[0NWY>/NJ/? KF_^%,>'^?]*FY.?^0?I_\
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M_(SZ;_W^%2GP%H1&"VKD$8P=:O/_ ([[FE'@/0P6(?6/F #?\3N\YQTS^]H
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MY.8^I]:  ^.='# >3K62 ?\ D!WO0\ _ZKN>*7_A.-'Z^1K6.Y_L.]P.,_\
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M;# 6J E<[<VUZ<^AY Z^I_#:LM%_LSQY9KI=[>2(EG(VK^?=O*)&.T0LRL2
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MXE:%)'\@H@9/,?A2S#),8P5&,GFLW1?$GB&?P_I4$!M;W5[NPEO\M$P4JK(
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M<W!XY/8F@#M:*RO^$G\/_P#0=TS_ ,"X_P#&C_A)_#__ $'=,_\  N/_ !H
MU:*RO^$G\/\ _0=TS_P+C_QI#XI\/#.=>TL8&3_ID?'ZT :U%9)\4>'P"3KN
MF #_ *>X_P#&D_X2OPY_T,&E?^!D?U]: ->BL?\ X2SPX1D>(-*QQ_R^1]^G
M?O0/%GALXQX@THY.!_IL?/ZT ;%%8I\7^&0"3XBT@ =<WL?_ ,50OC#PPP)7
MQ'I! QG%]%QG'^U[C\Z -JBL)_&OA2-BK^)M&5AU#7\0(_\ 'O8TW_A.O"&,
M_P#"5:'CU_M"+_XJ@#?HKG_^$[\'_P#0UZ'_ .#&'_XJC_A._!__ $->A_\
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M?Z%/S_XY0!T5%<[_ ,)SX?&/]*N.1G_CQGZ?]\4?\)QH.,^?=_\ @ON/_B*
M.BHKG/\ A.= P3Y]YP,_\@ZX_P#C?O2?\)WH &?.O?\ P6W/_P ;]Z .DHKG
M1XXT$D#[1=#/3-A<#_V2D'CSPSGY]46+K_K8I(^G^\HH Z.BN;/Q \)@$G7K
M,!>N7QCZ^E.'C[PB59O^$CTP!0"=UPHZG QD\\B@#HJ*YN7X@>$(796\2::=
MO4I<*P'XC(H'C_PFS!1K]D6/0!^M '25YS\.)"^OZVI_@M8%'_@5>GU]_;^M
M=(/'OA4C(UVS(()X?TZUR_PQ<2:WK4J3"2*6TMI(\=E-Q>8[=Q\W_ J /2J*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#A/$OP]N=?UV?4(]7AACE$16*2WF+1.BLNY7BGC/(<@@YZ"L
MI/A->CB3Q"K#.00+X$?^3A^G2O4** /,?^%1L0V[6025VCF\XX Y_P!+Y[_G
M2K\)90I4ZZ2&ZAA=-G\[D^ISZYKTVB@#S./X2O&@3^VP1T8-'<-N&",<W![$
MU'_PIR$A\ZG$6<89C!,203D\F<X.2>1S7J%% 'F!^#L.0?[4B!"[?^/:3\\>
M=U_R:<?A$ISG58,'_IQ(QSGM)^'TKTVB@#S0_"*W9%#:C#D'YB++[PY]7)'7
ML?IBE/P@LFDW&^BQDG_CR7)R>YS_ (5Z510!YJ_P>L&D=AJ &[/_ "YQGCT]
M^?\ />G?\*AL_-W_ -H1YRIQ]@AQD>V,9]/2O2** /-D^$%DJNO]H(0XPP-A
M$<_F*5/A%9QR!UU",L.A;3X6(X(ZD?3\OR](HH \U'P;TI4""XMMH '_ ""K
M;/OSLSS_ (^II&^#>ED-BYMEW CC2+0X^F8Z]+HH \W/P?TPL[?:+0;L\#1K
M/ SGI^[]Z;_PIS2\?\?-KVS_ ,2>SYP<_P#//CT./\*]*HH \V_X4_IQ.3=6
MA_[@EB/P_P!5Z\_ITXIX^$6G#'^D67!R/^)'9?\ QKT_QZ\UZ-10!YT/A#I>
MQ@;FW)(./^)+I^ 3_P!L,_K4\/PKTV!XI8KBW2>-@ZR)HU@I# Y!'[C(_ Y]
MQ7?44 <%<?"G2KFXDG>Y0R2'<Q;2-.8LQZDDV^22>>OYU&GPETJ,C9>A?[V-
M'TT9_P#):O0:* . _P"%3Z5D?Z:<#H/[(TWC_P EO3BC_A4^E[<?;F Z\:3I
MHY_\!OK^==_10!P)^$^DDL?MT@#?>QI>G ]^<_9N#[TT?"32-N#J%QG!&1I^
MGCJ<G_EV]3UKT"B@#@?^%4:7NS_:,PP"%*Z;IX*C.< _9N.2>GK2?\*FTL1[
M!JEWMR20;&P.<GD?\>W3VZ5W]% 'GX^$FDC/_$RN^>?^/&P]<_\ /MQT'\J5
MOA-I9((U6^7&?N6=BO4Y[6W_ .H<#BN_HH X/_A56F $#5+P G/RV-@,=.G^
MC<=!3?\ A4^F9R=6U GC_EULL\#'7[/[FN^HH X)?A3I8*[M4OW53G:;:R _
M2W!'X'VH7X4:2L(C_M+4" &&?)M0>?I!VQQZ5WM% '##X7:4,XU"]P1C_46A
MYQC/^H_^MWILGPJT:7K?7PZXVQVRXR2>T7/7OZ5W=% '"1_"G1XW#+J&I C/
M3R!G\HJ>OPOTI N-3U,%4V!MT.<=?^>?KSZ5W%% '#+\+M*7&-3U3 R NZ'&
M#CC'E],@'\*/^%6:3_T%-7XZ?OD^7C''R<?_ %S7<T4 </\ \*NTG!QJ>K#)
MS\LT8_DG^>/2C_A5^E^;YG]JZQO)!)\].2"2/X.Q)KN** .&'PLTH1[/[7UP
MC 7)NP6QSWVY[GZT\_#+3B2?[9US)+<BZ7//7^#IZ#MVKMJ* .(;X7Z86)76
M-=0$8PMY@?\ H-.;X8Z2Y).J:X"5*\:@PZ]\=,_RKM:* .-_X5II'F!O[1UK
M&<[?M[X/7_']*A'PLT7))U+7SEL_\A64?AP>E=Q10!Q:_#'2%D=QJOB'+YW#
M^UY^<]<_-D]32M\,]);[VJ^(B>>3K$_<8/\ %[FNSHH X[_A6ND9S_:7B#.<
M_P#(8N.N<Y^]ZT@^&FCA]XU'7PW7/]L7&?\ T*NRHH XT?#31E "ZCKX Z8U
M>XXZ_P"U[G\S2_\ "M=(SG^TO$&<8_Y#%QT_[Z]Z[&B@#CA\-M( P-2\08SN
M_P"0Q<=?7[W6C_A6VCY4_P!HZ_N4Y!_MBXS_ .A5V-% ')K\/-'5=HO==VX
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MR=#@SZ[GSUSZ^M=510!RJ_#;P<@4+H-LH7[H!88Z=.?8?D*%^&W@]  N@VP
M.X8+<'UZUU5% '*K\-O!R$%=!MEQTP6&/UJQ_P (#X1W!O\ A'-,&#N"BW7;
MV[8QC@<=*Z*B@#FS\/O![;<^&M+^4 #_ $9>QSZ>OY]Z/^%>^#2FS_A%M'Q_
MUYQY_/&>]=)10!S$WPZ\'3$%O#E@I'/[N+9_Z#C/2FGX<>$R#MTKR\C&8KF6
M,CKT*L,=3T_I74T4 <BOPS\+I]RVU!?IJUV/_:M.'PW\-CI'J8'7 U>[]?\
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MHKQ$?M W!<9\)1A-Q4M_:Z<$#O\ )_6K5M\?(]\;7OA2]BA89)M[A99!_P
M(7O@')'7C- 'LE%<+I/Q>\':K*(6OWL96(")>QF/=[YY4#KU(Z'TKM+:ZM[V
M!9[6>*>%NDD3AE/XB@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ"\O+?3[.6[NY1
M%;PKNDD;HJ]R?:JFG^(-(U5UCL-2MKB1XQ*J)(-S(>C =2O3GIS0!I4444 %
M%%% !13'ECC5V>155%W,6.-H]3Z#@_E5+2];L-9$WV*5V,) =9(7B89Y!VN
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M1T^X2XM+A=\<B'((_P 0<@^XJW0 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK9F$FPJHS*2#@]1'C'^U7BEM'!+:S33Z?/+$KA<P\J@ #98!>I!89( ('HO
M!I!$TB&Z=KR!$B2)4TN]B=G4]<C(RN,$[@!W^[D8Q+)[VR1M?FTFWO;:>9K2
M-I$W+)+MP> "0.. 5''X5-KTUO865K8VMS?263X=$D!4QDCYFS@@_=/3)RO3
MKB71]*TFXUD1Z7J-U-I]O I@:\;*>:1\R@ 9'/S<9X?G )- &I#X(UK3O JS
M00K'$Q8W<L,J;Y%8 [ALZJA''S$94D<=?0]-OX[O3=-E$;-/?HA$,8VR*"H
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MK6VNECMT\M$25\Y!PH5,C=@8.2>F#VY !H3ZE964;^==QP[FQEW&X$Y/3G'
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M",U)7(?"_4CJGPYT>5E8-#&ULVYMQ)B8QY)]]N?QKKZ "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IB,Y9P
MZ!0&PI#9W# Y]N<C\*S_ !#HT7B'P_?:3-+)$EU$8_,C.&0]B/H<5YJWBOXI
MZ#MT>7P:FKSQ@10ZE%*=DP'&]_0D#)R5Y/2@"WXD\;Z1X:^(FIZEJV\Q:5ID
M5M D:[V>:=FD(7LI*QCDXX!YIOPC\666MW&M?;3):^(;^\>\DM+@880[5$80
MD#<JJ .QSDXQ5#X,Q2:Y=>+-1UV&*ZU!]203-(JN@EC# %.. -V!R<#I78?$
M+P[]NTU/$&G)LU_1 ;NRE4',@7YFA8#[RN 1CU/UR =G17*7OQ T>Q\ 0>+Y
MBYM+B%'BA4@R.[](QS@L#D'TP3VK3\+^(K3Q7X>M=8LTDCCG!#12C#QNI*LK
M#U!!_G0!L5XWX7N[R^^)EOXK:28P:W?7NE11[AY8MH(]T;8QG<6B?/U^N?6-
M6O/[/T:^O<X^SV\DO3^ZI/\ 2O-]"L5L8/A5IL<1!$$U[+E@"I^S$N>.O[R8
M>_/?DT >J44C,J(SNP55&22< "JUAJ5AJMJ+K3KVVO+<DJ);>59$)'494D4
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M,^ M"U'1]%FN=<=)-<U.X:[OV7!"N0 J CLJA1CD9SBNJHHH **** "BBB@
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MD;_O23,ZKS)[ 9 )7.>">M=%X@M&OK6YU"ZC&F:A!<PI:S0;Q)*[(NX D G
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M&VAOKY[6]MI(@9$9899&C;(RK!HMI]B3Z5LGQ5HXG,(N)6DV22(%MI6\U8R
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MCT(Z:B@#D=+\(ZCI:^'4368)(]&LY;3#69S,&4*ASYGR[0B<<YYZ9&,R\\-
M>'=-\%3K>Z@Z2Q3?;H;<PI%&),R$R9*ABOF+M&20X&,9->@T4 13)*;9DMG2
M*3&$9DW!?PR/YUQD?P^N)O#<7AW5->DN])#AYXDM4B>?]X9"I;)P"V,X .!@
M$9KN** .7'@V.=_$T5]>&>RU[:'@2+RS"!&(OE;)S\JKVZC\*LZ1X>N[6TN+
M?6=:GUE98OLZ^=$L86/&"#M^\S=V//3IWWZ* .8TWP/I^G7.B7(DEEFTJV>%
M78_ZYVZR-SC()D(';S#Z"DL/"$^FZM<S6VNWBZ7/</=C3=B;%G=MQ(?&[9NR
MVP$#)],@]110!D^&]&?P_HD6FM>-=^4SL)6C"$[F+<@<=2:UJ** "BBB@ HH
MHH **"0.IQ2$A022 !R2: %HHHH **1F5$9W8*JC)). !0K*Z*Z,&5AD$'((
MH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""]NX["PN
M+R;/E6\32OCT4$G^5<K8VOBC5]"@UB+Q$]I>WD*W$=C]GA:UB#*"$)*>83ZM
MNZY.W'RUUTL4<\+PRH'CD4JZL,A@>"#7-Z;X=UG3-+BTB+7H_P"SX%6&%Q9_
MZ2D0& OF;]I8  ;MGX9YH 5_'.EC4S91PW4I,\MLDL:J5>:,$L@&[<#E2H)
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M'!)DC9MW/4'GOFDN/#4$VBV^C07=U::=%%Y3Q6[!6F7CAGQN&><E2"<]: .
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MET(Z9)/<9)/J:GT.WT]/AWX4B\0Z5J5RIUG.GQ0HY>W_ 'LAB=\8^0)_X[C
M[5T<_P ,[6YUNSU:7Q+XE:YM%98@;X;0&^^!\F1N& =I'0>E79O ZS'YO$_B
M91G.$U$KW![#/;^?K0!C7$-WJ-MJ\R;A+X@U1=-B#J1Y=I%E)/?!5+AQTYD'
MK4'BKP=-J/CITM+>(6.OZ8]OJ4O(\LQ.A5^."S!@HZ< G/%= _@:&5-DGB+Q
M*0.A759$(XQU7!/3/.>?K36\ VC$G^WO$XR2>-:N!Z_[7O\ I0!Q]GX<OM?^
M"MVVI::+;6VM$\H,O[S=:KB(^Q)5C_VT/;BG:%HFK3^-[6]U#3T2#7["#4M1
M!0@0SP."B?='S<Q9!(Z/US76CP!9@ ?V]XH.,9/]MW'/_CU+_P (#9\_\3WQ
M/US_ ,ANX_+[U 'G/BKPCJD=YXRMM/MXTT^U:'Q%9;(<DW."&3D892(Y#M'.
M=OJ0?2-"NFT>WT>RO+"X.H:V\UW<26\'[F"4@RLLC9X SL7/)VCWH_X0*R_Z
M#?B;_P 'ES_\72+X!L5&!K?B; _ZC=S_ /%T >-Z#I-U$FCW-OH]XDZ^-FG,
MOV-@T=H1'N).WA,'D\#BO1HO"ES;?$S4;2VL(5\.:F(-4NG\OY?/B<XC';+/
MMD/^Z?6M[_A ;'.?[:\2Y_[#=S_\72-X T]L9UCQ(3Z_VW<^_P#M^] 'GYTG
M5(M=\46&B12727MOJ$MO<SVS+<64Y?:\8D(P4DZKSS@'CDU5M-">:%Y/L6I6
MVCQ^#X--U%8+5DE^T[_F&P@;W4<MC/!([X/I+?#W3G#!M7\1D,<D'6KCGM_?
MI!\.],  &K>(@!G _MFX[]?XZ ,7P;JE_P"'M"BM+S2[K46GU<645Y8V93SX
MS&H%Q(AP$4 ;2?\ 8YR<D\GH5OX=E\416-YK>F+<67B6YFBCGC/VNXD8[!&Z
MLN/O#(8$Y 3@'@>CGX>Z:5V_VMXC"9R%_MJYP/\ Q^JO_"J?#K(89I]9FM-V
M\6LFJ3F(-N+;L!LYW$MG/7F@#B]%T375\0:%:W%O=?VI:Z_>7=[?/ VSR"G'
M[P#!60!5'/48Q\O'3^&O"<^E>,=7T\VT8T&*^76;1L8/G2HR&,#IM4J3V(.W
MCGC8_P"%<Z #\KZN/8:Q==,YQ_K*=;_#S0+:XBGC_M0O$P9=VJW+#(.1D&3!
M^G2@#JJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BCTYHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
2*** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex10-2_002.jpg
<TEXT>
begin 644 ex10-2_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML\E]?^29-@9M8FVEB?NYW]3TQUYIC^"M8N;1;.8V, DDU;S+B&9RT2W19DV
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M44 %%%% !1110 4444 %%%% !30I\PMO)4@ +CH>>?Y?E3J* "BBB@ HHHH
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MDK32N-R("3@?-_ "?ND5V5[X_P!2\,:=K5GJ*BX\4RWK&SLE+&)8VC5E8.P
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M9BQ7KST[:L[0=7BU_P /Z=J\*&-+VW2<(3DIN4';GOCI^%:- !1110 4444
M%%%% !1110 54U3_ )!-[_UP?_T$U;JIJG_()O?^N#_^@F@#FOA7_P DO\/?
M]>@_F:["N/\ A7_R2_P]_P!>@_F:["@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *:LB,[HIRR8W#TIU% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!#=NL=G.[G"K&Q/&>,>E<A\(_P#DE7A__K@W_H;5U>IG&E7A
M]('_ /037%_#2_MM+^$7AZ>Z=U0Q! %B9V9FD( "J"3R>PH [ZBJUA?V^IV@
MN;4R&,NZ?O(FC8,K%6!5@".0>HJS0 45'//#:V\MQ<2I%#$A>21SA44#))/8
M 5)0 4449 QD]>E !15"#6+6YU"YLXA*3;9$LOED1*P"DKNZ9PX/Y^AJK9^*
M=*O(A+YKP1-&DL<MQ&8TE1SA65CP<DC SGD<<B@#9HJ.>XAM8C+<2I%&" 7=
M@ "2 .3ZD@5)D9QGF@#A]<O+VQ\927<>@:AJ=TEDL.E"-3Y"N['S2\GW8R<1
MY+<[5XZD'H_#>F3:/H%M:7,BR77SS7#KT:61S)(1GMN9L9K5HH **** "LCQ
M4VSP?K;8)Q83G"C)/[MNE:]97B?_ )%/6?\ KQG_ /1;4 8?B&==::R%K?:Y
MIQMI3*'AT5Y S;< D21-TR<<=>>P-9BV%C::LE]';Z_=!)1>(K::Y(NC!Y!D
M)8 D[%R1TW$$'M6QXNGOH]8T"&P#2RS27"FV%Z]LLP$+, 64'HP7G''\^;\1
M:I>VPU:P66>"2S;1F23[9(SD27)#*<L0>A!(P6!&XG H ?!8*MI!%=7?BB[G
MM;R.[MI9=) \IU+YX5 &W>8^YCR=P.>,T1>&= LX[!;*UUW[/9):K) -.DS<
M>0[2(S%E'(=B3CJ.!Q5Z3QY>+N9?[,\N:Z2UA9I1_H[&9HV,HWYX '9<L=OO
M4>GZIJ,'PIN[LZC)+>17ES%+=JYE,<8O'1F4L6X6/D9)P #SB@"*'PYX4M]5
MO+Z'0-:(N(H[;R!:SJNU)/,WC.,#=LX)&-@P.M4XM'@T_1[/3]'?Q38V]E<2
MSJ(]+5WD:1F.?WB$?*&(& "/K6EX@U>[\+:XG]CW$MW;'3);BZ@NIWG2,JT8
MA?<S%DWYD7@X.W."0376:%J-S?C4([KR#+9WCVV^$$*X"JP."3@_-@C)Y% '
M.@6"Z\=4DL]5EOHX7M[>:729&2)6"@EMJAI"=J@DGH#C:"2: T#1;: /8MJ]
MKJ2WW]H&]71Y\O(4:,KL6,?)L8KM&.W4YSZ/10!SFDZAI6B:+8Z7;0ZL8+.W
M2",MI=R6*HH&3B/J<5<_X22Q_P">&J=,_P#(*NO_ (W6O10!D'Q)8@X\C5.F
M?^05=?\ QNAO$EBH),&J\>FE71_]IUKT4 9'_"26.,^1JG_@JNOK_P \Z4>(
M[$G_ %&J?^"NY_\ C=:U% &2/$=B?^6&J=,\Z7<__&Z0^)+ =8M2'./^09<]
M?^_=:]% &2?$=@" 8M2!/0'3+G_XW4:^*M+;.#>\#/\ R#[CI_WQ6U10!D#Q
M/I#'BZ/XPN/Z>]5]3\2:2=*O!]KZP/\ \LV_NGVK?JIJG_()O?\ K@__ *":
M .?^&4?E?#/PZNUES8QMAB#U&<\?6NKKE?AF"/AGX<R%'^@Q\+C'3V[^OO75
M4 %%%% !1110 4444 %%%% !1110 4444 %%(P)& 2/<4 $$\DY/?M0 M%%%
M !112 8'4GZT +1110 444B@A0&.2!R<8S0 M%%% !1110 44AW97:0!GYLC
M.1CMZ<XI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@"IJG_ "";W_K@_P#Z":X+P79F[^"V@VQT]K^-
MX5,D,,@BDQN)W(Q9<.IP0<CD<$=:[W5/^03>_P#7!_\ T$UQ/@36K;1?A+X9
MGG1V$T201HA4%G); RQ"CH>21^9Q0 RX\-:_>3Z:VHQ2ZC!"T@C$MVD4UL?.
M5HI6=0<ML&"R?-U SN-0WOA;5;G3;N%M&_TZ2\C\V\BO=K74(NA)DC(_Y9 K
M\W(W8'&3796_B2QDEM[>[$FGW<\<\BVUV45PD+[78X8KCD,""<KSV.+9UC3A
M>VUF;V#[1=1O) F\9D5,;B/7&1^OH: .$O/!E[<SZ[&VE1/)-;W45M>FZ4++
M&\86.)TV[CM(4?,2!LW Y.*36?"FJWNI^(;BVT>WC:^TNYLX98YU!)>" 1AL
M_P!UXG'&  V0,EB>^GU2Q@TRXU)[F(V=O&\DLJ-N550$MT],&LM/%,$5[;6V
MIVLNFB[ADGMY+ETVE4 9PQ#':0IW<\8!YXH YL>'=/C\8QV&CVEO;VUS"DNN
M6J19P8W\V%F;IN9F=3DY9<_W>+?B[POJ6N:RTL,<+QFSCCLKDN!)IUPLI9IE
MR."5*\KR3& < DUH1^,X)/"?_"3+I\[Z>PCDC\ID>1XVQR%!^\I;!3KD$#/>
M_!XEL;BZ79)%]@>R6]6^,H$91FP.O3US0!'H6ES:=+K<OV2&&:[O7GC8$8D4
MJ I8@9Z@GGU-<=<>#]5FTR\M+?31%8,]M<#2KFX62'SDN5DD\G.[9&R*PVG
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M;BY?9&1$[Y.0.=H.T9(Y.!R*=!XCTBYUA])AO4>]7>-@5L$IMWJK8VLR[ER
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-CTF'3;*YNK*"$72)Y)0E8Y\[D&Y2 !D8XR-H]Z ,N74_ 4,[VP\.QO)'((
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M =E17&)HWQ #L&\7Z65&0I_L?EA@8)'F<<Y_SQ0=&^(&2!XNTLC/!.D'./\
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M!U)4J2",C@\CZ&I* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<<(8*D<?$BDC:P"[1D]<'J:]*U?XC^'M O+.SU6>2&>>))93'&TD=NK\*9'
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M'YFG4 1V\ZW-M%<(&"2H'4.I4@$9Y!Z'VJ2BB@ HHHH **** "BBB@ HHHH
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MY(&$P O/?;A>#VHFTPP:=X?AFL=/6;49/M"7DUV55XRVP))R!&H*G/(/7D4
M)KWB:_U*WN;>YM'6VN)5DMFNGDEEBC4NRJ'8_-Q+R3R<CH.*^HOA ^_X4Z 1
MVA<?E(U?.'C"_O(]+DT^1KF>VN+M9P\EX+B&)T4_+"5Z#$O?&0%XZ&OISX::
M?+IGPV\/VLX(D%FDC*1@KO\ GP1ZC=C\* .JKC=7^'=OJWBM_$8U_7+*^,2P
MJMI<(B+&,'9C83@D9(SSFNRKR/6;%/%/CSQ;;ZMXFU'2[?1K: V45K=&(1AH
MM[S%1]_!./T], '56WPZL;;Q4^LK?WC0?:9+V.P8KY,5RZA6E48Z_>X.>34?
MA;X<Q^%=9EU"W\1:S=).SRSP7,J,LTK  N^%!8\<>E<?XI^*>J>$M,T5-(>S
MUF'^R(+J>XN(9O-D#$()6Q@1AC@Y8DY.,<@G;U_QQXET_6/%;:?;:3+I?A^V
MCD83,PEE>2+>,$-C Z]!D<#DY !TFH^!]/U:3Q%]NDDE@UN&&.2+ 'E&)2%9
M3USD@\^E9%U\+H9+2R@LM?U/3Q'IT6F7;6Q4?:X$! R""%;D_,.@.*P-&^*&
MO:EX3EGDM-.76CJD.EK"1)$('DX#2JW( .>G7IQ@U;'C?Q?!IMM9R6VCRZTF
MO+HL\F9/(DS!Y@<8^9??C'' '8 ZO1O VF:'JMY=V9D$%S8P6/V8GY5CB4J,
M'J21UJIH'P^AT0::#JMW<?V=;W%K;$JB[8I=G!P.2NS@^_YV_!.NZEK>A74F
MJ):G4K*]N+*86H98V>)RN1N)//'?O^%>;Z#9QWVB:!XSU/QQJUEJ6HZD/W8E
M>2%F,C 6RQ@G"\8R<@=\#B@#U33/"]CI_@^'PS)NNK%+8VS>;C,B$$'./K6+
MI_PRTRTNX[B[U36-2:VA>"R%[=EA:(Z[6V8 ^;!(W')P!Z UP":AXC_M2TBT
M_4VABN?&][&XDD9PR*050@-]P!7RN0.A]ZZSPUX\US7]:L-)-KI\5W;RW8UM
M?F_<)$X1-GS<%B1UR.": ([3X*:'I]G?VUKJ.H!+RP:Q;S/+.U#('!&%&2"/
MQ[UK^,_AM8^-)H'NM2OH%2/R9$0K(KID'(#@A'X^^H!]<U)\3;T1_"W7;JVN
M& -KF.6!\'E@ 00>G/Y5Y_;>+]2TC5-$TO7C*^L>&;2^EOH5E<BZB2UW1R;^
M Q(R.=QSDT =UK'PUM=1NWEM=7U"PBNK:.SU"&%@1>0(,!22,J<9&X=B?6C4
M?AK87L'B&&*[DMTUEK(LH0%85MMFU5&1P0F/;/M7*Z1\3_&&JZ5J<RZ%9I<6
MVEQZK!NBF598B_S+@D$DJ'VD<$KW!JSJ7Q2U1-/OM9T^'36T9M1@L--EF25G
MG+(6D;"9+8( "@#//.1@@'=^)O"MIXGCLC-=7=G=6,_VBUNK1PLD;X(_B!!!
MSR"*Q)/AM;2^'K[3WUG47OKR^34'U)BGFB9-NT@   #:.,5AZ-\2/$'B'3?#
M"V%CI<6I:O'=RS&Z=TA00/M*K@EB3U[X'K@UQ^C?$G5O"_P[T/[(]M<SS0WE
MY*MVD\[E4G90JE. ,9^<G QT]0#U>Z\ :??Z'KVE7=U<2)K%PMQ+-P)$=5C5
M2#C&08PW3N:SV^%MBVB1V@U.Z%^E_P#V@-0$46XRA=@RA785"8&,#D9[FF>/
M]?N9O@Q<:YI=W-97%W:VTL$L+%77S7CX!X(R&QGMG-<-82^(;OP[-IGV_6!-
M;>(?*N]/&J WPB$7,<<Y8"0$_,0,< ^A- 'HI^'RP6WAY;#6;JVN-&ED<7!C
M1VG60_O588 &[ID#BNTKP.ZGU"_^&.DZC<:YKR:U)=2Z1I\,.H&/S96F94:4
MH/G*J,$CJ![U<\50:I8OK,+>(=6C?PMHUM/9RFY8-=S.S%Y7^8EP2NS!R!TX
M[@'N%%>=K_;S?&/33J&H'[#)IDTT%C#N5(B/+5B_(WL6=NH( QCGD<_XR^,N
MD7GAV?3]!O9[34+I)HQ<74+PB!%0DL#CEFQL4#G<><<9 /9**\)U^^U#6_ /
MA"[T_P 6ZJM]<Z<L%M963LDUU>* )))),@E%VMDGTR"<U)J][XCC\2W5\?$%
M\;K1KS2K+['#-B&Y,R)YI:/ 'S%C@_7\ #W*BO/] CUR'XMZPFL:NMRLFF)/
M;6L*LL4,;3.H !/+ ("3CDMZ"O0* "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD8%E(#%2>XQD?G0
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M+"SA56$)3&[$C'<,[!D-QWXXI^IVFH3^.KF*^M[[3TMIQ)?"T4/-%@_-.0N
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MKN&!NR,YQU-=57E5Q8:5J_B'XBWWB6R^U6NGQ01^0Q*@0QQ>=PPP<DG/7TH
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M,&EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^G&/SH ]>HKR M\<RR#;H0!QD_+@?7_ZU/V_'%XB/,\/QMD 'C/UZ$?_ *J
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWQ,_Y)GXC_Z\9/Y4SX8#'PQ\.\8_T)* .MHHHH **** "BBB@ HHHH ****
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MGPV-FS_B66YQ]8P<_CU_&J/Q8D\OX6>(&QG-MMZXZL!_6M'P$"/AWX:R /\
MB5VW08_Y9+0!T-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!ROQ,_P"29^(_^O&3^57O!<8A\"^'H@VX)IELH/KB):S_ (G''PR\1'./
M]"<5I>#\_P#"$Z#D '^SK?(48 _=KTH VJ*** "BBB@ HHHH **** "BBB@
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MK5'XKRM%\+?$#* 2;;;R.Q8 _P ZUO!<1@\">'HCG*:9;*<C'2)10!N4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9Q@K+(G)A'.=Y&"HZ'D9S0!TM%06<[W5C;W$D$EN\L:NT,GWHR1DJ?<=*GH
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M:^#EAJLOA>V\0ZKK]]J,E];"-(+ALK$J2/@Y))8G/7CCCTP >E4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%(LYGB,<D:PC/F
MJT9+-QQM.1MY]0<^U2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% %+5K^32],EO(K"ZOWC*_Z-:*#*X+ ':"0#@'/7M7C$WA3
MP;/K/V]_ACXP#2,'\A84$.<_W1-P#W&<>PKW2J>K7#VFCWUS&RK)#;R2*S=
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M2:X;1+%K8W(42[KB27<%SM^^QQC)Z5O4 %%%% !1110 4444 %%%% !1110
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MC0O$QQSC^Q;@?S6@#JZ*Y7_A.[7<!_8/B49"G)TB8 9*@<XZ_-T[8/I5Q?%
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M01AQT]\BISX.M6>)CJVO80891JLP$G.<GYN/^ XKHJ* ,&?PCIUQ>274ESK
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M!&< \]>PJ'_A /"A(SH5H<=,J3C]?>NDHH YP> ?"BNK#0K/Y1@#9QCZ=/\
M"IW\&>&'M_L[>'M,,(8L$^RI@$YSQCOFMRB@#!_X0GPMY,T/_".Z7Y<W^L7[
M(F#P0.W8$X]*?_PAOAK)/]@Z=TQQ;+@#N,8K;HH YL_#[P<5V_\ ",:3VY%H
M@/'?.,Y]Z!\/O!RXQX7TCC'_ "YIZY]/S]1P>*Z2B@#GF\!^$'QN\+:+Q_TX
MQ>W^S["G+X&\)JC*OAK20&&TXLX\D8QC..F.U;]% '/GP)X0*[?^$6T4+D$@
M6$0!QZ_+S3?^$!\'$D_\(KHF3_TX1?\ Q/M7144 8+>!_"3XW>%M$;:,#.GQ
M' ]/NU(G@_PQ%+YL?AS2$DR&WK8Q Y'0YV]JVJ* ,7_A#_#'E^7_ ,(YI&SY
MOE^PQ8YZ\;>_>HQX'\)!&0>%]$",02HT^+!QT_A]ZWJ* ,!? WA%6#+X5T,,
M#D$:?%Q_X[5D>%O#P38-!TO;SQ]CCQR23V[DD_C6M10!D'PKX=8Y.@Z63@CF
MSCZ'\*8WA#PR\C2-X=T@NR[2QLH\D>F=O2MJB@#%'A#PR(A$/#ND", J$^Q1
MXP>HQMIX\*>' "!H&E $[B/L<?7KGI6O10!E-X9T!B"VAZ:2H &;2/@ 8';T
MXIC>$O#;9W>']*.>N;*/GC'IZ<5L44 8R^$O#2+M3P]I*KUP+*,#T_NU/_PC
MVBB59?['T_S% "O]F3(P,#!QV  K2HH RV\-:"[L[Z)IK,QR2;5"2?RIO_"+
M^'SC.A:9QT_T2/\ PK6HH S8_#VBQ!A'H^GH'&&"VR#/UXIT>@Z/%'LCTFQ1
M,[MJVZ 9]>E:%% %-=)TY69ET^U#,-I(A7)&<XZ>O-+_ &7I_P#SXVW_ 'Y7
M_"K=% %1M+T]AAK&V/&.85_PI%TG3D;<NGVJMG.1"H.?RJY10!5_LRPQC[#;
M8]/*7_"D&EZ<  +"U '_ $Q7_"K=% %>2PLY2#):0.0, M&#Q^5(^GV4AR]G
M;L<8R8E/]*LT4 5/[+T__GQMO^_*_P"%/-C9D$&U@(( (,8Y Z?E5BB@"LFG
MV4;AX[.W5U.0RQ*"/TI\=I;12"2.WB1P-H94 ('I]*FHH 0* 20 "3DX[T,H
M92K %2,$'O2T4 ! (((R#2%5))*@DC'3M2T4 ! /49HHHH ;L7).T9.,G'7'
M2H3I]DR[3:0%2Q?!C&-QZGIU-6** *8TC30<C3K0'.?]2O7UZ4O]E:=M"_8+
M7:"2!Y*X!/4]/8?E5NB@!J1QQ B-%3)R=HQD]/Z"G444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6;9^(
M=%U&^DL;'5["YNXP2\$-PCNH&,Y4'(ZBK\T2SP21,6"NI4E3@@$8X->2P>&-
M%E\6>&]'\(V@$7AFY\W4M20KD$I_JF;_ ):.Y W8&%'''0 'KM8FJ>,/#FB7
MAL]4UNQL[D()/*GF"-M.<'!^AK;KRS4(+N?XLZZ;?PO8:[MT^T5OM<ZQB%29
M#@91LEB,XX^[0!Z797UKJ5G'>6-S%<VTHS'-$X96&<<$<&K%>.:3JNH^&/!0
MOHK==+BTWQ)(-8T]51D@@E?.Q"."%$L3 \=^PP>T\)ZQJFN>)_%,\LK#1K2\
M%A90M$%(>(8F;=C)!<X'/:@#KZ*\]UG4]?C\:ZQ+;ZR;?1M#L8+Z>S%NC&X!
M68E-Y&5SY?7GVK \.>)/&\UYHM[.=8O8K^6#[9;2Z,L-O!'(,%XY V[Y<@Y/
M49.!TH ]AHKR6R\2>)K3QS;V^OZU/IR7&IO;QZ?<Z8/LMQ$<B,07"@DM]WAB
M,D^W+-1U3Q?=Z'KGC2P\2I:VVFW5P+;2VMD:*2&%BA$C?>W-M)Z\9&.H( /4
MAJ=D=7;21<+]N6 7)AP<B,L5#>F,@BK9( ))P!7COBG6K])-8\1V#/:7I\(V
M<\<BJ#Y9:>1B.?8__KKJO$U[>2>+(M+AU*:U@N=!O9!Y+J/W@:,*PR.2 6QC
MGK[T ="GBC1))]*ABU"*5]6\S["8@76;RQN?# $# ]2*UZ\0\)RZEH/AKP!)
M!?W%[!)#?7DT;?*BHMN2L73(4-@9YY)/H*T+"^\41^'_  [XTG\423OJ-Y;K
M<Z88T%NT4T@CV1CJ&4$')/4$GOD ]?HKQGQ--XDM[+QOXCM_$^HV\6DZ@@L;
M-"OEY"Q%MX(.Y#O&%X&03SDY]5U#4FLO#EUJBQ,[06CW C(P6*H6QC/MZT :
M-9%AXETS5-:OM)LI9)KBQXN6$+"-&_N;R,%N1P#7G=L_B/P_!X2\0S^);S5I
MM;N[>VO+*<HMOMG4MF)0/E*X'UP>@.*V?A1HO]E6GB*8ZA=7+SZW=JZS2!@&
MCD9-W3[S8!)[\>E '5:AXHTC3+;59Y[H$:2JO>K&I9H@PW+D>X.:UP<@$9Y]
M1BO%-=T=K&S^*4RZK?W4C&&,1W$IV*9(T;'/!P' 'H !6O>7>O>"O$L@EUF\
MUDR>'KJ]E2Y8;&N8<-F-%&(U.<;1GCUH ]5K-UG7++0H;66]+A;JZCM(MBYS
M)(<+GT&>]>3^';CQ9;3^&-9N+C7,:C<QC4&U+4+;['*DP&!!'OW Y(*J ">>
M.U=3\7HY)O#VBPPW!MYI=<LTCF !*,6.& /4CKCVH ]!HKRK4+G6/!-UXGL;
M'5]2U.*/06U.%]0E\Y[64,R\-C[I +8/]PT_RKWPAXF\)QV_B;4M2BU998[V
M.^N3.KA8BXF0'.P*>2!P1@=B: /4J*\'L]9UB+4_"VJ6VH>)+FVU#6$@DO[R
M[2.WNXG9AM2UW,5&,<X&-I/!(QH:W+K%EH/C?Q5%KFK-<Z=J%Q;65M]I/D1*
M=B%MAX)4.Q'IC@9H ]7N]:M;+6]-TF59?M&HB4PE4RH\L MN/;@\>M:->96^
MAOH?Q.\,Q1:WJ&IVD]G>2[+V?SS&X6,&17/(#;AQT!!QU-;/CJ22XU7PUHCZ
MG=Z;9:E=R)<3VLWDN^V,LD0?J-S8'&"<8[T =+K6L6?A_1KK5=0=DM;9-[E5
M+'K@  =220/QI='U,:QI4%^MG>6BS D0WD7E2K@D?,O;IGZ5X_XFTQ;C0/&7
MAV;4;R]L])N;%K)I[AG>(R[0T98$;P 2!NSC<.I%>D^+IIO#_P .=6DTMW26
MRTYQ [.79-J8#;B<D@#.3GD<YH TKW7K.QU[2]&F$OVO4EF:#:N5Q$H9LGMP
M14ND:I%K.G)>PP7,",SKY=U"8G!5BIRI^G'M7E]AHUEI'Q)\#)9ZO>WYGL;R
MYE>ZN7E,A:-?WHW'*[_P'RCC.:S-'L8_$-OX TZYO;Y+6ZCU<W @N9$:4K,K
M;6;@D!AG\* /<:*\#N&\1:R?%%S%)=HVE:A<V\-TVOM:K91H!Y1,.W:R\ EF
M.6Y]C73&P'C;Q?)9>(M1GB@L]$MKFU6SNC"LIE!\V?*XR R@>@XX]0#T@ZO9
MC7AHOF-]N-L;O9M.!&&"YSTZGI[&KV1G&>:\4>*UE\0?V_IFIW>IW]KX->ZM
M+IRZ_:9D+*)"A///\)X!(/).:=H^FV&EQ>!?$6C:C=RZWK=Q"+X27A8WR&,^
M>[HQ.3'D]/NDX[@T >TT5X=-H%H?"?BK6X-2DT_49M6N[*"XDN94CBB-WGRM
MJ\1[CD9Q_'SUKJOAF\.G:GK/A]K#4=.OH!%/-937@NK>/<"-T4GW_FQDJWMC
MO0!Z/D9QGFBO*=4\-Z#K_P 7=9M]=NY##_95O<+:"Y:!7P9%+G:06V#WP-YX
MK&T74)W;X7WVH7<DBQW6H0+=W)QYD>UDC8L?50N,]: /;\@YP>G6BO$+E;77
M+#4$BNBUK>^/8XO-BD*[TV1JP5A]& (^O-4?&GAS2M.UW4MEM#J6GZ5I\>VU
M.I26UYIJ@F0R0E\K*"6SGYCGY>",$ ]\W+NVY&[&<9YQ2>8@4L77:#@G/&<X
M_G7F&D:MIT'Q/BOIKH6UM<^$[::(WDRAV7S&//J0!SC/<USEO;:=J?@?P-I+
M6,NI+<+>316CW_V6WD6-]Q>4X+.1D$*/5B>E 'N1=0%)88;@<]:HZIK5CI&B
M7>KW,P-G:QM)(\?S<#J!CJ>U>%:2%U+X?6VD-</#9CQK'9JMK,76&,L&"Q2'
MG:"PPPYSSWK8U_PYI6C:+\2-%T^ IIL&GVEY%:M(S)#,1+EER21G8A^HH ]D
M2^@;35U!F\NW,(F);^%<;N<9[>E4]$\0V&O>'K;6[9S'97"ED:8JI W%><$@
M<CU_6LV+1]*A^&W]EVT44NFC3F15C.Y7783D9)SD\]37E7ANPT&Z\.^ =)U-
MXAH5Y!=3W2&<QQSWB[<"0Y!R!N(' R!UH ][5@RAE(*D9!'>F//#'(D;RHKR
M9V*S %L=<#OU%<7\,/LT>DZS:::^_2+75YXM/97WH(<*2%.3E0Y?!_G7DWQ$
M?2+Z[\97<=G:FZM[E87N]3U$B99%4 +:Q*N<<=R<]\ < 'T@S*B,[L%51DDG
M  ID<\,S,L<L;LF-P5@2N1D9^HKF_$CM??"S5Y"X=I]%F.\'(): \Y_&O/O#
M<'A6"]\!W/AV^2;7Y55+PQS&226#R&$GFC)P%95 STQ@=. #V"WU"RNY6BMK
MRWFD4;F2.56(&<9(!]01^%)%J5A/:M=17MM);JVTRI*I0'IC.<9Y%>&Z=H^B
M6GP7M]:E79%JE]&FKWL18$VOVPAA@?=&.,* >>E:$'AOPUJ_BO7?#/A"2V_L
MF[T'%X;>4RPI<B4>4=VXC=@$GZ>N: /9+F\BMX\EE:5D9HX@P#2;1DA<]:J:
M;K,=WHNG7UZ([":\MXYC;RRC*%E!*YXS@G'2O,/"NI#Q=J*7#.[_ /"/>'/L
M5VDBL-M[*,2 9ZX$)!//45R>JVNGS6>A2W<^BW!B\+62MIVK.ULQC*Y9[:7.
MWS#\W)!QCOV /?&U25?$T>D_8Y#$]HUS]J##:I#A=F.N3NS^'Y68-0LKJXFM
M[>\MYIH#MFCCE#-&?1@#D?C7D>J74]U=0:GIL<Z7C^ YYK=7EW2QDM'@YZE@
M&//<^]5_#\'@VWU?P+-X),*ZM<-B[2.5BS6OE.9?.!XR' QD#D<<8P >Q)JF
MG22PQ)?VK23;O*03*3)M)#;1GG!!SCI@U4\2ZK<Z'X>N]2M+);V: *1 ]PL
M8%@"2[<# )//7&.]>-:?X:T6V\$V'B=H$35%\2*3=[CO1?MVPCJ.-H)Q7?\
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M/$&GPS3!61&G&<, 5)'8$$')QP:H:GX]L;+QC)X:6>S2Y&G/=(\\I \WJJ'
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M4;$HP,>P![=_K63XRDM-/\;W8B%A>7MQ>VDTFDW]H\=Q/, BJ]K,O(!XP"V
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M6W:X6X:"(S*,"0H-P_'K4M% !1110 4444 %%%% !1110 4444 5WGE74H(
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M+6M3UJWOVT;4H+;_ (0Z2U"7<)5_M(E *,&SR0H(SU!S]+R^'=3E?1;(6LJ
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MGB*XU![-/$>J74=]!'$<Q6[P[/)3<>IQ& 3WS2)\-[ZWUCPNUM=PI86<,/\
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M;KQHO]FNFM:<-+\IM8.DFTD@VN-D#-@*_&T\#)P#SMKT,^+].PQ%IK9V]?\
MB27@_+,7/X5.GB6R>#SA:ZKL+8&=+N0W3KM*9Q^% '*^/9[+2?%_AO7]>B5M
M!LTN(GF,)D%O.^S8[  \':0#C@_45QL]C%J.CZ1<6^FR+HVH>.8+FSA,1V-:
MF/&\(<;49@[<@<-G%>O'Q%9 @?9]4.3CC2[GC_R'20>(K::!I#9:K%MSE)-.
MF#?HISG':@!/$EJLG@_5;.&P>Z5[&6%;.W<1M("A78I(POIG!QZ'I7D/A>6;
MQ!::K9>'KJ?5(?\ A&YK)+BZLU@N+.3&(K?S@ '4G?VXQG->NGQ+:?,19:L0
M%R#_ &9.,GT *9S]>.>M0?\ "66ZVY<:1KGRX!C&F2[AZ=L'\* /+_"HLM0U
MOPI8Q:AX@N;[22&:U:PBMH;$^6!(&;RE.#R, DMD<]S/IML(_@K974&E$W<V
MLI+<1F EW*:@?]:,9. N#D<>@KTYO%-F'918ZPV.XTJXP?S3Z?G]<0CQ= 6(
M_L?7>!G)TV7U^E 'E.MV_P!@N?&.B:K-XF>?4KV6ZM[+3[&.2*^1QE KF)V!
M4#:>1C9D9(Q3O%.GKHDPMVAU/396T2&SMW-LNH1ZD(TQY,R!,)(K8Y!P1SQ7
MK2>)4D@65-)UC)8KL:R96& /7'!W8S['T-13^*UM[HP-H6NN!C,D=B60?B#S
M^&: )+6ROKKP+%83Q16%_+IHA>.# 2"0QXPN. %/3'I7F&DDW]EX+\,6GA34
M;+4=#OX+B^>6W,44(0'S7#_Q!V)QS\W7G ->FKXGRJEM"UM"P^Z;3)'7K@GT
M_45#_P )=AB)/#OB!/?[%N'3_98T 4O!%K+;:SXQ9XIHXY=9:2,R1[0^8H\E
M3@9&<\^WUKAO'.G:E'XH\13:9I6MK>7JP;?)L5O;#4@B*%6964B,J<CDXQS7
MH\/BUI21_P (YKZ#G:7M -V/^!<9]\5(_B6Y0*?^$8UQE;'*QP\=>H\S/;TH
M X+7-*UN^\7^(+%K.=;K6_#2P17,,9-NDJA]\9<\ $\<\X8>O-G2FN_$NN^%
M[>/PYJ.CIH5G,MS-=VQB5"\/DB*+LZY^;(XP@KMO^$BNL*P\,ZT5*,Q.V ;<
M=L&7.3VP#48\3W;1LZ^%->.W^$K;@GZ9E% ' ^&&U2UTWPIX6?P5+]NTJ\(N
MKNYM2+:!%+;IHI>%9V#9'N3P>#5/X=>&M:\#S>'M1.GWUY!K%LMIJ,<T>9M.
M?<S(5! *1<_,#T/)YP*]'7Q7=/%O_P"$2\0!\?ZLQP _GYN/UIR^)[MF*GPG
MKRN#@ K;X/XB7'ZT :^G:@NHQ32);W$(BN)8,3IM+%&*EE]5)&0>XJW7/IXA
MU-EC)\':V-P!/[VS^7Z_Z12MXAU,' \'ZVQ_V9;/ _.X% &_16 /$.I$-GP?
MK@VC/,MGS],7%!\0ZDIY\(:WC86)$MF<8[<3]: -^BN?/B'5 ,CP;K?_ '^L
ML]<?\_'XTI\0:ID#_A#M:YQSYUEQ]?\ 2* -^BL(ZYJWF,%\)ZF4#8W&XM1N
M'J!YO\\5)'K6H/\ >\,:JG7[TMK_ $F/^10!LT5AS:SJR$>3X7OY ?6XMUQ]
M[K^\]E_[Z]C4,6NZ_)<!#X0NXHRX0R27MO@>K8#D[1^?M0!T5%<TNO\ B H&
M;P9?*>,K]MMB1QD_\M,=>.M7HM5U*64*?#M[$AQAY)X./7(60]/;- &O16$=
M9UD)G_A%KPMN.0MU;_=QQU<<^W3WIIU_5E7)\(:NS>B3VA&?QG'']#VZ4 ;]
M%<XGB'6F&7\&:JH)( %S:$C'K^^X]L9IZ>(]1=HP?!^NJ'/5I+/Y1ZG_ $CB
M@#H**HZ;J::D+D"WFMY;:;R98IMNY6VJ_P#"2.CKWJ]0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <_K%G%
MJ/B;2K6>6X5%M;J8""XDA)8-"H.Y&4]'/7U-6Y/#UC)<23F740\@ ;9J5PHX
M '"A\#@=AUYZFDN3CQ;IO7FQNNW^W!61X.UK7-6O]=@U5]/:/3+UK)&MH'1I
M2%5MYW.P'##@=^_'(!??P;HLA8O%>,6;<Q.H7')]3\]">#]'CB$:+?! =VW^
MT;C&>.?]9[#\JVIA*T$@@=$F*G8TB%U![$@$9'MD?6N*\)^+[Z;P[<ZSXMN]
M/LPEW)9K#!;O'MDC=D(^9V9V8C[H (QT- &P/!.@JY<6]R&/?[=/GIC^_P"Y
M_,TYO!/AUMV-."%FWLR2NA+?WLA@<^_6L/QCXR-KH.D:KH6J6@L[C5;>UN9B
M@?;&S_.,DX0@ @Y&1D]#S6X?&WA@:?'??VY9?9I+D6BR>8/]=_<(Z@]^>W/2
M@!#X)T$@@V]R0?\ I^G_ /BZ>?!VA$HQLF+H"%<SR%@#GC=NSCDU;T;Q#I'B
M*":?1]0@O8H9/*D>%MP#8!Q^1%<9JVO^*+/Q?KVG6NJZ2EI:Z8NH0?:[,DH2
M6'EEA(O]TG<<]1QZ@'31^"?#D3,T>EQH2I4E78<'J.M//@WPZSR.^DV[O(NU
MF<%CC.<9)XY Z>E8T/BIM4\'^&M6GOXM&FU2YMB49"XERP)B4D<;P,9[ ]>]
M;=UXLT.RU,:=<7ZK<^:D# 1NRI(^-B,X&U6.1@$@\B@"O%X$\+0"01:':1B0
MY<(N-WU]:LQ>$?#D",L.A:;$&C\IMELBDH>JY S@]_6FS>+M!M]6CTN;442Z
MDG%LH*-L,I (CWXV[SD?+G/M6W0!B_\ "'>& LB_\(YI&V0Y=?L4>&.0<D;>
M3D _@/2H5\"^$DZ>&='Z;>;*,\8QCD=,=JYOPOXUBM-0U+2M?U:6ZU%]<EL[
M=A:,J*,*(TRHV+T. 3DY[G)KI+GQIHMIK::7-/(LCSK:^?Y3& 3D;A"9.@<C
M!Q[XZ\4 *O@?PBF=OA;1!D8.-/BY'_?-.C\%>%(L^7X8T5,]=MA$,]O[ON:H
M1_$CPN_VK-[<1_9-_P!H\VRF3RRK!2#E/O$L,+U.1Q6!XY\<0R^$;^\T'6)[
M.]TB[MFO(# 4E\MW5=I1UR 0X.0/X: .R;PAX98REO#ND$S<RDV4?S_[WR\_
MC2Q^$_#<./*\/Z4F 5&VRC& 221T]2?SK*G^)'AN"TO[CSKQOL&TW40L9EDB
M1B<.590=G&=W2MJUUVSO-5738A/]H-FEZV8B%2-R0N6Z;B0W'^R: $'AK05C
MDC&B::$D^^HM4PW&.1CG@D?C41\)>&CC/A[23M&!FRCX'I]VJ^K^--(T6\EM
M[G[5)]GV&[D@MVD2U#_=,A XSZ#)QR0!S4.J^/=#T;5&L;I[C,<L<,\Z0DQ0
M.X!57?H"05Z9^\* -+_A&- +.QT/3,O]X_9(_FYSSQSSS2'PMX>/70=+/3_E
MSC[=.U<QK/Q4TS3;+5Y;32]7O9--EE@EV63K$'15)+.1A5RX'KWQC!,]AX@.
MIZEX5GN#JMO=W.ES71M$CVP3$JF=YS@L,$JN3C=DXR,@'3C0M($@D&E6(D!+
M!OLZ9!/!.<=33VTC379F;3K0LW4F%>?TKQZW\97W]H7WBB^3Q7#:6.JSPR6L
M2QM;",!8TB=3(-K;NI&0&/7%>LV^MQW/B2]T5+6XWVD$<TEQA?*^<G:O7.[Y
M2>F,#KR* + TG31OQI]H-_WOW*_-]>.::VBZ4ZE6TRR92""# I!SR>W>N!\4
M^*]2N3XYTB"UO[./2=,6:"_@<)ME\MY,E@V[#?(  #]ULXK4TGXAZ.ME/!/%
MJ<)T_2X[\R7-L5-Q 1C>@ZGD8Y Y/&>: .I71-)1MR:79*1CD6Z#IG';W/YF
MI?[,L,8^PVV/3RE_PKA=7^*(M_#&O7UEH>H)J&E)"TEK=*BM&LRYCE;:S#;Z
M@'<,<@=1UY\W6O#!,\5Y837-N24239-$2.,%&.&^A/I0!H&VMRRDP1DKR#L'
M%1+IM@IRME; ^HB7_"N7^%?VB3X<Z5=WE]>7MU=H9Y9KN=I6))/ +$X    '
M'?J326/Q#@O==@TUM&U" 7:7#V<DH0&X$)PV$)W*#_"3C- '7^1%ECY298DD
M[1SD8/Z 41V\$+L\4,:,P )50"<=*\_LOB[87D%I,/#GB!([R5X+9OLR,)I4
MSE%P_)^7KPHP<D8-=9X;\0P>)=/FNX;6YM6@N9;66"Y"B2.1&P0=I(_(F@#8
MHKQGQ%XEUG4_!_BZ]U"SO+&+2]:@BMS!=#)020(\>%(WYRS<\9? /R\=>GQ*
MM(]*UF[U'2KVPN-,GB@:TG*AY#*!Y>#G:-V>YP.IH [>BN8\&^,XO%\%[BQF
MLKBRE\J:-Y$D4D]TD0E6'!&1Z5CZ99R>-/$^O7>I7UZNFZ9>G3K;3[>X>&,L
MBHS2N4(+-E^.< #IG!H [^BO+M5TJ^\'S>'Y5N-5UN0:W-]GMS>$O)&]M)L1
MB[ ':4')Z#/K@Z%YXIL==3PO-=:1J,(DUMK?;YRH;:ZB\Q0L@4G>#A^!QQSZ
M$ ]!HK@1\3[=O$$=@NE326<NHG3DNXI5=MX.S>8QR(]X*[L]LUF>'K.[\6>.
M]9U#5[6XMVTC4E2VFM[\XC\N-/W.W RC;B[=,DX- 'J-%>2>(H=+MOBO=6E[
M:ZS<6<NBK>O#I\UP2)?/<,V(W!&0%'''';OI:?XJ3PAX2\.74UG<2:%J(65[
M^YNV=[,3,TBK)E26"AE4-GG'..X!Z317%WWCR6QT?1[F31G6]U4NT-I)/LV1
MJ-Q=V*\';CY<9RP!QSB"+XA7VI:5IL^B>&I[R^N[:6YELY[@6[6ZQL%Y)4DE
MB<+@<X[4 =W17(0>,[NXFE@.C>1,=%75K=9[@J3D8:*0;,HRMP3\PQS[51L_
M%6N:KXDT*6TTR+^SKW06U!HC=X;<_E$#E,%E)VCD AV)(P!0!WM%>8^%_%S6
M'AWPLUCX>%OH^K7TUHS2WQ9[:8SR ;AL.[<58]0-QQQP3J77Q#F@7;'I43S7
M&I7%G9;KIECGCA'SS%A&VT;@5P >>^,F@#NJ*YS1O%+ZMX);Q#)I=Q:3)#+(
M]E+D.&3/R@E02#C@XZ$<=JYCP[X.M=?\ VNK:G--+KNHVWVS^T1.ZR022#<F
MP@_*%RHP..,$'I0!Z52%@HR2!]:\6.KZEXO'PTMM3M+.\M=4BN);F*X9E6>2
M*)L[UVXQT8<$;O;!J'5=&MC;^+M1UCPW9ZA9:#)'#:PF_E5D2.&)MBMMSM(<
MLP/4MCMF@#W"BN+U7Q3K%M+=VGASP[%>_P!G6<%Q+#)<>4Y\S=MBC558$@+G
M.<=AG-4=9^(NI6.I7$5AX;N;^&R>**YBA2629I'17*IL0H"BN,AF!)SC&,D
M]"HKB='\6^(-7\:7^D#0;:+3M/NO)N;K[8&=5,1=#LP.2=F?3)'.,C2UC7=3
MC\01Z'HMI:37ALVO)'NYF1%4,$4#:I)).?3@4 =&S*BEG8*HZDG %"LKHKHP
M96&00<@BO']7\17WCJ'P-Y%E;0V.JW4_VJRO]Q1Y(5<-&^!ADRI(XZA20,8'
M6>*/#<MK\/4T;P_;HJVS1NMAYS 7*(^]X Y)8;P".OMTH [,NH!)8 #)Z^G6
ME5E=%=&#*PR"#D$5Y!H5QH#3>(+W2O#ZZ=J\6DNE_P"'+E&A0J&.2K!2N" 1
M\JX.5SC)-;5KXOGM-%\/V&C6-C 6\/KJ0BN)F\L1HJ 0(V<Y^;&XYP!D@YH
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MD=#5[PGX=U70]3UNYO[RQN$U.Z-V1;P.C(Y"KC)8Y7"_F35_Q;J6HZ3X6O\
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M%+'<<!3NXZ=.]32^!M9AN;/4]-\4/#K*QR17ES/:B9+A'?S"JH6_=J&SM /
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MRB.0%/(8'Y3C[IS@ F@"NWP]C6(2P:U?Q:HVH?VA-J&(S)*_EM'L*[=NS:Q
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M0<'!_'OW$UM!<@">&.4#D!U#8_.H;;4;*XGO+:WGC:2Q<17"#CRB4#@'_@+
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MD@#/S?6O=J* /$9O#EC-KGA6!O".IG2!J=U+(EW:23'RY$4!Y?E(0-+D[3T
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M&.<\XP<;Q3X$&OZQH>NVIAL]4L[RVENR';;<0)(KM&2!\Q!4%21VQQGCMJ*
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M'-5K3P=XOT[_ (1W2H(M,DL=$U-KB&^>Y8226[;QL9 @^;:YR<G)'U->JT4
M8GA_:;S7BF[:=2;[W<^3$#^&0:VZQM F$LVLC9M:/471C@#=\B$'\B/RK9H
M**** "BBB@ HHHH **** &"&(3M.(T$S*$,FT;BH)(&?0$GCW-/HHH ****
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M1C-1>'O&.OZMKJV,KZ?MO;:ZEMI([:1H8I(I%55$N_$PVMEBN #D ]JV](\
M:=HUW9O;W^I26=A+)+96$TRM!;,X8$J-H8X#L!N9L9JOI_PUTW3&LFM]6UO=
M8I+':EKO_4I)MRBC;C VC'';G.!@ Y[3?''BVY\/Z1JMP-%4Z[<P6>GI''(P
MB9F?>\@W#<-J' ##G'2M?P%%/#XK\;I=202W(U"$O+!%Y2-F!2/ER<'UY.3D
MU?7X<Z,/"=KX<:>^:SL[A;FTD,P$MNZG(*,!Q@ENN?O'VQ>\.^$K7PW>:C=P
MW^HWD^H.CSO>3[^57:"  !G &3UX'8 4 <WJOBW7Y+3Q/JVBO8K:^';AH9+.
MXA)>Y$:*\K%PXV<,=O!^[SUP(Q;2:[\5)UGDM[C3;CP]$Y@GM0V8)96S'G=P
M3L!S^8X%=#?^!=+U#4;^Z:>]BCU$QF^M8I0(;G9P-P()&0 #M(R!]<V3X5M_
M^$P/B4:AJ NS +8PB5?),8.0I7;GJ2>N<DT 8_CBVM6U?P5&\$;8U@(J&,$!
M?(ER/8<+^7M6=J.FV^B?&#0I-"2.VN-5M+F/4($3$1CC4&.5E7'(; SWZ9%=
M/X@\(VWB*^L;NXU#4;=[%M]N+694"/@@M]TG.#CKC'XT:+X/T[1;ZXU(37=[
MJMQ$(9;^\F,DI3.=HZ*BYYPH Z>@H X^P\1>)9M$\')ILND6TNK7%Q!<?Z$S
M(A7S&W(JNO0(>.YY)ZU-<>)O&#ZEJ4>G6]O<1:+-!!<M((X8Y_W:/.[,\FZ,
M -E<*PP.I[;]I\/M)L4TI+>ZU)4TIY)+4?:C\K29W$_WOO,.>S&IM1\"Z-J>
MO-J\_P!K6:7R_M,,5PR0W7E_<\U!P^.V: ,C3=?UK79FU:UU"UM=*CU233GM
M9$7<$!,8<N3_ *PR%<+TPP')KG?"FM:Q;^']+LQJNZ^UW7+N+[5+$K>2D;2%
MR!QEVV #.0-WM@]NO@+1$\2OKB"Z65YA<R6PN&^SO..DICZ%QV/J,]>:A/PX
M\/BRN+:,7D7FW0NXY4NG$EM(&9AY1_@ ,DAP/^>C>M '.77BKQ;9B]TWS[%[
MRPUVTL1=/;$K<0W&TKE0P"N ZY(P#T&.M+K/B+Q)H6M6EA>Z[;+$H@B-ZMEN
MAFF>4[HY0H9H&,93;S@]<]<=/+X!T.;2_L+_ &W!NOMCSI>2)-)."")&=2"Q
M&!C/3 QC IU]X#T34-3FOYQ=^;.\$DZ)=.J3-#CRV90<$C:.>O% ">--?N=&
MATFTLF6*YU;48K!+AU#" -DEL'@M@' /&2,YZ'C/%E[K5SX2\>:%?:G*[:3;
MQRI>Q0I&;F*5&)B<8(XP02NTD$=.0?2-<T+3_$6F-8:E"9(2RR(RL4>-U.5=
M&'*L#W'\B:R[GP%H=YHE[I=RMY+%?2B:[F>[D\V=A@#>^<E0  %^Z !@4 6;
MFPFMO"FH(-0N/M;VLG^FB...93M.T_*H4%1P..U>:^'K"]N=$^&?D:N\=TT-
MT5G>%':%6@/"C ''&"V[D@G/2O6K'2[>PTE--5II[=$*?Z5*TSLISD,S$D]<
M<]N*P-/^&WA;2Y+&6RL)X9+%F:W9;V<%&8;6/#X)*@+D_P ( Z "@#EH/%/B
M;4-*\.:=#>@:I=R7JSW2"*$S_9Y6B 0NCH&/#%0N< XQ75Z;?:W<?#F:XO);
M>;7(K:YB=[$[D:>,N@V]/FRHR!@9SBDE^&WA.?0HM%FTHR6$,[7$4;W4S,DC
M=2KE]PR>< XSFN@TO2[+1=,M].TZW2WM+=-D<2#@#_'.23W)H YCP5;Z(WPE
MTN$"+^RWTT?:2^ I)4^<7]#NWY]\UFWNJZE<7'B==-UI[&+P_:126EO''$ZS
M@V_F;I=Z%BI)V_*5^Z3UK8?X;>%I+VXN383!;F0RSVRW<HMY7)SN:(-L//;&
M.>E7=8\%^']>O_MNHV!EN#&L3LLTD8EC#!@DBJP$BY'1@10!PT>N>*=<O+B:
M#6Y=,AE\-P:O' +:)S#*V_Y06'*97)SDD8&15G2]6\12S^'I9_$$KMXAT62\
M\O[-$$MI46%QL&W)&)&!!)]?8=A>^"O#NHWUU>76FK)/=0"WF;S'&Z,8 7 .
M ..WOZFJC^"M+TJW2[T'2H?[5LK4V^GM<7,NV($' R2V!\QS@<T <OX=UK78
MD\):I?\ B-KJRUBPD:YAGMXT%NR0>9YBE0"0"I!+$YW#IFJN@:YXBF>_MY=8
MO&CG\.C4XIYXXF?SB>7C51E8R,81AD>@-=/X%\#6FA>';!-0T^,:I%:M;3$W
M#SI@X#;-QPH8*I(4#K5FV^&7@RS8-;Z!;1N(GAWAFW;'&&&<YZ$C/4 X'% '
M/Z!/KM]?Z7:7?B6Z=M8\.?;"RQQKY$RM#M:,!?21L@DYQZ8J+PKJ'B#5O$&D
M:1<:G>?:-"^U_P!O-@;+B0N! N<="-S <86NLC\&:/I$<5WHNE6Z:E86DD&G
MM+(Y6/.Y@I.<[2S'/?!-2^%-'O\ 3[:[OM9:V;6=3E6XO#:J1$A"*BHN23@*
M@Y/4DF@"GJ(-S\4M!AD#B*UTV\NHSN^5I"T4?3U"NW_?7Y^<>(+&.Q\">.HA
MJMS/=?VW&4CN+G>RCS[;#8/<;@,],8%>I^)-&O;VXT[5=(D@35=-D8PBX9EB
MEC<!9(W*@D @ @X.&1>*9?\ @'PIJEU=75]H5I<3W4BRS22+DLRKM!]N.PH
MX+5M:UKPK#XLTZ'Q!<W9@GL&6[ORI:S2X)61LA>@V\#;\N<X/?K? KZE#=ZK
M8:AK]OJRQ"": 1RF9X4<-D-)L4-DH2!R0,9ZC.G9^"/#-A+>26NCV\;7D!M[
M@X)\R(@ H<G[N !CVJ[H?A_2?#6G"PT:QBL[8$ML3)R3W).23[DT :=%%% !
M1110 4444 8OAY$636"JD%M1D+$]SM0<?@!6U6-X?96;5MN.-1E!(]<+6S0
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M<?F-'O?Y/D&]2O./RYKEK[1M5UF/5-=MO#U^/[5U/3I$L)3%%,D-L=SR,K.
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M$N(V\K86D7Y5'*E3C/8CG/4@'5Z_XITSPWY"W[3M+<+(\44$+2.RQKN=L <
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MS>%?&EOIUGH5M;:=<6ECK::A;WLMTP)B$QE",FW.X$\G)X!H [3QGKTNAZ/
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MC@<C]ZOUY]*THM/OIK*P\-G2[V/4[/Q$;QKXVC>3Y0G,OF^;MV$M&VW'7/!
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M9[M%7RTEF **,L"W!&2!QF@#6T7POI/A^YOKC38)HI;Z7SKDO<RRB1^[8=B
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MHP4N2=_RLG8<[L=: /4+N_LK66VMKN>-'O',,,;G_6M@DJ/7@&K( 4    <
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M0R1>7:F=E9%QNRS!5VL5&"6.#C-8-_X9\1W&@^)[9?#,[S:CXACOX5,]O\\
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MGA._TZQT^YT6%[:PR+90[J8P3D@,#G!/8G%=)##';PQPPHL<4:A$11@* ,
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M.:UJ* "BBB@#"\+$M;:FS-DG5+H?3$A _E6[6!X4S]FU0D8SJMUCC_IH:WZ
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MHY0EY.H(D9&1QM'SJ#@X^49]:-MH/AJT\4^"=-GL+B>RMX+]=NK0^9))"3F
MR*4  ),A1",C(R U>YUS5U\0?"5CJ$UA=Z[:6]U"Q66.5BA0@A><CCDCZCGI
MS0!4^&&%\ 6$ @E@\B2:/RI(V0J!*Y7A@#C:5(^M4[S4;=/C1IJ+%.S?V5-;
M22K Y17:2-U4N!CHK=3@9[&NTLK^SU.SCN["ZANK:092:&0.C?0CBJ6J>)-'
MT:YBMK^^CBN95+I" 7D91U;:H)Q[XQ0!YQXLAT[5/$?C9KC2Y[F2+0$MK>5K
M.27$O[W/E':<8+Q\K@ C/J:<]U96VH2R>)]*N9[;5O#]I#;'[&\A,BB3S(%
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M7W%WJ%Y>PZ^+>8BU^PR"SW/:>0<*2Q?Y]REU;H#D$CC![^U2>*UB2YF6>=5
M>54V!SZ[<G'YU-10 4444 %%%% !1110!C^'1M@U !@5_M"X( )(&7)/7W)/
M'&2:V*R-!4*-2 _Y_P"4]/4@UKT %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% '/7%V++Q=>7-PQ6V@TD2L>N
M,2.6./H!7#&;4M8\>^"_$NKZ9:6<'V:]N(%@8R2K'Y0*K*3@9PQ88Z$XX[]W
M-:K=^+[N&X4O;3:4L3(Q.&!D<,,=N",_4>E<_I7PYU&SU'29+[Q7<W]AI(EB
MM;5[2-2874)LD?G?A1C. ?3% %71/'_B35IUNE\,ROI5S8RW5L\4,H8,%+)&
MS$;6W #!7(R<?7#O/'>IZ]\,_$>H7MCH6HVD%M;YBB>15+.2)8Y%)WJR$+C[
MN>H/IUEG\.Y;"SO;&W\3ZJ+$V\L&G6S,"MCO1DW!AAGVAOER1CW/(K2_#&6\
MTS7H+_Q!))=ZVMNEU<P6<<(*Q9_@&1EBS9/7&!VY (O$_C;5]%U'5;;3HM)@
MM=%TR*]DCO2V^XW$_)&0P"X"D#(.20,<T_6O$WC>TU*\M+2QT-%MM(746DF>
M5]K#=N0@;2<E2!TZ9R?NU@>)/#^H3>.KJXO+;6YO+LK:WLKBSTVWNHY=H)9F
M\T%4.]C\HV^N<'CK;;P9J.I(NH:SKE_%J%YI"V%[! ("B$@%MA,9_B+]<_>Z
MX H R?$/Q#U>PLK:^T^"S,;Z1!J1M7@EGEF+MAD'ED>4H&/WC*1E@*?J.O:W
MI'C3Q7>27RW%EI>DQ30:>L#8<OYA7!\S[VY0"VTY!P ,<W[KX86ES9?9!KVL
M1Q'3DT]MDD:EXT9VCW$(/N[R,#&0!G/.="^\!Z?J.I3W5U>WSQW.G#3KF#S0
M%G4!@'? R7&]N?7GM0!@OXQ\8:5INJRZIHD4LJ+;IITB1&!9YY75/*V&1V.&
M88/< ]*?X>T_4;7XPZI)J<]C-<-HD#>9:6YA$@:9^64LW(*D9ST"]^NC%\-=
M,?2;VPU/4M5U4W,:PK<7MSOE@13E=A  !##=NQDGKFKFD^"DTSQ.VOS:WJNH
M79LULQ]K=,; Q;D(B@\D8X]3SF@#$^(WBW6?#K3-IDL:+:V/VPI]C:X,I#X*
MOM/[M, _,<<GKP:77?%VIZ?XTBTQ[J'3H9Y+1;-;FW+1W6Y_WZ&49"2!6&![
M#KNK8\1^ =*\37ES<W5SJ%NUU:"TN%M)_+69 25W<<D%C['H014<GP[TJ:]\
M^2\U-XS<6]R]L]SNBDEA551V!!))"+DYRV.: -/7/#D>M:GHM^;R>WETJZ-P
MBQGY9,J5*L/H<9]SZURFJ>$+K2=)LK/1-6BFU2VU675--MM04>7)\K;H?EP>
M [$-USZ#IZ-6-KOANUU][.66YO+6XLI&DMY[2;RW0D;3V((()&"* .!M?$]U
M!H^H'2]*.F>([S6H+*_LY&22.VE9%7?'C"ME$!&3]X\Y &36/%/CG1/"]_YY
MTT:M;WUNL ?;(\L$S%5$B(<*VX$9'7!P.,GL)O 6BW6AWVEWGVFZ^W2K/<74
MTQ,[2* $;>,8*A5 QP,=.3F!_ASHLVG?8Y[C5)MTJ32W$M](TTS(<IO<G)"G
MD#@ \]Z *-QJ&MZ#J5L=7N++4+F+1+^[+1V@C/F1O$=J-N)VE74$?[ )SVR[
M76?'T.EWLT[V,SW6EBXT\//")&N&91MC"@ H!(H&[<=VP9.ZNWF\,:?<ZK!J
M-PUS-+#:/9A))V9&C?&X,O0DX&3WP/2LNQ^''A_3]/N+* 7QCEB$*N][(SP(
M&#!8F)S& 54\8^ZN<XH / >O2:[::D[ZC-=BWNS"JW5L(+B#"*2DJJ I()."
MHQCOG-1Z!&K?$;QKNA7#+8@G:/G'E-U]?I_C6YHOAZQT(W;VIGDFNY!+<37$
MS2/(P4*"2?8 5ER^ -'FO;J[:XU=9;MPUQY>J3IYH&0JG#CY0"0!0!C_  SA
MBM=1\7VFGKMT>#5V2U1,>6C;09%0=@&/3H.U,^'L<,WC+QW>7*AM6&J^2SN!
MN6W"#R@.,@8!^N!Z5V^DZ1I^A:9#IVF6J6UI"#LC3/&3DDD\DD\DGDUF:GX-
MTG4]5.J'[59W[1^7)<V-R]N\JXP Y0C=@=">1VH P-6U!;'Q)8Z#H6J?96UC
M5)CJ%RI$KV\B0K(8T# JC. O4'&XD#-8%]XA\70"VTH:XL=U;^*(M*DO#;Q'
M[1;R1^8I9=N-X! .W&?UKO[KP5H%WIEO8/8E(K>?[3#)%*Z3)+G)<2@[]Q[M
MG)[U7;X?>&&AM(CI\NVTNFO8B+N8,9V()E<[\N_ Y;)Z^IH Y6YN_$I\/>(V
MM]<OY[K0=6 $B1PB2>V"1/(I 3!(5Y",+U '-+J_B+5GM+K7=(UE3IVI:G;Z
M?8>:ZQPQQC DE5]C$%G#J"0P'7!R .YT_P ,:3I;:D;2WD4ZG(9+OS+B23S&
M(()^9CC@XXQV]!2-X5T63PNGAN2Q5])2)8E@9FX5<$?-G=D$ YSG/- 'G>H7
MWC/2[.RL+GQ+;+?'7[:U+6I2X9()\X28M$@+#J, 9!&>HK0ATK4=.\;ZLK^(
M]2N+J#P]'(MPZQ$AC),/N[-O&P'H><YS72?\*Z\*?V;;:?\ V5_HMM<&YB3[
M1+D2G'SEMV6;@#))(' K1OO"^BZGJO\ :=Y81RWOV5[,3$G(B;.5&#Q]YAD<
MX8\\T >>Z6NI^*M3\(3_ -LW=A=7'AB22YN8$C,LA+P9QN#!<MAL@9XQQGB7
M0]9U#6-(\#7&IR>?=KK<\/G8P+A4@N4$HZ#D8_I78R> _#,MC9V9TM5ALPPM
M_+E=&B#?> 8,&P>XS@U<N/"^B74^F33:?&7TL 66"5$ &  H!QT 'TH \_\
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M%% !132ZB01EAO() ]0,9_F/SIU !1110 4444 %%%% !1110 4444 %%%%
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M?QS9Z[/X!URYTR+2Y+;RKF"$2"1W5L^6TF,84CGGGITSI0W&KV'AV*.W\&W
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MNF8Q:9N+R;!R-ZJB\!2H)/7UZ[4/ "WOB:Z\00^)-;LKZXB6 _9GA"+$,$*
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M?PJ+%7D'RRL4!8D?-Y9R2#_#@#G/4ZG\/?#FKLHNK680K9K8F"*XDCC:%#E
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MO[F(_>@182&+X/'S.%]"3CVKT&@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ,G"@9)P,#))ZFKM%% !1110 4444 %%%% !1110 4444 %%!('4XH) ZG%
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M=[8_O8L9_?\ V.>A^M &S17/GQKHHM#=%M0\H%1G^R[G)W*S# \O)X1LXZ<
MX)&:S?$/PZH4E]3 89'_ !)[OD9Q_P \O8T =317*_\ "QO#?_/34_\ P3W?
M_P :J=?'&D.A=+;6V4#((T.\((QG_GE[T ='17.2^-]*B S:ZX2QPH_L.\!8
M^@S%UZ_E39/'&FQ!-UAKN719%5='N6.TC/9#C'<=: .EHKESX[T[RU>/3/$,
MH/9-#NOZQX__ %U(OC6R<3%-+\0'REW<Z-<KN'^SE!D\].M '245B'Q/!GC3
M-88%-^[^SY1VSCD9SVQ4%QXNBMIS$VB:\^'V[X].D=3SC.1VSW].>G- '145
MSY\5H(1*=%US'.5^P,6&%#=!]<?4$4D?BV.258UT3706VC+:>Z@;NF2>/KZ=
MZ .AHK&C\0B214_LG5EW*&!:U('(SC.>#V.>]0/XRTV*,/)::VOR[B/[$NSM
M]B1$1^M '045@3^,=)MIVAECU564L,_V1=E25!)PPBP>AZ&F2^.-#AN3;L=2
M,H7<532KIN,9[1GM0!)X4"BTU(ALDZI=EACH?-;C^1_&MZL'PB1+I$]VJ3*E
MW>W$\?G1M&Q1I&VG:P##(P<$ UO4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% &-=Z7J7]N2:EI]_:0^;;1P
M217%H9?N.[ AA(I'^L(QST%2I!KP+;]1TTC!"[;!QSQR?WW3KQ^M:E% &*]M
MXG:*(1ZMI"2!2)"VF2L&;/! ^T#:,=LGZU$MIXNP=VMZ)G'&-(EZYZ_\?/IV
MK?HH P19^+>^N:+GVTB7'_I34HM/$?DA&UC3=_\ ?737'IV,Q]_SK9HH REM
M]?  .J::W'7^SWY_\C5!/8^))D94UVR@)'#1Z:20<@_Q2D= 1T_B^E;E% '.
M2:3XH=RR^*8(P?X5TQ<#\W)I?[(\3&<,?%2B+=G8NG)G'IDL:Z*B@#'CTW6!
M!*DGB!V=G4QN+2,;% .01T.2<YXZ#WJO-H>N2L"OBV]A"[N([2W^;/3.Y#T]
ML5T%% '.#P_K>U\^,=2)9&13]EMAM).0W$?4#CT]J;'X=UP +/XSU*0 .,BU
MMD.67:#D1_PGD>_7-=+10!S(\+:F98I'\::Z3& ,!+4!L'/($/X5&WA+50I$
M7CC7U.2072U;DX_Z8]..E=510!R[>&M>8ICQSJXP,/\ Z)9\^N/W/'ZT1^$+
MR.0,?&?B.101E&DM\,,YQQ#G\B#7444 <VGA*5;<POXH\02$MN$C7*!@.>.$
M''/?T%*_A*1R<>)O$"@L2P6Z3D>GW,@<GI@^_ KHZ* .;;PANE5SXB\0<?PB
M]P#_ ..T[_A$SO9CXAUX@L'Q]L  //3"].>G3@<5T5% &"?"L+(JMJVMY&=S
M#49 6SGK@X&,]L=!2-X3A:X>4:OKBJQ!\L:C)M7GH.<^W7O],;]% &"?"EKL
M<#4M;!8#YO[4GRIYY'S8[_3B@^$[3=E=1UM1G.!JMP1W]7/K^E;U% &1_P (
MY9%-IN-4/')_M2Y!_22HSX4TXQK&;G6-JD$$:S=@_GYN36W10!AR^%-.E"AK
MG60%SC9K5XO7UQ+S0/">FXD'VC6")!@YUJ\..0>/WO'0=,?J:W** ,"3P=I4
MKAVFUC<!@$:U>#^4O7WIW_"(Z9M=?.U;:^,K_;%W@8]!YN!^%;M% &2/#M@
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M!XEN SME7-K#F,>@^7![\G/'YU7&@:Z4(?QEJ.['!CL[4<\<\QGW_/O71T4
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M\/-'9ES>ZZ55MRH=9NL XQQ^\J1/A[X>C!"KJ>"P;!U>[ZCI_P M?7FNHHH
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M;(W.V,R@=P.F.^:]ZCT328K&:QBTRSCM)AME@2!51QC&"H&#P /PI;31M+L
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MQFO=!!$I4B)!M8L,*."<Y/U.3^=8_B+PS%KVFM;P7ESIEQ]H2Y6[LFV2>8O
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MN.4-'_"+^)0N$\?:F./XK&T;_P!IT =;17+S^&_$$WE$>-]2B*(H;R[.UPS
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M@+M&BVNW.<;3C/KUI3X'\,E=IT:V*^A!_P : .@II=06!8 J,GGH/7]#7/\
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MLU6L+"UTRRCL[*%8;>/.U%]SDGW))))/)))JS0 4444 %%%% !1110 4444
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M^>[:TAOK:2Y7.Z%)E+C!P<J#G@\&LW5?%^B:3HVHZH]]!<Q:>F^>.VF1W7G
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M<N,C)( Y'K576OB7H&F6EPT$\UU<)IWV^)8;6:1&0J2A9U4A0<=3C'>LK6_
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDD+=$Y!8[N7()/TJGING>.-*\*62S7-L+BPCM+>.PLT5A*B2()6>1ADEHPV
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,UVZ?ZI6_P"6<())2,# P#SU.2:K>,F^WQZ?X<3S/,U:X D9%!"P1D/*3G@
M@!._+BNGKG="3^T-=UC6VRR&46-FV>/*B^^0.Q,QE!/<(M '14444 %%%% !
M1110 5GZEH.CZR4.IZ597I3[AN(%D*_0D<=3^=:%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M% X ' _$U=H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW_2H_0#G$?/?\_7K,/ EYMVMXY\5$8'2XA'/_?JNQHH X7_A6LFT+_PG?C/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]7!.5Y_'^4?A/XI:3XKUK^RX['4+&::(SV37D6Q;N($@LGY'\CZ' !W-%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:&*4IYI"(2J\#)( YZT =O16=>:]I=CH?]M3WB?V;L1Q<1@R!@Y 7:%!+9+
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MEL#YL$8P.W0UZ310!YOI=WK7C3QSI.L3^']1T32M%BG8?;TV2W$TB;-H3KM
MR<]S7%0_#C5-.^'_ (;U1+/4[V\LIUFOM!GG=HI5WGE8]P"LO! '![@\@^^T
M4 <7K>FWU_\ $WP=J,=A(UI8P7KS3,<"%I(U50<=3VQ]3VKDM5\%>)?'&L>)
M]4DN1I$<B'2[:VN;(2O-!&0ZNKEAL#/SD9]>U>PT4 >2Q^'=7\3:EX$E\2Z"
MSQ6]A=VVIK,%(1S'L#'#<;MN05'&[\K?PW\*>(?#?C+Q&=37?IQAM[:RNF*Y
MFCB!6/@<Y"8!)[^M>GT4 <)X/TK4=&\%Z[%=Z4TMQ+>WT\5G(RG[0K,2J]<
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M5HYHI8VN%4!OG9FSCD?Q8QWK+L?AS'9W5M<'57=K>[M[E$6TAB0>4DB!55%
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M &44=RV.A]#0!UE%<[=>.-"M==BTAKB66YD\G+0PM)&GFMMBW.!@;B1BNBH
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M*V_:&Y!3*C:P;<<#'.>#6=;?"?1;77$U&.YNBHMA!)$Y5C(1"8-Y<C</D8\
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M02S<X&..*]+HH \X_P"$)U:#1],DM(;!-7C-[>74A<Y>ZGCD4?O,;BH,K?\
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MO2J* .,T[P9=P^(;/5[Z]MY)$N+B]N(X82JM<21K$FW).%6-2/4DD]\#"O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
..HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ex10-4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal; text-transform: uppercase">NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT
BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM
REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD
PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH
A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. THE NUMBER OF SHARES OF COMMON STOCK
ISSUABLE UPON EXERCISE OF THIS COMMON WARRANT MAY BE LESS THAN THE AMOUNTS SET FORTH ON THE FACE HEREOF PURSUANT TO SECTION</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal">1(a) <FONT STYLE="text-transform: uppercase">OF
THIS COMMON WARRANT.</FONT></FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sigma
Labs, Inc.</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
To Purchase Common Stock</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Warrant No.: ____________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Issuance: January 28, 2020 (&ldquo;<B>Issuance Date</B>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sigma
Labs, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, <FONT STYLE="text-transform: uppercase"><B>_________________________</B>.</FONT>,
the registered holder hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;), is entitled, subject to the terms set
forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant
to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof,
the &ldquo;<B>Common Warrant</B>&rdquo;), at any time or times on or after six month and one day anniversary of the Issuance Date
(the &ldquo;<B>Initial Exercisability Date</B>&rdquo;), but not after 11:59 p.m., New York time, on the Expiration Date (as defined
below), _____________ (subject to adjustment as provided herein) fully paid and non-assessable shares of Common Stock (as defined
below) (the &ldquo;<B>Warrant Common Shares</B>&rdquo;, and such aggregate number of Warrant Common Shares issuable hereunder
as of any time of determination, the &ldquo;<B>Warrant Common Number</B>&rdquo;). Except as otherwise defined herein, capitalized
terms in this Common Warrant shall have the meanings set forth in Section 17. This Common Warrant is one of the Warrants to Purchase
Common Stock (the &ldquo;<B>SPA Common Warrants</B>&rdquo;) issued pursuant to Section 1 of that certain Securities Purchase Agreement,
dated as of January 27, 2020 (the &ldquo;<B>Subscription Date</B>&rdquo;), by and among the Company and the investors (the &ldquo;<B>Buyers</B>&rdquo;)
referred to therein, as amended from time to time (the &ldquo;<B>Securities Purchase Agreement</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">1.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXERCISE OF COMMON WARRANT.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Mechanics of Exercise</U>. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth
in Section 1(f)), this Common Warrant may be exercised by the Holder on any day on or after the Initial Exercisability Date (an
&ldquo;<B>Exercise Date</B>&rdquo;), in whole or in part, by delivery (whether via facsimile or otherwise) of a written notice,
in the form attached hereto as <B><U>Exhibit A</U></B> (the &ldquo;<B>Exercise Notice</B>&rdquo;), of the Holder&rsquo;s election
to exercise this Common Warrant. Within one (1) Trading Day following an exercise of this Common Warrant as aforesaid, the Holder
shall deliver payment to the Company of an amount equal to the Exercise Price in effect on the date of such exercise multiplied
by the number of Warrant Common Shares as to which this Common Warrant was so exercised (the &ldquo;<B>Aggregate Exercise Price</B>&rdquo;)
in cash or via wire transfer of immediately available funds if the Holder did not notify the Company in such Exercise Notice that
such exercise was made pursuant to a Cashless Exercise (as defined in Section 1(d)). The Holder shall not be required to deliver
the original of this Common Warrant in order to effect an exercise hereunder. Execution and delivery of an Exercise Notice with
respect to less than all of the Warrant Common Shares shall have the same effect as cancellation of the original of this Common
Warrant and issuance of a new Common Warrant evidencing the right to purchase the remaining number of Warrant Common Shares. Execution
and delivery of an Exercise Notice for all of the then-remaining Warrant Common Shares shall have the same effect as cancellation
of the original of this Common Warrant after delivery of the Warrant Common Shares in accordance with the terms hereof. On or
before the first (1<SUP>st</SUP>) Trading Day following the date on which the Company has received an Exercise Notice, the Company
shall transmit by facsimile or electronic mail an acknowledgment of confirmation of receipt of such Exercise Notice, in the form
attached hereto as <B><U>Exhibit B</U></B>, to the Holder and the Company&rsquo;s transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;),
which confirmation shall constitute an instruction to the Transfer Agent to process such Exercise Notice in accordance with the
terms herein. On or before the second (2nd) Trading Day following the date on which the Company has received such Exercise Notice
(or such earlier date as required pursuant to the 1934 Act or other applicable law, rule or regulation for the settlement of a
trade of such Warrant Common Shares initiated on the applicable Exercise Date), the Company shall (X) provided that the Transfer
Agent is participating in The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) Fast Automated Securities Transfer Program and
such Warrant Common Shares are eligible to be resold pursuant to Rule 144 or an effective registration statement, upon the request
of the Holder, credit such aggregate number of shares of Common Stock to which the Holder is entitled pursuant to such exercise
to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit/Withdrawal at Custodian system, or
(Y) if the Transfer Agent is not participating in the DTC Fast Automated Securities Transfer Program or such Warrant Common Shares
are not eligible to be resold pursuant to Rule 144 or an effective registration statement, upon the request of the Holder, issue
and deliver (via reputable overnight courier) to the address as specified in the Exercise Notice, a certificate, registered in
the name of the Holder or its designee, for the number of shares of Common Stock to which the Holder shall be entitled pursuant
to such exercise. Upon delivery of an Exercise Notice, the Holder shall be deemed for all corporate purposes to have become the
holder of record of the Warrant Common Shares with respect to which this Common Warrant has been exercised, irrespective of the
date such Warrant Common Shares are credited to the Holder&rsquo;s DTC account or the date of delivery of the certificates evidencing
such Warrant Common Shares (as the case may be). If this Common Warrant is submitted in connection with any exercise pursuant
to this Section 1(a) and the number of Warrant Common Shares represented by this Common Warrant submitted for exercise is greater
than the number of Warrant Common Shares being acquired upon an exercise and upon surrender of this Common Warrant to the Company
by the Holder, then, at the request of the Holder, the Company shall as soon as practicable and in no event later than two (2)
Business Days after any exercise and at its own expense, issue and deliver to the Holder (or its designee) a new Common Warrant
(in accordance with Section 7(d)) representing the right to purchase the number of Warrant Common Shares purchasable immediately
prior to such exercise under this Common Warrant, less the number of Warrant Common Shares with respect to which this Common Warrant
is exercised. No fractional shares of Common Stock are to be issued upon the exercise of this Common Warrant, but rather the number
of shares of Common Stock to be issued shall be rounded up to the nearest whole number. The Company shall pay any and all transfer,
stamp, issuance and similar taxes, costs and expenses (including, without limitation, fees and expenses of the Transfer Agent)
that may be payable with respect to the issuance and delivery of Warrant Common Shares upon exercise of this Common Warrant. Notwithstanding
the foregoing, except in the case where an exercise of this Common Warrant is validly made pursuant to a Cashless Exercise, the
Company&rsquo;s failure to deliver Warrant Common Shares to the Holder on or prior to the later of (i) two (2) Trading Days after
receipt of the applicable Exercise Notice (or such earlier date as required pursuant to the 1934 Act or other applicable law,
rule or regulation for the settlement of a trade of such Warrant Common Shares initiated on the applicable Exercise Date) and
(ii) one (1) Trading Day after the Company&rsquo;s receipt of the Aggregate Exercise Price (or valid notice of a Cashless Exercise)
(such later date, the &ldquo;<B>Share Delivery Date</B>&rdquo;) shall not be deemed to be a breach of this Common Warrant. Notwithstanding
anything to the contrary contained in this Common Warrant or the Registration Rights Agreement, after the effective date of the
Registration Statement (as defined in the Registration Rights Agreement) and prior to the Holder&rsquo;s receipt of the notice
of a Grace Period (as defined in the Registration Rights Agreement), the Company shall cause the Transfer Agent to deliver unlegended
shares of Common Stock to the Holder (or its designee) in connection with any sale of Registrable Securities (as defined in the
Registration Rights Agreement) with respect to which the Holder has entered into a contract for sale, and delivered a copy of
the prospectus included as part of the particular Registration Statement to the extent applicable, and for which the Holder has
not yet settled. From the Issuance Date through and including the Expiration Date, the Company shall maintain a transfer agent
that participates in the DTC&rsquo;s Fast Automated Securities Transfer Program. Notwithstanding the foregoing, prior to the earlier
to occur of (x) the Share Increase Shareholder Approval Date (as defined in the Securities Purchase Agreement) and (y) the Shareholder
Meeting Deadline (as defined in the Securities Purchase Agreement), the Holder shall not be permitted to exercise this Warrant
to the extent that after such exercise the Holder shall have received, whether upon conversion of Preferred Shares and/or exercise
of this Warrant, as applicable, more than such Holder&rsquo;s Authorized Share Allocation (as defined below). NOTWITHSTANDING
ANY PROVISION OF THIS COMMON WARRANT TO THE CONTRARY, NO MORE THAN THE MAXIMUM ELIGIBILITY NUMBER OF WARRANT COMMON SHARES SHALL
BE EXERCISABLE HEREUNDER. For the avoidance of doubt, no ink original Exercise Notices, other notices or medallion guarantees
will be required by the Holder to exercise this Warrant or for the Holder take any other action in connection herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Exercise Price</U>. For purposes of this Common Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $1.00, subject to adjustment
as provided herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Company&rsquo;s Failure to Timely Deliver Securities</U>. If the Company shall fail, for any reason or for no reason, on or
prior to the Share Delivery Date, either (I) if the Transfer Agent is not participating in the DTC Fast Automated Securities Transfer
Program or such Warrant Common Shares are not eligible to be resold pursuant to Rule 144 or an effective registration statement,
to issue and deliver to the Holder (or its designee) a certificate for the number of Warrant Common Shares to which the Holder
is entitled and register such Warrant Common Shares on the Company&rsquo;s share register or, if the Transfer Agent is participating
in the DTC Fast Automated Securities Transfer Program and such Warrant Common Shares are eligible to be resold pursuant to Rule
144 or an effective registration statement, to credit the balance account of the Holder or the Holder&rsquo;s designee with DTC
for such number of Warrant Common Shares to which the Holder is entitled upon the Holder&rsquo;s exercise of this Common Warrant
(as the case may be) or (II) if a Registration Statement covering the resale of the Warrant Common Shares that are the subject
of the Exercise Notice (the &ldquo;<B>Unavailable Warrant Common Shares</B>&rdquo;) is not available for the resale of such Unavailable
Warrant Common Shares (solely to the extent such Unavailable Warrant Common Shares were ever available pursuant to such Registration
Statement) and the Company fails to promptly, but in no event later than as required pursuant to the Registration Rights Agreement
(x) so notify the Holder and (y) deliver the Warrant Common Shares electronically without any restrictive legend by crediting
such aggregate number of Warrant Common Shares to which the Holder is entitled pursuant to such exercise to the Holder&rsquo;s
or its designee&rsquo;s balance account with DTC through its Deposit/Withdrawal At Custodian system (the event described in the
immediately foregoing clause (II) is hereinafter referred as a &ldquo;<B>Notice Failure</B>&rdquo; and together with the event
described in clause (I) above, a &ldquo;<B>Delivery Failure</B>&rdquo;), then, in addition to all other remedies available to
the Holder, (X) the Company shall pay in cash to the Holder on each day after the Share Delivery Date and during such Delivery
Failure an amount equal to 2% of the product of (A) the sum of the number of shares of Common Stock not issued to the Holder on
or prior to the Share Delivery Date and to which the Holder is entitled, multiplied by (B) any trading price of the Common Stock
selected by the Holder in writing as in effect at any time during the period beginning on the applicable Exercise Date and ending
on the applicable Share Delivery Date, and (Y) the Holder, upon written notice to the Company, may void its Exercise Notice with
respect to, and retain or have returned, as the case may be, any portion of this Common Warrant that has not been exercised pursuant
to such Exercise Notice; provided that the voiding of an Exercise Notice shall not affect the Company&rsquo;s obligations to make
any payments which have accrued prior to the date of such notice pursuant to this Section 1(c) or otherwise. In addition to the
foregoing, if on or prior to the Share Delivery Date either (I) the Transfer Agent is not participating in the DTC Fast Automated
Securities Transfer Program or such Warrant Common Shares are not eligible to be resold pursuant to Rule 144 or an effective registration
statement, the Company shall fail to issue and deliver to the Holder (or its designee) a certificate and register such shares
of Common Stock on the Company&rsquo;s share register or, if the Transfer Agent is participating in the DTC Fast Automated Securities
Transfer Program and such Warrant Common Shares are eligible to be resold pursuant to Rule 144 or an effective registration statement,
the Transfer Agent shall fail to credit the balance account of the Holder or the Holder&rsquo;s designee with DTC for the number
of shares of Common Stock to which the Holder is entitled upon the Holder&rsquo;s exercise hereunder or pursuant to the Company&rsquo;s
obligation pursuant to clause (ii) below or (II) a Notice Failure occurs, and if on or after such Share Delivery Date the Holder
purchases (in an open market transaction or otherwise) shares of Common Stock corresponding to all or any portion of the number
of shares of Common Stock issuable upon such exercise that the Holder is entitled to receive from the Company and has not received
from the Company in connection with such Delivery Failure or Notice Failure, as applicable (a &ldquo;<B>Buy-In</B>&rdquo;), then,
in addition to all other remedies available to the Holder, the Company shall, within two (2) Business Days after the Holder&rsquo;s
request and in the Holder&rsquo;s discretion, either (i) pay cash to the Holder in an amount equal to the Holder&rsquo;s total
purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased
(including, without limitation, by any other Person in respect, or on behalf, of the Holder) (the &ldquo;<B>Buy-In Price</B>&rdquo;),
at which point the Company&rsquo;s obligation to so issue and deliver such certificate (and to issue such shares of Common Stock)
or credit the balance account of such Holder or such Holder&rsquo;s designee, as applicable, with DTC for the number of Warrant
Common Shares to which the Holder is entitled upon the Holder&rsquo;s exercise hereunder (as the case may be) (and to issue such
Warrant Common Shares) shall terminate, or (ii) promptly honor its obligation to so issue and deliver to the Holder a certificate
or certificates representing such Warrant Common Shares or credit the balance account of such Holder or such Holder&rsquo;s designee,
as applicable, with DTC for the number of Warrant Common Shares to which the Holder is entitled upon the Holder&rsquo;s exercise
hereunder (as the case may be) and pay cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over the
product of (A) such number of Warrant Common Shares multiplied by (B) the lowest Closing Sale Price of the Common Stock on any
Trading Day during the period commencing on the date of the applicable Exercise Notice and ending on the date of such issuance
and payment under this clause (ii) (the &ldquo;<B>Buy-In Payment Amount</B>&rdquo;). Nothing shall limit the Holder&rsquo;s right
to pursue any other remedies available to it hereunder, at law or in equity, including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver certificates representing shares
of Common Stock (or to electronically deliver such shares of Common Stock) upon the exercise of this Common Warrant as required
pursuant to the terms hereof. While this Common Warrant is outstanding, the Company shall cause its transfer agent to participate
in the DTC Fast Automated Securities Transfer Program. In addition to the foregoing rights, (i) if the Company fails to deliver
the applicable number of Warrant Common Shares upon an exercise pursuant to Section 1 by the applicable Share Delivery Date, then
the Holder shall have the right to rescind such exercise in whole or in part and retain and/or have the Company return, as the
case may be, any portion of this Common Warrant that has not been exercised pursuant to such Exercise Notice; provided that the
rescission of an exercise shall not affect the Company&rsquo;s obligation to make any payments that have accrued prior to the
date of such notice pursuant to this Section 1(c) or otherwise, and (ii) if a registration statement covering the issuance or
resale of the Warrant Common Shares that are subject to an Exercise Notice is not available for the issuance or resale, as applicable,
of such Warrant Common Shares and the Holder has submitted an Exercise Notice prior to receiving notice of the non-availability
of such registration statement and the Company has not already delivered the Warrant Common Shares underlying such Exercise Notice
electronically without any restrictive legend by crediting such aggregate number of Warrant Common Shares to which the Holder
is entitled pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit
/ Withdrawal At Custodian system, the Holder shall have the option, by delivery of notice to the Company, to (x) rescind such
Exercise Notice in whole or in part and retain or have returned, as the case may be, any portion of this Common Warrant that has
not been exercised pursuant to such Exercise Notice; provided that the rescission of an Exercise Notice shall not affect the Company&rsquo;s
obligation to make any payments that have accrued prior to the date of such notice pursuant to this Section 1(c) or otherwise,
and/or (y) switch some or all of such Exercise Notice from a cash exercise to a Cashless Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Cashless Exercise</U>. Notwithstanding anything contained herein to the contrary (other than Section 1(f) below), if at the
time of exercise hereof a Registration Statement (as defined in the Registration Rights Agreement) is not effective (or the prospectus
contained therein is not available for use) for the resale by the Holder of all of the Warrant Common Shares, then the Holder
may, in its sole discretion, exercise this Common Warrant in whole or in part and, in lieu of making the cash payment otherwise
contemplated to be made to the Company upon such exercise in payment of the Aggregate Exercise Price, elect instead to receive
upon such exercise the &ldquo;Net Number&rdquo; of Warrant Common Shares determined according to the following formula (a &ldquo;<B>Cashless
Exercise</B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
Number = <U>(A x B) - (A x C)</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the foregoing formula:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A=
the total number of shares with respect to which this Common Warrant is then being exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B
= the quotient of (x) the sum of the VWAP of the Common Stock of each of the twenty (20) Trading Days ending at the close of business
on the Principal Market immediately prior to the time of exercise as set forth in the applicable Exercise Notice, divided by (y)
twenty (20).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.8pt; text-align: justify; text-indent: -2.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C
= the Exercise Price then in effect for the applicable Warrant Common Shares at the time of such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.8pt; text-align: justify; text-indent: -2.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D
= as applicable: (i) the Closing Sale Price of the Common Stock on the Trading Day immediately preceding the date of the applicable
Exercise Notice if such Exercise Notice is (1) both executed and delivered pursuant to Section 1(a) hereof on a day that is not
a Trading Day or (2) both executed and delivered pursuant to Section 1(a) hereof on a Trading Day prior to the opening of &ldquo;regular
trading hours&rdquo; (as defined in Rule 600(b)(64) of Regulation NMS promulgated under the federal securities laws) on such Trading
Day, (ii) the Bid Price of the Common Stock as of the time of the Holder&rsquo;s execution of the applicable Exercise Notice if
such Exercise Notice is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours
thereafter pursuant to Section 1(a) hereof, or (iii) the Closing Sale Price of the Common Stock on the date of the applicable
Exercise Notice if the date of such Exercise Notice is a Trading Day and such Exercise Notice is both executed and delivered pursuant
to Section 1(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Warrant Common Shares are issued in a Cashless Exercise, the parties acknowledge and agree that in accordance with Section
3(a)(9) of the 1933 Act, the Warrant Common Shares take on the registered characteristics of the Common Warrants being exercised.
For purposes of Rule 144(d) promulgated under the 1933 Act, as in effect on the Subscription Date, it is intended that the Warrant
Common Shares issued in a Cashless Exercise shall be deemed to have been acquired by the Holder, and the holding period for the
Warrant Common Shares shall be deemed to have commenced, on the date this Common Warrant was originally issued pursuant to the
Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to Section 1(f) and only with respect to the Maximum Eligibility Number of Warrant Common Shares then issuable hereunder, this
Warrant shall be automatically exercised in a Cashless Exercise on the Expiration Date if the &ldquo;Net Number&rdquo; calculated
in the formula above as of the Expiration Date would result in the issuance to the Holder of any Warrant Common Shares; provided,
that any such Warrant Common Shares that, if issued to the Holder in connection with such automatic exercise, would result in
a violation of Section 1(f) would, in lieu of such automatic issuance, be held in abeyance for the benefit of the Holder and delivered
to the Holder, in whole or in part, within two (2) Trading Days of the Company&rsquo;s receipt of one (or more) written notices
from the Holder specifying that such delivery of such amount of Warrant Common Shares specified in such notice would no longer
result in a violation of Section 1(f) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Disputes</U>. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number
of Warrant Common Shares to be issued pursuant to the terms hereof, the Company shall promptly issue to the Holder the number
of Warrant Common Shares that are not disputed and resolve such dispute in accordance with Section 13.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Limitations on Exercises</U>. The Company shall not effect the exercise of any portion of this Common Warrant, and the Holder
shall not have the right to exercise any portion of this Common Warrant, pursuant to the terms and conditions of this Common Warrant
and any such exercise shall be null and void and treated as if never made, to the extent that after giving effect to such exercise,
the Holder together with the other Attribution Parties collectively would beneficially own in excess of 4.99% (the &ldquo;<B>Maximum
Percentage</B>&rdquo;) of the shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes
of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by the Holder and the other Attribution
Parties shall include the number of shares of Common Stock held by the Holder and all other Attribution Parties plus the number
of shares of Common Stock issuable upon exercise of this Common Warrant with respect to which the determination of such sentence
is being made, but shall exclude shares of Common Stock which would be issuable upon (A) exercise of the remaining, unexercised
portion of this Common Warrant beneficially owned by the Holder or any of the other Attribution Parties and (B) exercise or conversion
of the unexercised or unconverted portion of any other securities of the Company (including, without limitation, any convertible
notes or convertible preferred stock or warrants, including other SPA Common Warrants) beneficially owned by the Holder or any
other Attribution Party subject to a limitation on conversion or exercise analogous to the limitation contained in this Section
1(f). For purposes of this Section 1(f)(i), beneficial ownership shall be calculated in accordance with Section 13(d) of the 1934
Act. For purposes of determining the number of outstanding shares of Common Stock the Holder may acquire upon the exercise of
this Common Warrant without exceeding the Maximum Percentage, the Holder may rely on the number of outstanding shares of Common
Stock as reflected in (x) the Company&rsquo;s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report
on Form 8-K or other public filing with the SEC, as the case may be, (y) a more recent public announcement by the Company or (z)
any other written notice by the Company or the Transfer Agent, if any, setting forth the number of shares of Common Stock outstanding
(the &ldquo;<B>Reported Outstanding Share Number</B>&rdquo;). If the Company receives an Exercise Notice from the Holder at a
time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share Number, the Company
shall (i) notify the Holder in writing of the number of shares of Common Stock then outstanding and, to the extent that such Exercise
Notice would otherwise cause the Holder&rsquo;s beneficial ownership, as determined pursuant to this Section 1(f), to exceed the
Maximum Percentage, the Holder must notify the Company of a reduced number of Warrant Common Shares to be acquired pursuant to
such Exercise Notice (the number of shares by which such purchase is reduced, the &ldquo;<B>Reduction Shares</B>&rdquo;) and (ii)
as soon as reasonably practicable, the Company shall return to the Holder any exercise price paid by the Holder for the Reduction
Shares. For any reason at any time, upon the written or oral request of the Holder, the Company shall within one (1) Business
Day confirm orally and in writing or by electronic mail to the Holder the number of shares of Common Stock then outstanding. In
any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise
of securities of the Company, including this Common Warrant, by the Holder and any other Attribution Party since the date as of
which the Reported Outstanding Share Number was reported. In the event that the issuance of shares of Common Stock to the Holder
upon exercise of this Common Warrant results in the Holder and the other Attribution Parties being deemed to beneficially own,
in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section
13(d) of the 1934 Act), the number of shares so issued by which the Holder&rsquo;s and the other Attribution Parties&rsquo; aggregate
beneficial ownership exceeds the Maximum Percentage (the &ldquo;<B>Excess Shares</B>&rdquo;) shall be deemed null and void and
shall be cancelled ab initio, and the Holder shall not have the power to vote or to transfer the Excess Shares. As soon as reasonably
practicable after the issuance of the Excess Shares has been deemed null and void, the Company shall return to the Holder the
exercise price paid by the Holder for the Excess Shares. Upon delivery of a written notice to the Company, the Holder may from
time to time increase (with such increase not effective until the sixty-first (61<SUP>st</SUP>) day after delivery of such notice)
or decrease the Maximum Percentage to any other percentage not in excess of 9.99% as specified in such notice; provided that (i)
any such increase in the Maximum Percentage will not be effective until the sixty-first (61<SUP>st</SUP>) day after such notice
is delivered to the Company and (ii) any such increase or decrease will apply only to the Holder and the other Attribution Parties
and not to any other holder of SPA Common Warrants that is not an Attribution Party of the Holder. For purposes of clarity, the
shares of Common Stock issuable pursuant to the terms of this Common Warrant in excess of the Maximum Percentage shall not be
deemed to be beneficially owned by the Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the
1934 Act. No prior inability to exercise this Common Warrant pursuant to this paragraph shall have any effect on the applicability
of the provisions of this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph
shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 1(f) to the
extent necessary to correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended
beneficial ownership limitation contained in this Section 1(f) or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitation contained in this paragraph may not be waived and shall apply to a successor holder
of this Common Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Reservation of Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Required Reserve Amount</U>. So long as this Common Warrant remains outstanding, but only after the Share Increase Shareholder
Approval Date (as defined in the Securities Purchase Agreement), the Company shall at all times keep reserved for issuance under
this Common Warrant a number of shares of Common Stock at least equal to 150% of the maximum number of shares of Common Stock
as shall be necessary to satisfy the Company&rsquo;s obligation to issue shares of Common Stock under the SPA Common Warrants
then outstanding (without regard to any limitations on exercise) (the &ldquo;<B>Required Reserve Amount</B>&rdquo;); provided
that at no time shall the number of shares of Common Stock reserved pursuant to this Section 1(g)(i) be reduced other than proportionally
in connection with any exercise or redemption of SPA Common Warrants or such other event covered by Section 2(a) below. The Required
Reserve Amount (including, without limitation, each increase in the number of shares so reserved) shall be allocated pro rata
among the holders of the SPA Common Warrants based on number of shares of Common Stock issuable upon exercise of SPA Common Warrants
held by each holder on the Closing Date (without regard to any limitations on exercise) or increase in the number of reserved
shares, as the case may be (the &ldquo;<B>Authorized Share Allocation</B>&rdquo;). In the event that a holder shall sell or otherwise
transfer any of such holder&rsquo;s SPA Common Warrants, each transferee shall be allocated a pro rata portion of such holder&rsquo;s
Authorized Share Allocation. Any shares of Common Stock reserved and allocated to any Person which ceases to hold any SPA Common
Warrants shall be allocated to the remaining holders of SPA Common Warrants, pro rata based on the number of shares of Common
Stock issuable upon exercise of the SPA Common Warrants then held by such holders (without regard to any limitations on exercise).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Insufficient Authorized Shares</U>. If, notwithstanding Section 1(g)(i) above, and not in limitation thereof, at any time after
the Share Increase Shareholder Approval Date while any of the SPA Common Warrants remain outstanding, the Company does not have
a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation to reserve the Required Reserve
Amount (an &ldquo;<B>Authorized Share Failure</B>&rdquo;), then the Company shall immediately take all action necessary to increase
the Company&rsquo;s authorized shares of Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve
Amount for all the SPA Common Warrants then outstanding. Without limiting the generality of the foregoing sentence, as soon as
practicable after the date of the occurrence of an Authorized Share Failure, but in no event later than sixty (60) days after
the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its shareholders for the approval of an increase
in the number of authorized shares of Common Stock. In connection with such meeting, the Company shall provide each shareholder
with a proxy statement and shall use its best efforts to solicit its shareholders&rsquo; approval of such increase in authorized
shares of Common Stock and to cause its board of directors to recommend to the shareholders that they approve such proposal. In
the event that the Company is prohibited from issuing shares of Common Stock upon an exercise of this Common Warrant due to the
failure by the Company to have sufficient shares of Common Stock available out of the authorized but unissued shares of Common
Stock (such unavailable number of shares of Common Stock, the &ldquo;<B>Authorization Failure Shares</B>&rdquo;), in lieu of delivering
such Authorization Failure Shares to the Holder, the Company shall pay cash in exchange for the cancellation of such portion of
this Common Warrant exercisable into such Authorization Failure Shares at a price equal to the sum of (i) the product of (x) such
number of Authorization Failure Shares and (y) the greatest Closing Sale Price of the Common Stock on any Trading Day during the
period commencing on the date the Holder delivers the applicable Exercise Notice with respect to such Authorization Failure Shares
to the Company and ending on the date of such issuance and payment under this Section 1(f); and (ii) to the extent the Holder
purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder
of Authorization Failure Shares, any Buy-In Payment Amount, brokerage commissions and other out-of-pocket expenses, if any, of
the Holder incurred in connection therewith. Nothing contained in this Section 1(g)(ii) shall limit any obligations of the Company
under any provision of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2. <U>ADJUSTMENT OF EXERCISE PRICE AND
NUMBER OF WARRANT COMMON SHARES</U>. The Exercise Price and number of Warrant Common Shares issuable upon exercise of this Common
Warrant are subject to adjustment from time to time as set forth in this Section 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Stock Dividends and Splits</U>. Without limiting any provision of Section 2(b), Section 3 or Section 4, if the Company, at
any time on or after the Subscription Date, (i) pays a stock dividend on one or more classes of its then outstanding shares of
Common Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides
(by any stock split, stock dividend, recapitalization or otherwise) one or more classes of its then outstanding shares of Common
Stock into a larger number of shares or (iii) combines (by combination, reverse stock split or otherwise) one or more classes
of its then outstanding shares of Common Stock into a smaller number of shares, then in each such case the Exercise Price shall
be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event.
Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately after the record date for the
determination of shareholders entitled to receive such dividend or distribution, and any adjustment pursuant to clause (ii) or
(iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination. If any
event requiring an adjustment under this paragraph occurs during the period that an Exercise Price is calculated hereunder, then
the calculation of such Exercise Price shall be adjusted appropriately to reflect such event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Adjustment Upon Issuance of Shares of Common Stock</U>. If and whenever on or after the Subscription Date, the Company issues
or sells, or in accordance with this Section 2 is deemed to have grants, issues or sells (or enter into any agreement to grant
issue or sell), any shares of Common Stock (including the issuance or sale of shares of Common Stock owned or held by or for the
account of the Company, but excluding any Excluded Securities issued or sold or deemed to have been issued or sold) for a consideration
per share (the &ldquo;<B>New Issuance Price</B>&rdquo;) less than a price equal to the Exercise Price in effect immediately prior
to such issuance or sale or deemed issuance or sale (such Exercise Price then in effect is referred to herein as the &ldquo;<B>Applicable
Price</B>&rdquo;) (the foregoing a &ldquo;<B>Dilutive Issuance</B>&rdquo;), then immediately after such Dilutive Issuance, the
Exercise Price then in effect shall be reduced to an amount equal to the New Issuance Price. For all purposes of the foregoing
(including, without limitation, determining the adjusted Exercise Price and the New Issuance Price under this Section 2(b)), the
following shall be applicable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Issuance of Options</U>. If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue
or sell) any Options and the lowest price per share for which one share of Common Stock is at any time issuable upon the exercise
of any such Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option
or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed
to be outstanding and to have been issued and sold by the Company at the time of the granting or sale of such Option for such
price per share. For purposes of this Section 2(b)(i), the &ldquo;lowest price per share for which one share of Common Stock is
at any time issuable upon the exercise of any such Options or upon conversion, exercise or exchange of any Convertible Securities
issuable upon exercise of any such Option or otherwise pursuant to the terms thereof&rdquo; shall be equal to (1) the lower of
(x) the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any one share
of Common Stock upon the granting, issuance or sale of such Option, upon exercise of such Option and upon conversion, exercise
or exchange of any Convertible Security issuable upon exercise of such Option or otherwise pursuant to the terms thereof and (y)
the lowest exercise price set forth in such Option for which one share of Common Stock is issuable (or may become issuable assuming
all possible market conditions) upon the exercise of any such Options or upon conversion, exercise or exchange of any Convertible
Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof minus (2) the sum of all amounts
paid or payable to the holder of such Option (or any other Person) upon the granting, issuance or sale of such Option, upon exercise
of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option or
otherwise pursuant to the terms thereof plus the value of any other consideration received or receivable by, or benefit conferred
on, the holder of such Option (or any other Person). Except as contemplated below, no further adjustment of the Exercise Price
shall be made upon the actual issuance of such shares of Common Stock or of such Convertible Securities upon the exercise of such
Options or otherwise pursuant to the terms of or upon the actual issuance of such shares of Common Stock upon conversion, exercise
or exchange of such Convertible Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Issuance of Convertible Securities</U>. If the Company in any manner issues or sells (or enters into any agreement to issue
or sell) any Convertible Securities and the lowest price per share for which one share of Common Stock is at any time issuable
upon the conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price,
then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time
of the issuance or sale of such Convertible Securities for such price per share. For the purposes of this Section 2(b)(ii), the
&ldquo;lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise or exchange
thereof or otherwise pursuant to the terms thereof&rdquo; shall be equal to (1) the lower of (x) the sum of the lowest amounts
of consideration (if any) received or receivable by the Company with respect to one share of Common Stock upon the issuance or
sale of the Convertible Security and upon conversion, exercise or exchange of such Convertible Security or otherwise pursuant
to the terms thereof and (y) the lowest conversion price set forth in such Convertible Security for which one share of Common
Stock is issuable (or may become issuable assuming all possible market conditions) upon conversion, exercise or exchange thereof
or otherwise pursuant to the terms thereof minus (2) the sum of all amounts paid or payable to the holder of such Convertible
Security (or any other Person) upon the issuance or sale of such Convertible Security plus the value of any other consideration
received or receivable by, or benefit conferred on, the holder of such Convertible Security (or any other Person). Except as contemplated
below, no further adjustment of the Exercise Price shall be made upon the actual issuance of such shares of Common Stock upon
conversion, exercise or exchange of such Convertible Securities or otherwise pursuant to the terms thereof, and if any such issuance
or sale of such Convertible Securities is made upon exercise of any Options for which adjustment of this Common Warrant has been
or is to be made pursuant to other provisions of this Section 2(b), except as contemplated below, no further adjustment of the
Exercise Price shall be made by reason of such issuance or sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<U>Change in Option Price or Rate of Conversion</U>. If the purchase or exercise price provided for in any Options, the additional
consideration, if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at
which any Convertible Securities are convertible into or exercisable or exchangeable for shares of Common Stock increases or decreases
at any time (other than proportional changes in conversion or exercise prices, as applicable, in connection with an event referred
to in Section 2(a)), the Exercise Price in effect at the time of such increase or decrease shall be adjusted to the Exercise Price
which would have been in effect at such time had such Options or Convertible Securities provided for such increased or decreased
purchase price, additional consideration or increased or decreased conversion rate, as the case may be, at the time initially
granted, issued or sold. For purposes of this Section 2(b)(iii), if the terms of any Option or Convertible Security that was outstanding
as of the Subscription Date are increased or decreased in the manner described in the immediately preceding sentence, then such
Option or Convertible Security and the shares of Common Stock deemed issuable upon exercise, conversion or exchange thereof shall
be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 2(b) shall be
made if such adjustment would result in an increase of the Exercise Price then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<U>Calculation of Consideration Received</U>. If any Option and/or Convertible Security and/or Adjustment Right is issued in connection
with the issuance or sale or deemed issuance or sale of any other securities of the Company (as determined by the Holder, the
&ldquo;<B>Primary Security</B>&rdquo;, and such Option and/or Convertible Security and/or Adjustment Right, the &ldquo;<B>Secondary
Securities</B>&rdquo;), together comprising one integrated transaction, (or one or more transactions if such issuances or sales
or deemed issuances or sales of securities of the Company either (A) have at least one investor or purchaser in common, (B) are
consummated in reasonable proximity to each other and/or (C) are consummated under the same plan of financing) the aggregate consideration
per share of Common Stock with respect to such Primary Security shall be deemed to be equal to the difference of (x) the lowest
price per share for which one share of Common Stock was issued (or was deemed to be issued pursuant to Section 2(b)(i) or 2(b)(ii)
above, as applicable) in such integrated transaction solely with respect to such Primary Security, minus (y) with respect to such
Secondary Securities, the sum of (I) the Black Scholes Consideration Value of each such Option, if any, (II) the fair market value
(as determined by the Holder in good faith) or the Black Scholes Consideration Value, as applicable, of such Adjustment Right,
if any, and (III) the fair market value (as determined by the Holder) of such Convertible Security, if any, in each case, as determined
on a per share basis in accordance with this Section 2(b)(iv). If any shares of Common Stock, Options or Convertible Securities
are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor (for the purpose of determining
the consideration paid for such Common Stock, Option or Convertible Security, but not for the purpose of the calculation of the
Black Scholes Consideration Value) will be deemed to be the net amount of consideration received by the Company therefor. If any
shares of Common Stock, Options or Convertible Securities are issued or sold for a consideration other than cash, the amount of
such consideration received by the Company (for the purpose of determining the consideration paid for such Common Stock, Option
or Convertible Security, but not for the purpose of the calculation of the Black Scholes Consideration Value) will be the fair
value of such consideration, except where such consideration consists of publicly traded securities, in which case the amount
of consideration received by the Company for such securities will be the arithmetic average of the VWAPs of such security for
each of the five (5) Trading Days immediately preceding the date of receipt. If any shares of Common Stock, Options or Convertible
Securities are issued to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving
entity, the amount of consideration therefor (for the purpose of determining the consideration paid for such Common Stock, Option
or Convertible Security, but not for the purpose of the calculation of the Black Scholes Consideration Value) will be deemed to
be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such shares
of Common Stock, Options or Convertible Securities (as the case may be). The fair value of any consideration other than cash or
publicly traded securities will be determined jointly by the Company and the Holder. If such parties are unable to reach agreement
within ten (10) days after the occurrence of an event requiring valuation (the &ldquo;<B>Valuation Event</B>&rdquo;), the fair
value of such consideration will be determined within five (5) Trading Days after the tenth (10<SUP>th</SUP>) day following such
Valuation Event by an independent, reputable appraiser jointly selected by the Company and the Holder. The determination of such
appraiser shall be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall
be borne by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Record Date</U>. If the Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A)
to receive a dividend or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B) to
subscribe for or purchase shares of Common Stock, Options or Convertible Securities, then such record date will be deemed to be
the date of the issuance or sale of the shares of Common Stock deemed to have been issued or sold upon the declaration of such
dividend or the making of such other distribution or the date of the granting of such right of subscription or purchase (as the
case may be).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Number of Warrant Common Shares</U>. Simultaneously with any adjustment to the Exercise Price pursuant to Section 2(a) above,
the number of Warrant Common Shares that may be purchased upon exercise of this Common Warrant shall be increased or decreased
proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant
Common Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment (without regard
to any limitations on exercise contained herein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Holder&rsquo;s Right of Alternative Exercise Price Following Issuance of Certain Options or Convertible Securities</U>. In
addition to and not in limitation of the other provisions of this Section 2, if the Company in any manner issues or sells or enters
into any agreement to issue or sell, any Common Stock, Options or Convertible Securities (any such securities, &ldquo;<B>Variable
Price Securities</B>&rdquo;) after the Subscription Date that are issuable pursuant to such agreement or convertible into or exchangeable
or exercisable for shares of Common Stock at a price which varies or may vary with the market price of the shares of Common Stock,
including by way of one or more reset(s) to a fixed price, but exclusive of such formulations reflecting customary anti-dilution
provisions (such as share splits, share combinations, share dividends and similar transactions) (each of the formulations for
such variable price being herein referred to as, the &ldquo;<B>Variable Price</B>&rdquo;), the Company shall provide written notice
thereof via facsimile and overnight courier to the Holder on the date of such agreement and the issuance of such Convertible Securities
or Options. From and after the date the Company enters into such agreement or issues any such Variable Price Securities, the Holder
shall have the right, but not the obligation, in its sole discretion to substitute the Variable Price for the Exercise Price upon
exercise of this Common Warrant by designating in the Exercise Notice delivered upon any exercise of this Common Warrant that
solely for purposes of such exercise the Holder is relying on the Variable Price rather than the Exercise Price then in effect.
The Holder&rsquo;s election to rely on a Variable Price for a particular exercise of this Common Warrant shall not obligate the
Holder to rely on a Variable Price for any future exercises of this Common Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Stock Combination Event Adjustment</U>. If at any time and from time to time on or after the Issuance Date there occurs any
stock split, stock dividend, stock combination recapitalization or other similar transaction involving the Common Stock (each,
a &ldquo;<B>Stock Combination Event</B>&rdquo;, and such date thereof, the &ldquo;<B>Stock Combination Event Date</B>&rdquo;)
and the Event Market Price is less than the Exercise Price then in effect (after giving effect to the adjustment in clause 2(a)
above), then on the sixteenth (16th) Trading Day immediately following such Stock Combination Event, the Exercise Price then in
effect on such sixteenth (16th) Trading Day (after giving effect to the adjustment in clause 2(a) above) shall be reduced (but
in no event increased) to the Event Market Price. For the avoidance of doubt, if the adjustment in the immediately preceding sentence
would otherwise result in an increase in the Exercise Price hereunder, no adjustment shall be made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Other Events</U>. In the event that the Company (or any Subsidiary (as defined in the Securities Purchase Agreement)) shall
take any action to which the provisions hereof are not strictly applicable, or, if applicable, would not operate to protect the
Holder from dilution (other than with respect to Excluded Issuances) or if any event occurs of the type contemplated by the provisions
of this Section 2 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation
rights, phantom stock rights or other rights with equity features), then the Company&rsquo;s board of directors shall in good
faith determine and implement an appropriate adjustment in the Exercise Price and the number of Warrant Common Shares (if applicable)
so as to protect the rights of the Holder, provided that no such adjustment pursuant to this Section 2(f) will increase the Exercise
Price or decrease the number of Warrant Common Shares as otherwise determined pursuant to this Section 2, provided further that
if the Holder does not accept such adjustments as appropriately protecting its interests hereunder against such dilution, then
the Company&rsquo;s board of directors and the Holder shall agree, in good faith, upon an independent investment bank of nationally
recognized standing to make such appropriate adjustments, whose determination shall be final and binding absent manifest error
and whose fees and expenses shall be borne by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Calculations</U>. All calculations under this Section 2 shall be made by rounding to the nearest cent or the nearest 1/100<SUP>th
</SUP>of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned
or held by or for the account of the Company, and the disposition of any such shares shall be considered an issuance or sale of
Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Principal Market, the Company may at any time
during the term of this Common Warrant, with the prior written consent of the Required Holders (as defined in the Securities Purchase
Agreement), reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of
directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Floor Price</U>. No adjustment pursuant to this Section 2 shall cause the Exercise Price to be less than $0.95 (as adjusted
for any stock dividend, stock split, stock combination, reclassification or similar transaction occurring after the date of the
Securities Purchase Agreement) (the &ldquo;<B>Floor Price</B>&rdquo;). Notwithstanding the foregoing, nothing contained in this
Section 2(i) shall apply after Shareholder Approval (as defined in the Securities Purchase Agreement) is obtained and, on such
Shareholder Approval Date (as defined in the Securities Purchase Agreement), any adjustments that would have occurred hereunder
prior to the Shareholder Approval Date, but for the existence of this Section 2(i), shall be applied pursuant to this Section
2 on the Shareholder Approval Date (without regard to the limitations in this Section 2(i)) as if such event or Dilutive Issuance,
as applicable, occurred on the Shareholder Approval Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>RIGHTS UPON DISTRIBUTION OF ASSETS</U>. In addition to any adjustments pursuant to Section 2 above, if the Company shall declare
or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock,
by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities,
property, options, evidence of indebtedness or any other assets by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &ldquo;<B>Distribution</B>&rdquo;), at any time after the issuance of this
Common Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that
the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete
exercise of this Common Warrant (without regard to any limitations or restrictions on exercise of this Common Warrant, including
without limitation, the Maximum Percentage) immediately before the date on which a record is taken for such Distribution, or,
if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation
in such Distribution (provided, however, that to the extent that the Holder&rsquo;s right to participate in any such Distribution
would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled
to participate in such Distribution to the extent of the Maximum Percentage (and shall not be entitled to beneficial ownership
of such shares of Common Stock as a result of such Distribution (and beneficial ownership) to the extent of any such excess) and
the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time or times, if ever, as
its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, at which
time or times the Holder shall be granted such Distribution (and any Distributions declared or made on such initial Distribution
or on any subsequent Distribution held similarly in abeyance) to the same extent as if there had been no such limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">4.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>PURCHASE RIGHTS; FUNDAMENTAL TRANSACTIONS.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Purchase Rights</U>. In addition to any adjustments pursuant to Section 2 above, if at any time the Company grants, issues
or sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the
record holders of any class of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder
had held the number of shares of Common Stock acquirable upon complete exercise of this Common Warrant (without regard to any
limitations or restrictions on exercise of this Common Warrant, including without limitation, the Maximum Percentage) immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken,
the date as of which the record holders of shares of Common Stock are to be determined for the grant, issuance or sale of such
Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such
Purchase Right would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder
shall not be entitled to participate in such Purchase Right to the extent of the Maximum Percentage (and shall not be entitled
to beneficial ownership of such shares of Common Stock as a result of such Purchase Right (and beneficial ownership) to the extent
of any such excess) and such Purchase Right to such extent shall be held in abeyance for the benefit of the Holder until such
time or times, if ever, as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum
Percentage, at which time or times the Holder shall be granted such right (and any Purchase Right granted, issued or sold on such
initial Purchase Right or on any subsequent Purchase Right held similarly in abeyance) to the same extent as if there had been
no such limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Fundamental Transactions</U>. The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor
Entity assumes in writing all of the obligations of the Company under this Common Warrant and the other Transaction Documents
(as defined in the Securities Purchase Agreement) in accordance with the provisions of this Section 4(b) pursuant to written agreements
in form and substance satisfactory to the Holder and approved by the Holder prior to such Fundamental Transaction, including agreements
to deliver to the Holder in exchange for this Common Warrant a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Common Warrant, including, without limitation, which is exercisable for a
corresponding number of shares of capital stock equivalent to the shares of Common Stock acquirable and receivable upon exercise
of this Common Warrant (without regard to any limitations on the exercise of this Common Warrant) prior to such Fundamental Transaction,
and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account
the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital
stock, such adjustments to the number of shares of capital stock and such exercise price being for the purpose of protecting the
economic value of this Common Warrant immediately prior to the consummation of such Fundamental Transaction) and (ii) the Successor
Entity (including its Parent Entity) is a publicly traded corporation whose common stock is quoted on or listed for trading on
an Eligible Market. Upon the consummation of each Fundamental Transaction, the Successor Entity shall succeed to, and be substituted
for (so that from and after the date of the applicable Fundamental Transaction, the provisions of this Common Warrant and the
other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise
every right and power of the Company and shall assume all of the obligations of the Company under this Common Warrant and the
other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein. Upon consummation
of each Fundamental Transaction, the Successor Entity shall deliver to the Holder confirmation that there shall be issued upon
exercise of this Common Warrant at any time after the consummation of the applicable Fundamental Transaction, in lieu of the shares
of Common Stock (or other securities, cash, assets or other property (except such items still issuable under Sections 3 and 4(a)
above, which shall continue to be receivable thereafter)) issuable upon the exercise of this Common Warrant prior to the applicable
Fundamental Transaction, such shares of publicly traded common stock (or its equivalent) of the Successor Entity (including its
Parent Entity) which the Holder would have been entitled to receive upon the happening of the applicable Fundamental Transaction
had this Common Warrant been exercised immediately prior to the applicable Fundamental Transaction (without regard to any limitations
on the exercise of this Common Warrant), as adjusted in accordance with the provisions of this Common Warrant. Notwithstanding
the foregoing, and without limiting Section 1(f) hereof, the Holder may elect, at its sole option, by delivery of written notice
to the Company to waive this Section 4(b) to permit the Fundamental Transaction without the assumption of this Common Warrant.
In addition to and not in substitution for any other rights hereunder, prior to the consummation of each Fundamental Transaction
pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets with respect to or in exchange
for shares of Common Stock (a &ldquo;<B>Corporate Event</B>&rdquo;), the Company shall make appropriate provision to insure that
the Holder will thereafter have the right to receive upon an exercise of this Common Warrant at any time after the consummation
of the applicable Fundamental Transaction but prior to the Expiration Date, in lieu of the shares of the Common Stock (or other
securities, cash, assets or other property (except such items still issuable under Sections 3 and 4(a) above, which shall continue
to be receivable thereafter)) issuable upon the exercise of the Common Warrant prior to such Fundamental Transaction, such shares
of stock, securities, cash, assets or any other property whatsoever (including warrants or other purchase or subscription rights)
which the Holder would have been entitled to receive upon the happening of the applicable Fundamental Transaction had this Common
Warrant been exercised immediately prior to the applicable Fundamental Transaction (without regard to any limitations on the exercise
of this Common Warrant). Provision made pursuant to the preceding sentence shall be in a form and substance reasonably satisfactory
to the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Black Scholes Value</U>. Notwithstanding the foregoing and the provisions of Section 4(b) above, at the request of the Holder
delivered at any time commencing on the earliest to occur of (x) the public disclosure of any Fundamental Transaction, (y) the
consummation of any Fundamental Transaction and (z) the Holder first becoming aware of any Fundamental Transaction through the
date that is ninety (90) days after the public disclosure of the consummation of such Fundamental Transaction by the Company pursuant
to a Current Report on Form 8-K filed with the SEC, the Company or the Successor Entity (as the case may be) shall purchase this
Common Warrant from the Holder on the date of such request by paying to the Holder cash in an amount equal to the Black Scholes
Value. Payment of such amounts shall be made by the Company (or at the Company&rsquo;s direction) to the Holder on or prior to
the later of (x) the second (2<SUP>nd</SUP>) Trading Day after the date of such request and (y) the date of consummation of such
Fundamental Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Application</U>. The provisions of this Section 4 shall apply similarly and equally to successive Fundamental Transactions
and Corporate Events and shall be applied as if this Common Warrant (and any such subsequent warrants) were fully exercisable
and without regard to any limitations on the exercise of this Common Warrant (provided that the Holder shall continue to be entitled
to the benefit of the Maximum Percentage, applied however with respect to shares of capital stock registered under the 1934 Act
and thereafter receivable upon exercise of this Common Warrant (or any such other warrant)).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>NONCIRCUMVENTION</U>. The Company hereby covenants and agrees that the Company will not, by amendment of its Articles of Incorporation
(as defined in the Securities Purchase Agreement), Bylaws (as defined in the Securities Purchase Agreement) or through any reorganization,
transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issuance or sale of securities, or any other voluntary
action, avoid or seek to avoid the observance or performance of any of the terms of this Common Warrant, and will at all times
in good faith carry out all the provisions of this Common Warrant and take all action as may be required to protect the rights
of the Holder. Without limiting the generality of the foregoing, the Company (a) shall not increase the par value of any shares
of Common Stock receivable upon the exercise of this Common Warrant above the Exercise Price then in effect, and (b) shall take
all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable
shares of Common Stock upon the exercise of this Common Warrant. Notwithstanding anything herein to the contrary, if after the
eight (8) month anniversary of the Issuance Date, the Holder is not permitted to exercise this Common Warrant in full for any
reason (other than pursuant to restrictions set forth in Section 1(f) hereof), the Company shall use its best efforts to promptly
remedy such failure, including, without limitation, obtaining such consents or approvals as necessary to permit such exercise
into shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>COMMON WARRANT HOLDER NOT DEEMED A SHAREHOLDER</U>. Except as otherwise specifically provided herein, the Holder, solely in
its capacity as a holder of this Common Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of
share capital of the Company for any purpose, nor shall anything contained in this Common Warrant be construed to confer upon
the Holder, solely in its capacity as the Holder of this Common Warrant, any of the rights of a shareholder of the Company or
any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification
of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights,
or otherwise, prior to the issuance to the Holder of the Warrant Common Shares which it is then entitled to receive upon the due
exercise of this Common Warrant. In addition, nothing contained in this Common Warrant shall be construed as imposing any liabilities
on the Holder to purchase any securities (upon exercise of this Common Warrant or otherwise) or as a shareholder of the Company,
whether such liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 6, the Company
shall provide the Holder with copies of the same notices and other information given to the shareholders of the Company generally,
contemporaneously with the giving thereof to the shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">7.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>REISSUANCE OF COMMON WARRANTS.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Transfer of Common Warrant</U>. If this Common Warrant is to be transferred, the Holder shall surrender this Common Warrant
to the Company, whereupon the Company will forthwith issue and deliver upon the order of the Holder a new Common Warrant (in accordance
with Section 7(d)), registered as the Holder may request, representing the right to purchase the number of Warrant Common Shares
being transferred by the Holder and, if less than the total number of Warrant Common Shares then underlying this Common Warrant
is being transferred, a new Common Warrant (in accordance with Section 7(d)) to the Holder representing the right to purchase
the number of Warrant Common Shares not being transferred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Lost, Stolen or Mutilated Common Warrant</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company
of the loss, theft, destruction or mutilation of this Common Warrant (as to which a written certification and the indemnification
contemplated below shall suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking
by the Holder to the Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation
of this Common Warrant, the Company shall execute and deliver to the Holder a new Common Warrant (in accordance with Section 7(d))
representing the right to purchase the Warrant Common Shares then underlying this Common Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Exchangeable for Multiple Common Warrants</U>. This Common Warrant is exchangeable, upon the surrender hereof by the Holder
at the principal office of the Company, for a new Common Warrant or Common Warrants (in accordance with Section 7(d)) representing
in the aggregate the right to purchase the number of Warrant Common Shares then underlying this Common Warrant, and each such
new Common Warrant will represent the right to purchase such portion of such Warrant Common Shares as is designated by the Holder
at the time of such surrender; provided, however, no warrants for fractional shares of Common Stock shall be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Issuance of New Common Warrants</U>. Whenever the Company is required to issue a new Common Warrant pursuant to the terms of
this Common Warrant, such new Common Warrant (i) shall be of like tenor with this Common Warrant, (ii) shall represent, as indicated
on the face of such new Common Warrant, the right to purchase the Warrant Common Shares then underlying this Common Warrant (or
in the case of a new Common Warrant being issued pursuant to Section 7(a) or Section 7(c), the Warrant Common Shares designated
by the Holder which, when added to the number of shares of Common Stock underlying the other new Common Warrants issued in connection
with such issuance, does not exceed the number of Warrant Common Shares then underlying this Common Warrant), (iii) shall have
an issuance date, as indicated on the face of such new Common Warrant which is the same as the Issuance Date, and (iv) shall have
the same rights and conditions as this Common Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.<U>
NOTICES</U>. Whenever notice is required to be given under this Common Warrant, unless otherwise provided herein, such notice
shall be given in accordance with Section 9(f) of the Securities Purchase Agreement. The Company shall provide the Holder
with prompt written notice of all actions taken pursuant to this Common Warrant (other than the issuance of shares of Common
Stock upon exercise in accordance with the terms hereof), including in reasonable detail a description of such action and the
reason therefor. Without limiting the generality of the foregoing, the Company will give written notice to the Holder (i)
immediately upon each adjustment of the Exercise Price and the number of Warrant Common Shares, setting forth in reasonable
detail, and certifying, the calculation of such adjustment(s), (ii) at least fifteen (15) days prior to the date on which the
Company closes its books or takes a record (A) with respect to any dividend or distribution upon the shares of Common Stock,
(B) with respect to any grants, issuances or sales of any Options, Convertible Securities or rights to purchase stock,
warrants, securities or other property to holders of shares of Common Stock or (C) for determining rights to vote with
respect to any Fundamental Transaction, dissolution or liquidation, provided in each case that such information shall be made
known to the public prior to or in conjunction with such notice being provided to the Holder, (iii) at least ten (10) Trading
Days prior to the consummation of any Fundamental Transaction and (iv) within one (1) Business Day of the occurrence of an
Triggering Event (as defined in the Certificate of Designations), setting forth in reasonable detail any material events with
respect to such Triggering Event and any efforts by the Company to cure such Triggering Event. To the extent that any notice
provided hereunder constitutes, or contains, material, non-public information regarding the Company or any of its
Subsidiaries, the Company shall simultaneously file such notice with the SEC (as defined in the Securities Purchase
Agreement) pursuant to a Current Report on Form 8-K. If the Company or any of its Subsidiaries provides material non-public
information to the Holder that is not simultaneously filed in a Current Report on Form 8-K and the Holder has not agreed to
receive such material non-public information, the Company hereby covenants and agrees that the Holder shall not have any duty
of confidentiality to the Company, any of its Subsidiaries or any of their respective officers, directors, employees,
affiliates or agents with respect to, or a duty to any of the foregoing not to trade on the basis of, such material
non-public information. It is expressly understood and agreed that the time of execution specified by the Holder in each
Exercise Notice shall be definitive and may not be disputed or challenged by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>AMENDMENT AND WAIVER</U>. Except as otherwise provided herein, the provisions of this Common Warrant (other than Section 1(f))
may be amended and the Company may take any action herein prohibited, or omit to perform any act herein required to be performed
by it, only if the Company has obtained the written consent of the Holder. No waiver shall be effective unless it is in writing
and signed by an authorized representative of the waiving party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>SEVERABILITY</U>. If any provision of this Common Warrant is prohibited by law or otherwise determined to be invalid or unenforceable
by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed
amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such
provision shall not affect the validity of the remaining provisions of this Common Warrant so long as this Common Warrant as so
modified continues to express, without material change, the original intentions of the parties as to the subject matter hereof
and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective
expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred
upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s)
with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable
provision(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>GOVERNING LAW</U>. This Common Warrant shall be governed by and construed and enforced in accordance with, and all questions
concerning the construction, validity, interpretation and performance of this Common Warrant shall be governed by, the internal
laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the
State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the
State of New York. The Company hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof to the Company at the address set forth in Section 9(f) of the Securities
Purchase Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. The
Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York,
Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim
that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an
inconvenient forum or that the venue of such suit, action or proceeding is improper. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein shall be deemed or operate
to preclude the Holder from bringing suit or taking other legal action against the Company in any other jurisdiction to collect
on the Company&rsquo;s obligations to the Holder, to realize on any collateral or any other security for such obligations, or
to enforce a judgment or other court ruling in favor of the Holder. <B>THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY
HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING
OUT OF THIS COMMON WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<U>CONSTRUCTION; HEADINGS</U>. This Common Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall
not be construed against any Person as the drafter hereof. The headings of this Common Warrant are for convenience of reference
and shall not form part of, or affect the interpretation of, this Common Warrant. Terms used in this Common Warrant but defined
in the other Transaction Documents shall have the meanings ascribed to such terms on the Closing Date (as defined in the Securities
Purchase Agreement) in such other Transaction Documents unless otherwise consented to in writing by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">13.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>DISPUTE RESOLUTION</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Submission to Dispute Resolution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
In the case of a dispute relating to the Exercise Price, the Closing Sale Price, the Bid Price, Black Scholes Consideration Value,
Black Scholes Value or fair market value or the arithmetic calculation of the number of Warrant Common Shares (as the case may
be) (including, without limitation, a dispute relating to the determination of any of the foregoing), the Company or the Holder
(as the case may be) shall submit the dispute to the other party via facsimile (A) if by the Company, within two (2) Business
Days after the occurrence of the circumstances giving rise to such dispute or (B) if by the Holder, at any time after the Holder
learned of the circumstances giving rise to such dispute. If the Holder and the Company are unable to promptly resolve such dispute
relating to such Exercise Price, such Closing Sale Price, such Bid Price, such Black Scholes Consideration Value, Black Scholes
Value or such fair market value or such arithmetic calculation of the number of Warrant Common Shares (as the case may be), at
any time after the second (2<SUP>nd</SUP>) Business Day following such initial notice by the Company or the Holder (as the case
may be) of such dispute to the Company or the Holder (as the case may be), then the Holder may, at its sole option, select an
independent, reputable investment bank to resolve such dispute.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Holder and the Company shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered
in accordance with the first sentence of this Section 13 and (B) written documentation supporting its position with respect to
such dispute, in each case, no later than 5:00 p.m. (New York time) by the fifth (5<SUP>th</SUP>) Business Day immediately following
the date on which the Holder selected such investment bank (the &ldquo;<B>Dispute Submission Deadline</B>&rdquo;) (the documents
referred to in the immediately preceding clauses (A) and (B) are collectively referred to herein as the &ldquo;<B>Required Dispute
Documentation</B>&rdquo;) (it being understood and agreed that if either the Holder or the Company fails to so deliver all of
the Required Dispute Documentation by the Dispute Submission Deadline, then the party who fails to so submit all of the Required
Dispute Documentation shall no longer be entitled to (and hereby waives its right to) deliver or submit any written documentation
or other support to such investment bank with respect to such dispute and such investment bank shall resolve such dispute based
solely on the Required Dispute Documentation that was delivered to such investment bank prior to the Dispute Submission Deadline).
Unless otherwise agreed to in writing by both the Company and the Holder or otherwise requested by such investment bank, neither
the Company nor the Holder shall be entitled to deliver or submit any written documentation or other support to such investment
bank in connection with such dispute (other than the Required Dispute Documentation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The Company and the Holder shall cause such investment bank to determine the resolution of such dispute and notify the Company
and the Holder of such resolution no later than ten (10) Business Days immediately following the Dispute Submission Deadline.
The fees and expenses of such investment bank shall be borne solely by the Company, and such investment bank&rsquo;s resolution
of such dispute shall be final and binding upon all parties absent manifest error.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Miscellaneous</U>. The Company expressly acknowledges and agrees that (i) this Section 13 constitutes an agreement to arbitrate
between the Company and the Holder (and constitutes an arbitration agreement) under the rules then in effect under &sect; 7501,
et seq. of the New York Civil Practice Law and Rules (&ldquo;<B>CPLR</B>&rdquo;) and that the Holder is authorized to apply for
an order to compel arbitration pursuant to CPLR &sect; 7503(a) in order to compel compliance with this Section 13, (ii) a dispute
relating to the Exercise Price includes, without limitation, disputes as to (A) whether an issuance or sale or deemed issuance
or sale of Common Stock occurred under Section 2(b), (B) the consideration per share at which an issuance or deemed issuance of
Common Stock occurred, (C) whether any issuance or sale or deemed issuance or sale of Common Stock was an issuance or sale or
deemed issuance or sale of Excluded Securities, (D) whether an agreement, instrument, security or the like constitutes and Option
or Convertible Security and (E) whether a Dilutive Issuance occurred, (iii) the terms of this Common Warrant and each other applicable
Transaction Document shall serve as the basis for the selected investment bank&rsquo;s resolution of the applicable dispute, such
investment bank shall be entitled (and is hereby expressly authorized) to make all findings, determinations and the like that
such investment bank determines are required to be made by such investment bank in connection with its resolution of such dispute
(including, without limitation, determining (A) whether an issuance or sale or deemed issuance or sale of Common Stock occurred
under Section 2(b), (B) the consideration per share at which an issuance or deemed issuance of Common Stock occurred, (C) whether
any issuance or sale or deemed issuance or sale of Common Stock was an issuance or sale or deemed issuance or sale of Excluded
Securities, (D) whether an agreement, instrument, security or the like constitutes and Option or Convertible Security and (E)
whether a Dilutive Issuance occurred) and in resolving such dispute such investment bank shall apply such findings, determinations
and the like to the terms of this Common Warrant and any other applicable Transaction Documents, (iv) the Holder (and only the
Holder), in its sole discretion, shall have the right to submit any dispute described in this Section 13 to any state or federal
court sitting in The City of New York, Borough of Manhattan in lieu of utilizing the procedures set forth in this Section 13 and
(v) nothing in this Section 13 shall limit the Holder from obtaining any injunctive relief or other equitable remedies (including,
without limitation, with respect to any matters described in this Section 13).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<U>REMEDIES, CHARACTERIZATION, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF</U>. The remedies provided in this Common Warrant
shall be cumulative and in addition to all other remedies available under this Common Warrant and the other Transaction Documents,
at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit
the right of the Holder to pursue actual and consequential damages for any failure by the Company to comply with the terms of
this Common Warrant. The Company covenants to the Holder that there shall be no characterization concerning this instrument other
than as expressly provided herein. Amounts set forth or provided for herein with respect to payments, exercises and the like (and
the computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly provided herein,
be subject to any other obligation of the Company (or the performance thereof). The Company acknowledges that a breach by it of
its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate.
The Company therefore agrees that, in the event of any such breach or threatened breach, the holder of this Common Warrant shall
be entitled, in addition to all other available remedies, to specific performance and/or temporary, preliminary and permanent
injunctive or other equitable relief from any court of competent jurisdiction in any such case without the necessity of proving
actual damages and without posting a bond or other security. The Company shall provide all information and documentation to the
Holder that is requested by the Holder to enable the Holder to confirm the Company&rsquo;s compliance with the terms and conditions
of this Common Warrant (including, without limitation, compliance with Section 2 hereof). The issuance of shares and certificates
for shares as contemplated hereby upon the exercise of this Common Warrant shall be made without charge to the Holder or such
shares for any issuance tax or other costs in respect thereof, provided that the Company shall not be required to pay any tax
which may be payable in respect of any transfer involved in the issuance and delivery of any certificate in a name other than
the Holder or its agent on its behalf.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">15.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>PAYMENT OF COLLECTION, ENFORCEMENT AND OTHER
COSTS</U><FONT STYLE="text-transform: none">. If (a) this Common Warrant is placed in the hands of an attorney for collection
or enforcement or is collected or enforced through any legal proceeding or the holder otherwise takes action to collect amounts
due under this Common Warrant or to enforce the provisions of this Common Warrant or (b) there occurs any bankruptcy, reorganization,
receivership of the company or other proceedings affecting company creditors&rsquo; rights and involving a claim under this Common
Warrant, then the Company shall pay the costs incurred by the Holder for such collection, enforcement or action or in connection
with such bankruptcy, reorganization, receivership or other proceeding, including, without limitation, attorneys&rsquo; fees and
disbursements.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.
<U>TRANSFER</U>. This Common Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company,
except as may otherwise be required by Section [2(g)] of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.
<U>CERTAIN DEFINITIONS</U>. For purposes of this Common Warrant, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<B>1933 Act</B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;<B>1934 Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;<B>Adjustment Right</B>&rdquo; means any right granted with respect to any securities issued in connection with, or with
respect to, any issuance or sale (or deemed issuance or sale in accordance with Section 2) of shares of Common Stock (other than
rights of the type described in Section 3 and 4 hereof) that could result in a decrease in the net consideration received by the
Company in connection with, or with respect to, such securities (including, without limitation, any cash settlement rights, cash
adjustment or other similar rights).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&ldquo;<B>Affiliate</B>&rdquo; means, with respect to any Person, any other Person that directly or indirectly controls, is controlled
by, or is under common control with, such Person, it being understood for purposes of this definition that &ldquo;control&rdquo;
of a Person means the power directly or indirectly either to vote 10% or more of the stock having ordinary voting power for the
election of directors of such Person or direct or cause the direction of the management and policies of such Person whether by
contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&ldquo;<B>Adjusted Share Amount</B>&rdquo; means, with respect to any given Adjustment Time, the product of (x)_______ multiplied
by (y) the aggregate number of Warrant Preferred Shares to be issued to the Holder pursuant to the corresponding Exercise Notice
(as defined in the Preferred Warrant) delivered to the Company (or its designee) with respect to such Adjustment Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&ldquo;<B>Adjustment Time</B>&rdquo; means, with respect to any given Exercise Notice (as defined in the Preferred Warrant), the
time the Holder (or its designee) shall have delivered such Exercise Notice to the Company (or its designee) and, solely if not
a Cashless Exercise (as defined in the Preferred Warrant) thereunder, the Aggregate Exercise Price (as defined in the Preferred
Warrant) related thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&ldquo;<B>Approved Stock Plan</B>&rdquo; means any employee benefit plan which has been approved by the board of directors of
the Company prior to or subsequent to the date hereof pursuant to which shares of Common Stock and options to purchase Common
Stock may be issued to any employee, consultants, officer or director for services provided to the Company in their capacity as
such.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
&ldquo;<B>Attribution Parties</B>&rdquo; means, collectively, the following Persons and entities: (i) any investment vehicle,
including, any funds, feeder funds or managed accounts, currently, or from time to time after the Issuance Date, directly or indirectly
managed or advised by the Holder&rsquo;s investment manager or any of its Affiliates or principals, (ii) any direct or indirect
Affiliates of the Holder or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together
with the Holder or any of the foregoing and (iv) any other Persons whose beneficial ownership of the Company&rsquo;s Common Stock
would or could be aggregated with the Holder&rsquo;s and the other Attribution Parties for purposes of Section 13(d) of the 1934
Act. For clarity, the purpose of the foregoing is to subject collectively the Holder and all other Attribution Parties to the
Maximum Percentage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&ldquo;<B>Bid Price</B>&rdquo; means, for any security as of the particular time of determination, the bid price for such security
on the Principal Market as reported by Bloomberg as of such time of determination, or, if the Principal Market is not the principal
securities exchange or trading market for such security, the bid price of such security on the principal securities exchange or
trading market where such security is listed or traded as reported by Bloomberg as of such time of determination, or if the foregoing
does not apply, the bid price of such security in the over-the-counter market on the electronic bulletin board for such security
as reported by Bloomberg as of such time of determination, or, if no bid price is reported for such security by Bloomberg as of
such time of determination, the average of the bid prices of any market makers for such security as reported in the &ldquo;pink
sheets&rdquo; by OTC Markets Group Inc. (formerly Pink Sheets LLC) as of such time of determination. If the Bid Price cannot be
calculated for a security as of the particular time of determination on any of the foregoing bases, the Bid Price of such security
as of such time of determination shall be the fair market value as mutually determined by the Company and the Holder. If the Company
and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved in accordance
with the procedures in Section 13. All such determinations shall be appropriately adjusted for any stock dividend, stock split,
stock combination or other similar transaction during such period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
&ldquo;<B>Black Scholes Consideration Value</B>&rdquo; means the value of the applicable Option, Convertible Security or Adjustment
Right (as the case may be) as of the date of issuance thereof calculated using the Black Scholes Option Pricing Model obtained
from the &ldquo;OV&rdquo; function on Bloomberg utilizing (i) an underlying price per share equal to the Closing Sale Price of
the Common Stock on the Trading Day immediately preceding the public announcement of the execution of definitive documents with
respect to the issuance of such Option or Convertible Security (as the case may be), (ii) a risk-free interest rate corresponding
to the U.S. Treasury rate for a period equal to the remaining term of such Option, Convertible Security or Adjustment Right (as
the case may be) as of the date of issuance of such Option, Convertible Security or Adjustment Right (as the case may be), (iii)
a zero cost of borrow and (iv) an expected volatility equal to the greater of 100% and the 30 day volatility obtained from the
&ldquo;HVT&rdquo; function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately
following the date of issuance of such Option, Convertible Security or Adjustment Right (as the case may be).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
&ldquo;<B>Black Scholes Value</B>&rdquo; means the value of the unexercised portion of this Common Warrant remaining on the date
of the Holder&rsquo;s request pursuant to Section 4(c), which value is calculated using the Black Scholes Option Pricing Model
obtained from the &ldquo;OV&rdquo; function on Bloomberg utilizing (i) an underlying price per share equal to the greater of (1)
the highest Closing Sale Price of the Common Stock during the period beginning on the Trading Day immediately preceding the announcement
of the applicable Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending
on the Trading Day of the Holder&rsquo;s request pursuant to Section 4(c) and (2) the sum of the price per share being offered
in cash in the applicable Fundamental Transaction (if any) plus the value of the non-cash consideration being offered in the applicable
Fundamental Transaction (if any), (ii) a strike price equal to the Exercise Price in effect on the date of the Holder&rsquo;s
request pursuant to Section 4(c), (iii) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to
the greater of (1) the remaining term of this Common Warrant as of the date of the Holder&rsquo;s request pursuant to Section
4(c) and (2) the remaining term of this Common Warrant as of the date of consummation of the applicable Fundamental Transaction
or as of the date of the Holder&rsquo;s request pursuant to Section 4(c) if such request is prior to the date of the consummation
of the applicable Fundamental Transaction, (iv) a zero cost of borrow and (v) an expected volatility equal to the greater of 100%
and the 30 day volatility obtained from the &ldquo;HVT&rdquo; function on Bloomberg (determined utilizing a 365 day annualization
factor) as of the Trading Day immediately following the earliest to occur of (A) the public disclosure of the applicable Fundamental
Transaction, (B) the consummation of the applicable Fundamental Transaction and (C) the date on which the Holder first became
aware of the applicable Fundamental Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
&ldquo;<B>Bloomberg</B>&rdquo; means Bloomberg, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
&ldquo;<B>Business Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City
of New York are authorized or required by law to remain closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
&ldquo;<B>Certificate of Designations</B>&rdquo; has the meaning ascribed to such term in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
&ldquo;<B>Closing Sale Price</B>&rdquo; means, for any security as of any date, the last closing trade price for such security
on the Principal Market, as reported by Bloomberg, or, if the Principal Market begins to operate on an extended hours basis and
does not designate the closing trade price, then the last trade price of such security prior to 4:00:00 p.m., New York time, as
reported by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security,
the last trade price of such security on the principal securities exchange or trading market where such security is listed or
traded as reported by Bloomberg, or if the foregoing does not apply, the last trade price of such security in the over-the-counter
market on the electronic bulletin board for such security as reported by Bloomberg, or, if no last trade price is reported for
such security by Bloomberg, the average of the ask prices of any market makers for such security as reported in the &ldquo;pink
sheets&rdquo; by OTC Markets Group Inc. (formerly Pink Sheets LLC). If the Closing Sale Price cannot be calculated for a security
on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market
value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market
value of such security, then such dispute shall be resolved in accordance with the procedures in Section 13. All such determinations
shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during such
period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
&ldquo;<B>Common Stock</B>&rdquo; means (i) the Company&rsquo;s shares of common stock, $0.001 par value per share, and (ii) any
capital stock into which such common stock shall have been changed or any share capital resulting from a reclassification of such
common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
&ldquo;<B>Convertible Securities</B>&rdquo; means any stock or other security (other than Options) that is at any time and under
any circumstances, directly or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the
holder thereof to acquire, any shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
&ldquo;<B>Eligible Market</B>&rdquo; means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the
Nasdaq Global Market or the Principal Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
&ldquo;<B>Event Market Price</B>&rdquo; means, with respect to any Stock Combination Event Date, the quotient determined by dividing
(x) the sum of the VWAP of the Common Stock for each of the five (5) lowest Trading Days during the twenty (20) consecutive Trading
Day period ending and including the Trading Day immediately preceding the sixteenth (16th) Trading Day after such Stock Combination
Event Date, divided by (y) five (5). All such determinations shall be appropriately adjusted for any stock dividend, stock split,
stock combination, recapitalization or other similar transaction during such period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
&ldquo;<B>Excluded Securities</B>&rdquo; means (i) shares of Common Stock or options to purchase Common Stock issued to directors,
consultants, officers or employees of the Company for services rendered to the Company in their capacity as such pursuant to an
Approved Stock Plan (as defined above), provided that (A) all such issuances (taking into account the shares of Common Stock issuable
upon exercise of such options) after the Subscription Date pursuant to this clause (i) do not, in the aggregate, exceed more than
15% of the Common Stock issued and outstanding immediately prior to the Subscription Date and (B) the exercise price of any such
options is not lowered, none of such options are amended to increase the number of shares issuable thereunder and none of the
terms or conditions of any such options are otherwise materially changed in any manner that adversely affects any of the Buyers;
(ii) shares of Common Stock issued upon the conversion or exercise of Convertible Securities (other than options to purchase Common
Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) issued prior to the Subscription Date, provided
that the conversion price of any such Convertible Securities (other than options to purchase Common Stock issued pursuant to an
Approved Stock Plan that are covered by clause (i) above) is not lowered, none of such Convertible Securities (other than options
to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) are amended to increase
the number of shares issuable thereunder and none of the terms or conditions of any such Convertible Securities (other than options
to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) are otherwise materially
changed in any manner that adversely affects any of the Buyers; (iii) the shares of Common Stock issuable upon conversion of the
Preferred Shares or otherwise pursuant to the terms of the Certificate of Designations; provided, that the terms of the Certificate
of Designations is not amended, modified or changed on or after the Subscription Date (other than antidilution adjustments pursuant
to the terms thereof in effect as of the Subscription Date), (iv) the Preferred Shares issuable upon exercise of the Preferred
Warrants provided, that the terms of the Preferred Warrants are not amended, modified or changed on or after the Subscription
Date (other than antidilution adjustments pursuant to the terms thereof in effect as of the Subscription Date), (v) the shares
of Common Stock issuable upon exercise of the SPA Common Warrants; provided, that the terms of the SPA Common Warrant are not
amended, modified or changed on or after the Subscription Date (other than antidilution adjustments pursuant to the terms thereof
in effect as of the Subscription Date) and (vi) shares of Common Stock and Common Stock issued upon the conversion or exercise
of Convertible Securities or Options (other than options to purchase Common Stock issued pursuant to an Approved Stock Plan on
or after the date of this Warrant that are covered by clause (i) above) issued or issuable pursuant to strategic alliances, strategic
mergers and acquisitions, strategic partnerships, strategic license agreements and other similar transactions, provided that (I)
the primary purpose of such issuance is not to raise capital, (II) the purchaser or acquirer of such shares of Common Stock, Options
and/or Convertible Securities in such issuance solely consists of the actual participants in such strategic transaction or the
stockholders, partners, members or Affiliates of the such participants, and (III) to the extent there are multiple participants
in such transaction, the number or amount (as the case may be) of such shares of Common Stock, Options and/or Convertible Securities
issued to such Person by the Company in such transaction shall not be disproportionate to such Person&rsquo;s actual participation
in such strategic transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
&ldquo;<B>Expiration Date</B>&rdquo; means the date that is the fifth (5<SUP>th</SUP>) anniversary of the Initial Exercisability
Date or, if such date falls on a day other than a Trading Day or on which trading does not take place on the Principal Market
(a &ldquo;<B>Holiday</B>&rdquo;), the next date that is not a Holiday.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
&ldquo;<B>Fundamental Transaction</B>&rdquo; means (A) that the Company shall, directly or indirectly, including through subsidiaries,
Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company
is the surviving corporation) another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially
all of the properties or assets of the Company or any of its &ldquo;significant subsidiaries&rdquo; (as defined in Rule 1-02 of
Regulation S-X) to one or more Subject Entities, or (iii) make, or allow one or more Subject Entities to make, or allow the Company
to be subject to or have its Common Stock be subject to or party to one or more Subject Entities making, a purchase, tender or
exchange offer that is accepted by the holders of at least either (x) 50% of the outstanding shares of Common Stock, (y) 50% of
the outstanding shares of Common Stock calculated as if any shares of Common Stock held by all Subject Entities making or party
to, or Affiliated with any Subject Entities making or party to, such purchase, tender or exchange offer were not outstanding;
or (z) such number of shares of Common Stock such that all Subject Entities making or party to, or Affiliated with any Subject
Entity making or party to, such purchase, tender or exchange offer, become collectively the beneficial owners (as defined in Rule
13d-3 under the 1934 Act) of at least 50% of the outstanding shares of Common Stock, or (iv) consummate a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme
of arrangement) with one or more Subject Entities whereby all such Subject Entities, individually or in the aggregate, acquire,
either (x) at least 50% of the outstanding shares of Common Stock, (y) at least 50% of the outstanding shares of Common Stock
calculated as if any shares of Common Stock held by all the Subject Entities making or party to, or Affiliated with any Subject
Entity making or party to, such stock purchase agreement or other business combination were not outstanding; or (z) such number
of shares of Common Stock such that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under
the 1934 Act) of at least 50% of the outstanding shares of Common Stock, or (v) reorganize, recapitalize or reclassify its Common
Stock, (B) that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or
more related transactions, allow any Subject Entity individually or the Subject Entities in the aggregate to be or become the
&ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, whether through acquisition,
purchase, assignment, conveyance, tender, tender offer, exchange, reduction in outstanding shares of Common Stock, merger, consolidation,
business combination, reorganization, recapitalization, spin-off, scheme of arrangement, reorganization, recapitalization or reclassification
or otherwise in any manner whatsoever, of either (x) at least 50% of the aggregate ordinary voting power represented by issued
and outstanding Common Stock, (y) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common
Stock not held by all such Subject Entities as of the date of this Common Warrant calculated as if any shares of Common Stock
held by all such Subject Entities were not outstanding, or (z) a percentage of the aggregate ordinary voting power represented
by issued and outstanding shares of Common Stock or other equity securities of the Company sufficient to allow such Subject Entities
to effect a statutory short form merger or other transaction requiring other shareholders of the Company to surrender their shares
of Common Stock without approval of the shareholders of the Company or (C) directly or indirectly, including through subsidiaries,
Affiliates or otherwise, in one or more related transactions, the issuance of or the entering into any other instrument or transaction
structured in a manner to circumvent, or that circumvents, the intent of this definition in which case this definition shall be
construed and implemented in a manner otherwise than in strict conformity with the terms of this definition to the extent necessary
to correct this definition or any portion of this definition which may be defective or inconsistent with the intended treatment
of such instrument or transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
&ldquo;<B>Group</B>&rdquo; means a &ldquo;group&rdquo; as that term is used in Section 13(d) of the 1934 Act and as defined in
Rule 13d-5 thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
&ldquo;<B>Maximum Eligibility Number</B>&rdquo; means initially ________ and shall be increased at each Adjustment Time by an
amount equal to the corresponding Adjusted Share Amount with respect thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
&ldquo;<B>Options</B>&rdquo; means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
&ldquo;<B>Parent Entity</B>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person and
whose common stock or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such
Person or Parent Entity, the Person or Parent Entity with the largest public market capitalization as of the date of consummation
of the Fundamental Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
&ldquo;<B>Person</B>&rdquo; means an individual, a limited liability company, a partnership, a joint venture, a corporation, a
trust, an unincorporated organization, any other entity or a government or any department or agency thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
&ldquo;<B>Preferred Shares</B>&rdquo; has the meaning ascribed to such term in the Securities Purchase Agreement, and shall include
all shares of preferred stock issued in exchange therefor or replacement thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
&ldquo;<B>Preferred Warrant</B>&rdquo; has the meaning ascribed to such term in the Securities Purchase Agreement, and shall include
all Common Warrants to purchase preferred stock issued in exchange therefor or replacement thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
&ldquo;<B>Principal Market</B>&rdquo; means the Nasdaq Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
&ldquo;<B>Registration Rights Agreement</B>&rdquo; means that certain registration rights agreement, dated as of the Closing Date,
by and among the Company and the initial holders of the Preferred Shares relating to, among other things, the registration of
the resale of the Preferred Shares, the Common Stock issuable upon conversion of the Preferred Shares or otherwise pursuant to
the terms of the Certificate of Designations and exercise of the SPA Common Warrants, as may be amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
&ldquo;<B>SEC</B>&rdquo; means the United States Securities and Exchange Commission or the successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<B>&ldquo;Subject Entity</B>&rdquo; means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons
or Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
&ldquo;<B>Successor Entity</B>&rdquo; means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting
from or surviving any Fundamental Transaction or the Person (or, if so elected by the Holder, the Parent Entity) with which such
Fundamental Transaction shall have been entered into.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
&ldquo;<B>Trading Day</B>&rdquo; means, as applicable, (x) with respect to all price or trading volume determinations relating
to the Common Stock, any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the
principal trading market for the Common Stock, then on the principal securities exchange or securities market on which the Common
Stock is then traded, provided that &ldquo;Trading Day&rdquo; shall not include any day on which the Common Stock is scheduled
to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during
the final hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing
time of trading on such exchange or market, then during the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise
designated as a Trading Day in writing by the Holder or (y) with respect to all determinations other than price or trading volume
determinations relating to the Common Stock, any day on which The New York Stock Exchange (or any successor thereto) is open for
trading of securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
&ldquo;<B>VWAP</B>&rdquo; means, for any security as of any date, the dollar volume-weighted average price for such security on
the Principal Market (or, if the Principal Market is not the principal trading market for such security, then on the principal
securities exchange or securities market on which such security is then traded), during the period beginning at 9:30 a.m., New
York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg through its &ldquo;VAP&rdquo; function (set to 09:30
start time and 16:00 end time) or, if the foregoing does not apply, the dollar volume-weighted average price of such security
in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30 a.m., New
York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg, or, if no dollar volume-weighted average price is
reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask
price of any of the market makers for such security as reported in the &ldquo;pink sheets&rdquo; by OTC Markets Group Inc. (formerly
Pink Sheets LLC). If the VWAP cannot be calculated for such security on such date on any of the foregoing bases, the VWAP of such
security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and
the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved in accordance
with the procedures in Section 13. All such determinations shall be appropriately adjusted for any stock dividend, stock split,
stock combination, recapitalization or other similar transaction during such period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
&ldquo;<B>Warrant Preferred Shares</B>&rdquo; has the meaning ascribed to such term in the Securities Purchase Agreement, and
shall include all shares of preferred stock issued in exchange therefor or replacement thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>signature
page follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> the Company has caused this Warrant to Purchase Common Stock to be duly executed as of the Issuance Date
set out above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Sigma
    Labs, Inc.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
A</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXERCISE
NOTICE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO
BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS<BR>
WARRANT TO PURCHASE COMMON STOCK</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">SIGMA
LABS, INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned holder hereby elects to exercise the Warrant to Purchase Common Stock No. _______ (the &ldquo;<B>Common Warrant</B>&rdquo;)
of Sigma Labs, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;) as specified below. Capitalized terms used herein
and not otherwise defined shall have the respective meanings set forth in the Common Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Form of Exercise Price</U>. The Holder intends that payment of the Aggregate Exercise Price shall be made as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    &ldquo;<U>Cash Exercise</U>&rdquo; with respect to _________________ Warrant Common Shares; and/or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">[&nbsp;&nbsp;]</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    &ldquo;<U>Cashless Exercise</U>&rdquo; with respect to _______________ Warrant Common Shares.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that the Holder has elected a Cashless Exercise with respect to some or all of the Warrant Common Shares to be issued
pursuant hereto, the Holder hereby represents and warrants that (i) this Exercise Notice was executed by the Holder at __________
[a.m.][p.m.] on the date set forth below and (ii) if applicable, the Bid Price as of such time of execution of this Exercise Notice
was $________.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Payment of Exercise Price</U>. In the event that the Holder has elected a Cash Exercise with respect to some or all of the
Warrant Common Shares to be issued pursuant hereto, the Holder shall pay the Aggregate Exercise Price in the sum of $___________________
to the Company in accordance with the terms of the Common Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Delivery of Warrant Common Shares</U>. The Company shall deliver to Holder, or its designee or agent as specified below, __________
shares of Common Stock in accordance with the terms of the Common Warrant. Delivery shall be made to Holder, or for its benefit,
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
Check here if requesting delivery as a certificate to the following name and to the following address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    to:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
Check here if requesting delivery by Deposit/Withdrawal at Custodian as follows: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.5in; width: 1.65in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC
    Participant:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
        _____________ __,</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
        of Registered Holder</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 45%"></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:</FONT></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
        ID:____________________________</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.45pt; text-indent: -18.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile:__________________________</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.45pt; text-indent: -18.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail
        Address:_____________________</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
B</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACKNOWLEDGMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby acknowledges this Exercise Notice and hereby directs ______________ to issue the above indicated number of shares
of Common Stock in accordance with the Transfer Agent Instructions dated _________, 201_, from the Company and acknowledged and
agreed to by _______________.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Sigma
    Labs, Inc.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>ex10-5.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-variant: normal; text-transform: uppercase">&nbsp;</FONT></FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal; text-transform: uppercase">E</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal">xhibit
<FONT STYLE="text-transform: uppercase">10.5</FONT></FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal; text-transform: uppercase">[NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT
BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM
REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD
PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH
A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.] THE NUMBER OF PREFERRED SHARES ISSUABLE
UPON EXERCISE OF THIS WARRANT MAY BE LESS THAN THE AMOUNTS SET FORTH ON THE FACE HEREOF PURSUANT TO SECTION </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal">1(a)
<FONT STYLE="text-transform: uppercase">OF THIS WARRANT.</FONT></FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sigma
Labs, Inc.</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
to Purchase<BR>
Series D Convertible Preferred Stock</FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
Warrant No.: __________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Issuance: January 28, 2020 (&ldquo;<B>Issuance Date</B>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sigma
Labs, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, <FONT STYLE="text-transform: uppercase"><B>______________________</B></FONT>,
the registered holder hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;), is entitled, subject to the terms set
forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant
to Purchase Series D Convertible Preferred Stock (including any Warrants to Purchase Series D Convertible Preferred Stock issued
in exchange, transfer or replacement hereof, this &ldquo;<B>Warrant</B>&rdquo;), at any time or times on or after the Issuance
Date, but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), ________ (subject to adjustment as provided
herein) fully paid and non-assessable shares of Series D Convertible Preferred Stock (the &ldquo;<B>Warrant Preferred Shares</B>&rdquo;
and such aggregate number of Warrant Preferred Shares issuable hereunder as of any time of determination, the &ldquo;<B>Warrant
Preferred Number</B>&rdquo;). Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set
forth in Section 16. This Warrant is one of the Preferred Warrants (as defined in the Securities Purchase Agreement (as defined
below)) to purchase Preferred Shares (as defined in the Securities Purchase Agreement) (the &ldquo;<B>SPA Preferred Warrants</B>&rdquo;,
as exercised, the &ldquo;<B>SPA Warrant Preferred Shares</B>&rdquo;) issued pursuant to Section 1 of that certain Securities Purchase
Agreement, dated as of January 27, 2020 (the &ldquo;<B>Subscription Date</B>&rdquo;), by and among the Company and the investors
(the &ldquo;<B>Buyers</B>&rdquo;) referred to therein, as amended from time to time (the &ldquo;<B>Securities Purchase Agreement</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">1.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXERCISE OF WARRANT.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Mechanics of Exercise</U>. Subject to the terms and conditions hereof, this Warrant may be exercised by the Holder on any day
on or after the Issuance Date (an &ldquo;<B>Exercise Date</B>&rdquo;), in whole or in part, by delivery (whether via facsimile
or otherwise) of a written notice, in the form attached hereto as <B><U>Exhibit A</U></B> (the &ldquo;<B>Exercise Notice</B>&rdquo;),
of the Holder&rsquo;s election to exercise this Warrant. Within one (1) Trading Day following an exercise of this Warrant as aforesaid,
the Holder shall deliver payment to the Company of an amount equal to the Exercise Price in effect on the date of such exercise
multiplied by the number of Warrant Preferred Shares as to which this Warrant was so exercised (the &ldquo;<B>Aggregate Exercise
Price</B>&rdquo;) in cash or via wire transfer of immediately available funds (if such exercise was not made pursuant to a Cashless
Exercise (as defined in Section 1(d)(ii) below)). The Holder shall not be required to deliver the original of this Warrant in
order to effect an exercise hereunder. Execution and delivery of an Exercise Notice with respect to less than all of the Warrant
Preferred Shares shall have the same effect as cancellation of the original of this Warrant and issuance of a new Warrant evidencing
the right to purchase the remaining number of Warrant Preferred Shares. Execution and delivery of an Exercise Notice for all of
the then-remaining Warrant Preferred Shares shall have the same effect as cancellation of the original of this Warrant after delivery
of the Warrant Preferred Shares in accordance with the terms hereof. On or before the second (2<SUP>nd</SUP>) Trading Day following
the date on which the Company has received such Exercise Notice (or such earlier date as required pursuant to the 1934 Act or
other applicable law, rule or regulation for the settlement of a trade of such Warrant Preferred Shares initiated on the applicable
Exercise Date), the Company shall issue and deliver (via reputable overnight courier) to the address as specified in the Exercise
Notice, a certificate, registered in the name of the Holder or its designee, for the number of Warrant Preferred Shares to which
the Holder shall be entitled pursuant to such exercise. Upon delivery of an Exercise Notice and the release, at the direction
of the Holder, of a wire of the Aggregate Exercise Price to the Company (the &ldquo;<B>Exercise Conditions</B>&rdquo;), the Holder
shall be deemed for all corporate purposes to have become the holder of record of the Warrant Preferred Shares with respect to
which this Warrant has been exercised (including, without limitation, the right to convert such Warrant Preferred Shares), irrespective
of the date of delivery of the certificates evidencing such Warrant Preferred Shares (as the case may be). If a certificate with
respect to this Warrant is delivered to the Company in connection with any exercise pursuant to this Section 1(a) and the number
of Warrant Preferred Shares represented by this Warrant submitted for exercise is greater than the number of Warrant Preferred
Shares being acquired upon an exercise, then, at the request of the Holder, the Company shall as soon as practicable and in no
event later than two (2) Business Days after any exercise and at its own expense, issue and deliver to the Holder (or its designee)
a new Warrant (in accordance with Section 6(d)) representing the right to purchase the number of Warrant Preferred Shares purchasable
immediately prior to such exercise under this Warrant, less the number of Warrant Preferred Shares with respect to which this
Warrant is exercised. No fractional Warrant Preferred Shares are to be issued upon the exercise of this Warrant, but rather the
number of Warrant Preferred Shares to be issued shall be rounded up to the nearest whole number. The Company shall pay any and
all transfer, stamp, issuance and similar taxes, costs and expenses that may be payable with respect to the issuance and delivery
of Warrant Preferred Shares upon exercise of this Warrant. Notwithstanding the foregoing, except in connection with a Cashless
Exercise hereunder, the Company&rsquo;s failure to deliver Warrant Preferred Shares to the Holder on or prior to the later of
(i) two (2) Trading Days after receipt of the applicable Exercise Notice (or such earlier date as required pursuant to the 1934
Act or other applicable law, rule or regulation for the settlement of a trade of such Warrant Preferred Shares initiated on the
applicable Exercise Date) and (ii) one (1) Trading Day after the Company&rsquo;s receipt of the Aggregate Exercise Price (or the
date of the applicable Exercise Notice electing to effect a Cashless Exercise hereunder) (such later date, the &ldquo;<B>Share
Delivery Deadline</B>&rdquo;) shall not be deemed to be a breach of this Warrant. For the avoidance of doubt, the Holder may convert
the Warrant Preferred Shares into shares of Common Stock in accordance with the terms of the Certificate of Designations at any
time, at the option of the Holder, following its satisfaction of the applicable Exercise Conditions (whether or not a certificate
with respect to such Warrant Preferred Shares has been delivered to the Holder on or prior to such time of conversion). For the
avoidance of doubt, no ink original Exercise Notices, other notices or medallion guarantees will be required by the Holder to
exercise this Warrant or for the Holder take any other action in connection herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Exercise Price</U>. For purposes of this Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $975 subject to adjustment as provided
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Disputes</U>. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number
of Warrant Preferred Shares to be issued pursuant to the terms hereof, the Company shall promptly issue to the Holder the number
of Warrant Preferred Shares that are not disputed and resolve such dispute in accordance with Section 12.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Forced Exercise; Cashless Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Forced Exercise</U>. Commencing on the initial Issuance Date (the &ldquo;<B>Eligibility Date</B>&rdquo;), so long as (I) no
Equity Conditions Failure then exists (unless waived in writing by the Holder) and (II) no Forced Exercise (as defined below)
has occurred in the twenty (20) Trading Day period immediately prior to the applicable date of determination, the Company shall
have the right to require the Holder to exercise this Warrant, in whole or in part, as designated in the applicable Forced Exercise
Notice (as defined below) into up to such aggregate number of fully paid, validly issued and non-assessable Warrant Preferred
Shares equal to the difference of (x) the Holder Pro Rata Amount (as defined in the Certificate of Designations) of 72 Warrant
Preferred Shares less (y) such aggregate number of Warrant Preferred Shares issued to the Holder pursuant to any Forced Exercise
prior to such date of determination (the &ldquo;<B>Maximum Forced Exercise Share Amount</B>&rdquo;) to be issued and delivered
in accordance with Section 1(a) hereof (each, a &ldquo;<B>Forced Exercise</B>&rdquo;). The Company may exercise its right to require
a Forced Exercise under this Section 1(d)(i) by delivering a written notice thereof, at one, or more times, by facsimile or electronic
mail to all, but not less than all, of the holders of SPA Preferred Warrants (each, a &ldquo;<B>Forced Exercise Notice</B>&rdquo;,
and the date thereof, each a &ldquo;<B>Forced Exercise Notice Date</B>&rdquo;). For purposes of Section 1(a) hereof, &ldquo;Forced
Exercise Notice&rdquo; shall be deemed to replace &ldquo;Exercise Notice&rdquo; for all purposes thereunder as if the Holder delivered
an Exercise Notice to the Company on the Forced Exercise Notice Date, <I>mutatis mutandis</I>. Each Forced Exercise Notice shall
be irrevocable. Each Forced Exercise Notice shall state (i) the Trading Day selected for the Forced Exercise in accordance with
this Section 1(d)(i), which Trading Day shall be the second (2nd) Trading Day following the applicable Forced Exercise Eligibility
Date (each, a &ldquo;<B>Forced Exercise Date</B>&rdquo;), (ii) the aggregate portion of this Warrant and the SPA Preferred Warrants
subject to forced exercise from the Holder and all of the holders of the SPA Preferred Warrants pursuant to this Section 1(d)(i)
(and analogous provisions under the SPA Preferred Warrants), (iii) the Maximum Forced Exercise Share Amount applicable to the
Holder (including calculations and any other documents reasonably requested by the Holder with respect thereto) and (iv) that
there has been no Equity Conditions Failure (or specifying any such Equity Conditions Failure that then exists, with an acknowledgement
that unless such Equity Conditions are waived, in whole or in part, such Forced Exercise Notice will be invalid). Notwithstanding
anything herein to the contrary, if an Equity Conditions Failure occurs at any time after a Forced Exercise Notice Date and prior
to the related Forced Exercise Date, (A) the Company shall provide the Holder a subsequent notice to that effect and (B) unless
the Holder waives the applicable Equity Conditions Failure, the Forced Exercise shall be cancelled and the applicable Forced Exercise
Notice shall be null and void. For the avoidance of doubt, if any Triggering Event has occurred and continuing, unless such Triggering
Event (as defined in the Certificate of Designations) has been waived, in whole or in part, in writing by the Holder, Company
shall have no right to effect a Forced Exercise; provided, that such Triggering Event shall have no effect upon the Holder&rsquo;s
right to exercise this Warrant in its discretion. If the Company elects to cause a Forced Exercise of this Warrant pursuant to
this Section 1(d)(i), then it must simultaneously take the same action in the same proportion with respect to all of the SPA Preferred
Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Cashless Exercise</U>. Notwithstanding anything contained herein to the contrary, if the Company fails to deliver a Triggering
Event Redemption Price (as defined in the Certificate of Designations) to the Holder as required, from time to time, pursuant
to the terms of the Certificate of Designations and the Holder and the Company, negotiating in good faith, are unable to reach
a resolution with respect to a waiver or cure of all Triggering Events (as defined in the Certificate of Designations) then outstanding
after a ten (10) Trading Day period after the date of such payment default, but only so long as any Triggering Events then remain
outstanding, the Holder may, in its sole discretion, exercise this Warrant, in whole or in part, and, in lieu of making the cash
payment otherwise contemplated to be made to the Company upon such exercise in payment of the Aggregate Exercise Price, elect
instead to receive upon such exercise (each, a &ldquo;<B>Cashless Exercise</B>&rdquo;) such aggregate number of Warrant Preferred
Shares equal to the lesser of (A) the Warrant Number, (B) such aggregate number of Warrant Preferred Shares elected by the Holder
in the applicable Exercise Notice to be exercised in such Cashless Exercise and (C) the difference of (I) the quotient of (x)
[TBD]% of the aggregate unpaid Triggering Event Redemption Price as of the applicable Exercise Date, divided by (y) the Exercise
Price then in effect for the applicable Warrant Shares at the time of such exercise, less (II) such aggregate number of Warrant
Preferred Shares previously issued to the Holder hereunder pursuant to one or more Cashless Exercise prior to the time of delivery
of the Exercise Notice to the Company. If Preferred Shares are issued in a Cashless Exercise, the parties acknowledge and agree
that in accordance with Section 3(a)(9) of the 1933 Act, such Preferred Shares take on the registered characteristics of the Warrants
being exercised. For purposes of Rule 144(d) promulgated under the 1933 Act, as in effect on the Subscription Date, it is intended
that the Preferred Shares issued in a Cashless Exercise shall be deemed to have been acquired by the Holder, and the holding period
for the Preferred Shares shall be deemed to have commenced, on the date this Warrant was originally issued pursuant to the Securities
Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Reservation of Shares</U>. So long as this Warrant remains outstanding, the Company shall at all times keep reserved for issuance
under this Warrant a number of Preferred Shares at least equal to 100% of the maximum number of Preferred Shares as shall be necessary
to satisfy the Company&rsquo;s obligation to issue Preferred Shares under the SPA Preferred Warrants then outstanding (without
regard to any limitations on exercise) (the &ldquo;<B>Required Reserve Amount</B>&rdquo;); provided that at no time shall the
number of Preferred Shares reserved pursuant to this Section 1(e) be reduced other than proportionally in connection with any
exercise or redemption of SPA Preferred Warrants or such other event covered by Section 2(a) below. The Required Reserve Amount
(including, without limitation, each increase in the number of shares so reserved) shall be allocated pro rata among the holders
of the SPA Preferred Warrants based on number of Preferred Shares issuable upon exercise of SPA Preferred Warrants held by each
holder on the Closing Date (without regard to any limitations on exercise) or increase in the number of reserved shares, as the
case may be (the &ldquo;<B>Authorized Share Allocation</B>&rdquo;). In the event that a holder shall sell or otherwise transfer
any of such holder&rsquo;s SPA Preferred Warrants, each transferee shall be allocated a pro rata portion of such holder&rsquo;s
Authorized Share Allocation. Any Preferred Shares reserved and allocated to any Person which ceases to hold any SPA Preferred
Warrants shall be allocated to the remaining holders of SPA Preferred Warrants, pro rata based on the number of Warrant Preferred
Shares issuable upon exercise of the SPA Preferred Warrants then held by such holders (without regard to any limitations on exercise).
If, notwithstanding the foregoing, and not in limitation thereof, at any time while any of the SPA Preferred Warrants remain outstanding,
the Company does not have a sufficient number of authorized and unreserved Preferred Shares to satisfy its obligation to reserve
the Required Reserve Amount (an &ldquo;<B>Authorized Share Failure</B>&rdquo;), then the Company shall immediately take all action
necessary to increase the Company&rsquo;s authorized Preferred Shares to an amount sufficient to allow the Company to reserve
the Required Reserve Amount for all the SPA Preferred Warrants then outstanding. Without limiting the generality of the foregoing
sentence, as soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event later than ninety
(90) days after the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its shareholders for the
approval of an increase in the number of authorized Preferred Shares. In connection with such meeting, the Company shall provide
each shareholder with a proxy statement and shall use its best efforts to solicit its shareholders&rsquo; approval of such increase
in authorized Preferred Shares and to cause its board of directors to recommend to the shareholders that they approve such proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT PREFERRED SHARES</U>. The Exercise Price and number of Warrant Preferred
Shares issuable upon exercise of this Warrant are subject to adjustment from time to time as set forth in this Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Stock Dividends and Splits</U>. If the Company, at any time on or after the Subscription Date, (i) pays a stock dividend on
one or more classes of its then outstanding Warrant Preferred Shares (other than Capitalized Dividends (as defined in the Certificate
of Designations) and Capitalized Dividends (as defined in the securities purchase agreement for the Insider Financing (as defined
in the Securities Purchase Agreement) as in effect on the Subscription Date) or otherwise makes a distribution on any class of
capital stock that is payable in Warrant Preferred Shares, (ii) subdivides (by any stock split, stock dividend, recapitalization
or otherwise) one or more classes of its then outstanding Warrant Preferred Shares into a larger number of shares or (iii) combines
(by combination, reverse stock split or otherwise) one or more classes of its then outstanding Warrant Preferred Shares into a
smaller number of shares then in each such case the Exercise Price shall be multiplied by a fraction of which the numerator shall
be the number of Warrant Preferred Shares outstanding immediately before such event and of which the denominator shall be the
number of Warrant Preferred Shares outstanding immediately after such event. Any adjustment made pursuant to clause (i) of this
paragraph shall become effective immediately after the record date for the determination of shareholders entitled to receive such
dividend or distribution, and any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective immediately
after the effective date of such subdivision or combination. If any event requiring an adjustment under this paragraph occurs
during the period that an Exercise Price is calculated hereunder, then the calculation of such Exercise Price shall be adjusted
appropriately to reflect such event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Number of Warrant Preferred Shares</U>. Simultaneously with any adjustment to the Exercise Price pursuant to this Section 2,
the number of Warrant Preferred Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately,
so that after such adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Preferred Shares
shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment (without regard to any limitations
on exercise contained herein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Principal Market, the Company may at any time
during the term of this Warrant, with the prior written consent of the Holder (as defined in the Securities Purchase Agreement),
reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors of
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">3.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>FUNDAMENTAL TRANSACTIONS.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Fundamental Transactions</U>. The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor
Entity assumes in writing all of the obligations of the Company under this Warrant and the other Transaction Documents (as defined
in the Securities Purchase Agreement) in accordance with the provisions of this Section 3(a) pursuant to written agreements in
form and substance reasonably satisfactory to the Holder and approved by the Holder prior to such Fundamental Transaction, including
agreements to deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Warrant, including, without limitation, which is exercisable for a corresponding
number of shares of capital stock equivalent to the shares of Series D Convertible Preferred Stock acquirable and receivable upon
exercise of this Warrant prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Series D Convertible Preferred Stock
pursuant to such Fundamental Transaction and the value of such shares of capital stock, such adjustments to the number of shares
of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior
to the consummation of such Fundamental Transaction) and (ii) the Successor Entity (including its Parent Entity) is a publicly
traded corporation whose common stock is quoted on or listed for trading on an Eligible Market. Upon the consummation of each
Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of the
applicable Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the
obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity
had been named as the Company herein. Upon consummation of each Fundamental Transaction, the Successor Entity shall deliver to
the Holder confirmation that there shall be issued upon exercise of this Warrant at any time after the consummation of the applicable
Fundamental Transaction, in lieu of the shares of Series D Convertible Preferred Stock (or other securities, cash, assets or other
property) issuable upon the exercise of this Warrant prior to the applicable Fundamental Transaction, such shares of publicly
traded common stock (or its equivalent) of the Successor Entity (including its Parent Entity) which the Holder would have been
entitled to receive upon the happening of the applicable Fundamental Transaction had this Warrant been completely exercised (and
the underlying Warrant Preferred Shares completely converted) immediately prior to the applicable Fundamental Transaction (without
regard to any limitations on the conversion of the Warrant Preferred Shares), as adjusted in accordance with the provisions of
this Warrant. Notwithstanding the foregoing, the Holder may elect, at its sole option, by delivery of written notice to the Company
to waive this Section 3(a) to permit the Fundamental Transaction without the assumption of this Warrant. In addition to and not
in substitution for any other rights hereunder, prior to the consummation of each Fundamental Transaction pursuant to which holders
of shares of Common Stock are entitled to receive securities or other assets with respect to or in exchange for shares of Common
Stock (a &ldquo;<B>Corporate Event</B>&rdquo;), the Company shall make appropriate provision to insure that the Holder will thereafter
have the right to receive upon an exercise of this Warrant and conversion of the underlying Warrant Preferred Shares at any time
after the consummation of the applicable Fundamental Transaction but prior to the Expiration Date, in lieu of the shares of the
Common Stock (or other securities, cash, assets or other property) issuable upon the exercise of the Warrant and conversion of
the underlying Warrant Preferred Shares prior to such Fundamental Transaction, such shares of stock, securities, cash, assets
or any other property whatsoever (including warrants or other purchase or subscription rights) which the Holder would have been
entitled to receive upon the happening of the applicable Fundamental Transaction had this Warrant been exercised and converted
into Warrant Preferred Shares immediately prior to the applicable Fundamental Transaction (without regard to any limitations on
the exercise of this Warrant). Provision made pursuant to the preceding sentence shall be in a form and substance reasonably satisfactory
to the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Black Scholes Value</U>. Notwithstanding the foregoing and the provisions of Section 3(a) above, at the request of the Holder
delivered at any time commencing on the earliest to occur of (x) the public disclosure of any Fundamental Transaction, (y) the
consummation of any Fundamental Transaction and (z) the Holder first becoming aware of any Fundamental Transaction through the
date that is ninety (90) days after the public disclosure of the consummation of such Fundamental Transaction by the Company pursuant
to a Current Report on Form 8-K filed with the SEC, the Company or the Successor Entity (as the case may be) shall purchase this
Warrant from the Holder on the date of such request by paying to the Holder cash in an amount equal to the Black Scholes Value.
Payment of such amounts shall be made by the Company (or at the Company&rsquo;s direction) to the Holder on or prior to the later
of (x) the second (2<SUP>nd</SUP>) Trading Day after the date of such request and (y) the date of consummation of such Fundamental
Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Application</U>. The provisions of this Section 3 shall apply similarly and equally to successive Fundamental Transactions
and Corporate Events and shall be applied as if this Warrant (and any such subsequent warrants) were fully exercisable and without
regard to any limitations on the exercise of this Warrant (provided that the Holder shall continue to be entitled to the benefit
of the Maximum Percentage, applied however with respect to shares of capital stock registered under the 1934 Act and thereafter
receivable upon exercise of this Warrant (or any such other warrant)).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>NONCIRCUMVENTION</U>. The Company hereby covenants and agrees that the Company will not, by amendment of its Articles of Incorporation
(as defined in the Securities Purchase Agreement), Bylaws (as defined in the Securities Purchase Agreement) or through any reorganization,
transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issuance or sale of securities, or any other voluntary
action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good
faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights of the Holder.
Without limiting the generality of the foregoing, the Company (a) shall not increase the par value of any Warrant Preferred Shares
receivable upon the exercise of this Warrant above the Exercise Price then in effect, and (b) shall take all such actions as may
be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Warrant Preferred
Shares upon the exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>WARRANT HOLDER NOT DEEMED A SHAREHOLDER</U>. Except as otherwise specifically provided herein, the Holder, solely in its capacity
as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the
Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity
as the Holder of this Warrant, any of the rights of a shareholder of the Company or any right to vote, give or withhold consent
to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance
or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the
Holder of the Warrant Preferred Shares which it is then entitled to receive upon the due exercise of this Warrant. In addition,
nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon
exercise of this Warrant or otherwise) or as a shareholder of the Company, except for Forced Exercise, described under Section
1(d) herein, whether such liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section
5, the Company shall provide the Holder with copies of the same notices and other information given to the shareholders of the
Company generally, contemporaneously with the giving thereof to the shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">6.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>REISSUANCE OF WARRANTS.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Transfer of Warrant</U>. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon
the Company will forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 6(d)), registered
as the Holder may request, representing the right to purchase the number of Warrant Preferred Shares being transferred by the
Holder and, if less than the total number of Warrant Preferred Shares then underlying this Warrant is being transferred, a new
Warrant (in accordance with Section 6(d)) to the Holder representing the right to purchase the number of Warrant Preferred Shares
not being transferred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Lost, Stolen or Mutilated Warrant</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the
loss, theft, destruction or mutilation of this Warrant (as to which a written certification and the indemnification contemplated
below shall suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking by the
Holder to the Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation of this
Warrant, the Company shall execute and deliver to the Holder a new Warrant (in accordance with Section 6(d)) representing the
right to purchase the Warrant Preferred Shares then underlying this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Exchangeable for Multiple Warrants</U>. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal
office of the Company, for a new Warrant or Warrants (in accordance with Section 6(d)) representing in the aggregate the right
to purchase the number of Warrant Preferred Shares then underlying this Warrant, and each such new Warrant will represent the
right to purchase such portion of such Warrant Preferred Shares as is designated by the Holder at the time of such surrender;
provided, however, no warrants for fractional Warrant Preferred Shares shall be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Issuance of New Warrants</U>. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant,
such new Warrant (i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant,
the right to purchase the Warrant Preferred Shares then underlying this Warrant (or in the case of a new Warrant being issued
pursuant to Section 6(a) or Section 6(c), the Warrant Preferred Shares designated by the Holder which, when added to the number
of Warrant Preferred Shares underlying the other new Warrants issued in connection with such issuance, does not exceed the number
of Warrant Preferred Shares then underlying this Warrant), (iii) shall have an issuance date, as indicated on the face of such
new Warrant which is the same as the Issuance Date, and (iv) shall have the same rights and conditions as this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>NOTICES</U>. Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall
be given in accordance with Section 9(f) of the Securities Purchase Agreement. The Company shall provide the Holder with prompt
written notice of all actions taken pursuant to this Warrant (other than the issuance of Warrant Preferred Shares upon exercise
in accordance with the terms hereof), including in reasonable detail a description of such action and the reason therefor. Without
limiting the generality of the foregoing, the Company will give written notice to the Holder (i) immediately upon each adjustment
of the Exercise Price and the number of Warrant Preferred Shares, setting forth in reasonable detail, and certifying, the calculation
of such adjustment(s), (ii) at least fifteen (15) days prior to the date on which the Company closes its books or takes a record
for determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in each case
that such information shall be made known to the public prior to or in conjunction with such notice being provided to the Holder,
(iii) at least ten (10) Trading Days prior to the consummation of any Fundamental Transaction and (iv) within one (1) Business
Day of the occurrence of a Triggering Event (as defined in the Certificate of Designations), setting forth in reasonable detail
any material events with respect to such Triggering Event and any efforts by the Company to cure such Triggering Event. To the
extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or
any of its Subsidiaries, the Company shall simultaneously file such notice with the SEC (as defined in the Securities Purchase
Agreement) pursuant to a Current Report on Form 8-K. If the Company or any of its Subsidiaries provides material non-public information
to the Holder that is not simultaneously filed in a Current Report on Form 8-K and the Holder has not agreed to receive such material
non-public information, the Company hereby covenants and agrees that the Holder shall not have any duty of confidentiality to
the Company, any of its Subsidiaries or any of their respective officers, directors, employees, affiliates or agents with respect
to, or a duty to any of the foregoing not to trade on the basis of, such material non-public information. It is expressly understood
and agreed that the time of execution specified by the Holder in each Exercise Notice shall be definitive and may not be disputed
or challenged by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>AMENDMENT AND WAIVER</U>. Except as otherwise provided herein, the provisions of this Warrant may be amended or waived and
the Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the
Company has obtained the written consent of the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>SEVERABILITY</U>. If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable
by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed
amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such
provision shall not affect the validity of the remaining provisions of this Warrant so long as this Warrant as so modified continues
to express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited
nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations
or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the
parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s)
with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable
provision(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>GOVERNING LAW</U>. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning
the construction, validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State
of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York
or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York.
The Company hereby irrevocably waives personal service of process and consents to process being served in any such suit, action
or proceeding by mailing a copy thereof to the Company at the address set forth in Section 9(f) of the Securities Purchase Agreement
and agrees that such service shall constitute good and sufficient service of process and notice thereof. The Company hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of Manhattan, for
the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein,
and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that
the venue of such suit, action or proceeding is improper. Nothing contained herein shall be deemed to limit in any way any right
to serve process in any manner permitted by law. Nothing contained herein shall be deemed or operate to preclude the Holder from
bringing suit or taking other legal action against the Company in any other jurisdiction to collect on the Company&rsquo;s obligations
to the Holder, to realize on any collateral or any other security for such obligations, or to enforce a judgment or other court
ruling in favor of the Holder. <B>THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A
JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION
CONTEMPLATED HEREBY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>CONSTRUCTION; HEADINGS</U>. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not
be construed against any Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall
not form part of, or affect the interpretation of, this Warrant. Terms used in this Warrant but defined in the other Transaction
Documents shall have the meanings ascribed to such terms on the Closing Date (as defined in the Securities Purchase Agreement)
in such other Transaction Documents unless otherwise consented to in writing by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
DISPUTE RESOLUTION.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Submission to Dispute Resolution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
In the case of a dispute relating to the Exercise Price, Closing Sale Price, the Black-Scholes Value or fair market value or the
arithmetic calculation of the number of Warrant Preferred Shares (as the case may be) (including, without limitation, a dispute
relating to the determination of any of the foregoing), the Company or the Holder (as the case may be) shall submit the dispute
to the other party via facsimile or electronic mail (A) if by the Company, within two (2) Business Days after the Company learned
of the circumstances giving rise to such dispute or (B) if by the Holder, at any time after the Holder learned of the circumstances
giving rise to such dispute. If the Holder and the Company are unable to promptly resolve such dispute relating to such Exercise
Price, such Closing Sale Price, such Black-Scholes Value or such fair market value or such arithmetic calculation of the number
of Warrant Preferred Shares (as the case may be), at any time after the second (2<SUP>nd</SUP>) Business Day following such initial
notice by the Company or the Holder (as the case may be) of such dispute to the Company or the Holder (as the case may be), then
the Holder or the Company, as applicable, and as the party originally providing notice of such dispute, may, at its sole option,
select an independent, reputable investment bank to resolve such dispute.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Holder and the Company shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered
in accordance with the first sentence of this Section 12 and (B) written documentation supporting its position with respect to
such dispute, in each case, no later than 5:00 p.m. (New York time) by the fifth (5<SUP>th</SUP>) Business Day immediately following
the date on which the Holder or the Company, as applicable, has selected such investment bank (the &ldquo;<B>Dispute Submission
Deadline</B>&rdquo;) (the documents referred to in the immediately preceding clauses (A) and (B) are collectively referred to
herein as the &ldquo;<B>Required Dispute Documentation</B>&rdquo;) (it being understood and agreed that if either the Holder or
the Company fails to so deliver all of the Required Dispute Documentation by the Dispute Submission Deadline, then the party who
fails to so submit all of the Required Dispute Documentation shall no longer be entitled to (and hereby waives its right to) deliver
or submit any written documentation or other support to such investment bank with respect to such dispute and such investment
bank shall resolve such dispute based solely on the Required Dispute Documentation that was delivered to such investment bank
prior to the Dispute Submission Deadline). Unless otherwise agreed to in writing by both the Company and the Holder or otherwise
requested by such investment bank, neither the Company nor the Holder shall be entitled to deliver or submit any written documentation
or other support to such investment bank in connection with such dispute (other than the Required Dispute Documentation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The Company and the Holder shall cause such investment bank to determine the resolution of such dispute and notify the Company
and the Holder of such resolution no later than ten (10) Business Days immediately following the Dispute Submission Deadline.
Such investment bank&rsquo;s resolution of such dispute shall be final and binding upon all parties absent manifest error.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
The fees and expenses of such investment bank shall be borne solely by the Company, and such investment bank&rsquo;s resolution
of such dispute shall be final and binding upon all parties absent manifest error.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Miscellaneous</U>. The Company expressly acknowledges and agrees that (i) this Section 12 constitutes an agreement to arbitrate
between the Company and the Holder (and constitutes an arbitration agreement) under the rules then in effect under &sect; 7501,
et seq. of the New York Civil Practice Law and Rules (&ldquo;<B>CPLR</B>&rdquo;) and that the Holder or the Company is authorized
to apply for an order to compel arbitration pursuant to CPLR &sect; 7503(a) in order to compel compliance with this Section 12,
(ii) the terms of this Warrant and each other applicable Transaction Document shall serve as the basis for the selected investment
bank&rsquo;s resolution of the applicable dispute, such investment bank shall be entitled (and is hereby expressly authorized)
to make all findings, determinations and the like that such investment bank determines are required to be made by such investment
bank in connection with its resolution of such dispute, in its sole discretion, shall have the right to submit any dispute described
in this Section 12 to any state or federal court sitting in The City of New York, Borough of Manhattan in lieu of utilizing the
procedures set forth in this Section 12 and (iii) nothing in this Section 12 shall limit the Holder from obtaining any injunctive
relief or other equitable remedies (including, without limitation, with respect to any matters described in this Section 12).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<U>REMEDIES, CHARACTERIZATION, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF</U>. The remedies provided in this Warrant shall
be cumulative and in addition to all other remedies available under this Warrant and the other Transaction Documents, at law or
in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right
of the Holder to pursue actual and consequential damages for any failure by the Company to comply with the terms of this Warrant.
The Company covenants to the Holder that there shall be no characterization concerning this instrument other than as expressly
provided herein. Amounts set forth or provided for herein with respect to payments, exercises and the like (and the computation
thereof) shall be the amounts to be received by the Holder and shall not, except as expressly provided herein, be subject to any
other obligation of the Company (or the performance thereof). The Company acknowledges that a breach by it of its obligations
hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company
therefore agrees that, in the event of any such breach or threatened breach, the holder of this Warrant shall be entitled, in
addition to all other available remedies, to specific performance and/or temporary, preliminary and permanent injunctive or other
equitable relief from any court of competent jurisdiction in any such case without the necessity of proving actual damages and
without posting a bond or other security. The Company shall provide all information and documentation to the Holder that is requested
by the Holder to enable the Holder to confirm the Company&rsquo;s compliance with the terms and conditions of this Warrant (including,
without limitation, compliance with Section 2 hereof). The issuance of shares and certificates for shares as contemplated hereby
upon the exercise of this Warrant shall be made without charge to the Holder or such shares for any issuance tax or other costs
in respect thereof, provided that the Company shall not be required to pay any tax which may be payable in respect of any transfer
involved in the issuance and delivery of any certificate in a name other than the Holder or its agent on its behalf.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">14.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>PAYMENT OF COLLECTION, ENFORCEMENT AND OTHER
COSTS</U><FONT STYLE="text-transform: none">. If (a) this Warrant is placed in the hands of an attorney either (x) for collection
of any cash payment obligation arising hereunder or (y) enforcement or such collection or enforcement occurs through any legal
proceeding or the holder otherwise takes action to collect any cash payment obligation arising hereunder or to enforce the provisions
of this Warrant or (b) there occurs any bankruptcy, reorganization, receivership of the company or other proceedings affecting
company creditors&rsquo; rights and involving a claim under this Warrant, then the Company shall pay the costs incurred by the
Holder for such collection, enforcement or action or in connection with such bankruptcy, reorganization, receivership or other
proceeding, including, without limitation, attorneys&rsquo; fees and disbursements.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<U>TRANSFER</U>. This Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company, except
as may otherwise be required by Section 2(g) of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.
<U>CERTAIN DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<B>1933 Act</B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;<B>1934 Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;<B>Affiliate</B>&rdquo; means, with respect to any Person, any other Person that directly or indirectly controls, is controlled
by, or is under common control with, such Person, it being understood for purposes of this definition that &ldquo;control&rdquo;
of a Person means the power directly or indirectly either to vote 10% or more of the stock having ordinary voting power for the
election of directors of such Person or direct or cause the direction of the management and policies of such Person whether by
contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&ldquo;<B>Attribution Parties</B>&rdquo; means, collectively, the following Persons and entities: (i) any investment vehicle,
including, any funds, feeder funds or managed accounts, currently, or from time to time after the Issuance Date, directly or indirectly
managed or advised by the Holder&rsquo;s investment manager or any of its Affiliates or principals, (ii) any direct or indirect
Affiliates of the Holder or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together
with the Holder or any of the foregoing and (iv) any other Persons whose beneficial ownership of the Company&rsquo;s Common Stock
would or could be aggregated with the Holder&rsquo;s and the other Attribution Parties for purposes of Section 13(d) of the 1934
Act. For clarity, the purpose of the foregoing is to subject collectively the Holder and all other Attribution Parties to the
Maximum Percentage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&ldquo;<B>Black Scholes Value</B>&rdquo; means the value of the unexercised portion of this Warrant (assuming, for such purpose,
that this Warrant is exercisable into such aggregate number of shares of Common Stock issuable upon conversion of such aggregate
number of Warrant Preferred Shares that are then issuable hereunder at the Alternate Conversion Price (as defined in the Certificate
of Designations) then in effect) remaining on the date of the Holder&rsquo;s request pursuant to Section 3(b), which value is
calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg utilizing (i)
an underlying price per share equal to the greater of (1) the highest Closing Sale Price of the Common Stock during the period
beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction (or the consummation
of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to
Section 3(b) and (2) the sum of the price per share being offered in cash in the applicable Fundamental Transaction (if any) plus
the value of the non-cash consideration being offered in the applicable Fundamental Transaction (if any), (ii) a strike price
equal to the Alternate Conversion Price in effect on the date of the Holder&rsquo;s request pursuant to Section 3(b), (iii) a
risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the greater of (1) the remaining term of
this Warrant as of the date of the Holder&rsquo;s request pursuant to Section 3(b) and (2) the remaining term of this Warrant
as of the date of consummation of the applicable Fundamental Transaction or as of the date of the Holder&rsquo;s request pursuant
to Section 3(b) if such request is prior to the date of the consummation of the applicable Fundamental Transaction, (iv) a zero
cost of borrow and (v) an expected volatility equal to the greater of 100% and the 30 day volatility obtained from the &ldquo;HVT&rdquo;
function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the earliest
to occur of (A) the public disclosure of the applicable Fundamental Transaction, (B) the consummation of the applicable Fundamental
Transaction and (C) the date on which the Holder first became aware of the applicable Fundamental Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&ldquo;<B>Bloomberg</B>&rdquo; means Bloomberg, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&ldquo;<B>Business Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City
of New York are authorized or required by law to remain closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
&ldquo;<B>Certificate of Designations</B>&rdquo; means that certain Certificate of Designation for the Series D Convertible Preferred
Stock of the Company, dated as of January __, 2020, as amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&ldquo;<B>Common Stock</B>&rdquo; means (i) the Company&rsquo;s shares of common stock, $0.001 par value per share, and (ii) any
capital stock into which such common stock shall have been changed or any share capital resulting from a reclassification of such
common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
&ldquo;<B>Eligible Market</B>&rdquo; means The New York Stock Exchange, Nasdaq Global Select Market, the Nasdaq Global Market,
the NYSE American or the Principal Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
&ldquo;<B>Equity Conditions</B>&rdquo; means, with respect to an given date of determination: (i) on such applicable date of determination
one or more Registration Statements (each, the &ldquo;<B>Forced Exercise Registration Statement</B>&rdquo;) shall be effective
and the prospectus contained therein shall be available on such applicable date of determination (with, for the avoidance of doubt,
any Warrant Preferred Shares previously issued pursuant to such prospectus deemed unavailable) for the resale by the Holder of
all of such Warrant Preferred Shares to be issued in connection with the event requiring such determination and all shares of
Common Stock (the &ldquo;<B>Conversion Shares</B>&rdquo;) issuable upon conversion of such Preferred Shares and any other Preferred
Shares then outstanding, in each case, without regard to any limitations on conversion set forth in the Certificate of Designations,
at the Alternate Conversion Price (as defined in the Certificate of Designations) then in effect (such applicable aggregate number
of Preferred Shares and shares of Common Stock, each, a &ldquo;<B>Required Minimum Securities Amount</B>&rdquo;); (ii) on each
day during the period beginning thirty (30) calendar days prior to the applicable date of determination and ending on and including
the applicable date of determination (the &ldquo;<B>Equity Conditions Measuring Period</B>&rdquo;), the Common Stock (including
all shares of Common Stock issuable upon conversion of the Preferred Shares then outstanding and the Warrant Preferred Shares
to be issued in the event requiring this determination) is listed or designated for quotation (as applicable) on an Eligible Market
and shall not have been suspended from trading on an Eligible Market (other than suspensions of not more than two (2) days and
occurring prior to the applicable date of determination due to business announcements by the Company) nor shall delisting or suspension
by an Eligible Market have been threatened (with a reasonable prospect of delisting occurring after giving effect to all applicable
notice, appeal, compliance and hearing periods) or reasonably likely to occur or pending as evidenced by (A) a writing by such
Eligible Market or (B) the Company falling below the minimum listing maintenance requirements of the Eligible Market on which
the Common Stock is then listed or designated for quotation (as applicable) other than as disclosed in the SEC Documents (as defined
in the Securities Purchase Agreement) prior to the Issuance Date; (iii) during the Equity Conditions Measuring Period, the Company
shall have delivered all Warrant Preferred Shares issuable upon exercise of this Warrant on a timely basis as set forth in Section
1 hereof and all other shares of capital stock required to be delivered by the Company on a timely basis as set forth in the other
Transaction Documents; (iv) any Warrant Preferred Shares to be issued in connection with the event requiring determination (and
the Required Minimum Securities Amount of Conversion Shares related thereto and issuable upon conversion of the Preferred Shares
then outstanding (in each case, without regard to any limitations on conversion set forth in the Certificate of Designations and
at the Alternate Conversion Price then in effect) may be issued in full without violating the rules or regulations of the Eligible
Market on which the Common Stock is then listed or designated for quotation (as applicable); (v) on each day during the Equity
Conditions Measuring Period, no public announcement of a pending, proposed or intended Fundamental Transaction shall have occurred
which has not been abandoned, terminated or consummated; (vi) the Company shall have no knowledge of any fact that would reasonably
be expected to cause the applicable Forced Exercise Registration Statement to not be effective or the prospectus contained therein
to not be available for the resale by the Holder of any Warrant Preferred Shares to be issued in connection with the event requiring
determination (and the Required Minimum Securities Amount of Conversion Shares related thereto and issuable upon conversion of
the Preferred Shares then outstanding (in each case, without regard to any limitations on conversion set forth in the Certificate
of Designations and at the Alternate Conversion Price then in effect) and no Current Public Information Failure exists or is continuing;
(vii) the Holder shall not be in possession of any material, non-public information provided to any of them by the Company, any
of its Subsidiaries or any of their respective affiliates, employees, officers, representatives, agents or the like; (viii) on
each day during the Equity Conditions Measuring Period, the Company otherwise shall have been in compliance with each, and shall
not have breached any representation or warranty in any material respect (other than representations or warranties subject to
material adverse effect or materiality, which may not be breached in any respect) or any covenant or other term or condition of
any Transaction Document, including, without limitation, the Company shall not have failed to timely make any payment pursuant
to any Transaction Document; (ix) on the applicable date of determination (A) no Authorized Share Failure shall exist or be continuing
and (B) all Warrant Preferred Shares to be issued in connection with the event requiring this determination may be issued in full
without resulting in an Authorized Share Failure (as defined in Section 1(e) above); (x) on each day during the Equity Conditions
Measuring Period, there shall not have occurred and there shall not exist a Triggering Event (as defined in the Certificate of
Designations) or an event that with the passage of time or giving of notice would constitute a Triggering Event; (xi) the issuance
of the Conversion Shares issuable upon conversion of such Warrant Preferred Shares and the Preferred Shares then outstanding (assuming,
for such purpose, that all the Preferred Shares then outstanding and such Warrant Preferred Shares are converted at the Alternate
Conversion Price then in effect and without regard to any limitations on conversion set forth in the Certificate of Designations)
will not result in an Authorized Share Failure (as defined in the Certificate of Designations); (xii) the shares of Common Stock
issuable upon conversion of all of the Preferred Shares issued pursuant to the Securities Purchase Agreement and issuable upon
exercise of the SPA Preferred Warrants are duly authorized and listed and eligible for trading without restriction on an Eligible
Market (assuming, for such purpose, that all the Preferred Shares then outstanding and such Warrant Preferred Shares are converted
at the Alternate Conversion Price then in effect and without regard to any limitations on conversion set forth in the Certificate
of Designations); and (xiii) the Company shall have obtained the Shareholder Approval (as defined in the Securities Purchase Agreement),
which shall remain in full force and effect as of such date of determination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
&ldquo;<B>Equity Conditions Failure</B>&rdquo; means that on each day during the period commencing twenty (20) Trading Days prior
to the applicable Forced Exercise Notice Date through and including the applicable Forced Exercise Date, the Equity Conditions
have not been satisfied (or waived in writing by the Holder).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
&ldquo;<B>Expiration Date</B>&rdquo; means the date that is the first anniversary of the Applicable Date (as defined in the Securities
Purchase Agreement) (or such later date as extended by written consent of the Company and the Holder) or, if such date falls on
a day other than a Trading Day or on which trading does not take place on the Principal Market (a &ldquo;<B>Holiday</B>&rdquo;),
the next date that is not a Holiday.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
&ldquo;<B>Fundamental Transaction</B>&rdquo; means (A) that the Company shall, directly or indirectly, including through subsidiaries,
Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company
is the surviving corporation) another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially
all of the properties or assets of the Company or any of its &ldquo;significant subsidiaries&rdquo; (as defined in Rule 1-02 of
Regulation S-X) to one or more Subject Entities, or (iii) make, or allow one or more Subject Entities to make, or allow the Company
to be subject to or have its Common Stock be subject to or party to one or more Subject Entities making, a purchase, tender or
exchange offer that is accepted by the holders of at least either (x) 50% of the outstanding shares of Common Stock, (y) 50% of
the outstanding shares of Common Stock calculated as if any shares of Common Stock held by all Subject Entities making or party
to, or Affiliated with any Subject Entities making or party to, such purchase, tender or exchange offer were not outstanding;
or (z) such number of shares of Common Stock such that all Subject Entities making or party to, or Affiliated with any Subject
Entity making or party to, such purchase, tender or exchange offer, become collectively the beneficial owners (as defined in Rule
13d-3 under the 1934 Act) of at least 50% of the outstanding shares of Common Stock, or (iv) consummate a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme
of arrangement) with one or more Subject Entities whereby all such Subject Entities, individually or in the aggregate, acquire,
either (x) at least 50% of the outstanding shares of Common Stock, (y) at least 50% of the outstanding shares of Common Stock
calculated as if any shares of Common Stock held by all the Subject Entities making or party to, or Affiliated with any Subject
Entity making or party to, such stock purchase agreement or other business combination were not outstanding; or (z) such number
of shares of Common Stock such that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under
the 1934 Act) of at least 50% of the outstanding shares of Common Stock, or (v) reorganize, recapitalize or reclassify its Common
Stock, (B) that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or
more related transactions, allow any Subject Entity individually or the Subject Entities in the aggregate to be or become the
&ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, whether through acquisition,
purchase, assignment, conveyance, tender, tender offer, exchange, reduction in outstanding shares of Common Stock, merger, consolidation,
business combination, reorganization, recapitalization, spin-off, scheme of arrangement, reorganization, recapitalization or reclassification
or otherwise in any manner whatsoever, of either (x) at least 50% of the aggregate ordinary voting power represented by issued
and outstanding Common Stock, (y) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common
Stock not held by all such Subject Entities as of the date of this Warrant calculated as if any shares of Common Stock held by
all such Subject Entities were not outstanding, or (z) a percentage of the aggregate ordinary voting power represented by issued
and outstanding shares of Common Stock or other equity securities of the Company sufficient to allow such Subject Entities to
effect a statutory short form merger or other transaction requiring other shareholders of the Company to surrender their shares
of Common Stock without approval of the shareholders of the Company or (C) directly or indirectly, including through subsidiaries,
Affiliates or otherwise, in one or more related transactions, the issuance of or the entering into any other instrument or transaction
structured in a manner to circumvent, or that circumvents, the intent of this definition in which case this definition shall be
construed and implemented in a manner otherwise than in strict conformity with the terms of this definition to the extent necessary
to correct this definition or any portion of this definition which may be defective or inconsistent with the intended treatment
of such instrument or transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
&ldquo;<B>Group</B>&rdquo; means a &ldquo;group&rdquo; as that term is used in Section 13(d) of the 1934 Act and as defined in
Rule 13d-5 thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
&ldquo;<B>Parent Entity</B>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person and
whose common stock or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such
Person or Parent Entity, the Person or Parent Entity with the largest public market capitalization as of the date of consummation
of the Fundamental Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
&ldquo;<B>Person</B>&rdquo; means an individual, a limited liability company, a partnership, a joint venture, a corporation, a
trust, an unincorporated organization, any other entity or a government or any department or agency thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
&ldquo;<B>Principal Market</B>&rdquo; means the Nasdaq Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
&ldquo;<B>SEC</B>&rdquo; means the United States Securities and Exchange Commission or the successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
&ldquo;<B>Subject Entity</B>&rdquo; means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons
or Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
&ldquo;<B>Successor Entity</B>&rdquo; means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting
from or surviving any Fundamental Transaction or the Person (or, if so elected by the Holder, the Parent Entity) with which such
Fundamental Transaction shall have been entered into.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
&ldquo;<B>Trading Day</B>&rdquo; means, as applicable, (x) with respect to all price or trading volume determinations relating
to the Common Stock, any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the
principal trading market for the Common Stock, then on the principal securities exchange or securities market on which the Common
Stock is then traded, provided that &ldquo;Trading Day&rdquo; shall not include any day on which the Common Stock is scheduled
to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during
the final hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing
time of trading on such exchange or market, then during the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise
designated as a Trading Day in writing by the Holder or (y) with respect to all determinations other than price or trading volume
determinations relating to the Common Stock, any day on which The New York Stock Exchange (or any successor thereto) is open for
trading of securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<B>VWAP</B>&rdquo; means, for any security as of any date, the dollar volume-weighted average price for such security on
the Principal Market (or, if the Principal Market is not the principal trading market for such security, then on the principal
securities exchange or securities market on which such security is then traded), during the period beginning at 9:30 a.m., New
York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg through its &ldquo;VAP&rdquo; function (set to 09:30
start time and 16:00 end time) or, if the foregoing does not apply, the dollar volume-weighted average price of such security
in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30 a.m., New
York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg, or, if no dollar volume-weighted average price is
reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask
price of any of the market makers for such security as reported in the &ldquo;pink sheets&rdquo; by OTC Markets Group Inc. (formerly
Pink Sheets LLC). If the VWAP cannot be calculated for such security on such date on any of the foregoing bases, the VWAP of such
security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and
the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved in accordance
with the procedures in Section 12. All such determinations shall be appropriately adjusted for any stock dividend, stock split,
stock combination, recapitalization or other similar transaction during such period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>signature
page follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> the Company has caused this Warrant to Purchase Series D Convertible Preferred Stock to be duly executed
as of the Issuance Date set out above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>Sigma Labs, Inc.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
A</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXERCISE
NOTICE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO
BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS<BR>
WARRANT TO PURCHASE SERIES D CONVERTIBLE PREFERRED STOCK</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">SIGMA
LABS, INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned holder hereby elects to exercise the Warrant to Purchase Series D Convertible Preferred Stock, No. [&nbsp;&nbsp;]
(the &ldquo;<B>Warrant</B>&rdquo;) of Sigma Labs, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;) as specified below.
Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Payment of Exercise Price</U>. The Holder intends that payment of the Aggregate Exercise Price shall be made as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
a &ldquo;<U>Cash Exercise</U>&rdquo; with respect to _________________ Warrant Shares; and/or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
a &ldquo;<U>Cashless Exercise</U>&rdquo; with respect to _______________ Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that the Holder has elected a Cashless Exercise with respect to some or all of the Warrant Shares to be issued pursuant
hereto, the Holder hereby represents and warrants that this Exercise Notice was executed by the Holder at __________ [a.m.][p.m.]
on the date set forth below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Delivery of Warrant Preferred Shares</U>. The Company shall deliver to Holder, or its designee or agent as specified below,
__________ shares of Series D Convertible Preferred Stock in accordance with the terms of the Warrant. Delivery shall be made
to Holder, or for its benefit, as a certificate to the following name and to the following address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; padding-right: 5.4pt; padding-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    to:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 80%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
_____________ __, _____</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Registered Holder</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18.45pt; text-align: justify; text-indent: -18.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
ID:____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18.45pt; text-align: justify; text-indent: -18.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile:__________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18.45pt; text-align: justify; text-indent: -18.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail
Address:_____________________</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>7
<FILENAME>ex10-7.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit 10.7</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex10-7_001.jpg" ALT="Z:\2020 OPERATIONS\2020 EDGAR\01 January\SIGMA LABS, INC\01-28-2020\Form 8-K\Draft\Production" STYLE="height: 867; width: 670">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex10-7_002.jpg" ALT="" STYLE="height: 867; width: 670">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Sigma
Labs, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
OF CERTIFICATE OF DESIGNATION OF PREFERENCES,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RIGHTS
AND LIMITATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
E CONVERTIBLE PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>PURSUANT
TO SECTION 78 OF THE Nevada REVISED STATUTES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, John Rice, Chief Executive Officer, does hereby certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
He is the Chief Executive Officer of Sigma Labs, Inc., a Nevada corporation (the &ldquo;<U>Corporation</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The Corporation is authorized to issue up to ten million (10,000,000) shares of preferred stock, of which (a) shares of Series
A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock were authorized, none of which are presently issued
and outstanding, nor will be outstanding, and (b) up to 7,796 shares of Series D Convertible Preferred Stock have been authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
The following resolutions were duly adopted by the board of directors of the Corporation (the &ldquo;<U>Board of Directors</U>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the certificate of incorporation of the Corporation provides for a class of its authorized stock known as preferred stock, consisting
of 10,000,000 shares, $0.001 par value per share, issuable from time to time in one or more series;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Board of Directors is authorized to fix the dividend rights, dividend rate, voting rights, conversion rights, rights and terms
of redemption and liquidation preferences of any wholly unissued series of preferred stock and the number of shares constituting
any series and the designation thereof, of any of them; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the rights, preferences, restrictions
and other matters relating to a series of the preferred stock, which shall consist of, except as otherwise set forth in the Purchase
Agreement, up to 500 shares of Series E Preferred Stock (the &ldquo;<U>Preferred Stock</U>&rdquo;) which the Corporation has the
authority to issue, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, BE IT RESOLVED, that the Board of Directors does hereby provide for the issuance of a series of preferred stock for
cash or exchange of other securities, rights or property and does hereby fix and determine the rights, preferences, restrictions
and other matters relating to such series of preferred stock as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERMS
OF PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. For the purposes hereof, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Additional
Amount</U>&rdquo; means, as of the applicable date of determination, with respect to each Preferred Share, all declared and unpaid
dividends on such Share and any other unpaid amounts then due and payable hereunder with respect to said Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Alternate
Consideration</U>&rdquo; shall have the meaning set forth in Section 7(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bankruptcy
Event</U>&rdquo; means any of the following events: (a) the Corporation or any Significant Subsidiary (as such term is defined
in Rule 1-02(w) of Regulation S-X) thereof commences a case or other proceeding under any bankruptcy, reorganization, arrangement,
adjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction relating to the
Corporation or any Significant Subsidiary thereof, (b) there is commenced against the Corporation or any Significant Subsidiary
thereof any such case or proceeding that is not dismissed within 60 days after commencement, (c) the Corporation or any Significant
Subsidiary thereof is adjudicated insolvent or bankrupt or any order of relief or other order approving any such case or proceeding
is entered, (d) the Corporation or any Significant Subsidiary thereof suffers any appointment of any custodian or the like for
it or any substantial part of its property that is not discharged or stayed within 60 calendar days after such appointment, (e)
the Corporation or any Significant Subsidiary thereof makes a general assignment for the benefit of creditors, (f) the Corporation
or any Significant Subsidiary thereof calls a meeting of its creditors with a view to arranging a composition, adjustment or restructuring
of its debts, or (g) the Corporation or any Significant Subsidiary thereof, by any act or failure to act, expressly indicates
its consent to, approval of or acquiescence in any of the foregoing or takes any corporate or other action for the purpose of
effecting any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action
to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Buy-In</U>&rdquo;
shall have the meaning set forth in Section 6(c)(iv).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable
parties thereto and all conditions precedent to (i) each Holder&rsquo;s obligations to pay the Subscription Amount and (ii) the
Corporation&rsquo;s obligations to deliver the Securities have been satisfied or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the Corporation&rsquo;s common stock, par value $0.001 per share, and stock of any other class of securities
into which such securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Corporation or the Subsidiaries including without limitation the Corporation&rsquo;s
Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Convertible Preferred Stock, and any other
class of preferred stock or other equity other than the Preferred Stock which would entitle the holder thereof to acquire at any
time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Amount</U>&rdquo; means the sum of the Stated Value at issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Date</U>&rdquo; shall have the meaning set forth in Section 6(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Price</U>&rdquo; shall have the meaning set forth in Section 6(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Shares</U>&rdquo; means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock and
dividends in accordance with the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Letter</U>&rdquo; shall have the meaning set forth in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Dividend
Date</U>&rdquo; means the first Trading Day of each calendar month, but with the first Dividend Date commencing on March 1, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Dividend
Rate</U>&rdquo; means nine percent per annum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Dividend
Share Amount</U>&rdquo; shall have the meaning set forth in Section 3(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; means the date that all of the Conversion Shares and Dividend Conversion Shares have been sold pursuant to Rule
144 or may be sold pursuant to Rule 144 without the requirement for the Company to be in compliance with the current public information
requirement under Rule 144 and without volume or manner-of-sale restrictions and Company counsel has delivered to the Transfer
Agent and Holders a standing written unqualified opinion that resales may then be made by Holders of the Conversion Shares and
Dividend Conversion Shares pursuant to such exemption which opinion shall be in form and substance reasonably acceptable to such
holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Equity
Conditions</U>&rdquo; means, during the period in question, (a) the Corporation shall have duly honored all conversions scheduled
to occur or occurring by virtue of one or more Notices of Conversion of the applicable Holder on or prior to the dates so requested
or required, if any, (b) the Corporation shall have paid all liquidated damages and other amounts owing to the applicable Holder
in respect of the Preferred Stock, (c) all of the Conversion Shares issuable pursuant to the Transaction Documents (and shares
issuable in lieu of cash payments of dividends) may be resold pursuant to Rule 144 without volume or manner-of-sale restrictions
or current public information requirements as determined by the counsel to the Corporation as set forth in a written opinion letter
to such effect, addressed and acceptable to the Transfer Agent and the affected Holders, (d) the Common Stock is trading on a
Trading Market and all of the shares issuable pursuant to the Transaction Documents are listed or quoted for trading on such Trading
Market (and the Corporation believes, in good faith, that trading of the Common Stock on a Trading Market will continue uninterrupted
for the foreseeable future), (e) there is a sufficient number of authorized, but unissued and otherwise unreserved, shares of
Common Stock for the issuance of all of the shares then issuable pursuant to the Transaction Documents, (f) Shareholder Approval
has been obtained, (g) there has been no public announcement of a pending or proposed Fundamental Transaction that has not been
consummated, (h) the applicable Holder is not in possession of any information provided by the Corporation that constitutes, or
may constitute, material non-public information, (i) the Corporation is not in material default of any of its obligations pursuant
to the Purchase Agreement, and (j) a Material Adverse Effect (as defined in the Purchase Agreement) has not occurred</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Fundamental
Transaction</U>&rdquo; means the occurrence after the date hereof of any of (a) an acquisition after the date hereof by an individual
or legal entity or &ldquo;group&rdquo; (as described in Rule 13d 5(b)(1) promulgated under the Exchange Act), other than a legal
entity majority owned by, or a group wholly consisting of, officers and directors of the Corporation and their Affiliates, of
effective control (whether through legal or beneficial ownership of capital stock of the Corporation, by contract or otherwise)
of in excess of 50% of the voting securities of the Corporation (other than by means of conversion or exercise of Preferred Stock
and the Securities issued together with the Preferred Stock), (b) the Corporation merges into or consolidates with any other Person,
or any Person merges into or consolidates with the Corporation and, after giving effect to such transaction, the stockholders
of the Corporation immediately prior to such transaction own less than 50% of the aggregate voting power of the Corporation or
the successor entity of such transaction, (c) the Corporation, directly or indirectly, effects any sale, lease, license, assignment,
transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions,
(d) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Corporation or another Person) is
completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities,
cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (e) to the extent not covered
by clauses (a) &ndash; (d) above, the Corporation, directly or indirectly, in one or more related transactions effects any reclassification,
reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is
effectively converted into or exchanged for other securities, cash or property, or (f) the execution by the Corporation of an
agreement to which the Corporation is a party or by which it is bound, providing for any of the events set forth in clauses (a)
through (f) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
means United States generally accepted accounting principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Holder</U>&rdquo;
shall have the meaning given such term in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
means (a) any liabilities for borrowed money or amounts owed in excess of $300,000 (other than trade accounts payable incurred
in the ordinary course of business), (b) all guaranties, endorsements and other contingent obligations in respect of indebtedness
of others, whether or not the same are or should be reflected in the Corporation&rsquo;s balance sheet (or the notes thereto),
except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course
of business, but in all cases excluding trade accounts payable incurred by the Corporation and its Subsidiaries in the ordinary
course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Junior
Securities</U>&rdquo; means the Common Stock and all other Common Stock Equivalents of the Corporation, at any time outstanding
or issuable, including the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock of the Corporation
but not the Company&rsquo;s Series D Convertible Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liquidation</U>&rdquo;
shall have the meaning set forth in Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Make-Whole
Amount</U>&rdquo; means as of any given date, the amount of any dividend that, but for any conversion on such date, would have
accrued with respect to the Conversion Amount being redeemed hereunder at the Dividend Rate then in effect for the period from
such date through the third anniversary of the Initial Issuance Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>New
York Courts</U>&rdquo; shall have the meaning set forth in Section 10(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Notice
of Conversion</U>&rdquo; shall have the meaning set forth in Section 6(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Original
Issue Date</U>&rdquo; means the date of the first issuance of any shares of the Preferred Stock regardless of the number of transfers
of any particular shares of Preferred Stock and regardless of the number of certificates which may be issued to evidence such
Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preferred
Shares</U>&rdquo; shall have the meaning set forth in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preferred
Stock</U>&rdquo; shall have the meaning set forth in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchase
Agreement</U>&rdquo; means with respect to the Series E Preferred Stock, the Securities Purchase Agreement entered into by the
Corporation and the initial issuees of Preferred Stock, at or about January 27, 2020, as amended, modified or supplemented from
time to time in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Preferred Stock, the Warrants, the Warrant Shares and the Underlying Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Senior
Securities</U>&rdquo; means the Series D Preferred Stock and any series of preferred stock which by its terms is expressly senior
in rank to the Series E Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
D. Preferred Stock</U>&rdquo; means the Series D Convertible Preferred Stock, par value $0.001.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
E Preferred Stock</U>&rdquo; means the Series E Preferred Stock, par value $0.001, issued at or about January 28, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Share
Delivery Date</U>&rdquo; shall have the meaning set forth in Section 6(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shareholder
Approval</U>&rdquo; shall have the meaning attributed to such term in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stated
Value</U>&rdquo; shall have the meaning set forth in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; shall mean, as to each Holder, the aggregate amount to be paid for the Preferred Stock purchased pursuant to
the Purchase Agreement as specified below such Holder&rsquo;s name on the signature page of the Purchase Agreement and next to
the heading &ldquo;Subscription Amount&rdquo; and on the Exercise Notice in United States dollars and in immediately available
funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Corporation as set forth on Schedule 3.1(a) of the Disclosure Letter (as defined in the Purchase Agreement)
and shall, where applicable and with regard to future events, also include any direct or indirect subsidiary of the Corporation
identified on the SEC Reports and formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Successor
Entity</U>&rdquo; shall have the meaning set forth in Section 7(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on
the date in question: the NYSE American, the NASDAQ Capital Market, the NASDAQ Global Market, the NASDAQ Global Select Market,
the New York Stock Exchange, the OTC Bulletin Board, the OTCQB or the OTCQX (or any successors to any of the foregoing). As of
the date of the Purchase Agreement and the Initial Closing Date, the NASDAQ Capital Market is and will be the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Certificate of Designations, the Purchase Agreement, the Disclosure Letter, the Warrants, the
Lockup Agreement, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with
the transactions contemplated pursuant to the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Issuer Direct Corporation, 1981 Murray Holladay Road, Suite 100, Salt Lake City, Utah 84117, and any successor
transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Underlying
Shares</U>&rdquo; means the shares of Common Stock issued and issuable upon conversion or redemption of the Preferred Stock, the
Warrant Shares and shares of Common Stock issued and issuable in lieu of the cash payment of dividends on the Preferred Stock
in accordance with the terms of this Certificate of Designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.13(b) of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then
listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the OTC Bulletin Board is not
a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the OTC
Bulletin Board, (c) if the Common Stock is not then listed or quoted for trading on the OTC Bulletin Board and if prices for the
Common Stock are then reported on the OTCQX, OTCQB or OTC Pink Marketplace maintained by the OTC Markets Group, Inc. (or a similar
organization or agency succeeding to its functions of reporting prices), the volume weighted average price of the Common Stock
on the first such facility (or a similar organization or agency succeeding to its functions of reporting prices), or (d) in all
other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Corporation, the
fees and expenses of which shall be paid by the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Stock purchase warrants delivered to the Holder at the Closing in accordance with the Purchase
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Designation, Amount and Par Value; Ranking</U> The series of preferred stock shall be designated as its Series E Convertible
Preferred Stock (the &ldquo;<U>Preferred Stock</U>&rdquo;) and the number of shares (the &ldquo;<U>Preferred </U>Shares&rdquo;)
so designated shall be 500 (which shall not be subject to increase without the written consent of the holders of a majority of
the then outstanding shares of Preferred Stock (each, a &ldquo;<U>Holder</U>&rdquo; and collectively, the &ldquo;<U>Holders</U>&rdquo;)).
Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value equal to $1,500 (the &ldquo;<U>Stated
Value</U>&rdquo;). The Preferred Stock shall be junior in rank to the Series D Preferred Stock in respect of the preferences as
to dividends, distributions and payments upon the liquidation, dissolution and winding up of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Dividends</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
From and after January 28, 2020 (the &ldquo;<U>Initial Issuance Date</U>&rdquo;), each holder of a Preferred Share (each, a &ldquo;<U>Holder</U>&rdquo;
and collectively, the &ldquo;<U>Holders</U>&rdquo;) shall be entitled to receive dividends (&ldquo;<U>Dividends</U>&rdquo;), which
Dividends shall be computed on the basis of a 360-day year and twelve 30-day months and shall increase the Stated Value of the
Preferred Shares on each Dividend Date (each, a &ldquo;<U>Capitalized Dividend</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
Prior to the capitalization of Dividends on a Dividend Date, Dividends on the Preferred Shares shall accrue at the Dividend Rate
and be payable by way of inclusion of the Dividends in the Conversion Amount on each Conversion Date in accordance with Section
6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Other Securities</U>. So long as any of the Preferred Stock issued pursuant to the Purchase Agreement or Dividends shall remain
outstanding, neither the Corporation nor any Subsidiary thereof shall redeem, purchase or otherwise acquire directly or indirectly
any Junior Securities. So long as any of the Preferred Stock issued pursuant to the Purchase Agreement or Dividends shall remain
outstanding, neither the Corporation nor any Subsidiary thereof shall directly or indirectly pay or declare any dividend or make
any distribution upon, nor shall any distribution be made in respect of, any Junior Securities, nor shall any monies be set aside
for or applied to the purchase or redemption (through a sinking fund or otherwise) of any Junior Securities or shares <I>pari
passu</I> with the Preferred Stock. So long as any of the Preferred Stock issued pursuant to the Purchase Agreement or Dividends
shall remain outstanding, neither the Corporation nor any Subsidiary thereof shall issue any security or Common Stock Equivalent
which shall be <I>pari passu</I> or senior to the Preferred Stock in terms of rights upon Liquidation, Dividends or redemption
except for the Series D Convertible Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Voting Rights</U>. Except as otherwise provided herein or as otherwise required by law, the Preferred Stock shall have
no voting rights. In any event, and notwithstanding the foregoing limitation, as long as any shares of Preferred Stock are outstanding,
the Corporation shall not, without the affirmative vote of the Holders of a majority of the then outstanding shares of the Preferred
Stock, (a) alter or amend this Certificate of Designation, or (b) increase the number of authorized shares of Preferred Stock,
or (c) enter into any agreement with respect to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Liquidation</U>. Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary
(a &ldquo;<U>Liquidation</U>&rdquo;), the Holders shall be entitled to receive out of the assets, whether capital or surplus,
of the Corporation an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon and any other fees or liquidated
damages then due and owing thereon under this Certificate of Designation, for each share of Preferred Stock before any distribution
or payment shall be made to the holders of any Junior Securities, but after distribution or payment to holders of the Series D
Preferred Stock and any other Senior Securities, and if the assets of the Corporation shall be insufficient to pay in full such
amounts, then the entire assets to be distributed to the Holders shall be ratably distributed among the Holders in accordance
with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full. Upon occurrence
of a Liquidation which is also a Fundamental Transaction, the Holder may elect to receive the rights and benefits of this section
5 and/or the rights and benefits set forth in Section 7(e) or any other rights set forth in the Transaction Documents. The Corporation
shall mail written notice of any such Liquidation, not less than 45 days prior to the payment date stated therein, to each Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
6</U>. <U>Conversion</U>. At any time after the Initial Issuance Date, each Preferred Share shall be convertible into validly
issued, fully paid and non-assessable shares of Common Stock (as defined below), on the terms and conditions set forth in this
Section 6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Holder&rsquo;s Conversion Right</U>. At any time or times on or after date of Shareholder Approval, each Holder shall be entitled
to convert any portion of the outstanding Preferred Shares held by such Holder into validly issued, fully paid and non-assessable
shares of Common Stock in accordance with Section 6(c) at the Conversion Rate(as defined below). The Company shall not issue any
fraction of a share of Common Stock upon any conversion. If the issuance would result in the issuance of a fraction of a share
of Common Stock, the Company shall round such fraction of a share of Common Stock up to the nearest whole share. The Company shall
pay any and all transfer, stamp, issuance and similar taxes, costs and expenses (including, without limitation, fees and expenses
of the Transfer Agent (as defined below)) that may be payable with respect to the issuance and delivery of Common Stock upon conversion
of any Preferred Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Conversion Rate</U>. The number of shares of Common Stock issuable upon conversion of any Preferred Share pursuant to section
6(a) shall be determined by dividing (x) the Conversion Amount of such Preferred Share by (y) the Conversion Price (the &ldquo;<U>Conversion
Rate</U>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
    Amount</U>&rdquo; means, with respect to each Preferred Share, as of the applicable date of determination, the sum of (A)
    the Stated Value thereof plus (B) the Additional Amount thereon, plus (C) the Make-Whole amount.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
    Price</U>&rdquo; means, with respect to each Preferred Share, as of any Conversion Date or other date of determination, $0.13
    above the consolidated closing bid price of the Common Stock for the Trading Day immediately preceding the date of the Purchase
    Agreement, subject to adjustment as provided herein.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Mechanics of Conversion</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Certificate Upon Conversion</U>. To convert a Preferred Share into shares of Common Stock on any date (a &ldquo;<U>Conversion
Date</U>&rdquo;), a Holder shall deliver a copy of an executed notice of conversion to the Company with the form of said notice
attached hereto as Annex A (a &ldquo;<U>Notice of Conversion</U>&rdquo;). Not later than two (2) Trading Days after each Conversion
Date (the &ldquo;<U>Share Delivery Date</U>&rdquo;), the Corporation shall deliver, or cause to be delivered, to the converting
Holder (A) a certificate or certificates representing the Conversion Shares, which, on or after the Effective Date, shall be free
of restrictive legends and trading restrictions (other than those which may then be required by the Purchase Agreement), provided
that the Conversion Shares meet the requirements of the Securities Act for removing such restrictive legends, representing the
number of Conversion Shares being acquired upon the conversion of the Preferred Stock (including, if the Corporation has given
notice pursuant to Section 3(c) for payment of dividends in shares of Common Stock at least 20 Trading Days prior to the date
on which the Notice of Conversion is delivered to the Corporation, shares of Common Stock representing the payment of accrued
dividends otherwise determined pursuant to Section 3(a) but assuming that the Dividend Notice Period is the 20 Trading Days period
immediately prior to the date on which the Notice of Conversion is delivered to the Corporation and excluding for such issuance
the condition that the Corporation deliver the Dividend Share Amount as to such dividend payment prior to the commencement of
the Dividend Notice Period), and (B) a bank check in the amount of accrued and unpaid dividends (if the Corporation has elected
or is required to pay accrued dividends in cash). On or after the Effective Date, the Corporation shall deliver any certificate
or certificates required to be delivered by the Corporation under this Section 6 electronically through the Depository Trust Company
or another established clearing corporation performing similar functions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Failure to Deliver Certificates</U>. If, in the case of any Notice of Conversion, such certificate or certificates are not
delivered to or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written
notice to the Corporation at any time on or before its receipt of such certificate or certificates, to rescind such Conversion,
in which event the Corporation shall promptly return to the Holder any original Preferred Stock certificate delivered to the Corporation
and the Holder shall promptly return to the Corporation the Common Stock certificates issued to such Holder pursuant to the rescinded
Conversion Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Obligation Absolute; Partial Liquidated Damages</U>. The Corporation&rsquo;s obligation to issue and deliver the Conversion
Shares upon conversion of Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective of
any action or inaction by a Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery
of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination,
or any breach or alleged breach by such Holder or any other Person of any obligation to the Corporation or any violation or alleged
violation of law by such Holder or any other person, and irrespective of any other circumstance which might otherwise limit such
obligation of the Corporation to such Holder in connection with the issuance of such Conversion Shares; <U>provided</U>, <U>however</U>,
that such delivery shall not operate as a waiver by the Corporation of any such action that the Corporation may have against such
Holder. In the event a Holder shall elect to convert any or all of the Stated Value of its Preferred Stock, the Corporation may
not refuse conversion based on any claim that such Holder or anyone associated or affiliated with such Holder has been engaged
in any violation of law, agreement or for any other reason, unless an injunction from a court, on notice to Holder, restraining
and/or enjoining conversion of all or part of the Preferred Stock of such Holder shall have been sought and obtained, and the
Corporation posts a surety bond for the benefit of such Holder in the amount of 150% of the Stated Value of Preferred Stock and
Dividends which are subject to the injunction, which bond shall remain in effect until the completion of arbitration/litigation
of the underlying dispute and the proceeds of which shall be payable to such Holder to the extent it obtains judgment. In the
absence of such injunction, the Corporation shall issue Conversion Shares and, if applicable, cash, upon a properly noticed conversion.
If the Corporation fails to deliver to a Holder such certificate or certificates pursuant to Section 6(c)(i) on the second Trading
Day after the Share Delivery Date applicable to such conversion, the Corporation shall pay to such Holder, in cash, as liquidated
damages and not as a penalty, for each $1,000 of Stated Value of Preferred Stock being converted, $10 per Trading Day (increasing
to $20 per Trading Day on the fifth Trading Day after such damages begin to accrue) for each Trading Day after such second Trading
Day after the Share Delivery Date until such certificates are delivered or Holder rescinds such conversion. Nothing herein shall
limit a Holder&rsquo;s right to pursue actual damages for the Corporation&rsquo;s failure to deliver Conversion Shares within
the period specified herein and such Holder shall have the right to pursue all remedies available to it hereunder, at law or in
equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of any such rights
shall not prohibit a Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Certificates Upon Conversion</U>. In addition to any other rights available
to the Holder, if the Corporation fails for any reason to deliver to a Holder the applicable certificate or certificates by the
Share Delivery Date pursuant to Section 6(c)(i), and if after such Share Delivery Date such Holder is required by its brokerage
firm to purchase (in an open market transaction or otherwise), or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by such Holder of the Conversion Shares which such Holder was entitled to
receive upon the conversion relating to such Share Delivery Date (a &ldquo;<U>Buy-In</U>&rdquo;), then as such Holder&rsquo;s
sole remedy against the Corporation and the Corporation&rsquo;s sole liability in respect of such Buy-In the Corporation shall
(A) pay in cash to such Holder (in addition to any other remedies available to or elected by such Holder) the amount, if any,
by which (x) such Holder&rsquo;s total purchase price (including any brokerage commissions) for the Common Stock so purchased
exceeds (y) the product of (1) the aggregate number of shares of Common Stock that such Holder was entitled to receive from the
conversion at issue multiplied by (2) the actual sale price at which the sell order giving rise to such purchase obligation was
executed (including any brokerage commissions) and (B) at the option of such Holder, either reissue (if surrendered) the shares
of Preferred Stock equal to the number of shares of Preferred Stock submitted for conversion (in which case, such conversion shall
be deemed rescinded) or deliver to such Holder the number of shares of Common Stock that would have been issued if the Corporation
had timely complied with its delivery requirements under Section 6(c)(i). For example, if a Holder purchases shares of Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted conversion of shares of Preferred
Stock with respect to which the actual sale price of the Conversion Shares (including any brokerage commissions) giving rise to
such purchase obligation was a total of $10,000 under clause (A) of the immediately preceding sentence, the Corporation shall
be required to pay such Holder $1,000. The Holder shall provide the Corporation written notice indicating the amounts payable
to such Holder in respect of the Buy-In and, upon request of the Corporation, evidence of the amount of such loss. Nothing herein
shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Corporation&rsquo;s failure to timely
deliver certificates representing shares of Common Stock upon conversion of the shares of Preferred Stock as required pursuant
to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>Reservation of Shares Issuable Upon Conversion</U>. The Corporation covenants that it will at all times reserve and keep available
out of its authorized and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Preferred Stock
and payment of dividends on the Preferred Stock, each as herein provided, free from preemptive rights or any other actual contingent
purchase rights of Persons other than the Holder (and the other holders of the Preferred Stock), not less than such aggregate
number of shares of the Common Stock as shall (subject to the terms and conditions set forth in the Purchase Agreement) be issuable
(taking into account the adjustments and restrictions of Section 7) upon the conversion of the then outstanding shares of Preferred
Stock and payment of dividends hereunder. The Corporation covenants that all shares of Common Stock that shall be so issuable
shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Fractional Shares</U>. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of
the Preferred Stock. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion,
the Corporation shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such
fraction multiplied by the Conversion Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Transfer Taxes and Expenses</U>. The issuance of certificates for shares of the Common Stock on conversion of this Preferred
Stock shall be made without charge to any Holder for any documentary stamp or similar taxes that may be payable in respect of
the issue or delivery of such certificates, provided that the Corporation shall not be required to pay any tax that may be payable
in respect of any transfer involved in the issuance and delivery of any such certificate upon conversion in a name other than
that of the Holders of such shares of Preferred Stock and the Corporation shall not be required to issue or deliver such certificates
unless or until the Person or Persons requesting the issuance thereof shall have paid to the Corporation the amount of such tax
or shall have established to the satisfaction of the Corporation that such tax has been paid. The Corporation shall pay all Transfer
Agent fees required for same-day processing of any Notice of Conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
7</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Stock Splits</U>. If the Corporation, at any time while this Preferred Stock is outstanding: (i) pays a
stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock
or any other Common Stock Equivalents (which, for avoidance of doubt, shall not include Securities upon the exercise or exchange
of or conversion of any Securities issued or issuable pursuant to the Transaction Documents), (ii) subdivides outstanding shares
of Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding shares
of Common Stock into a smaller number of shares, or (iv) issues, in the event of a reclassification of shares of the Common Stock,
any shares of capital stock of the Corporation, then the Conversion Price shall be multiplied by a fraction of which the numerator
shall be the number of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately before
such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event.
Any adjustment made pursuant to this Section 7(a) shall become effective immediately after the record date for the determination
of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date
in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 7(a) above, if at any time the Corporation
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata
to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder of will
be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could
have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of such Holder&rsquo;s
Preferred Stock immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights,
or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the
grant, issue or sale of such Purchase Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. The Corporation, at any time while this Preferred Stock is outstanding, shall include Holders,
on an as-if-converted-to-Common-Stock basis, in all distributions of any kind (including cash and cash dividends) issued to all
holders of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Preferred Stock is outstanding, a Fundamental Transaction occurs, then,
upon any subsequent conversion of this Preferred Stock, the Holder shall have the right to receive, for each Conversion Share
that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction, the number
of shares of Common Stock of the successor or acquiring corporation or of the Corporation, if it is the surviving corporation,
and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental
Transaction by a holder of the number of shares of Common Stock for which this Preferred Stock is convertible immediately prior
to such Fundamental Transaction. For purposes of any such conversion, the determination of the Conversion Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share
of Common Stock in such Fundamental Transaction, and the Corporation shall apportion the Conversion Price among the Alternate
Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction,
then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this Preferred
Stock following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to
the Corporation or surviving entity in such Fundamental Transaction shall file a new Certificate of Designation with the same
terms and conditions and issue to the Holders new preferred stock consistent with the foregoing provisions and evidencing the
Holders&rsquo; right to convert such preferred stock into Alternate Consideration. The Corporation shall cause any successor entity
in a Fundamental Transaction in which the Corporation is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume
in writing all of the obligations of the Corporation under this Certificate of Designation and the other Transaction Documents
(as defined in the Purchase Agreement) in accordance with the provisions of this Section 7(d) pursuant to written agreements in
form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such
Fundamental Transaction and shall, at the option of the holder of this Preferred Stock, deliver to the Holder in exchange for
this Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance
to this Preferred Stock which is convertible for a corresponding number of shares of capital stock of such Successor Entity (or
its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of this Preferred Stock
(without regard to any limitations on the conversion of this Preferred Stock) prior to such Fundamental Transaction, and with
a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such
number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of this Preferred
Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and
substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be
substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Certificate of Designation
and the other Transaction Documents referring to the &ldquo;Corporation&rdquo; shall refer instead to the Successor Entity), and
may exercise every right and power of the Corporation and shall assume all of the obligations of the Corporation under this Certificate
of Designation and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Corporation
herein. Notwithstanding the foregoing or anything contained herein to the contrary, in the event of a Fundamental Transaction
in which the Corporation&rsquo;s stockholders receive consideration consisting primarily of cash and in which the Corporation
ceases to be listed or quoted on a Trading Market, the Holder shall only have the right to receive the Alternate Consideration
upon consummation of such Fundamental Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding as
of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued
and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to the Holders</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Conversion Price</U>. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 7,
the Corporation shall promptly deliver to each Holder a notice setting forth the Conversion Price after such adjustment and setting
forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Conversion by Holder</U>. If (A) the Corporation shall declare a dividend (or any other distribution in whatever
form) on the Common Stock, (B) the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common
Stock, (C) the Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe
for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Corporation
shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Corporation
is a party, any sale or transfer of all or substantially all of the assets of the Corporation, or any compulsory share exchange
whereby the Common Stock is converted into other securities, cash or property or (E) the Corporation shall authorize the voluntary
or involuntary dissolution, liquidation or winding up of the affairs of the Corporation, then, in each case, the Corporation shall
cause to be filed at each office or agency maintained for the purpose of conversion of this Preferred Stock, and shall cause to
be delivered to each Holder at its last address as it shall appear upon the stock books of the Corporation, at least twenty (20)
calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a
record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to
be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common
Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such
notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified
in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding
the Corporation or any of the Subsidiaries, the Corporation shall simultaneously file such notice with the Commission pursuant
to a Current Report on Form 8-K. The Holder shall remain entitled to convert the Conversion Amount of this Preferred Stock (or
any part hereof) during the 20-day period commencing on the date of such notice through the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
8</U>. <U>Redemption</U>. The Corporation shall have no right to require Holders to surrender Preferred Stock for redemption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
9</U>. <U>Intentionally Omitted</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
10</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Conversion, shall be in writing and delivered personally, by facsimile, or sent by a nationally recognized
overnight courier service, addressed to the Corporation, at: 3900 Paseo del Sol, Santa Fe, New Mexico 87507, Attn: John Rice,
President and CEO, e-mail: rice@sigmalabsinc.com, or such other facsimile number or address as the Corporation may specify for
such purposes by notice to the Holders delivered in accordance with this Section 11. Any and all notices or other communications
or deliveries to be provided by the Corporation hereunder shall be in writing and delivered personally, by facsimile, or sent
by a nationally recognized overnight courier service addressed to each Holder at the facsimile number or address of such Holder
appearing on the books of the Corporation, or if no such facsimile number or address appears on the books of the Corporation,
at the principal place of business of such Holder, as set forth in the Purchase Agreement. Any notice or other communication or
deliveries hereunder shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication
is delivered via facsimile at the facsimile number set forth in this Section prior to 5:30 p.m. (New York City time) on any date,
(ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile
number set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading
Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service,
or (iv) upon actual receipt by the party to whom such notice is required to be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Absolute Obligation</U>. Except as expressly provided herein, no provision of this Certificate of Designation shall alter or
impair the obligation of the Corporation, which is absolute and unconditional, to pay liquidated damages, accrued dividends and
accrued interest, as applicable, on the shares of Preferred Stock at the time, place, and rate, and in the coin or currency, herein
prescribed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Lost or Mutilated Preferred Stock Certificate</U>. If a Holder&rsquo;s Preferred Stock certificate shall be mutilated, lost,
stolen or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated
certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of
Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction
of such certificate, and of the ownership hereof reasonably satisfactory to the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Certificate
of Designation shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without
regard to the principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation,
enforcement and defense of the transactions contemplated by any of the Transaction Documents (whether brought against a party
hereto or its respective Affiliates, directors, officers, shareholders, employees or agents) shall be commenced in the state and
federal courts sitting in the City of New York, Borough of Manhattan (the &ldquo;<U>New York Courts</U>&rdquo;). Each party hereto
hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement
of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper
or inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process
being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices to it under this Certificate of Designation and
agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each party hereto
hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal
proceeding arising out of or relating to this Certificate of Designation or the transactions contemplated hereby. If any party
shall commence an action or proceeding to enforce any provisions of this Certificate of Designation, then the prevailing party
in such action or proceeding shall be reimbursed by the other party for its attorneys&rsquo; fees and other costs and expenses
incurred in the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Waiver</U>. Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designation shall
not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of
this Certificate of Designation or a waiver by any other Holders. The failure of the Corporation or a Holder to insist upon strict
adherence to any term of this Certificate of Designation on one or more occasions shall not be considered a waiver or deprive
that party (or any other Holder) of the right thereafter to insist upon strict adherence to that term or any other term of this
Certificate of Designation on any other occasion. Any waiver by the Corporation or a Holder must be in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Severability</U>. If any provision of this Certificate of Designation is invalid, illegal or unenforceable, the balance of
this Certificate of Designation shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it
shall nevertheless remain applicable to all other Persons and circumstances. If it shall be found that any interest or other amount
deemed interest due hereunder violates the applicable law governing usury, the applicable rate of interest due hereunder shall
automatically be lowered to equal the maximum rate of interest permitted under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Next Business Day</U>. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day,
such payment shall be made on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Headings</U>. The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designation
and shall not be deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Status of Converted or Redeemed Preferred Stock</U>. Shares of Preferred Stock may only be issued pursuant to the Purchase
Agreement. If any shares of Preferred Stock shall be converted, redeemed or reacquired by the Corporation, such shares shall resume
the status of authorized but unissued shares of preferred stock and shall no longer be designated as Series E Convertible Preferred
Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>No Cash Payments</U>. Notwithstanding any provision of this Certificate of Designations to the contrary, during the period
that any shares of Series D Preferred Stock are outstanding, the Company shall not make any cash payments otherwise required to
be paid hereunder but in lieu thereof shall increase the Stated Value by the amount of such payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">RESOLVED,
FURTHER, that the Chairman, the president or any vice-president, and the secretary or any assistant secretary, of the Corporation
be and they hereby are authorized and directed to prepare and file this Certificate of Designation of Preferences, Rights and
Limitations in accordance with the foregoing resolution and the provisions of Nevada law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned has executed this Certificate this 27th day of January, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    John Rice</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    Rice</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANNEX
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF CONVERSION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">(To
be Executed by the Registered Holder in order to Convert Shares of Preferred Stock)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby elects to convert the number of shares of Series E Convertible Preferred Stock indicated below into shares
of common stock, par value $0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), of Sigma Labs, Inc., a Nevada corporation
(the &ldquo;<U>Corporation</U>&rdquo;), according to the conditions hereof, as of the date written below. If shares of Common
Stock are to be issued in the name of a Person other than the undersigned, the undersigned will pay all transfer taxes payable
with respect thereto and is delivering herewith such certificates and opinions as may be required by the Corporation in accordance
with the Purchase Agreement. No fee will be charged to the Holders for any conversion, except for any such transfer taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
calculations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.5in">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
        to Effect Conversion: _____________________________________________</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
        of shares of Preferred Stock owned prior to Conversion: _______________</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
        of shares of Preferred Stock to be Converted: ________________________</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
        Dividends Being Converted: _________________________________</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
        Price: $____________________</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
        Conversion Amount to be Converted:____________________________</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
        of shares of Common Stock to be Issued: ________________</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
        for Delivery: ______________________</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>or</U></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DWAC
        Instructions:</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker
        no: _________</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
        no: ___________</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[HOLDER]</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex10-7_001.jpg
<TEXT>
begin 644 ex10-7_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH PO&.
MAV?B7PQ=:-?7#6\=WMC25>JR;@4/O\P''>O/=)UCQGX,\0Z3X?\ &44.K:7=
MW"P6.JP_?23D*&[DXZY&>O)Q7J&L:/::Y8?8KX2&#S$DQ%*T;;E8,N&4@CD
M\$51C\+PMJ-O>W^H7VI-:N9+6.[,>RW8@C*A$4L<'&7+$>M$='?^O^'"6JM_
M7_#'GO[0_P#R*&D?]A1/_0'KUQ6"0!F("A<DGL,5RWC3P#9>.8[>'4]3U*&V
M@<2)!:F)5WC(W$M&S9P<8SCVK2U'P^^I^'&T:?6=24.NR2[C,2S2+W!Q'M (
MXX44)V@UYW_!('K)/R_6YXUX^U1++6M#\>65OJ0O+6\/VKS=.N(D-NQP@\QT
M"?=XX/)<D5[U:W,5Y:0W5NX>&9!(C#HRD9!K$USPI'XA\+G0+[5+XP.H6:95
MA$DH'8YCVCL<JH/ I_A_PROAOPZ-%M-6U&6&-2D$UPT;R0+C "G8 0.HW _E
MQ36D7'[OU_S^\'JT_O\ Z_KH>=?!K_D=/B%_V$O_ &I+3OB.MT_QD\#+930P
MW)67RY)HC(BGW4,I/YBNP\+_  \L_">L7VI66L:K-)?R&6[CN#"4E?DY.V,$
M<L3\I I-:^'EOKGB>T\03Z[K$-[9$FT$)@"09Z@ Q'/_  +-'6'E;\$T#UY_
M._Z&SX>BN[72+:/5I(WU+=*))%7:')=B2HZ@'@X],5YQ^T0+H^"=/,>_[*+]
M?M&WTVMC/MG]<5Z%IWAM[/6?[4NM=U74IA"T*)=F$1H"020L<:#/RCFM/4M-
MLM8TZ?3]0MTN+2==DD3C(8?Y[TGT?:S^[_AAQT.>\9_9?^%6ZSC9]F_LJ39Z
M8\OY?Z5XW>K=K^RQ:_:M_-VIBW]?+\TX_#KBO8F^']E-IT>DW6K:M<Z+&%5=
M-EE3RMJXPI<()&48Z%S4GBKP)8>+-&AT>XOKVRTR(*!:V7E(AV_=Y:-B,>@(
M%*6O-;K;\'<4=%%/I?\ *Q6\&6>NH8IM6NK6ZLGTVU%H(+<QB,@$L&!9LMRO
M.>W05T'B#_D7=1_Z]W_E4FCZ:=(TN"P^VW-XL*A$EN0F_:. /D51P/;/KFF:
MWI3:SIDEB-0N[)9.'DM?+WE<<K\ZL #[#/O5SE>5U_6MR8*T4GV_2QY3XNTV
M[^%OB[_A-]"@+Z'>L$U>RC'"DG[X';D\>A]FJU\6Y5G^!=M,F=L@M&7/H<&O
M46TZ*?26TZ_=K^*2(Q3-<*N901@[@H"_D!7/>)/A_8>)O#]KH5SJ6I6VF6Z(
M@@MFB&_9C:69HV;(QV(%0U[O+YK[OZV+3][F^_U_K<=X5M]5MXIIM;N;6X@:
MUM6MWA@,2(H4\$,S?,#SG/<=*Y?XMQ2:!J?A[QW:K\VEW(AN]O!>!S@@_J/^
M!5U:^#)2ME%<>*-<N+6TDC=+=S;HC[""H<I"K,.!QFMC7-&M/$.AWFD7P8VU
MW$8WV$!@#W&0>1U%5)Z\RZ/^OONR8*RY7V*VA31ZG)<ZU&ZR0W)$=LZG(,*Y
MP1[,Q8Y[@BN ^+,-MXDTG5=/\C49+JPB5[,V^G7$R>=]YOG1"@.W"\GC)S7I
M\%E%:Z;'8VI,$440BC* 90 8&,@C(^E9NC>'7T;2KBPCUK4KD2L[K/<^2TD3
M,225(C )R2?F#?EQ4R5]OD5%M6;,3P+XE'BKX80:@[[KE+5X+GG)\Q%P2?KP
M?QKD/A&L#_ G45NMOV<_:_,W=-NWG-=7H?PPM/#EOJ,&E^(M<@BOR6F3-N5W
M'JR@PX4XXX'3Z##=+^%6F:7H+Z#'K6M2Z-(S-+9/+$JR9Z@ND:R8/H& IS][
MF\U_PY,5RN/D_P .AA_!"[GL/A&UW?>8;>&:9X1@DF,8X4#D_-NP/6N:U#4X
M?"WQ3T#Q/''?Q0:DOV35FN;"XMD\QCUS*BY R.!G CKU[4O"EM>Z59:99WMW
MI-I9NCQ1V'EJ#L(*@AT8$ @''?OFJ_B_P19^-=(@TS4]1OTMHF#MY'E!I&'1
MB6C.#U^[MZFJ<O?YU_2M9_?_ )!&/N\K\_OZ'3]:*I:1IQTG2[>Q-[=7ODKL
M$]T5,C#MDJJ@X'&<9]<U=I/?0%YA1112&%%%% !1110 4444 %%%% !1110
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M_NKFNAV6=I?Q6MLD<DS@BYPQ,:9 'EDY.0&ZL#C'XUS=X$A=A-=7),$X>&$
MM&(F.7.<_+EN,8YYKI;9)9K>*.#2K"W26/RWE:=?,=B"I(,C?+SG[H%>CAY>
MUIRAT:O_ %\[,XL3'EDI=CTCX77K-HU[I;L2;"Y(BSU\I_F7]=]=[7D_PYNU
MC\7W2,P07U@DV"<<JX4#Z_,:]8KAGO?N>C1=X(****DU"BBB@ HHHH ****
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MWDDD161B4W?*'+#A%Y*CH>G&>MINW3S_ #T$K]0HHHI#"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N#^+7_(I0?]?:_^BWKO
M*YWQSIPU+PCJ"_,7@@DFC"]V6-L#I[U4':29,U>+1Y$8W:=I! SJN\!Q>QP
M H ?O#GCG-<Q?200ZX[F:YAV66V)K9Q(V[Y@H+# *GH2.V>*Z! \T4;P6,-W
M,+=3\_F$\Y#8"D# R,D^U94R^3K5M(]W;Z8T@,,T\($L<<;J5 P"<GA\C/\
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MR;X=6@E\873L@<65@L.XJ" 6<,#['Y37K-<E1W=_ZZG9AU:F%%%%0;A1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ[)R26SU^5G_ %ZDJ_*V]U^>G^9T>O?$K3_#.IZ58:OI&JV\NIE1"V(6522
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MUYK/B*^$<LP3;YLDARP5<G V@C\?>N_\+:)K'AV"PL+[4;*33+.T6&%+>V:
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MD;.9$\Q=A(39\N5VX; ))/#MK8F^ESO[J[MK&VDN;NXBM[>,;GEF<(JCU)/
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MN!0[!O3<R2#WW<57+K;^NG_!![7_ *ZGI5%%%2 4444 %%%% !1110 4444
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M")F$XC+R( 5XRICSG.#TXI-:#2;_ *_KS.VT^WL],G^Q?;FGOI5,I-S,&F=
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MN%SWKH?!4=M+>RW&F,DNEVUC!917"'(GD4LTC!NC<L!G^]NH2NKC9VE%%%(
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ***HZEK%AI"(U[<;&D)$4:JSR2D#)"(H+,<=@#0!ROB/5(V\::1
M#<6.K/8Z;YEU))!I=Q,CSE0L:AD0@X#N?0$#G-4]8M_$%W-K'BBPLI[>XCT[
M[#IUNXQ,P+AI)2H#$'IM7!/R],G%=MINL6.K"3['*S-%@2H\3QO&2,@,K %3
MCG! ."#W%7J+:6_K7^K#OK_70\CN=+M+?PUJ<L^G31C6FMK(Q)92EV4$EW\M
ME\V651O;>R G:,#C)NWWA\3:9KMS!I-U;V>J_9K.*W6%S(RY*O<R1@$[L.?O
M#/R*3@].^O=#L=0U*SU"Y%P;BS;= 4NI413R,E%8*W!(Y!X..E:-._\ 7W"U
M7]?UY'F^I65SJ.E>)?M6CW+->2V^G11FW9RML"!OZ')!>1LC@8'/%6KCP[:6
M/C".QTK1X;:TU'2)+>Y\B!4C4!T +@<$[68#U^G3OJIZ=I5EI,+Q64/EJ[L[
M98L2223RQ)QDGCH,\4)_U\K?\$/3^M4_T(-7E-GIT<26$E[ ["&6)$WXB(.X
MD=^!TY)Z $\5PDC:[:>%=8BT2VU)],%S"EBES'+%<) 2/."@H90HY"G:6&3@
M' KTZH;:ZM[R(RVL\4\89D+Q.&&Y20PR.X((([$4N[_K^O\ -AV_K^O^ CSJ
MVTY]*TMKB+3KV&QU'4D>^CL;.1&$(CX*Q+F7YF"AR0&.6) %:%UX5L+K5- M
M;#1A86,$\U_(R0!=F%"A%/\ RS+E@Q P?E/0UUFHZHNG3V$36T\WVR<0*T6S
M"'!;+;F!QA3T!/'2EU?6++0M/>_OWE2W0A6:*!Y2"3@?*@)Z^U._4/(\ZUW0
M;B[UJX\/'29/[&2VCCT_$,DRKDDR,I*^6DF> [OE< A3GG0OK!X=5\1ZU;:1
M<)?Q+;V5O=QVA>80X'F2QG:2[ .W3)/E@>@KLM)UW3]:$_V&60O P6:*:!X9
M(R1D;D<!AD<C(YK1H6BM_7]6T"^M_P"OZOJ>8MHL:Q^*&T_P]-'YUG%96R7%
ML6%PS\F9P0=Q)9=Q//[OYL8XN>(/"&G:)X<LKFQL3<:C97-B%G"[I6$<JKA?
M[N5+#"XX.*]"JE_9-E_:QU0P9O#&L7F%B0%4L1A<X!^9N<9YH3M^'X!9=1NG
M6JV-K-)(JQO/(UQ,!T4GJ/P '/?K7!V^D6UCH-C<II4EO8:G>O=Z@FF6;&1H
MCN:&-DB7>5Y3.!ZYX)KL/%4.F_V.^H:G9SW<6GYN!'!)L8X4@C[RA@5)!5C@
M],&M.*[MGF%LLL:W B64V^X;T0\ E0>!D$9Z<&DN_P#7]?Y!_7]?UU//F\+3
M7MA8:>VEK9VEQK/VV.%(5QI\$:Y 7 *QLY4<#&/,8>M=]IVFVFDVIMK*'RH3
M(\A7<6RS,68Y))Y))JW13OI;^NG^0!1112 **** "BBB@ HHHH **** "BBB
M@ HHHH **** /+M'*>-OB=XIM==BCN].T;R[>UL)E#PY;):1D/#-\O!(XSQ2
M6HBTOXM7G@V.!)O#VH:7]I-A(H>&%P2"%4\*I ^Z.,GI75W7A%H?$EQXAT.]
M33]2NHA%=": S03@=&9 R'<.@(8>^:+#PE)97^H:V]_'<^(+R(0_;)K?]U"@
MZ(D08$+GG&_)[FET7H[^;U_77R!ZM_*WEM_P?O/)/A)I.DZAHTUI?^#H-0CG
MU66%M1E@A98$V A<D^8#D<8&/FZYJSJ&BZ3IOQQN;2'PG%JULFC"3[#'! 0S
MY'[PB0JI/J1EN>AKT;X>^"+OP-8W=C)J\-_;7$[7 Q9F%U=L \^8P(P.F/QJ
M*/P-JJ?$AO&!URS+M#]F-K_9S8\G.<;O.^_@?>QC_9[57VEZ?^VV_/\ S!OX
MO7];_D<3\6/#6AV'@#2[FST>SM'GU*!RL<(7R]Z_.J\?*IP,@<<5O:O*+_XG
MZ-X%B7['H-M8&\EM;;]TL_4+&=N/D&,[>A[UT'C_ ,%WGC?3[6PBU:&PMX9U
MN#NLS,[.N<<^8H Y/&#]:FU7P:VJWFF:P=0%KXAT]"J7UO!B.0$'*O$S'*'/
M3=D=B*$^_?\ 2R^YB:VMV_&]_P 471X0T2(PK:Z?!;6J!UDLX8PEO,K*5(>(
M?(W7J1G\Z\?^&>D:/=MJUC>>#[:_AEUR>W^W2V\+);H%R$!)WCIQ@8&[KFO9
MX++6O)9[K5;62[",(C#9M' &/1F0R,S8]-X'X\CE?#'@3Q%X3MM1AT_Q-ISB
M^NGNI&GTAV*.W7;BX'' ZYI+1N_;]1]-._Z'4ZK<#PYX1O+BUCWC3K)VB1CG
M.Q. ?RKBOA_X;TSQ1X'M-<\06T6IZMJ(>:2]G7=+%\YVB-NL87'&W&#7?V-B
M\&D165[,+R3RMD\K(%$S'[Q*\XR2>/>N<TWP;J'A^Q?2O#^N)::2SLR0SV?G
M2V^XY(BDWJ .3C<K8]Z'O*^M_P#@W^\%LDM+?TON/&_$-]+KGP5U)M547M]H
MNK_8;>_F4-*8]P_CZYQ@'UP,UZYX2T31Y+N.]C\'PZ'=V2)Y4@AA224.A#$F
M(D%3Z$YR.U5-=^%D=_X(@\)Z5J2:?8B3SIY9;4SS329SN+;U ).<\'MC&*[C
M3+>ZM=-@M[VXAN)XUVM+#"8E;'3"EF(XQW-4G:_R_))O[[_>)ZM?/\[I?<<;
M\3_#NCW/@[Q#K%SIMK/J":<ZQW$T2N\04$C82/EY)/%4/ ?@_P .W/PXT>_E
MT6P:YETTK,_V=/WP(R=_'S<@'GN*[#Q;H=UXD\-W>CVU]#9B[0Q2RR6YF^0@
M@[0'7!Z<G/TJIH'AS5-!\%QZ"FK6DTUO%Y-O<M8L%5/]M/-^8]>0R]N..8M[
MLE]WX_YE?:B_ZZ?Y'C?@Z"V_X49JX;PA+=F6.X9]05+4J"H;:QW2"3Y,G&%)
M'.*KZ[H6D0? CPKJ46D68OYKJ$2SI @EE!+Y!;&3G ZG%>H:+\.=5T3P#?>$
MXO$-I)!<JZ+.^FMN19,[^!-@GG@\8[Y[4+WX5:Q?>#--\+2>*+);+3Y%EAE3
M26\TE<XW$SD'[Q["K;]Z_P#A_#?^NHNG_@7XK3^NATGA;1=(^VS:E;^%(=!N
M[:1K=42&*-W0JA.[RB5()/&">GUKKJP+73/$3:C:S:EKEA-:P$LUO:Z<T)D;
M:0,LTS\#.< 5OTF)!1112&%%%% !1110 4444 %%%% !1110 4444 %9YUNP
M']H#S)=VGC-P@@D+*,9!5=N7!&<%0<X('(K0Z"N#N8+N_NY];TRTNP]Y.=.N
M8YX)('^SD*JR!74'Y&RP/3#MWH6KL'F=I8WL.HV4-Y;^9Y,RAT\R)HV(]U8
MC\14SND8R[*H) R3CDG 'YUP2OK,^N2SLFK)):7,YEC42I;_ &5481I&!\LK
MN=C97+*<C(X!K0Z%J,-OX:_M.YUR[GV">[5+F<HC1QL54[3G)9USN)W;/PHT
MW"S6G4[^PO[;4K;[1:NSQ;WCRR,AW*Q5AA@#P016-J5QIVO:J^@QW^HVNI66
MVY+P6S ("" =TD;1,#DC!SR#CE>,KP1::O9WLL>I-<@?8()&1D=8O.=Y'<+G
MY<KD XY)//;#M(UU?[;UF<Z;K#7%W<JENKZ7<1KY21@ EW0*!NWGD]_7BAJS
MU[?U^H)]OZ_I'3Z5I<&D67V:!G<%C([N%!=SR6(4!1GT  ]JLW-Q':6LMS*'
M,<2%V\N-G; Y.%4$D^P!->:6ESJ3275U>MXHA$^F())([:X8+<2L0QCA )7R
M]H&  <'/<L>N1I[3P!)+!:7PN18O(MO+))<3^85)VY<EV.>@//;BB5TF^O\
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M;G&!FO)/@?;:U)X:TZ:"ZM_[*CU6<W$ @/FY\H@'?NQMR1QM'U/2KOQ>E/\
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MAZMVQ6^$]N)#("V'\L?>&>>>O->M>';/6H+C5&UVYM[J5[D/;R00F-!'Y:@
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M-A<6R>8QZYE1<@9' S@1U[AK'.AW_P#U[2?^@FIE=4^;U^]?TAQLY\OI^/\
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M&RMU'\3(6+$>PW!?J#3M_7R%_7XFI=:K8V5]965Q.$N;UV2WCVDERJECT'
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !5+4M'TO684AU33;.^B1MRI=0+*JGID!@<&KM%
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M0&+GJ/O&B.C_ *]/R=_D-ZJW]?U=?B:>CZ0;J#4+M=1U)8;^Z9@K7LK[85)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBJ>JO=QZ5<R6,L$=RD99&GB,B CGE0RD_F*3=E=C2N[%
MRBO)[3XA>*$\):!XEN8])NXM4N%@;3K:VDBG&6*YC8RL'(QDC:.*].N-3L+2
MZM[6YOK:"YN3B"&655>4^B@G)_"J::_(E-/8M45Q;^+[F^^($OAO2;G2<64<
M<MTMPY:24,2'5-I^5D !((.=P^[UKHQX@T5K.YO!J]@;6U?9/.+E-D39QAFS
MA3ST-+I<?6QHT51AUG2[A)7@U*SE6*-99&2=6"(PRK'!X! )!Z&HF\1Z&EM:
MW+:UIRP7;;+>4W2!9F]$.<,?I0!IT53M]6TZ[LY+RVU"UFM8BRR31S*R(5Z@
ML#@8[TR+7-(GTQ]3AU6QDT],EKI+A#$N.N7!P,?6@"_14,-Q%>6B7%G/%+%*
MNZ*5&#HP/0@@\CZ&N#T_QKK%IXME\->(UL();M7_ +(U"&!UAG925*LC.3NR
M,X#<].XHZV#I<]"HK"TW61;V5DFOZKIB7]XQ$*(/LXEY^ZB.[%B..A[]*F_X
M2KP[]A^W?V]I?V/S?)^T?;(_+\S&=F[.-V.W6@#7HK+;Q+H*1R2/K>FJD4H@
MD8W2 )(>B$YX;VZUBWWBJXTWXAV^C7<]A%I,^G/=>;("CHZN%P7+;2#GT%']
M?J!UU%4[K5M-L;%;Z[U"TM[1L;;B694C.>F&)QS3+C6])M;J.UN-4LH;B2,R
MI%)<(KN@!)8 G)'!YZ<4 7Z*J0:II]U+%%;W]K+)+$)XTCF5B\9Z. #ROOTJ
MW0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !15>\:Z6W(LTC:=
MB ID^ZO/+$=3@=AU]NM<E_PE^H:59^($UBWMYKO2GB6*2U5HX[HR@>6-K%BA
MR0#R?6C^OZ^\#M:*YJSUG5H]4NM%OHK2;45M5NH)(%:*)U9BI!#,Q&TXR<\@
M\ =*ICQ5?Z-=Z[;:^MK,FF6*WZW-G&T:O&=PV%&9B&RAYSSGH* 6IV-%<6_C
M"]T,$^(H[;;+ITNHQ&T1E""/:6B;<QW,-PPPP#S\HJ[I6NZFNLVFFZU':B6_
MM&N[=K5&41[2NZ)MS'<1O!W#&>?E%.S_ *^?^3#I?^OZU.GHKF=)\42ZKXPO
MM+CMU6P@M$GAG/WIB79"1_L_+QZ]>A%)9^*)[[QI-I,-JIL([)YTGS\TSK($
M.WG 4'(R>I'IU0/3<Z>BN4?7-:TSQ'9VFJ16<ME?02R(;5&62V:-0Q5B6(<$
M'[P"\]N:JZ3XMU*Y;0KV[2T;3=>R+5(482V[;"ZAV+$/E5.2 N#QSUII7_K^
MNP':T5RLUYXGM-;TNWFO-)DCO9VWV\=C('BB52S'S#-@D?*N=@R6' JEIGB[
M5-0U;B.S^R_VE)I[V*HWVJ$)G]ZS;L8( .W:.&!W'NEJ#T.WHHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J6KM,
MFD7?V:TENYC$52&)D5F)XX+LJ]^Y%7:*35U8:=G<\1\/> ?$'AW1=#UO2M"^
MR>)=,)@OK1IH0NHP,Q)^97(W $8+8/'? K<U+PAK>L>,KV]NDU6'2]6MK<%;
M::U#VKQ'(23>&.-W(,1/.>M>I45?,[W_ *_K2Y*5E;^OZ_0\TO/#WB#4/&'B
M]X[*>TM=3TI;*TOFFB(#JI&=H<L 2W''KTJG9^#M9B\":Q'+::G)K-QI TQ;
M6:>T\IMH(0QF,*-HW'ESNQV->KT5%O=Y?ZZ_YE7UO_73_)'F^K^#]2O?A58Z
M;IUDMEJ\$-J)82T0>00D$QEQN4\Y(SD9//4UG:_X/U>;0+$66FZI?W,VMPZG
M>17L]H'C"@!A\A6/G X7.>2<9KUFBJ<FY.7G<E*R2\K?U]YX]_PB'BB[T7Q7
M FEM:37>MKJ=K%<3Q;+F,,#Y9*,VTG;WP.1SUK?\7>']6UO0]/NM(TQ]-O(=
M2CU"YLXW@669E&"=WS1EQP06)!P,UZ%126B27E^&@WJ[OS_$P_"VD?V)HGD
MWK-)+)<,MX\1E#.=S ^6 @Y)X''/6LC5/#G_  F_A2XL-4TVZTFZ2X>6TEE>
M-I(9-Q9)%,;L.^",@]?8UV=%#U!:'GFL^'->D\.>#<6_VZ_TB]M[B]1)45I
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%4/[;TG^T_[-_M2R^WXS]E^T)YN/79G/Z5>!#*&4@@C(([T +1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ.HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;>)I&7(SR!TX(.3@#N: M<UZ*;%()8DD7(#J&&?>G4!N%%1PS1W$0EB<.A)
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M_ OAZSOQ>VEI/;3+ ;9?L][/&J1$?=5%<*HYSP.O/7FET_KLU_D#UV_K5/\
M1G*>&=9O?$,/A_1M0O+I8YK.YGFGBG:*6<Q3"-5\Q2&Z'<<$$G';(-&QO[S3
MO[0TVU9&%]XDN;=Y+B^:UW 1 A?-1&96)'4 $XZBNY@\"^'K;38+"&TN$@MY
MC/ 1>S^9"YZE)-^]0>X! .3ZTLO@3PO/97]I+HML\5^_F7.X$M(W.#NSN!&3
M@@\9XIM_U\T']?G_ )G(:O'XHT;0XEN]7:VQK-JL$5K>M<N()'52DDLD:NW.
MX@]><$G%:FNI?:!=>;NUF_TJ.-W:6UO"\]F[,Y+M'D>;& > =VW9P#6HOPZ\
M*QZ1;Z5#IKP65O,)TCM[J:(^8,8=F5P688&"Q.,<5K7WA_3=1</<Q2E]JHS1
MW$D9D5<X5RK#>O)^5L@YY%#>G]=D"_K[SF=/OKZ3QUJ,$&K2W-J^B0W5LLQ'
ME([,PW  #@[0><GD\U1T%=9O;O1?L]_KL,C1>9K,DH+PR-L!7RFE1DP6_P">
M.!@\X.*Z.^\)6*75[K&G6N=8DM6MX_.NYA R[<*C1AMH3V"^_6N7T'X9^'+;
M4(KNU\(W^BWUM(K+=OJ)8-S\VS9,W!''S*O!_"A;_P!=W_FOZ0FM/Z[+_(H+
M>ZG;>#;O57UG4I[VQU\V\4DEP0&C^TK&5=%PK J3P1@=L5I74WB;Q#?ZJ^D2
M6EO=:=>-#$TNL31")5QCS+=8BCJPYRQ)PW!%=#_PKSPW_9<FF_9KTV<MQ]I>
M,ZE<_-+G.[/F9SGGZX/44^_^'WA34]6M]5OM&@N+ZW"A9I&8EL# +\XD(P.6
MR:%T_KHOU7XC?]?>_P!&8-[/+XAL?%\]S=7,1TL26T$,%PR1X\@,791P^XL<
M;@1@#&#S74>$0&\$:(IS@Z? .#@_ZL4^^\+:-J-])>7-HQGFB\F8QSR1B9,$
M8=58!\9.-P..V*N:?I=CI.FQZ?I]K':VD8*I%"-H7/)QCOSUI=&O3]0ZI_UT
M_P CRVVTTZ7H'Q"O].U'4[6[L[N?RI1>R2<+%&W(D+*22,;B-V. 173,SS>*
M?!3O(QD?3KDER<L28XN>>]:*?#_P[':W]JL-^8-0S]J1M4NF$Q.,DYDZG !/
M4C@\5*G@?0DN]/NEBO?/TZ/RK5SJ-P?*7N/]9R#T.<Y  Z 4^WR_)K]0?7Y_
MBU_D<*]_K/\ PB"S'7M1,\/B?[&TN] TL7V@1[6PO QV7 ]L<5NFYU*PUWQA
MINGW[_N=.BN[5KZ=I%AF<2 G<Y.U?E!QT'H!6I_PK?PQ]F-M]FO_ "3<?:BG
M]JW6/.SGS/\ 6?>SSGUYI=6\'6++J=]96;7&HWT MYUN;V9DFBZ%2K,5'&['
M'!/N:5]+?ULE^:;&M_Z[M_EH9_A]-2F\06;6=SKL.F);,]_'J 8A[GY=JJTR
MEBN"Y/E$)P,>AU?%5_-#?Z#IB2R06^IWC03S1,58*(W<*K#E2Q4#(YZX(/-8
M7A7X>^'M+U.'5--\*WVA7D#$%Y[_ ,PNI'( 6:12#[XZ5VVIZ59:S9-9ZA;K
M- Q#8)*E6!R&5A@JP/((((JFUI_7]?\  )6AY]KUO/%:>,/#\MU?W&FP:2+V
MW>2[D,D3%9 8VDW;G4[,X8GJ0<CBJ>J^'K(>'O F)]2_>WUJ&SJ=R<;HB3M_
M>?+TX(QCMC-=_-X4TBXTB?3)8;AK:XQYY^V3"6;C'SR[][#'&"QXXJI-X"T"
MXM;*VECU!HK%MUL/[5NAY1'0@^9G(Z#T' Q4K_+\+_Y_@-Z_C^-CGY]5U#0-
M=\8^5>75Y#IVCPW-K;W$F\1MB3@'J?N#)8ECW)J])YFF>'I?%.EZS=WP.FO*
M8)9VFCN9-FY74$D)C!X0 $$\<5NVWA72+36I]7BBN3>W$8BE>2\FD5T P%*,
MY4@<]NY]:K:+X#\+>';ZYO=)T:WMKBY!61QN;Y3U4 DA1[# HZ?+_/\ ._\
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M4Y).5(.>:FL/!?A[2M(32[#34M;6-S(@AD=75R"N\2 []V"1NSGWIW_K[O\
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M=+US1?*>S&DWEP+:X,D#-(CE6*$,'  ) 7E3@D=<\9&F>)=>OY=?T_[5I?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"*UMK.2<P1>>KG=Y:D*< M@]R0,XKT^"X6YM$N(ED"R)N598VC;GU5@&!]B
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M_P# .QTO7+#6/.6SED\R$@2PS0O#(F>F4<!@#@X..:NRRI!"\TK!8XU+,QZ
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M3@UI)+GMY_K;\M2(M\M_+]+_ )Z'H^FZS8ZLURMG*[/;2>7-')"\3HV,C*N
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M,<[21D'T)KD8H+O6?#_A_1FTV]LM0TJYMI+AWMF6.(0_>*2$;7# $#82?FY
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MUD,4XFB>)XWXX*N P)R,<<Y&,YIEKXETF\MKJX2Z,26@S<+<Q/ \0[%DD"L
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M'_X,8?\ XJC_ (3OP?\ ]#7H?_@QA_\ BJ .@HKG_P#A._!__0UZ'_X,8?\
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M/_P8P_\ Q5 '045S_P#PG?@__H:]#_\ !C#_ /%4?\)WX/\ ^AKT/_P8P_\
MQ5 &[+$D\9CD&4/49(S['V]J?7/_ /"=^#_^AKT/_P &,/\ \51_PG?@_P#Z
M&O0__!C#_P#%4 =!17/_ /"=^#_^AKT/_P &,/\ \51_PG?@_P#Z&O0__!C#
M_P#%4 =!17/_ /"=^#_^AKT/_P &,/\ \51_PG?@_P#Z&O0__!C#_P#%4 =!
M17/_ /"=^#_^AKT/_P &,/\ \51_PG?@_P#Z&O0__!C#_P#%4 =!17/_ /"=
M^#_^AKT/_P &,/\ \51_PG?@_P#Z&O0__!C#_P#%4 =!17/_ /"=^#_^AKT/
M_P &,/\ \51_PG?@_P#Z&O0__!C#_P#%4 =!17/_ /"=^#_^AKT/_P &,/\
M\51_PG?@_P#Z&O0__!C#_P#%4 =!17/_ /"=^#_^AKT/_P &,/\ \51_PG?@
M_P#Z&O0__!C#_P#%4 =!17/_ /"=^#_^AKT/_P &,/\ \51_PG?@_P#Z&O0_
M_!C#_P#%4 =!17/_ /"=^#_^AKT/_P &,/\ \51_PG?@_P#Z&O0__!C#_P#%
M4 =!17/_ /"=^#_^AKT/_P &,/\ \51_PG?@_P#Z&O0__!C#_P#%4 3_ /"/
MF/4I;NTU?4;1)I/-FMHS&\<C8 )^=&9>@^Z16O'&L481!A1ZG-8/_"=^#_\
MH:]#_P#!C#_\51_PG?@__H:]#_\ !C#_ /%4 =!17/\ _"=^#_\ H:]#_P#!
MC#_\51_PG?@__H:]#_\ !C#_ /%4 =!17/\ _"=^#_\ H:]#_P#!C#_\51_P
MG?@__H:]#_\ !C#_ /%4 =!17/\ _"=^#_\ H:]#_P#!C#_\51_PG?@__H:]
M#_\ !C#_ /%4 =!17/\ _"=^#_\ H:]#_P#!C#_\51_PG?@__H:]#_\ !C#_
M /%4 =!17/\ _"=^#_\ H:]#_P#!C#_\51_PG?@__H:]#_\ !C#_ /%4 =!1
M7/\ _"=^#_\ H:]#_P#!C#_\51_PG?@__H:]#_\ !C#_ /%4 =!17/\ _"=^
M#_\ H:]#_P#!C#_\51_PG?@__H:]#_\ !C#_ /%4 =!17/\ _"=^#_\ H:]#
M_P#!C#_\51_PG?@__H:]#_\ !C#_ /%4 =!17/\ _"=^#_\ H:]#_P#!C#_\
M51_PG?@__H:]#_\ !C#_ /%4 =!17/\ _"=^#_\ H:]#_P#!C#_\51_PG?@_
M_H:]#_\ !C#_ /%4 =!17/\ _"=^#_\ H:]#_P#!C#_\51_PG?@__H:]#_\
M!C#_ /%4 =!17/\ _"=^#_\ H:]#_P#!C#_\51_PG?@__H:]#_\ !C#_ /%4
M =!17/\ _"=^#_\ H:]#_P#!C#_\51_PG?@__H:]#_\ !C#_ /%4 =!17/\
M_"=^#_\ H:]#_P#!C#_\51_PG?@__H:]#_\ !C#_ /%4 =!17/\ _"=^#_\
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MVK"3N<__ ,(;I?\ S]:Y_P"#V]_^/4?\(;I?_/UKG_@]O?\ X]7044AG/_\
M"&Z7_P _6N?^#V]_^/4?\(;I?_/UKG_@]O?_ (]7044 <_\ \(;I?_/UKG_@
M]O?_ (]1_P (;I?_ #]:Y_X/;W_X]7044 <__P (;I?_ #]:Y_X/;W_X]1_P
MANE_\_6N?^#V]_\ CU=!10!S_P#PANE_\_6N?^#V]_\ CU'_  ANE_\ /UKG
M_@]O?_CU=!10!S__  ANE_\ /UKG_@]O?_CU'_"&Z7_S]:Y_X/;W_P"/5T%%
M '/_ /"&Z7_S]:Y_X/;W_P"/4?\ "&Z7_P _6N?^#V]_^/5T%% '/_\ "&Z7
M_P _6N?^#V]_^/4?\(;I?_/UKG_@]O?_ (]7044 <_\ \(;I?_/UKG_@]O?_
M (]1_P (;I?_ #]:Y_X/;W_X]7044 <__P (;I?_ #]:Y_X/;W_X]1_PANE_
M\_6N?^#V]_\ CU=!10!S_P#PANE_\_6N?^#V]_\ CU'_  ANE_\ /UKG_@]O
M?_CU=!10!S__  ANE_\ /UKG_@]O?_CU'_"&Z7_S]:Y_X/;W_P"/5T%% '/_
M /"&Z7_S]:Y_X/;W_P"/4?\ "&Z7_P _6N?^#V]_^/5T%% '/_\ "&Z7_P _
M6N?^#V]_^/4?\(;I?_/UKG_@]O?_ (]7044 <_\ \(;I?_/UKG_@]O?_ (]1
M_P (;I?_ #]:Y_X/;W_X]7044 <__P (;I?_ #]:Y_X/;W_X]1_PANE_\_6N
M?^#V]_\ CU=!10!S_P#PANE_\_6N?^#V]_\ CU'_  ANE_\ /UKG_@]O?_CU
M=!10!S__  ANE_\ /UKG_@]O?_CU'_"&Z7_S]:Y_X/;W_P"/5T%% '/_ /"&
MZ7_S]:Y_X/;W_P"/4?\ "&Z7_P _6N?^#V]_^/5T%% '/_\ "&Z7_P _6N?^
M#V]_^/4?\(;I?_/UKG_@]O?_ (]7044 >9^/]._X1K18[S2M1UF&=TO$+/J]
MU*,"PNG'#R$ AD1@<9!48K>MM'\+WM_/8VFNZA/>6^?.MXO$MVTD>#@[E$V1
MSZUF_%S_ )%B#_M^_P#3;>5)XET.ZU'Q7/J>D2"+6]-LK>6T9C\L@+S;XF_V
M7 Q['![4==1I73+MII'A6_OI[&SUZ_N+NWSYT$/B6[>2/!P=RB;(YXYJ_P#\
M(;I?_/UKG_@]O?\ X]7*0^-)I]/N]<TJ.&-VU*SM+RVNHF+QLQ6-TX8892W7
MD<=.:M:MXQ\0:7)KR1V^F77]GW]K!&6$D7[J?&,\MN8%@,C:.IQVIVV7]=/\
MT+^OZ^YG0_\ "&Z7_P _6N?^#V]_^/5%'X6T2::6&+4=8>6+'F(OB"\+)GID
M>=Q6'JOBSQ)ID7B4XTESH:QW);R9!Y\3J6V8W_*PP?GR0?[HJ@;N_P!"U7QQ
MJVC1:?'%;&"\N()HF_?#R-SA65AM8\G<0W/:EY] M?1;_P!?\ [#_A#=+_Y^
MM<_\'M[_ /'J/^$-TO\ Y^M<_P#![>__ !ZL"#QCXDU74?.T?0#-I<5PL$QE
M,2$# +MO,P92N?N^4<XZ\UJ^#M:UKQ!#<WFH?V?!##<SVIMK>-V;?&^W=YI8
M C@\;!VY'2G85T6O^$-TO_GZUS_P>WO_ ,>JI>Z#X;TPPB_UG4[4SN(XO/\
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M "BBB@ HHHH **** "N?\=_\D\\2_P#8*NO_ $4U=!7/^._^2>>)?^P5=?\
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M:/\ A4>A_P#/Q_Y2-,_^1:+@>@45Y_\ \*CT/_GX_P#*1IG_ ,BT?\*CT/\
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M8WW'<2WUY]*DF\-)=6$,-SJ=_-=P3>?#?N8Q-&^",J @0<$C&S!!.0<FG?\
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M\:VPMRBHQ!;AXF/)53DGMQBA?!6DKI5U9$W+R74RW,UXTN9WF4@K)N[$$#
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MH\"?\D\\-?\ 8*M?_12T =!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 53U;38=9T:^TNX:18+VWDMY&C(#!
M74J2,@C.#Z&KE% '!S_"K2;JXEN+B]DFGE<O)))I>FLSL3DDDVN22><U'_PJ
M/0_^?C_RD:9_\BUZ!10!Y_\ \*CT/_GX_P#*1IG_ ,BT?\*CT/\ Y^/_ "D:
M9_\ (M>@44 >?_\ "H]#_P"?C_RD:9_\BT?\*CT/_GX_\I&F?_(M>@44 >?_
M /"H]#_Y^/\ RD:9_P#(M'_"H]#_ .?C_P I&F?_ "+7H%% 'G__  J/0_\
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M6O0** //_P#A4>A_\_'_ )2-,_\ D6C_ (5'H?\ S\?^4C3/_D6O0** //\
M_A4>A_\ /Q_Y2-,_^1:/^%1Z'_S\?^4C3/\ Y%KT"B@#S_\ X5'H?_/Q_P"4
MC3/_ )%H_P"%1Z'_ ,_'_E(TS_Y%KT"B@#S_ /X5'H?_ #\?^4C3/_D6C_A4
M>A_\_'_E(TS_ .1:] HH \__ .%1Z'_S\?\ E(TS_P"1:/\ A4>A_P#/Q_Y2
M-,_^1:] HH \_P#^%1Z'_P _'_E(TS_Y%H_X5'H?_/Q_Y2-,_P#D6O0** //
M_P#A4>A_\_'_ )2-,_\ D6C_ (5'H?\ S\?^4C3/_D6O0** //\ _A4>A_\
M/Q_Y2-,_^1:/^%1Z'_S\?^4C3/\ Y%KT"B@#S_\ X5'H?_/Q_P"4C3/_ )%H
M_P"%1Z'_ ,_'_E(TS_Y%KT"B@#S_ /X5'H?_ #\?^4C3/_D6C_A4>A_\_'_E
M(TS_ .1:] HH \__ .%1Z'_S\?\ E(TS_P"1:/\ A4>A_P#/Q_Y2-,_^1:]
MHH \_P#^%1Z'_P _'_E(TS_Y%H_X5'H?_/Q_Y2-,_P#D6O0** //_P#A4>A_
M\_'_ )2-,_\ D6C_ (5'H?\ S\?^4C3/_D6O0** //\ _A4>A_\ /Q_Y2-,_
M^1:/^%1Z'_S\?^4C3/\ Y%KT"B@#S_\ X5'H?_/Q_P"4C3/_ )%H_P"%1Z'_
M ,_'_E(TS_Y%KT"B@#S_ /X5'H?_ #\?^4C3/_D6C_A4>A_\_'_E(TS_ .1:
M] HH X.'X5:3;.7@O9(G*,A9-+TU2592K#BUZ%201W!(J/\ X5'H?_/Q_P"4
MC3/_ )%KT"B@#S__ (5'H?\ S\?^4C3/_D6C_A4>A_\ /Q_Y2-,_^1:] HH
M\_\ ^%1Z'_S\?^4C3/\ Y%H_X5'H?_/Q_P"4C3/_ )%KT"B@#S__ (5'H?\
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M\U!0M%)G-+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC]"*\J\-:#-XEUZ#3HLB-COG<?P1CJ?KV'N:^D[>".UMHK>% D42!$4=  ,
M5GB:G,_4JE"Q,**0=*6N4V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI?/;QW+EA\FP1JF1D'C;D^O&*=@$\&>"XO"D%U-/>RZEJ]\XDO-0G'SRD=%
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M=X+V"\D\N2)Y&D9)1Y7S@;L!2#Z@CI6Q)I_C2;Q)INLRZ;H!DL[66W>-=3F
MD,A0E@?LYVXV=.>O6NRM+VVOX#/:3+-%O9-Z]-RL58?@014]%[?UY6'_ %^)
MF:*FJK'.VJ0V-L6DS%;V4AD1%ZDEBB$L6))X_K6G112 **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFXO([PV^0LT<!BRI)/*EFYY/.?PK:HI ]0HHHH **** "BBB@ HHHH ****
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M[]9-*EO?M[6GD8<S=1F3=C8" =NW.0/F(XJJ?!>JCPA=>&(M?@%@UN;6V9[
MM)%$>,.?, <A> 0%]3FI6RO_ %M_P?4:W.EL=1GO/*+Z5>6J2*S;YFBPN",9
M"NQ^8'(XZ YP>*X_QI]G@\9: ;JZUQ;6ZBN%GATVXN_G**I0^7 <\$GD#ZUV
MEM#>Q?9EDN;=XTAV2A8"I>3C#*=YVKU^4@GD<\<XNM^']8U#Q'I^K6&K6-J+
M&.1(X9[!YMQD #$L)D[ 8  []:'NK?UN"VU_K8Q_!%Y=:NOB"TBU.\-A!>+%
M:&[8F\B3:-X<-\ZY.=I?YL<^E07=YJGA>S\72V5W<W-A:Q1?86O)FG:*X8$.
MH=R691E#@DX)(K9L?">H64VL:F-9B;7=35$:Z^QXAB5 0H6+?G@$\ESS^53Q
M>&KRYT:[TC6;ZSN+&>!H1'9V;6Y&[JS,TLA+=\Y'.2<]G_E_E_7JPZ_/^OZ[
M>IGV\=WI?BJ+0(]3O)(+_3GN#+<2F:2.5'1792Q.-P?H/E4@8 Z52N[S4/"A
M\67-G<W5WIEEIZSPK=W#3F.YPQ90[DMC&PD$X&>.M;EOX;U**:>_EUB&;5S:
M_9+:Y-F0D$><Y,>_YF)P2=P!P, 4ZT\.W[Z;<Z9K-_8W=A/"\3Q6MDT!<O\
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M6HZ-:_;[6S?RE1%+Q+$&#!7QW8-SV4@>M"Z_U_6N@[:I+J>@45Y]JGBSQ%I
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MEST>BN,\'>)?$/B*>.\N]%%OHUW;>?;W&8P4)(PIQ*Y?(.<[4QC&*[.AIK<
MHHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
J444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex10-7_002.jpg
<TEXT>
begin 644 ex10-7_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z8# 2(  A$! Q$!_\0
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MG_Q-?2F** /FK_AG;Q+G_D*:5C_>D_\ B*=_PSKXC+8.K:7CUS)_\37TI24
M?-O_  SKXB '_$VTS/?F3_XF@_L[>(L<:MIA/UD_^)KZ3HH ^;3^SIX@S_R%
M]-_\?_\ B:4?LZ>(/^@QIG_D3_XFOI&CBD!\W?\ #.OB#_H+Z;_X_P#X4U?V
M=_$3==6TP?C)_P#$U])\4E,#YL/[.WB/./[6TO'KF3_XFE_X9V\0\8U?3/?_
M %G_ ,37TG28H ^;/^&=O$F?^0KI>/7=)_\ $T@_9W\29P=4TO\ [ZD_^)KZ
M5HH ^:C^SOXC[:KIA/IF3_XFC_AGCQ'D ZIIF/7+_P#Q-?2N*0B@#RCX1>!]
M1\"ZWK=GJ$]O,9[>WE1H"2,;I!@Y ]**]"@&/%5U_P!>4/\ Z')10!\W_ @D
M?$J/'>TE'Z"OJ45\M_ ;=_PLE,*#_HDN<]AQ7U+0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !WHHH
MH **** "BBB@ HHHH **** "BBB@ HHHH 04M%% !1110 4444 %%%% !111
M0 4444 %&:** $YS[4M)0:  >E+11F@ HHHH **** "DI:* "BBB@!*J:O<R
M6>BWUU#CS8;>21,C(R%)'\JN5G:__P BYJG_ %Z2_P#H!H X#16^)VMZ!8ZO
M'K^@PQ7=NEPJO9-E RAL'GMFH;'4_&&J3FWL/B+X.NI@I<QVZ+(P4=3@,>!7
M8?#XX^''APG.!IL'09_Y9BL#08+Z+POK.HQ7.LQSH]Z]K:S:;M:%VD=T:)&B
M#-N##J'ZD<<BCN^P[;#+:V^(MZ\J6OC7P],T1 D$5GO*$@$ X/&00?H:6>R^
M(UM)!'<>-M!ADN'\N%7L0ID;&=J@GDX!.!Z5!?:SX@,%Y<Z19ZBEQ*UI]HFD
MT^:)E3RCN*!H'W$/M!"QOC)X'43'4-?N=1TD:M%?_NI[5REII\C6\BE/GE9C
M&'1@Y(VG;@<E>X=M;$]+DW]D?$KSO)_X331Q+MW;/[.&<=,XSTIW]@_$T]?&
M>F#Z:6/\:E\7:SK5AK,MOI\NKB-H;=H_LNE-<1JWG8D^81,/]7DD$]AC!ZR3
M7&KZG\-];C634SJ,8N8H97LS#/* 6V$(4 )9=O*KWXP:2U5RK:V,^VTOX@WI
MF%M\0-(F\F0Q2B+3D;RW'56P>",]#4W_  COQ*/_ #/5@/II"?XU0TJ^UBPU
MN\^QC69UN;MP%NM*=$EQ:H%E9_*7:?,0+U5>3QW&MX?E\4:UX2UJWU&9X-0D
MC>.V>2*2-HG9,8RT,0(#="H;C^(]22T6G82U=F9EI9^-;^[GM+/XGZ/<7-OQ
M-##IT+O%_O -D?C43P^+4=D?XLZ,C+,+=E_L^WR)3T0@M][VZUI6L,EV?#4%
MEIE]ILFCJ?MCO:,@B3R60QHQ7$I+%3\FX?+D]JYG3=+G$ND33'7S)_9EV)VE
MT3)\P,&C5LV_)X9AG)R!C[V&;T?]?UK8:5SHXO#GQ#GB26+XCVKQN RNFC0D
M,#T(.>13_P#A%?B*>OQ(B'TT.'_&F6FL>*;FV64-?QWRV(D@M)M+80W+^3SO
M<H#$XER,%E& /E.<C1\,ZAXFN/"FI3WB&?4DWFT2>)XV)V A6W0P@_-GE5QC
M')ZT-6OY"CJEYF7=>'?'=E;27-W\4H+>WC&YY9=%MU5!ZDEL 4^'POX^N(4F
MA^*221.H9'CT*W*L#T(.[D51U&?7+_3(DGN=>:V74+-TF&E8GR&S*K1B$C8F
M 0VW!/&6[^FV\$-K;QP6\210QJ%2-%"JH'8 <"BVEQ7N['"?\(CX_/7XFO\
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M>O'2KW_" ZKW\?>)/^^XO_B*S=0T3Q7'ID!MH+QKN2SN4FBL=0\I(YS,)(W
M,BC&-XR.3N ;CI!+8>*9;RZ(TKQ,L,DMRPQJT0 1D!C5<7&00XSVP#C..*&)
M%^V\(7-W=75K%X_\4F:T8),I*)@D9&"8\,,=QD5;_P"%?7IZ^._%/X7,0_\
M:=5TTGQ'+J5K=K#>VUW+';/)<&[41(43$J2QJY#L>Q"L!G.1CG-TG1?&*?8X
M]4?6)LWR&Y,-V(E$9C=9&#?:F9E+%#@!-N,JBFFEK;^MP3ZFW_PKVZ[^.O%G
MX7D0_P#:='_"O)^_CCQ=_P"!T?\ \;KM0,  9X]3FEI#.)_X5W+_ -#MXN_\
M&"?_ !NC_A7<G_0Z^+__  8K_P#$5VU% '$_\*Z;OXS\7G_N)#_XBC_A7/\
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M@F@#'^'1S\./#G_8.@_] %6?$/B"3208;2T%W=B"2Y9&E\M(XT'+.V#CG
M.3[ D<_\/O$VC0>!-%L[C4K:WN+?3H#)'<2",A2@.X;L97GJ,C.1U%84FJ:Y
MXK36[C1]'^WZ;?7!M#="X1 UI$0K)'GJSEI<$\#/7B@#U6VF^T6T4VTKYB!M
MI[9&:EK/TC5K/5=,6[M24C7*/'(-K0L/O(X_A8="*T,@C(H **Y8ZGJ$GC%4
M2["Z<MR; VQC'SR>09S)NQGCY5P..M=3F@ HHHH *,BN:\8:R=*CTJ-9_(^T
MWZ"67< $AC!EE)]ML9!_WJ9X.AOI/[1U6\DO0E]/NMX;M\LD0X4[> F[.=H
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M *$Z3\=1AI?[<\4'IX0/XZE%_A2&=/17,_VUXI_Z%)/QU./_ .)H_MGQ4?\
MF4XOQU-/_B* .FHKFO[7\5?]"M;_ (ZHO_QNC^U?%9_YEBT'UU4?_&J .EHK
MF_[4\6'_ )EJQ'UU;_[51_:7BW_H7-._\&S?_&: .DHKG/[0\7'_ )E[2Q]=
M7?\ ^,4OV_Q>?^8!I ^NL2?_ "/0!T5<5X0X\=^.A_T^6W_I.E:GVWQ?_P!
M+11]=8E_^1JP_ KW;^-/&YOH(8+DW5J7C@F,J+_HZXPQ52>,?PC^M '>T444
M &:2EHH *3-+2$4 9%N6_P"$MO <8^PPG/?[\M%,M_\ D=+W_KP@_P#1DM%
M'SG\"'=?B5"%(PUK*&SZ8!_F!7U.*^6?@.I;XE1D 8%I*3[=!_6OJ8#% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 44E% "T444 %%%% !1110 4444 %%%% !1110 44@I: "BBB@ HHH
MH **** "BBB@ HHHH **** "BBDH 6BBB@ HHHH **** #-%%% !1110 49H
MHH *I:N,Z+?C_IWD_P#035VJFJC.CWH_Z8/_ .@F@#DO!=EI]Q\+/#\]_96]
MRMOIT<B^;$K[<+GC(XZ5G_"/7].?P7I>F27(CU%DEG,,J-&7#R.^4W !P-W5
M<UL?#Z!+SX4Z';2%@DNFI&Q4X(!7'%,?X5^$9;.WM9-/D\F )A$N)(U9E& S
M*K ;NN3CG)H XWQ+J$>I>*=<FL)A-X>TG[+<:U"BDK<2K(5=#_> B!+#H3&H
M-=7\//$,=[H]MIJ1@+8Z=;RSR&0?NFDW%8\?[*@9/;IUS5]_AUX<+*D=J\%F
M41);&&0I!/M)*^8@^^02>O7OG%2-\/O#9%NB6+100Q"'R(IW2*6,,7"R*#AQ
MN9CAL\D^M 'FS^+1'JVJW&GW*S/:ZA(\)BVR#RW=/-N&]$6(!5/<NV,XIGBS
MQW?OXKL-;TZY0Z!::C'96\L<S%+LLN9B%7[P'W<D'MMY)KV]+>&(8CB11M"_
M*H' Z#Z5CKX.\/IK;:R-*M_[19_,^T,N6#8P2,\ _2@#';X@6]CX*DU_58A;
M3?:9K:.S_C,BR.J1GT8A03Z9STK7\'ZQ=:]X5L-3O1 )[E"Y$ 8(!N.W ;D?
M+C.>^:H:Q\.M UG4QJ,D4UO=,6,LELX0RY7:<\'!P,;EPV.,XIX^'/A)9'>/
M1((BYRPA9HU)^BD"@#F/&46H3?$K2+A[2+5=+L+22]%HHVO'AT1G'7S&&00I
MP./7&?2+.\M[ZRAN[:598)T$D;J>&4C((K/LO#>GZ;J,5W91"W6*V:V2"-0L
M:AGWL<>I-5=,\(:?IR)%\\D-M>27=DA)7[,7Y91@\C<SD9[-CMF@"+P*[3>'
MYKJ9-EW/?W3W*]U<3.NT_154?0"L"^^*B0^%!JMII4EQ>3W$\5I9A\&5(B=T
MI;'RJ%&3QP>/>NEG\+'[==W%AK%_IR7K;[F*W\LJ[X +C>C%6( !(QG&>O-<
MIK7PV\,:)X<O'CEU*-3:M:B)+EV,VYLI%CJ<N1\JXR3SG- &C!\5O#ZOHMIJ
M,CVNI:G%#)]F"EQ"90"H9@,#J/S[5U$OB#3(M*DU(W2FU0L-P'+$,5PHZDEA
M@ =3TSFO*- \!:M=R:3XA9+"^2X:.ZG@F9H'BD"QX4MAMR1M%A5 7/0DC-;V
MC> -:BTFROKJ\MH=?M$5;:)D,MK J@\%01N<EF8OU!; X'(!0\=Z[+XHN_!F
MG>'VVWEQJ9NP)T(,)MR5;S%_V6W9'<IQZUW.E^)7U'Q7J6C) IAL(TW7(;[T
MA^\-O8#/KU#>E<QHWPPO].OFUF3Q+*-<<R9GBM4\I5D=Y'78V<Y=R<Y!X';B
MM.V\':SHEW>WNAZ[$;B_<2W8U&S$HEEZ;@8RFT8XQS_.@#5\=D#X?>(LG_F&
MW'_HMJWV0/&R$D!@0=K$'\".17GGB[0];NO!.N7/B'5;>X6VTVYECM;*V,,1
M<1-M9RS,S8Z@<#//.!7H;(DD3)(JLC AE89!'H:3V \QT7^TM*\-7VNW,5W<
MQ112!/,U^ZD,Z^:025<$1LJJ,%<Y_O#-;/\ ;%SIFI7$"127:S:O+%%YU](O
ME'[*)0.C90D,,=!D$ XQ4VGZEX!O-!U*ST^'2I=*M)_+N[2&R!C,N1@>4%^<
MD@ ;0<D<9-0WG_"MK9M-M;S3]"0ZK+FUBDL$_>OTR1L^4]LMCGCKQ5>7I^7]
M,-G=^?\ 7RN$'CR]FT4WIT1!<-%;3PP)=/)O28$C.V(OD;6X5&.,'UQ>OWU#
M6?!*W5U'/HVH,%E1+>Y?="V["[CA-W!R488[$&L_4="\$WT5[IT,-EIC6ZB2
MXEM["%5*1]03)$T<BJ2,C!VG'0XK3M+;PLW@WR9;>VET2U#/)'>V@18RI+$M
M$R (1UQM&,\#I0[:OT!)Z(Q9=>N;#5K^]GBEDU#3K.-;JT:]EC@(:3'FHGS)
MRO(XSU!((-6;OQW>VQFV:+!*(1>%R+XCBW*Y_P"6?=6_ \=.:Z.YDT5UMH+I
M+5AJ*?9XHY(@?.3:6V8(^[M!.#Q7+12?##4[:^NHM-T&Z2QG$$Y735=A(2%"
MJNS+DD #:#G&!FEK_7]=P5M_Z_K<6\\0ZA?7EB8;06]Y:ZD(?(^WNL,Z/;-(
MN\A?=<@JV".,]:=;_$2:]OX+6TT*XE+PJ\K_ +PI$[*Q7+K$R;,KC<6!Y!"F
MKK+X%M](C<:=I/V/4RH6"*P5C<E.@\I5+,5YXQE?:M2ZT_PY>ZO#:W>GZ=<:
MA';%HUEME=TASM."1PISC'?GWH?9!=:?UU_X<F\/ZI/K6AVFIS6J6HNHDF2-
M9?,(5E!Y.T<\G]/7 TZAM+2VL+6.UL[>&WMXAMCBA0(B#T ' J:F[-Z"5[:A
M1112&%%%% !1110 4444 %<5X4_Y*'X['_3S9G_R66NUKBO"W'Q'\>#_ *;V
M7_I,M ':=:6BB@ HHHH *0FEI* ,B#'_  E]YTW?88?K]^2BHXI0OCFYA(.Y
M]-B8'MA9'!_]"%% 'SM\!B1\2DQT^R2Y_2OJ6OEKX"MM^)*#'WK.4?RKZEH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "DI:* "BBB@ HHHH **** "
MBBB@ HHHH 3%+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%(.E
M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ,/QISX$\0C_ *AMS_Z*:M2W!DL(P'*%HQAEQD<=1GBLSQD,^!]?'_4-N/\
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MOIUW8L;BS,+ EF8ND).U"O 8,.=W8'O2^S?^NO\ D+K;^NG^9Z!17C&E^?\
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M)(/L]G"A-S(F3;S,P8XA."4('&=O3D<TUY_UM_P0M_7WG7ZO;#1]*N-0EO\
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MP*^YHF62U7*MDY8^?G^(M@9Z_0_"=[I5SI$A@M"UK$8Y9Y;@32(GS$)&! @
M^8<C8, #:<"G8;WT-[_A';/_ )^-3/\ W$KC_P"+H_X1VR_Y[ZG_ .#.Y_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P!\_P#UZ^J1STH 6BBB@ HHHH **** "BBB@ HHIK,$!8D #DDT *3BO/\
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M %%%% !1110 C=*1<XYI3TH'2EU ,<T=Z6BF 4444 %%%% !1110 @S1110
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M'_;=** /G[X&-M^)UI[P3 _]\U]5#.*^5/@=S\3;,8!_<2]3T^6OJM1C%
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MD'(Q7(:3\.+S3]5T.^FNX)GM9[NZNP%*AY)P/N#L!CO6UX?\)7NC_#^3P_\
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MY&E82Y&6#':N >BCG IUA\*]0CT75[>ZFL4NKK3UL87A,C X(.YRY.,D#@#
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MBC-% !1110 4444 %%1S-(L9,2AG[!FP/SP:>.E "T444 (:,TC,!UH/ S0
MN>:6DI: "D-+FD- ')L1_P +9B QG^PY,_\ ?]**SM4GDMOB[;M$VW=H4@/
M/2=/\:* /$O@6N?B=:G)^6VF/7_9_P#KU]4]Z^5/@:2/B?9X&<P39]OD-?5F
M,F@!*=110 4444 %%%% !110: $-?*?Q?\)?\(KXU-Y!;XT^_8SQ#L'S\Z_3
M)_(U]6US?CCPE:^,O#5QIDX19B-UO,5R8G'0C^1]J /D34KQM2U:>]L[1+4
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MV<@]!GJ*]U'2N6O/A]H%[K<6JR02+*C1L\*2E8I6C&$+IT)7M75#B@ HHHH
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MH 6BBB@ HHHH **** $/2@=*#TH'2EU 6BD%+3 **** "BBB@ HHHH ****
M"BBB@ HHHH **!10 44A.*44 %%%% !11FD- "T4E+0 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M10 4444 '>BBB@ HHHH ***3- !2T&B@ HHHH ,T444 %%%% !1110 444E
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M !1110 444ASCB@!:*.U% !1110 4444 %%%% !1110 4444 %%%% !1110
MF:6BB@ HHHH **** $/6EHHH **** $/2@4'I0.E+J M%%%, HHHH ***3%
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M<,,>E2AY(W4DN-ZMP1]* .[%%(*6@ HHHH ***.M 'E_Q _Y*K\/_P#KO/\
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MXWMUT:;1M2\F">ZLO-5X-N[B2,KQS@Y^E 'LUS?6UFB/<SQ0H[K&ID<+N8G
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M'2O+/'J@_%WP#@@MYDV1WQ@?I_\ 7KU.@ HHHH **** "BBB@ HHHH ****
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M .@)7JE>6? HY\+:O_V%I?\ T%*]3H **** "BDQS2T %%%% !1110 4444
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MKUYQG&>U=A10!SGAK3;R._U?5]1B\JZOK@!(]P8I#&-J D<9/S-Q_>KHZ**
M ]*1>E*>E(.E+J M%%%, HHHH **** "DI:* /*O&63\<O! [>7-_)J]5KRO
MQE_R7'P0/^F<W_H+5ZI0 4444 %&*** "BBB@ HHHH **** "BBC- !1110
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M "BBB@ HHHH 2EH-)]* %HHHH **** "BBB@ HHHH ****  ]*1>E!Z4"EU
M6BBBF 4444 %%%% !110: /+/%RM+\=O!:(,E+>9SSVVO_A7J=>5>*9/+^/G
M@\Y W6DJY/TDKU3M0 N:*0#FB@!:*** "BBD[T +1110 4444 %%%% !1110
M 4444 %%%% "4M%% "<]J6BB@ HHI* %HHHH **** "BBB@ HHI#[4 +1110
M 4444 %%%% !1110 4444 %%%% !1110 E&/>EHH **** "BBB@#YZ^. /\
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M2CCJR_\ QRO7Z* /(E\0?&9<HWA;2W(_B\P '_R+2CQ'\9.G_"):9GU\P?\
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M(R)X$A4D_*7EP /<[N:E7X@?$3&&^'DA9>&(N,#(]*]7Q1B@#R<_$#XB<_\
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M$M-$\$Z:EM;+!)/!'-<8.2\I49)/X5U= !1110 4444 %%%% !1110 4444
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M P-Z X%3T4 0RVL$\0BEACDC'174$?D:$MH$F,RPHLA4(7"@':.@SZ5-10!
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M2?4],=*M6UGIVJ?'778]8ABN)8+&#[#'.H90I WD \'DG\S2 O:/X4\)^([
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ME?4% !FEI** %HI ,  4M !1110 4444 %%%% !1110 4444 %%%% !1110
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MCTZWN9P\TABMY7@98YF_V6^O'.*V;?Q7IUS?ZW9QB7S-&"M=$KQ@J6^7UX%
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MQGVH Y;3;)-/T;4M.C\#>(Y?[3C*7EU-/"TTP((Y8OZ$T]Q&IT&>3P/XE5=
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MUX1O]"US16;;);66BM9R3*< RF16P!UQP:X[5O 'B.\:65M%@N=22_\ M/\
M:4VH%FEC$N51$/"_+@<XX%>O&QNC%L_M.Y#8 W[(\\=3]WO43:9>F:1UUBZ
M;[J;(\+_ ..Y_6@#B-5\.:W+J?C>*"Q,EOK>GH;><2J-LJ1E/+(//.>O2IQI
M_B3PWKEWJ6G:0FJ1ZE:6Z2QBX6)H)HD*\YZJ<]O2NR_L^](CW:K.&7.[;''A
MOS6G_P!GW/EE3J=UNY^;;'QSG^[^% '#^&_!NH:!JGA=7C66.SM+S[7,C#:L
MLK*V #SC.?RK:T6#5M&MM2QIAFDN=:DD"^:J_N789D_ 9..O%;,>EWRAM^MW
MCDG(S'",#T^Y4\=E<JH#ZE<.V<D[(QG_ ,=H NCI2UGRV-W(&":I<(2!@A(S
M@^OW?\YI'T^\.[;JMRN5P/DC.#Z_=H T:*RI=-U"2/:NLSQD'ADACS^.5-*^
MFWS21E=8N4C6/:RB.++M_>)V_H* -2BLX:?>*K :K<$GH7CC..?912"QOR@#
M:K)D=6$*#//T]./QH TJ*S_L%UMQ_:=SGCYML?I_N_YQ3(M/OXY06U>>5/[K
MPQ]/J%% &G16;)87[NQ75940]%6%,C\2*C.EZB8%3^V[GS #^\$,7)[$C;0!
MK45BKI6K#;_Q/YFQUS;1<_\ CM2OIE^S*1K5PH!Y"Q1\]/5?;]: -6BL]K&[
MP^S4YAG&W=&AV^O\/-1C3]0$C-_:\Q4G(4PQ\?I0!J45E2:;J+_<UF>,;B>(
M8R<>G*]*A?2]7,Q*:]((RQ)4VT9(&. #C^8- &UWI:QQINJE"KZY(#GADMHQ
MQ[Y!Y^F*D_L_4-V3K$V.P$,?Z\4 :E&:PGTO6VF8IX@9(B20OV2,L!V&?_K4
MY-+UD$%]?<COBUC']* -NBLM-/U!!AM7FD//+0Q_T ]_SJB^E>(C/NC\1HL>
M3\K6*$X^N>O^<4 =%25@QZ3KBL3)XB=QD%5%G&..X/K^&*E_LO551MNNSEL'
M;NMXL9[9PH_G0!M9HK!>P\1,"/[;ME('!6QZGWRYX^F*@FTCQ*SDQ>)413CC
M[ AQZ]Z .D[TN:PX])U=57?X@E9QU/V:( _I44FE^(Y)BP\11QQD\(E@O ^I
M8^U '0YHS7.0Z/XB#+YWB=G7G<$L8U/MC.:L/IFM YAUYOI+:QL!_P!\[3^M
M &UFEKG?[+\2D\^(H IQG&GKGKV^;^>:4Z7XBW@KX@C"@8VFQ4Y/J3N_E0!T
M.:,UB_8==#975X, 8 :T!R?4_-_+% L->+_-K,&S9C"V?.[USNZ>V* -K-%<
M[_9?B4R1D^(8=@^^!8*"WX[N*N?9-:WQ_P#$S@V8_>#[+R3['=Q^M &M16.+
M/7!@G5;8]<C['],?Q_7_ #UKR:;XD)/EZ_;J 05W6 )^A^?^6* .@HK(2UUT
M2 OJ5F4V\J+0@[OKOZ5$;+Q$("HUBT,I(PQLN ._&^@#<HK!6Q\2+)O.L64@
MS_JS9$#''</GU_.I4M=?\_,FI6?E9^ZMH<_GO_I0!LT5E_9=7\]S_:4/E'&Q
M?LW(]<G=S^0J-+37$A(;4[624M]XVNT*/8!NOXT ;%%8GV;Q%Y3K_:=AYA V
MM]C; ..3CS.>:1;3Q&)4+:K8&/C<OV%LGCG!\SUH VZ6L22U\1&1_+U*P"'[
MFZS;(^OS\T@MO$F7+ZCIP'.T+:-QZ9^>@#<HK$>T\0MNV:K9*,#;FS)(/'7Y
M^>]*L/B(*0U]IQ89P1;.,^G&_P"M &U16$UMXE+NRZCIH3'R(;1C@^YW\]NU
M2"WUY8WQJ%B\NT;0;5@N[W^?.* -FBL#RO%7!^UZ3TP5\B3CWSN_3'/J*G2/
MQ"IB#W.G.!_K"('4GKT&XX[?K0!KDXI:P[B'Q-Y?^CWNF;]W22V?&W\'ZT1)
MXF8KYL^EH PR5CD8L/S&#T]?QH W",T5B+'XE^TN7N=,,/.T+"X;V!^;_P#7
M[4^:/Q 1F&?3@=IX>-SEN,<YZ=?TH V,8HKG8?\ A*Y 2TNC8Y7Y5D.#TSUY
MY'2K,<?B(K$)9]-!#'S"L3G*]L?-P: -FBL"?_A*5N'\D:2\.04WF16'3.>N
M>]1*_C$RX:/15C)ZB24D#\N?TH Z2BL1/^$D#J9&TPK@Y55DZ]N<_P!*?&?$
M)4^:--#!N-I<@KCZ<'/UH V**YSS/%PDD'D:,4W'8?-E!QSU^7KTJU')X@RP
MD@T['\)65_R(V_K0!LT5CSS>( SBWM-.8;1M+W+CYN^1LZ571_%A*AH='7(^
M9A)*<'TQMY_.@#H**Q+2\UB*_C@U.&R"3,PC:VD<D8!/(([C\O>MN@ HHHH
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M=P"$"."Q]!D@9I =P&XYZT%@.IKPK6AIMF_BW4(M4D^T6.KVKVF;YB%SY>_
MW<_QCG.,$=JZ"^O='NO$&KQ:[<2Q:JEY!+I0MW/F20@*8Q#V.YMP;Z\]C0!Z
MO15.QU*TU![J.UG65K28P3 9^1P 2.?8BKE !124M !1110 44=Z* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $[
MT=^E%+20!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "@C-%&: $
M I:** "D*ANHHI: $Z4TQKYA?'S$ 9^G_P"NGTE  !2T44 %%%% !BBBB@ H
MQ110 @P.!0>M+2&@ I:!10 4444 )2T44 %%%% &3J!!US2(\?-NE?/H F/_
M &85K5E7JY\1:8V>D<_X_<K5H **** "BBB@ I.<TM% "'I0**6@ S128I:
M TE+1F@ HHHH ^9/VA"?^%@6O Q_9\8'_?<E%'[0ISX^M.G_ "#T_P#0WHH
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MC_@(JX6QVK$A&O6UI#!%:Z:?+4)DW#@8 P,#95I9=6.=UI:#'I<L<]/]CZT
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MEHHH **** $-+110 449S10 4449% !1110 4444 %%%% !1129H 6DQ2T4
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M7[2V]U+:LNHNIE5U/W,@_, #UZT =GCFBEZTG>@ [TN*** #%&*** "BBB@
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M:;=_:ECCC^\=K+USU);)/.<5TM)UH !THI:* $%+110 4444 %%%% !1110
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M]0TGQ#=:WJ:Z5!<2V_V?R=+A:..09!WN#_%QV]ZVOL_B_!_T_1\XXQ:2=?\
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M8],QCG][)S_X[0!LT5CK)XA!8O;:<P/W0L[C'U.SGM4D3ZV5_?06"G/\$[G
M_P"^!S0!J45BM+XCWX2UTS'JUQ)Z_P"YZ8J-9/%.X[K;2=O;$\F3_P".4 ;U
M%9$<FOE 7M=/5L<@7+GGZ[.E->3Q%YIV6NF^7CC=</G/_?% &S16597.J#4!
M;ZA':*KQLZ>0[-C! .<@?WA^M:M !1110 4444 %%%% !1110 AQFBBEQ0 4
M444 %(>E+10!\O?'_CXB1].;&+_T)Z*7X_G_ (N)'Q_RXQ<YZ_,]% $OP!A,
M?Q&ND<'?'8R@XZ AT!KZ;KYL^!/_ "4_4^O_ !YS?^C4KZ3H **** "BBDH
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M >GRCCIS]*=@/3M<U>+0]'N=2F@FGBMT,CK" 6VCDGDBKMO.MQ;13*"%D0,
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M:@#T/5-3M='TNYU&\DV6UO&9)& S@#V[UG67B47=G>SMI6I0O9L \$D(WN"
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MC/'IUHDIC,9D6%0Q0_PDXZ>U&G:9I>C6S0:;:6UI"S;V2% BDGN<5?8!D*D
M@C!![UY5H36VFZAXNLX_#%U>PR:B\>ZWBC*!-B'9\S# !).,8YH ]!N_#^B:
ME=27-WIMG<SO'Y+R21*S%/[I/I1_PC6A?.?['L/G78W^C)\R^AXY%<%X/UL:
M#X"\-VUG9"2]U%96(*O@;22S-L5F/51T[^@KN?#VKW.M:!%?3V$MG=-N#6TP
M92K D=P#@XR#CH: '-X?T*[2,/I=A*L*F*,&!"$7D%1QP.O%.N?#>BW<EK)<
M:59RO:8\AF@4^5C^[QQ7'V7BQ-(T&S=;"SL'O;Z[1Q/<L(ED5WS\^T\LP.,X
MKI[W4;[_ (1"75H8UAO!8F<02-E5?9NP2!DXZ4 71I6EQ7KSK96B74X*O((E
M#R#N">IJ+_A&]%6UGMETFR6"X $L:P*%<#H",<UY\T^I2>)?!.IBVM[C4[G3
MIP2)BJL/+0AF;'N>@[UL0_$66XTG27BTW.I7RSL]N6<K%Y+;7R54D_-@#CO3
ML NL^!+BZUR.ZLXM&EL8[9;>*SO[0R);@$DF/!'7C/T%;>B^$-*TK3[>":TL
M[B>/?B8VZC 9B2JYR54;B ,]*L:'KLNL>&DU6?3KBQF*,6M;A2KJ5SQR!UQP
M<=ZY;P9H&G>*/#:Z]K,(O+[5-\KO(Q/D@L0$C_NA0!T[\T@.KG\,Z!=V4=C-
MI%A):HWF)"T"[5;U Q1JGA[2-2CM8;O3[*80$>0L\*L$ QD*.W Q^7I7$-IM
MUX2\6Z7%I-NVHW(T::(^?.8U81O'@L><''' Y/YU>;Q%;ZWJ_@K4)-,Q'=I-
M/#.;@Y@<1'>I4##<=Z+ ;G_"&::FN:5J-O!!;1Z9'(L$$,(09?@DD=L9X]3F
MM2[T/2M0U&WOKJR@FN[;_4RNN63G/'X@&N5TKQY?:M?6*1:))]DU&*1[><>9
MMC*C*B4E, ,.ZDX]ZI^ -.?7&/B74HU74(KVZ5989V.\;V3:RD8VJ  OTSQ0
M!VM]H6CZC<QW-]I]I<3(,+)+&&8#.<9/;-$OA[1;F>6>;2[*665=LCO I+CT
M)QS7F%[;Z=8>,O&!N="N]4MH8H)8XH!N6(F,EN-PQD\\ UT5WXCN?!>EZ- M
M@L^E2P+##<&=F<2[,HC#;_$<*#^= '2CPCX>65Y5T>R5WB,)(A _=D8*_3':
MK]MI-A::8NFV]I#'9*A00*@V;3U&/2N<U/Q7J&FK86CZ=&^JW-L]P\*R.R1A
M< C*H23E@.@'7FH!XUU*]M(6TS0I'O/L/VVXM;F0Q/&"6"Q@;22Q*MC@#@>M
M '1Q^'=&AL9[&+2K*.UG&)84@4))]0!S4<'AK1+6\BNX-*M(KB*,Q1R)$%*(
M>JC'0<FL-_&&HK-JL#Z7''+9Z9'J*(\Y!(;=E&^7@C:>F:S;#Q=KFJ^)='^S
M6=N+*[T9KXP&<ABQ*]3MZCH/J3[4 ==IOAS0]-2Y&G:;9P+<$^<(HE ?J"#C
MKU/%4=3\%Z5=>&+W0[&TM+&WO,>9Y=NN,Y!W8X^;C@]CBN9T#Q2VGZ%HL]GH
ML=MIFHZA+!,SW3,;:1I7&3\O()'MR0*UI_&UQ!$V;"-WFOI;6SVR,1(D>=TC
M80D $$8 /- '706T<-G'; ;HT0(-W.0!CFLNU\)^'K"\%W:Z190W )99%B *
MD]2/2J^B^)9-3\+3ZK+I\]I/ L@DMI5(.Y,]"0,@XX..]<UX?\*VGB'P3'JV
MH332ZMJ</VHWAD(>W=AE1&?X57(X'I0!U;^#_#CI*CZ/9,LLHFD#1 AG'1C[
M\]:G30=%@ENY5L+17O5VW!\L?OAZ-ZBO,&US5O$^A^!TNHH)TOKN2.Z5I&19
MVC5P,X!^4XW?7M39O#:!O$EE?:<E[9Z-;PM;J]^XD1 C/M5]O&><]/3FBP'I
ML'A7P]!I?]G1:/8BP9_,\CR%*%O7&.M73I-@VF'33:0_8BNTP; $QG.,=*XV
MP\3W0TC3;'0-%B>5='COO(>Y(5$/"QJ<$LQP0"<=*74?B'=VA:.VT"ZN+FWM
M(;F[MQNWH9.?+7:ARP&2<X''Y &]%X(\,P&/RM#L4\MPZ8A'RL.A'I5MO#6B
M/%+$^DV3QS3>?(K0*0\G]XC'7WKG+'QKJNI^*9])M= /DV_D//-)<A62.5=P
M;81G(]/K6UK6N7-GJNGZ386T<U]>I)(IFD*(B(!DD@$DY8 "@"Q/X;T2?4K?
M49M+M'O+<!8IFB&Y .F#[=O2G?V#H_\ :W]K?V=:?VAC'VGRAYG3'7K7 >(/
M%=_KOA6%(;..WF.LQZ9?023'AA(N5!"\JPZGT/2N@O\ PO-I_@#4]*T-S;75
MPKNBF8E5D8@E%8\@'[H],T ;DGAW0YKMKJ32[)[EY!*TIA4LSCH2<<D4RX\+
M:!?_ &EI]*LYOM3J\Y:('S&48!/KBO/O"EYIS>)?,MM+FTC6K>PFCFT>=F43
M<H0Z-T(^4@GKR*V/#/B!+;PKX>M]%TQ8WU,SM#!<7+%8PI9FR^"23V&._M0!
MW+:?:-]EW6\9^RG,'R_ZL[2O'IP2*J:CX;T;5[R"[U'3+6ZN+?\ U4DL88KS
MGO[URT7C[5+FUT26'P\I;5)Y+=%-Z/D9-V23MZ?*WX"J\'Q&U(JDUSH2PV\6
MJ#2[I_M62LI;:&0;?F4<=<'GB@#T0H"NTC@]JQ[7PKX?T^\6[M=)LH;A265T
MA *D]2/3\*Y^;X@2VWB*'3KC34CCEU'[ @:XQ,<])?+V_</KFI/BCIUM>^$&
MEF0^9!/#Y;J2"NZ5%89'8@D4 =!+X;T6YU%M2ETZVDO'7:9R@+E<8QGTQ58>
M#O#,%HUO_8M@MLSB1D,*[2PSAL=,\G\ZNW<L>A:#-+:V;2):0,T=M",%MHR%
M7WKS'Q?XJ7Q+X+\4:=<VT"SV%K!<J]M<F5?F;IG P1@@]: /2W\/:--JD6J/
MIMJU]$ J7!B&]0.F#0?#6BMJYU8Z9:_V@R[3<^4-Y&,=?IQ7(#QY?Z3%=6VJ
MZ$89+?3EO;<Q3[UFC!56!(7Y2"PSUXS71>%O$4_B&&[EDMH$BBD"PS6\_FQS
MJ5!W*VT>N"/44 1ZAX+TF7PW?:)86MK8P7O^MV0 @G(R<?WN.#V.#6V;"VET
MW[#+$LML8_*:-QD,N,8/K6#\1+6*Z\ :TTB_-#:22QN."CJI((/8UA1^(]0T
M$V6AZ1H<$T2:0+Y9'NM@(&-P(VGDGZY)H ZJR\'>'-.\S[)HUE&9(_*<B($L
MG]TD]15FP\/:1I<$L%CI]O!',,2*D8PXQC!]17.S>-[NYA1M&T=KV0:='J,L
M;3;2%?.U%P#N<X;T''O77VTQGMHI6C:-G4,4?JI(Z'WH R4\(>'H].FT^/1[
M..TF<2211Q!0S Y!..X/2M"PTNQTNT^S6-M'!#DL50=2>I/J?>H]9U%]*T>[
MOTM9;IX(RZP1?>D(["L3PIXO;Q%J&IV$MM#'-8>46>WG\Y&#J3P<#D8(- %]
M/"7AQ(EB71;#RU<R!?LZD!SU;IU]ZG.@:.^I/J!TZT-\Z%&G\I=Y7&,9Z]*X
M?Q'9ZEHWCB36?#D1DEALA/>V.X[;M&=@Q4= XQD>M/M=;T2/5-6\7:?;BX5]
M.MG4(/F,CR2(5[D-D*#QGCO0!V=KX9T6TTN;38-+M8K*<DRVZQ#8Y/7([TJ^
M&-#721I2Z5:#3PVX6XB79NSG.,=?>N7E\>ZG#I.IWC:"R_V?)'O=WD2*2)N"
MZLT8)V]QCM5^_P#%MY:G4W@L(+BVLS!&)A<$*7DVDECMP%56#$\\&BP%_4-)
MOK'1X['PJFGV)\SYO-B)14.=Q 7'S9(/-:.C:?#I&DVNFPL&6VB6/.,%B!R2
M/4G)KE[?QX7T6]NFLDDNX+]=/BBAFREQ(VW:58C@8;GCC!ZUSVGZM=Z#XK\:
M7KZ<CW.ZR!@CN28UW@@N6(R%&23QQS0!Z/-H6E7&J1ZG+IUK)?1C"7#1*77Z
M-C-0OX:T.36#JSZ7:-J)7!N3$-^,8Z^N.]5?"7B8>)K&[F,4<;VMT]L_E2;T
M<KCYE.!P015&#QE=7M[$]CHTEUI;W[6)NHY,LI7(:0KC[@8$9SVZ4 ;-MX9T
M2TT^ZT^WTRUBM+K/GPI& LF1@Y%)'X6T&*59(])LTD6'R%=85!6/&-H/88KG
M(O'\LD5CJ7]E?\26^O?L<-UY_P X)8HKLFWA688Z^E5+KX@ZY;Z=JVH#PQ&;
M339I())/MXRSH5' V<@[OTH V]3\+R6^CG2O#,-AIUO<EH[H^4<B-@02@! W
M<]_6NCLK2*QL8+2%=L4$:QH/10,#^5<1+\1+C2KR^@U[16L1%8F^MV2X$GFJ
M&"[#P,/E@,<CFK%SXVU#3Y;NVOM%6.Z2P:_MPESN29%QO7=M&&7(XQ0!O7OA
M70=1>X>[TFTF>Y*M,S1#,A7[NX]\>](?">@$W!;2;1C<QB*8M&"9$&, ^H&!
M7/IXUU9=.M;N\T.*S2[^>&2>\Q&L?EA\NVWY6).T#O5>?QAJE]J?@I["WCCM
M-922:5'EYXCSM)VG@9SD=2!TH ZB/POX?%O=01Z38K%<H(IT2%0)%7H#CTJ[
M;:586=P9[:UBBE,2P[D4#Y%SM7Z#)KA]*\2V^D6M^(-*,-Y=:^]DL!N"X>=@
MI+EL?*N.< 'I5N^\?76F1:C%<Z/YE]87$$4L,%P"&24@(ZD@$\G&,=118#N:
M0L >3BL#P]X@N=6O=3L;VP%E=V$B*\8F\P,KJ&4YP/?CVK'BFO-6\7:Y=B-9
M(]$58+&&1BJ&9HP[N<9YPP4<<#/K0!V^1ZTM>/'5M5U"W\!Z[=0?:+^>ZDV1
M6\VT2!HW.&!P!@X]< 5U$?Q"SID#R::8]0FOY=/^S>875)(\EB6522N!GA>]
M.P'<TF1ZUA>&M>G\1Z1-<2V,VGW$<KP-'*#U'\2Y )4YXX%<]9Z!XBTV'1+J
M\N[20:;]IDO$5I,3%LE7&3]_KG/ W'%(#OLBE!S7F_@_1+?QAX8B\1:W)<7%
M_J.Z0,D[H+==Q"I&%(VX Z]<]:T;34[[0O(\+:? NJ7]C8_:)I9K@QY3<0@S
MAB7;'?CB@#MZ3O7G\7Q'O;^ZL[?2O#<]V]U9_:U!N4CV@.$=3GN&R/?'XU'%
M\3;K$5S=>'+BWTXWYT^:Y-PK>7)O*@[0,D9ZGCGUIV ]%HKBKGQW)$EUJ$.G
M+-HUG>?9+BZ$^'!!"LZIMY4$X/(/!XJ/_A.]2-_J<">%[QXM.9EGD29">(O,
M7"CJ6X''3(HL!W-)D9QFO/-0\?WDGAGQ%+:6MO'J&EVZ.2ER)8QO!_B"_>7!
MR,=1UJ<:U':^,+>;5K.:WGAT66=[D7&Z QAD+87 RWOQ^-(#O:*XRU\<7$LE
MDL^BRPIJ5N\]@WG ^;M7<$;@;&*\]Q[U6TCQM=>(C86TVB2V=MK%I*]M-]I!
M8LH&1@#*\'@_I0!W98>M+7"V/@S48UT:WNM4N&M[6SF@NPMPQ\[>?E'//RYX
M;(/RBM/P5JEU>V-]8W\OG7>EWDEF\Q&#*% *N?<JPS[YH Z>BC-% !1110 4
M444 49!_Q/+<_P#3O)C_ +Z2KU9TI/\ PD-L.WV67G_@4=:- !1110 4444
M%)2TE "TE+10 @I:3I2YS0 E+110 4E+29H ^7_C[_R49><_Z%'VZ<M13/CV
M2?B-C/2SB_FU% %_X&*#\4-0.\C%K-P._P"\6OI6OFOX%@_\+/U' X^RS9/I
M^\2OI2@ HHHH **** "BBB@ JGJPSH]Z..8).O\ NFKE4]6)&CWN#@^0^/\
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M^-/#=Y<>1;ZU922^5YQ42@'9C.[Z8Y^E %K1-.N].M'%]?O?7<KF264J$7.
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MC'XUQ&KOK#Z=XIT/Q T,UW!HQN(=2LF:-IHU+;5D7/!SG(Z')KU#4-&T[5K
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M"2QN$6-6WHW/!/W3GKCJ*K2^"=0$MI-:Z_+!-'I_V"XD-NC&9 <@CLI&3V-
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M3R5S)&^#@>G('/)QWS0!G2_$/5]4\*ZSJ&FV5G$;:R:=7-P6:%@2"DB;05<
M9 Z'UJQJ7Q U70M*MI[O3K:0I81WD[?:"OFAFP5C&WE@/F.< ?CFK=O\/9I4
MU%]5U..XNK[3CI\DUO;^47']]^3N?ISQ5>]^&E[?12K+XCFW7&F#3[EC:QG>
M 25(_NCGD#KCKWIZ 7-4\:ZQ!J-S9Z?H"W'E6*WZ22700/&2<]C@\<"G7_B2
M77;0:=I5E#<O<:8+R=;B8QB..1?D7@$[CS^ H/@[5EO);A=;B<R::-/^>TYP
M.=_##G)/Z5'%X%U&S%E-IVN"VO([)+&YD^RAEGB3[IVD\,!GG- &#H-[Y!\
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MFAW#SVEU!#=+]H&9 44(X'11AEX'/-6;WQ[J%G$D<OA^2._,<MQ]FDGSF)2
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MR V<Y Z5T=% "  #%%+10!F<#Q+S]XVG'TWUIUF$#_A)5.1G[(1CO]\<UIT
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M1W$@8LKHN=A ..>H-9^D>,M8N] \37-ZFGPW^C3R0B.,,4)49!/S9^;H/ZT
M=%XKT.X\1^';G28;N.V^T *\K1%\ $'@9'H*HS^%]1U:[L'UO5(I[6RF6X2U
MMK;RE>1?NEB68D \XXJE)X@\26GBCP_I%T--VZE#)+,R1/F(HH+*/GYZXS3U
MUOQ%/XKUO2H9--$%A;I/$[0.2Q?.%;Y^VT\TP(-8\":AJUOXE@_M6WBCUJ2)
M\?923$$"@<[QDD*.?K5[5O#>M3WNGZGI6L0V>HP6_P!FN"]OOBF0D$_+NR""
M,CGO5#0_$7BG4](TC5I%T@V]])&&MXT<2!2?F(8M@D $].QJG>>-/$UI=^*
MMOI4L.@B.1E8.C3(R[^#N(! ![<F@#6N?!VI)J"WNF:_);2S6B6MZ98!(9@I
M)#CD;7^9O4<].*-0\#-J%WJ:-J!33]0LHK>2)8\R;XPP5]Y],@^Y%1:YXEUK
M[+X:N](:SAAUB2.)ENH6=HRZ%P>&'88Q6SH-QK+7^H6VJW-C<K!Y>R2TC,>&
M()96!9N0-I_X%2N!E2>$-5O[@7>HZK;274-E)9VS1VK!5\S =V!?YB0,8R!3
M9?!^I#POI6BK>6%S'9Q&"9+FV)BF3;A25#<,, YSZU:L/&45YX^O?#FP!(8
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MFFJV,NEC4XKJ.2R*>8)T.5*^H([5QNA^-);XOK-SJFFIHG[R-XMC++$X<K&
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MA:8Q2EP>5 )PPXSCMBM75/&-AI=_=6AMKNY>SB6>[:VC#+;HW0MD@] 3A<G
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M596VO_%O)!P/?-=E=^,=*MM%L=63S[BSO7C2*2"(L!O(4%O[HR0.:WN,9Z4
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M?-C?.#(H7OGK[U[*^E:?(\<DEE;L\2[$9HE)5?0<<#VICZ+I<J(DFG6CJGW
MT*D+]..* .!O;S9?^)((M8GM-VC6LL4D\Q/D,QD&XC.4_ASCIUKGI%M;OP[,
M-5@6U>SURS^T%;XRP(IV LCYX4KR03QFO89=+TYWEFELK9GE3;*[1*2R^A/<
M4#2=-6Q:R%C;"T;&Z 1+L/U7&.PH \PUV_M8X?&YL-6F41Z3;W-L4O'#(=LF
M-O.0/N\>X]:5)I]/U#5K?3M<G\R?PR+T27%R9=DP)^< DXX[ 8]J]0ETRPG+
MF6SMY#(,.6C!W#CKZ]!^596M^%+'4M&O;*SC@L+BX@, N885#H,8Q],<8]*
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M)(T0<@C"DG/I]VO1/!,<$7A=8(-3N-1M(W=8KN<8WIG^$]U'0'VK>&G60@:
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MB@ K-\0';X=U)O2UD/\ XZ:TJS/$(+Z#>(" 'C*G/<'@C\030!I#I2T@Z4M
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M7A32[G2]'(O=GVVZGENKD(<@/(Q8J/H,#\*W: "BBB@ HHHH **** "BBDH
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M_J&S_*E:^5<_N+AL8Z1'V_QH MT52;40I&;6ZP>XB)_ES4@O5)QY4W7'^J-
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M,>21B@#0HK,_MALG&FW_  N?]4.?;KUI1JZF-F%E?97JIMV!/T]: -*BJ/\
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M&90!^M5K?Q-H-Q/]G@UJPEE'\"7*,?T- &MBEJI_:FGY8?;;?*C+#S5X'YU
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M"OS+\KA@!@E>H]2>W6CP]XK>RT:TLM%TSSM1U74[T0Q3W)\M CDN[-@D+TP
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M8_PJU10!5&FV(.19VX.,9\L?X4'3K(C'V2#'/_+,=_PJU10!4;3+!E"M96Q
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ML>% W_"__&?I]EBS_P!\Q5ZO7E/A21!\?O&<9/SM;1$#V"QY_F*]6H ****
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M !1110 4444 %)BEI#0 M%%% !1110 48HHH **** "BBB@ QS1110 4444
M%%%% "8I 23[4XTE "T44AH 6DHHH *6DQS10 4HHHH *0TM% !1110 4444
M %%%% !1110 $9HHHH *0TM% !1110 4#I110 4444 %%%% !112$X% 'RA\
M;]O_  M'4-I&?*AS]?+%%)\;1CXHZ@?6.$_^0UHH ]9\*!?^&@_&/R9;[)'A
MO3Y8N/Q_I7K%>6^%[=T^/GC&1B!_HD&!ZAEC_P *]2H **** "BBB@ HHHH
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M4 %%%% !1110 4444 %%%% !12 4M !1110 4444 %%)2T %%%% !24M(30
MM%)2T %%%% !1110 4444 %%%% !1110 E+110 4444 (:,4O:@4 )1WHQS1
MB@!:2EHH 0]:6D[TM "4M)2T %%%% !1110 4@-+2<4 +1110 4444 %%%%
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MJ_0 4444 %%%% !1110 4AI:*  #%%%% !1110 4444 %%%% !1110 4444
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M5IQ)_8VJL?[5MD&Z0IM2Y7H)$^N.1V.:Z"L#7[JSE1K)0\VI;=T"6X!EB8Y
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M?#E]') A;RIV0'@#GY6)QUZ#M5BR\0Z9+I22/J5O?7$$)FD-O\W(7).!G'?
M- &UI]E#ING6UE;KMAMXUB0>@ P*LUR.A>+7O!YM_/IPBDC1HUM93(ZLQ.4<
M <$#;^.:=J'BR87]M86L"6AN(VD%SJ1\E H(!"J>2W.<'''>@#K**Q8-<TJR
M@$=WK]E)(.KR3QKG\ :0^+_#PE$0UBS>1CA4CE#L3[ 9S0!MT5@KXNTUYVB5
M;S"XS)]DD"=0,YVX[UK65[;ZA:1W5K()()!E' ."/QH L444=Z "BBB@ HHH
MH **** "BBB@ HHHH **** "@T44 (:!0:!0 M%!HH *.]%% !1110 4444
M%%%% !1110 4444 %%%% !1110 8I!G-+10 4444 %%%)GF@!11110 4444
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MP/X&K%% &1IGAZTT=S]BEND@Q@6[3L\:_0-G'X5KXHHH 0@$8(R*,4M% "$
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M8J<,!<IP?SH TZ*S_P"W=(QG^U++_P "%_QJ.;Q+H=M&9)M9T^-!W:Y0#^=
M&I165!XGT&YC,D&M:?(@_B6Y0C^=.'B/1"<?VQI__@2G^- &G16+-XO\-VX)
MEU[3$P,G-TG^-/C\4^'Y8U>/6].9&&01=)@_K0!KT5D2>*O#T2%Y-=TU5'))
MNDX_6H(_&_A667RH_$>E,^=NT7:9S^= &]165_PDNA?]!K3_ /P)3_&AO$V@
MH,MK6G >]RG^- &K16''XR\,RW#6Z:_IK2KG*"Y3(Q^-6H?$&C7-PEO!JUC+
M,YPL<=PC,Q]  : -*BBB@ H-%!H 04M(!S2]Z "BBB@ HHHH **** "BBB@
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MBW^FZ?'#HBWTLUXGR2X.TI_L@8.3[U8UKQ_XD@\4O#8);-I]HUJDJ[05G\T
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MKP>K!AX;TW(_Z=U-=110!S$GP[\'RN6?PWIF<8XMU'\J:/AQX-4C'AO3>/6
M&NIHH Y\>!O"@Z>&])_\ T_PJNWPY\'.Y=O#6FDDDG]P,?E7444 <Q'\._!\
M;;E\-:9GWME/\ZDD\ ^$I$96\-Z5ANN+1!^H%='10!RO_"M?!G_0MZ=_WY%2
MI\/O""$%?#>E\'/-LI_I72T4 <Y-X"\)7";9/#>ED>UJ@_D*?8^!_#&F7D5Y
M8Z%86]S$<I+'  RGIP:Z"B@ HHHH *0TM("#0 "EHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ***0G S0 "C'.<T4N* "BBB@ H[T44 %%%% "<YI:.]%
M !1110 4444 %%%% !1110 A.*6BB@ HHHH *3/.*6C% !1110 4444 %!HH
MH 3WI:2@T +1110 444F>U 'R1\9<?\ "U-9P,<Q?^BDHI?C)S\4]8R.\7_H
MI** /?=)7/QD\1MZ:=:C'XM7="N&T@C_ (7%XD'<Z=:']6KN: "BBB@ HHHH
M ***#0 4&DYS2T 8C^$/#TFK_P!K/H]HU^&W^>8QNW>OU]ZH>(O!%KK.G36]
MG)'8R370NIF\A94F?&/G5NO;TZ5U5% '+>&/!5IH&FK#=-%?7(NWO/.,"H$D
M88RBC[N ,5I3>%]"N%03:39R!)FG4/"IQ(W+-TZFM>B@#(/AC1#<6,_]F6PD
ML RVI5 /*##!  [<GBJ]EX)\-:>DRVFBV<0F1XY,1#+JV-RD]P<#BM^B@#%U
M+PGH.L1VD>H:7;W"6F/(5UXC [#VX''3BM*YL;6\LWL[F".6VD7:T3J"I'IB
MK%'2@#&L?"FAZ=I9TRUTRWCLFD$K1;<@L"""<]P0/RK1O+*VU"TDM;N!)H)5
MVO'(,JP]"*L44 8>D^#] T*WN(--TJWMX[@;9@JYWCT)/)'M5Z/1M-B:!DL;
M=6MX3!"1&,I&>JCT''2KU% &)J'A#P_JD%I!>Z3:RPV?_'O&4PL?L .W'2IY
M_#FC76I0ZC<:7:2WD*A8YWB5F0 Y&">F*U** *MGIUGIYG-I;1PF>4S2E% W
MN>K'U-6J** "BBB@ HHHH **** $H'3FEHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBDH 6BBB@ HHHH **** "BBB@ HHH
MH ***0,&Z$'''% "T4F32T %%%% !1110 4444 %%%% !110>E "4M%% !11
M10 444AZ<4 +11VHH ***3/- "TE%+B@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@!**6DQ0 9H YHQBB@!"P!Q1ZT;031C!)H ^1_C$H
M7XIZS@Y^:/\ ]%K11\8S_P 74UKV:+_T4E% 'T'I"G_A<'B1LC T^T&/7EZ[
M>N)T<+_PMWQ*?XA86F.>WSUVU !1110 4444 %%%% !110>AH ,TF1ZUX/=^
M*9W\4^(+;4?B%<Z*EM?R0V]LEOYF4!X.0.G:NSU/5KS3M:U*RCU>[DDMO#1N
M$1XUVF09 ESG.XXZ8Q0!Z-FBO+M%\1:A-JW@9;K4;IC?Z5+-/$JKLF<)G<Q[
M'Z"KFG?%NRU V$HT35([*[NOL?VMT7RTE)P%)SS]: /1:*X/5_BII6DWFIQ?
MV=J=S;Z8WEW5W!$#$DG9,D]<G'L:Z.YU$WO@Z75+9GA,U@;B(_Q)F/</Q% &
MQD4O:O$? VIG7-2T@R_$F_N=08":;3?)*J2!N9"<8('(KL;;XK:-<:E# MIJ
M"V-Q<_9(=1:$""27.-H.<_CB@#O:*X.]^*>F6E]=*NG:A-IUG<"VNM2CC!AA
MD)Q@\Y(!(R0*Z.'77E\52Z(-/N1'':BY^VX_=')P$!]>I_"@#8)Q1FO*?C+K
M6K:;%IL%O?W&G:;.6,]W F3Y@*[4)'*CJ??%:1U?Q3#\/+:32;FSU_4IF9$U
M"(XC6( GS&_VAC&/6@#T7-&:\UTB+Q'XF^%NA7-AXD?3[]E\VXNY(Q(9%^8$
M'/X?E7.:'XB\2VGPY\4>)M0UZ6]A"M!IDSQJA)!*>8 !W9A@'/W: /;:2O*?
MA-K=YJUY>?;/%=QJLBP(6M)[7RC&2?OJ3]Y>V<5:\;:KXDU#QM!X:\.ZHNFM
M#IS:A++Y88N02%7GMG^= 'I@ZTM>.Q>)_$GC/3?"EAINJC2[S4+6>XNKI(PQ
MS$VS '8$\UVWPZUN]USPE%-J,@EOK>:6UGD P':-BN?Q&#0!UE%%% !1110
M4444 %%%)0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 =Z3'-+
M10 4444 %%%% !1110 4444 %%%% !1110 4@4+T &>>*6B@ HI*6@ HHHH
M0YS2T44 %%%% !1110 4444 %%%% !124M !2<TM)VH 6BBB@!,T444 %+11
M0 4E+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+1
M0 F*#TI:0T ?(WQB&/BIK77[T1_\A)12_&-L_%36?9HA_P"0DHH ^@]'3/Q;
M\3/Z6-F/SW_X5VU<CIMNL?Q4UV1<Y?3+,MD]]\P_DHKKJ "BBB@ HHHH ***
M* "D/2EHH X+PQX+CAUSQ/>:UI5I,+S4FGM7E1)"8S^>.>U-UWPQJ=]XTU*_
MMXE-I<>'I+!&+CF4L2!CJ!@]:[^DQ0!YAI'A#6K;5?!%Q-$@CTK39K>[)E!*
MNR8 'KSZ4S2_ ^LVOP]TG1I8X?MEKJZ7;@2941B;<3GUQVKU/%)B@#P#Q)?S
M:3#X^T2TN=,>TN9GNI7GF*3QNX7,:H1\Y)& 0<#]*]<TNUDG^'%G:(G[Z32D
MB"GCYC$ ,U=O/"VA:AJ'V^\TBQN+KC][+;JS<=.2*U@   !@"@#F/!OAJ+1O
M"VE6UU8VL>H6]LL<KHBDAL8/S=37G6E_#;6K&\M-'FTFVN+&WO\ [2=1DO9-
MICW$@"$$8<>M>VT4 >)W'PSU:WU#4-/ATBSOK&]O_M$=[/>NHA1F!96A!&XC
MD BO4K=M9C\2-;&VM1H:6@V3!CYIFR!MQG[N,UM44 ><?%FR\02Z-Y^E^7=6
M'EF.\L) /G!8%74XSD$8QZ&M7P3X:N]#\(7%E<K#%<74LTY@@.8X/,Z(I]!Q
M79$9I * .!T_P_K>E_!IM!BC4ZPEE)"JI(,;F+=&/L:O3>&;^W^&T.AZ1+%;
M7T%K&J%T#(77!(;(QAB""??-=C10!YMHND^*YM:U#Q5JFG6-IJ4>F&RLK.*7
M<KL"6RY[<@#KT)J'6]&\7)JVF>*M.T^SGU9],-C>VGF[%1B=P96SR >U>GXI
M,4 >51^"?$/AG2_"]UHB6U]J.EPS07%O))L202G<Q#>S5V/@70+GP[X9CM+U
MHVO)99+BX,?W0[L6('L,@?A72T4 %%'>B@!!2T44 %%%% !1110 4444 %%%
M% !1110 4444 %)2T4 %%%% !1110 444E "T444 %%%% !1110 4444 %%%
M% !1110 4E+10 4444 %%%% !110: "BBB@ HHHH **** "BBB@ H-%% !0:
M** $S@T4=<T=* #-+VI*6@ HHHH **!10 4444 %%%% !1110 4444 %%%%
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M5!,DB?(Q'\)S@^U95_X\UZQE72I-.M?[7^TO$[Q)--#Y:QK(&"H"Y)#@8[4
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MDX43N(Q(F 'V [<X &<5!9?#W0+$R^5'=,KQ21*DER[K&)/O[ 3A2?45U5%
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M07 OKQ+>*6&7[("ACW1 !2,KE?NC(! .*UK[0+34=5M=0N"[/;0RPHF?EQ(
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH 2EI,4M #6&X8IU%% !1110 4444 %%%% !1110 4444 %%%% !1110
M=J**0T +124M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !2=:6DH *7M24M ""EHHH **** "BBB@ I#2TAZ4 ?'GQ4;=\3M>/\ T\8_
M\=%%)\4L_P#"S->SU^T]O]T44 ?5<:L/&5\Y4;386P#9YSYD_P#B*V1TJF(0
M-8EFV\M!&N[Z,YQ^M710 4444 %%%% !1110 444&@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ***,T %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%!Z4@H 6BBDH
M6BBB@ HHHH 2EHHH **** "BBB@ I.M+10 4444 %%%% !BBDS2T %%%% !1
M110 4444 %)WI:* "BBB@ HI#G/M2]: "BBB@ HHHH **** "C%%% !1110
M4444 )S2T44 %%%% !1110 44AHH 6BDSFEH **** "D/0TM(>E 'QY\5/\
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MWGQ9QYBY^M%%  9XPVW>N?3/- GBQ_K%_.BB@!1-&?XU_.E\Q?6BB@!/,&<
MTI<#O110 ;ACK0",=:** %R*"1110 T.#2[OK110 M&<T44 &31FBB@ S32>
C.E%% 'R/\2=*U*Y^(NN2PZ=>21M<G:R0,P/ Z'%%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>10
<FILENAME>ex10-8.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit 10.8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO,
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A
LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
OF THE DATE OF THE PURCHASE AGREEMENT AND INITIAL ISSUE DATE OF THE PREFERRED STOCK, THE COMPANY IS SUBJECT TO THE REQUIREMENTS
OF NASDAQ LISTING RULE 5635(D). FOR SO LONG AS NASDAQ LISTING RULE 5635(D) APPLIES TO THE COMPANY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLASS
A COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>SIGMA
LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrant
    Shares: __________</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.35in; text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuance
    Date: January 28, 2020</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrant
    No: ___________</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, <B>________________</B>,
or its registered assigns (the &ldquo;<U>Holder</U>&rdquo;), with an address at: <B>_________________</B>, is entitled, upon the
terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time commencing on the later
to occur of Shareholder Approval or one hundred and eighty (180) days after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;)
and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the &ldquo;<U>Termination
Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from <B>SIGMA LABS, INC.</B>, a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;),
up to <B>________</B> shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Shares. The
purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in <U>Section 2(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Section 1.</U> <U>
Definitions</U><FONT STYLE="text-decoration: none">. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;Purchase Agreement&rdquo;), dated January 27, 2020, among the Company and the purchasers signatory
thereto.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U><FONT STYLE="text-decoration: none">. </FONT><U>Exercise</U><FONT STYLE="text-decoration: none">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after
the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of
the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books
of the Company) of a duly executed facsimile copy of the Notice of Exercise Form annexed hereto. Within two (2) Trading Days following
the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable
Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank. Notwithstanding anything herein to
the contrary (although the Holder may surrender the Warrant to, and receive a replacement Warrant from, the Company), the Holder
shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares
available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the
Company for cancellation within three (3) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial
exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable
number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased
and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise Form within one (1) Trading
Day of delivery of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by
reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of
Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Exercise Price</U>. The exercise price per share of the Common Shares under this Warrant shall be <B>US $1.13, </B>subject
to adjustment as described herein (&ldquo;<U>Exercise Price</U>&rdquo;). The Company shall have the right in its sole discretion
to reduce the Exercise Price at any time and from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>[Intentionally Omitted]</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Delivery of Certificates Upon Exercise</U>. Certificates for shares purchased hereunder shall be transmitted by the Transfer
Agent to the Holder by physical delivery to the address specified by the Holder in the Notice of Exercise by the date that is
two (2) Trading Days after the latest of (A) the delivery to the Company of the Notice of Exercise, (B) surrender of this Warrant
(if required) and (C) payment of the aggregate Exercise Price as set forth above (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;). The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named
therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Warrant has been
exercised, with payment to the Company of the Exercise Price and all taxes required to be paid by the Holder, if any, pursuant
to Section 2(d)(vi) prior to the issuance of such shares, having been paid. The Company understands that a delay in the delivery
of the Warrant Shares after the Warrant Share Delivery Date could result in economic loss to the Holder. As compensation to the
Holder for such loss, the Company agrees to pay (as liquidated damages and not as a penalty) to the Holder for late issuance of
Warrant Shares upon exercise of this Warrant the proportionate amount of $10 per Trading Day (increasing to $20 per Trading Day
after the fifth (5<SUP>th</SUP>) Trading Day) commencing three (3) Trading Days after the Warrant Share Delivery Date for each
$1,000 of Exercise Price of Warrant Shares for which this Warrant is exercised which are not timely delivered. The Company shall
pay any payments incurred under this Section in immediately available funds upon demand</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the certificate or certificates representing
Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares
called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<U>Revocation of Exercise</U>. In addition to any other remedies which may be available to the Holder, in the event that the Company
fails for any reason to effect delivery of the Warrant Shares by the Warrant Share Delivery Date, the Holder may revoke all or
part of the relevant Warrant exercise by delivery of a notice to such effect to the Company, whereupon the Company and the Holder
shall each be restored to their respective positions immediately prior to the exercise of the relevant portion of this Warrant,
except that the liquidated damages described above shall be payable through the date notice of revocation or rescission is given
to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<U>Compensation for Buy-In on Failure to Timely Deliver Certificates Upon Exercise</U>. In addition to any other rights available
to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder a certificate or the certificates representing
the Warrant Shares pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely
due to any unreasonable action or inaction by the Holder with respect to such exercise), and if after such date the Holder is
required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise
purchases, Common Shares to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated
receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount,
if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the Common Shares so
purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver
to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase
obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number
of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to
the Holder the number of Common Shares that would have been issued had the Company timely complied with its exercise and delivery
obligations hereunder. For example, if the Holder purchases Common Shares having a total purchase price of $11,000 to cover a
Buy-In with respect to an attempted exercise of Common Shares with an aggregate sale price giving rise to such purchase obligation
of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The
Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon
request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other
remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver certificates representing Common Shares upon exercise
of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the
Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction
multiplied by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
<U>Charges, Taxes and Expenses</U>. Issuance of certificates for Warrant Shares shall be made without charge to the Holder for
any issue or transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses
shall be paid by the Company, and such certificates shall be issued in the name of the Holder or in such name or names as may
be directed by the Holder; <U>provided</U>, <U>however</U>, that in the event certificates for Warrant Shares are to be issued
in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment
Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient
to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing
of any Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of its Common Shares or any other equity or equity equivalent securities
payable in Common Shares (which, for avoidance of doubt, shall not include any Common Shares issued by the Company upon exercise
of this Warrant or pursuant to any of the other Transaction Documents), (ii) subdivides outstanding Common Shares into a larger
number of shares, (iii) combines (including by way of reverse stock split) outstanding Common Shares into a smaller number of
shares, or (iv) issues by reclassification of shares of the Common Shares any shares of capital stock of the Company, then in
each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Common Shares (excluding
treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of Common
Shares outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately
adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this <U>Section
3(a)</U> shall become effective immediately after the record date for the determination of stockholders entitled to receive such
dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination
or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to <U>Section 3(a)</U> above, if at any time the Company
grants, issues or sells any Common Shares Equivalents or rights to purchase stock, warrants, securities or other property pro
rata to the record holders of any class of Common Shares (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled
to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired
if the Holder had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a
record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of Common Shares are to be determined for the grant, issue or sale of such Purchase Rights (provided, however,
to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the
Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or
beneficial ownership of such Common Shares as a result of such Purchase Right to such extent) and such Purchase Right to such
extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Pro Rata Distributions</U>. If the Company, at any time while this Warrant is outstanding, shall distribute to all holders
of Common Shares (and not to the Holder) evidences of its indebtedness or assets (including cash and cash dividends) or rights
or warrants to subscribe for or purchase any security other than the Common Shares (which shall be subject to 3(c)), then in each
such case the Exercise Price shall be adjusted by multiplying the Exercise Price in effect immediately prior to the record date
fixed for determination of stockholders entitled to receive such distribution by a fraction of which the denominator shall be
the VWAP determined as of the record date mentioned above, and of which the numerator shall be such VWAP on such record date less
the then per share fair market value at such record date of the portion of such assets or evidence of indebtedness so distributed
applicable to one outstanding share of the Common Shares as determined by the Board of Directors in good faith. In either case
the adjustments shall be described in a statement provided to the Holder of the portion of assets or evidences of indebtedness
so distributed or such subscription rights applicable to one Common Share. Such adjustment shall be made whenever any such distribution
is made and shall become effective immediately after the record date mentioned above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Shares are permitted to sell,
tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of
the outstanding Common Shares, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification,
reorganization or recapitalization of the Common Shares or any compulsory share exchange pursuant to which the Common Shares are
effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in
one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires more than 50% of the outstanding Common Shares (not including any Common Shares held by the
other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such
stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then,
upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder,
the number of Common Shares (or successor security) of the successor or acquiring corporation or of the Company, if it is the
surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result
of such Fundamental Transaction by a holder of the number of Common Shares for which this Warrant is exercisable immediately prior
to such Fundamental Transaction. For purposes of any such exercise, the determination of the Exercise Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one Common
Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in
a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Shares are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder
shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any
Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within
30 days after, the consummation of the Fundamental Transaction, purchase this Warrant from the Holder by paying to the Holder
an amount of cash equal to the Black Scholes Value of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based on the Black and
Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg, L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) determined
as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest
rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the
applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100
day volatility obtained from the HVT function on Bloomberg as of the Trading Day immediately following the public announcement
of the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the sum of the
price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental
Transaction and (D) a remaining option time equal to the time between the date of the public announcement of the applicable Fundamental
Transaction and the Termination Date. The Company shall cause any successor entity in a Fundamental Transaction in which the Company
is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under
this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements
in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such
Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is
exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to
the Common Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of
this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to
such shares of capital stock (but taking into account the relative value of the Common Shares pursuant to such Fundamental Transaction
and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose
of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which
is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor
Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this
Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Calculations</U>. All calculations under this <U>Section 3</U> shall be made to the nearest cent or the nearest 1/100th of
a share, as the case may be. For purposes of this <U>Section 3</U>, the number of Common Shares deemed to be issued and outstanding
as of a given date shall be the sum of the number of Common Shares (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section 3</U>,
the Company shall promptly give notice to the Holder setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a statement of the facts requiring such adjustment (&ldquo;<U>Dilutive
Issuance Notice</U>&rdquo;). For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant
to this Section 3, upon the occurrence of any Dilutive or other reduction of the Exercise Price, the Holder is entitled to receive
a number of Warrant Shares based upon the reduced Exercise Price regardless of whether the Holder accurately refers to the Exercise
Price in the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever
form) on the Common Shares, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common
Shares, (C) the Company shall authorize the granting to all holders of the Common Shares rights or warrants to subscribe for or
purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall
be required in connection with any reclassification of the Common Shares, any consolidation or merger to which the Company is
a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby
the Common Shares are converted into other securities, or (E) the Company shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of the Company, then, in each case, to the extent that such information constitutes material
non-public information (as determined in good faith by the Company) the Company shall follow the procedure described in Section
13 of the Subscription Agreement and shall deliver to the Holder at its last address as it shall appear upon the Warrant Register
of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating
(x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Shares of record to be entitled to such dividend,
distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that
holders of the Common Shares of record shall be entitled to exchange their shares of the Common Shares for securities, cash or
other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that
the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate
action required to be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material,
non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with
the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the
period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise
be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Increase in Warrant Shares</U>. In the event the Exercise Price is reduced for any reason, including but not limited to pursuant
to Section 3(e) of this Warrant, the number of Warrant Shares issuable hereunder shall be increased such that the aggregate Exercise
Price payable hereunder, after taking into account the decrease in the Exercise Price, shall be equal to the aggregate Exercise
Price prior to such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><U>Section
4.</U>&#8239;<U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the provisions of the Purchase Agreement,
this Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached
hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making
of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants
in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this
Warrant shall promptly be cancelled. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder
for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office
of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued,
signed by the Holder or its agent or attorney. Subject to compliance with <U>Section 4(a)</U>, as to any transfer which may be
involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the
Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall
be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant
Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose
(the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and
treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>No Rights as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other
rights as a stockholder of the Company prior to the exercise hereof as set forth in <U>Section 2(d)(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant
Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case
of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate,
if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation,
in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next
succeeding Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Authorized Shares</U>. Subsequent to the Company obtaining Shareholder approval to increase its authorized shares of Common
Stock, the Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued
Common Shares a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to
its officers who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for
the Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law
or regulation, or of any requirements of the Trading Market upon which the Common Shares may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized,
validly issued, fully paid and non-assessable and free from all taxes, liens and charges created by the Company in respect of
the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue). Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its
certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions
as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting
the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable
therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or
appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise
of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any
public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under
this Warrant. Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant
is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto,
as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Jurisdiction</U>. All questions concerning governing law, jurisdiction, venue and the construction, validity, enforcement and
interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant will have restrictions
upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Non-waiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting
any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any
provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts
as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including
those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing
any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Notices</U>. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder
shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered
or certified, return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid,
or (iv) transmitted by hand delivery, telegram, facsimile, or electronic mail, addressed as set forth below or to such other address
as such party shall have specified most recently by written notice. Any notice or other communication required or permitted to
be given hereunder shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated
by the transmitting facsimile machine, at the address or number designated below (if delivered on a business day during normal
business hours where such notice is to be received), or the first business day following such delivery (if delivered other than
on a business day during normal business hours where such notice is to be received), or (b) upon receipt, when sent by electronic
mail (provided confirmation of transmission is electronically generated and keep on file by the sending party), or (c) on the
second business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon
actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be: (i) if to the Company,
to: Sigma Labs, Inc., 3900 Paseo del Sol, Santa Fe, New Mexico 87507, Attn: John Rice, President and CEO, e-mail: rice@sigmalabsinc.com,
with a copy by electronic mail only to: TroyGould PC, 1801 Century Park East, Suite 1600, Los Angeles, CA 90067-2367, Attn: Darren
Freedman, Esq., e-mail: dfreedman@troygould.com (which shall not constitute notice), and (ii) if to the Holder, to: the address
and fax number indicated on the front page of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability
of the Holder for the purchase price of any Common Shares or as a stockholder of the Company, whether such liability is asserted
by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not
be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees
to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant
and shall be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company
and the Holders of not less than a majority of the outstanding Warrants issued pursuant to the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such
provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions
or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
deemed a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>IN
WITNESS WHEREOF</B>, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date
first above indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SIGMA LABS, INC.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF EXERCISE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:
SIGMA LABS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer
taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[&nbsp;&nbsp;]</B> in lawful money of the United States</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name
as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
After giving effect to this Notice of Exercise, the undersigned will not have exceeded the Beneficial Ownership Limitation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery of a certificate to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>[SIGNATURE
OF HOLDER]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT>____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT>____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT>____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT>___</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
assign the foregoing warrant, execute</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
form and supply required information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Do
not use this form to exercise the warrant.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>SIGMA
LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, <B>[____]</B> all of or <B>[_______]</B> shares of the foregoing Warrant and all rights evidenced thereby are
hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________________
whose address is</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________________________________.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
______________, _______</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 1.5in; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Signature: _____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Address: _____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
Guaranteed: ___________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE:
The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration
or enlargement or any change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those
acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>11
<FILENAME>ex10-9.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.9</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLACEMENT
AGENCY AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dawson
James Securities, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
North Federal Highway</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boca
Raton, Florida 33432</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
27, 2020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
letter (this &ldquo;<U>Agreement</U>&rdquo;) constitutes the agreement between Sigma Labs, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;)
and Dawson James Securities, Inc. (&ldquo;<U>Dawson</U>&rdquo; or the &ldquo;<U>Placement Agent</U>&rdquo;) pursuant to which
Dawson shall serve as the exclusive placement agent (the &ldquo;<U>Services</U>&rdquo;) for the Company, on a best efforts basis,
in connection with the proposed private offer and placement (the &ldquo;<U>Offering</U>&rdquo;) by the Company of its Securities
(as defined Section 3 of this Agreement). The Company and Dawson hereby mutually agree to the terms of the Offering and the Securities,
and nothing in this Agreement may be construed to suggest that Dawson would have the power or authority to bind the Company or
an obligation for the Company to issue any Securities or complete the Offering. The Company expressly acknowledges and agrees
that Dawson&rsquo;s obligations hereunder are on a reasonable &ldquo;best efforts basis&rdquo; only and that the execution of
this Agreement does not constitute a commitment by Dawson to purchase the Securities and does not ensure the successful placement
of the Securities or any portion thereof or the success of Dawson placing the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Appointment of Dawson James Securities, Inc. as Exclusive Placement Agent. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the basis of the representations, warranties, covenants and agreements of the Company herein contained, and subject to all the
terms and conditions of this Agreement, the Company hereby appoints the Placement Agent as its exclusive placement agent in connection
with a distribution of its Securities to be offered and sold by the Company in reliance upon the exemption from securities registration
afforded by Section 4(2) of the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), and Rule 506(b)
of Regulation D (&ldquo;<U>Regulation D</U>&rdquo;) as promulgated by the United States Securities and Exchange Commission (the
&ldquo;<U>SEC</U>&rdquo;) under the Securities Act, and Dawson agrees to act as the Company&rsquo;s exclusive Placement Agent.
Pursuant to this appointment, the Placement Agent will solicit offers for the purchase of or attempt to place all or part of the
Securities of the Company in the proposed Offering. Until the final closing or earlier upon termination of this Agreement or expiration
of the Exclusive Term pursuant to Section 5 hereof, the Company shall not, without the prior written consent of the Placement
Agent, solicit or accept offers to purchase the Securities other than through the Placement Agent. The Company acknowledges that
the Placement Agent will act as an agent of the Company and use its reasonable &ldquo;best efforts&rdquo; to solicit offers to
purchase the Securities from the Company on the terms, and subject to the conditions, set forth in the Subscription Documents
(as defined in Section 3). The Placement Agent shall use commercially reasonable efforts to assist the Company in obtaining performance
by each Purchaser whose offer to purchase Securities has been solicited by the Placement Agent, but the Placement Agent shall
not, except as otherwise provided in this Agreement, be obligated to disclose the identity of any potential purchaser or have
any liability to the Company in the event any such purchase is not consummated for any reason. Under no circumstances will the
Placement Agent be obligated to underwrite or purchase any Securities for its own account and, in soliciting purchases of the
Securities, the Placement Agent shall act solely as an agent of the Company. The Placement Agent&rsquo;s services provided pursuant
to this Agreement shall be on an &ldquo;agency&rdquo; basis and not on a &ldquo;principal&rdquo; basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Placement Agent will solicit offers for the purchase of the Securities in the Offering at such times and in such amounts as the
Placement Agent deems advisable and will communicate to the Company, orally or in writing, each reasonable offer to purchase Securities
received by the Placement Agent as an agent of the Company. The Company shall have the sole right to accept offers to purchase
Securities and may reject any such offer, in whole or in part. The Placement Agent may retain other brokers or dealers to act
as sub-agents on its behalf in connection with the Offering and may pay any sub-agent a solicitation fee with respect to any Securities
placed by it. The Company and Placement Agent shall negotiate the timing and terms of the Offering and acknowledge that the Offering
and the provision of Placement Agent services related to the Offering are subject to market conditions and the receipt of all
required related clearances and approvals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Fees and Expenses; Tail.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Placement Agent services described above, the Company shall pay to Dawson the following compensation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
<U>Placement Agent&rsquo;s Fee</U>. As compensation for services rendered: (i) the Company shall pay to the Placement Agent in
cash or by wire transfer in immediately available funds to an account or accounts designated by the Placement Agent an amount
(the &ldquo;<U>Placement Fee</U>&rdquo;) equal to 8.0% of the aggregate gross proceeds received by the Company from the sale of
the Securities at the closing on or about the date hereof (the &ldquo;<U>Closing</U>&rdquo; and the date on which the Closing
occurs, the &ldquo;<U>Closing Date</U>&rdquo;), as well as from any exercise through June 30, 2020 of warrants to purchase preferred
stock to be issued on the Closing Date. In the event that proceeds from any such exercise of the foregoing warrants to purchase
preferred stock are received by the Company, the Company shall remit the Placement Fee with respect to the same to the Placement
Agent within two trading days of the Company&rsquo;s receipt of such proceeds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
<U>Placement Agent Warrants</U>. As additional compensation for the services rendered by the Placement Agent, the Company shall
issue to the Placement Agent on the Closing Date warrants (the &ldquo;Placement Agent Warrants&rdquo;) to purchase a number of
shares of common stock equal to 8% of the aggregate number of shares issuable upon conversion of the convertible preferred stock
issued in the Offering on the Closing Date. In addition, in the event that any warrants to purchase preferred stock that are issued
on the Closing Date are exercised on or before June 30, 2020, the Company shall issue to the Placement Agent within two trading
days of the exercise of those warrants to purchase preferred stock (the &ldquo;Newly Issued Preferred Stock&rdquo;) additional
placement agent warrants (the &ldquo;Additional Warrants&rdquo;) to purchase an additional number of shares of common stock equal
to 8% of the number of shares of common stock that would be issuable upon conversion of the Newly Issued Preferred Stock at the
initial conversion price set forth in the Series D Preferred Stock Certificate of Designations (i.e., $1.00), and without the
application of any price protection provisions set forth in the Series D Preferred Stock Certificate of Designations. The Placement
Agent Warrants and any Additional Warrants issued will be in a form reasonably acceptable to the Placement Agent. For purposes
of clarity, the form of placement agent warrant previously utilized by the Company and the Placement Agent shall be deemed &ldquo;reasonable&rdquo;
for these purposes, subject to certain reasonable adjustments (e.g., taking into account the provisions of this Section 2(b),
the inability of the Company to reserve a sufficient number of shares of common stock underlying the warrants until shareholder
approval of an increase in the Company&rsquo;s authorized shares of common stock is obtained, etc.). The Placement Agent Warrants
and any Additional Warrants issued will be exercisable six months following the date of their issuance at a price per share of
Common Stock of $1.13; and will contain traditional anti-dilution protection (for stock dividends and splits and recapitalizations),
a cashless exercise feature, and shall have a term of five years from the date they become exercisable. The warrants shall not
provide for &ldquo;price protection&rdquo; nor shall they contain registration rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
<U>Offering Expenses</U>. The Company agrees to pay all costs, fees and expenses incurred by the Company in connection with the
performance of its obligations hereunder and in connection with the transactions contemplated hereby, including, without limitation:
(a) all filing fees and expenses and disbursements relating to the registration or qualification of the Securities under the &ldquo;blue
sky&rdquo; securities laws of such states and other jurisdictions as the Placement Agent may reasonably designate (including,
without limitation, all filing and registration fees, and reasonable fees and disbursements of &ldquo;blue sky&rdquo; counsel,
which will be the Company&rsquo;s counsel); (b) the fees and expenses of the Company&rsquo;s legal counsel and other agents and
representatives; and (c) the Placement Agent&rsquo;s legal and diligence expenses, up to an aggregate amount of $25,000. The Company
agrees to wire to Placement Agent such $25,000 amount upon the Closing; provided, however, that in the event that the Offering
is terminated, the Company agrees to reimburse the Placement Agent for up to $25,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
<U>Tail; Right of First Refusal</U>. The Placement Agent shall be entitled to all fees per this section with respect to any public
or private offering or other financing or capital-raising transaction of any kind other than pursuant to the Subscription Documents
(&ldquo;<U>Tail Financing</U>&rdquo;) to the extent that such financing or capital is provided to the Company by investors whom
the Placement Agent had introduced to the Company and who conducted discussions with the Company, if such Tail Financing is consummated
at any time during a period of nine (9) months from the Closing. If the Closing occurs, the Company grants the Placement Agent
the right of first refusal (&ldquo;ROFR&rdquo;) (i) to act as the lead placement agent, for any and all future equity, equity-linked
or debt (excluding commercial bank debt) private offerings of the Company, or any successor to or any subsidiary of the Company,
through December 30, 2020, and (ii) beginning May 3, 2020, to act as the lead managing underwriter or book runner, or as lead
placement agent, for any and all future equity, equity-linked or debt public offerings of the Company, or any successor to or
any subsidiary of the Company through the close of business on December 30, 2020 (excluding commercial bank debt and securities
purchased by strategic investors engaged in business with the Company). The Placement Agent shall have the sole right to determine
whether or not any other broker dealer shall have the right to participate in any such offering and, with the mutual agreement
of the Company, the economic terms of any such participation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Description of the Offering.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Securities to be offered directly to one or more investors (each, an &ldquo;<U>Investor</U>&rdquo; or &ldquo;<U>Purchaser</U>&rdquo;
and, collectively, the &ldquo;<U>Investors</U>&rdquo; or the &ldquo;<U>Purchasers</U>&rdquo;) in the Offering shall be preferred
stock, warrants and/or common stock of the Company, $.001 par value, (the &ldquo;<U>Common Stock</U>&rdquo; or the &ldquo;<U>Securities</U>&rdquo;).
The Company will offer the Securities on a &ldquo;best efforts&rdquo; basis. The Securities Purchase Agreements, all ancillary
agreements and documents and all exhibits attached thereto to be entered into on or about the date hereof (collectively, the foregoing
are referred to as the &ldquo;<U>Subscription Documents</U>&rdquo;). If the Company shall default in its obligations to deliver
Securities to Purchasers whose offer it has accepted, the Company shall indemnify and hold the Placement Agent harmless against
any loss, claim, damage or expense arising from or as a result of such default by the Company under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Delivery and Payment; Closing.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
purchasing Securities shall by check or wire transfer pay for such Securities as set forth in the Subscription Documents. The
Closing shall occur at such place as shall be agreed upon by the Placement Agent and the Company. In the absence of an agreement
to the contrary, each Closing shall take place at the offices of Schiff Hardin LLP, 901 K Street, NW, Suite 700, Washington, DC
20001. Deliveries of the documents with respect to the purchase of the Securities, if any, shall be made at the offices of Schiff
Hardin, LLP, 901 K Street, NW, Suite 700, Washington, DC 20001 on the Closing Date. All actions taken at a Closing shall be deemed
to have occurred simultaneously.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Term and Termination of Agreement.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of this Agreement will commence upon the execution of this Agreement and will terminate at the earlier of the Closing of
the Offering or 11:59 p.m. (New York Time) on July 31, 2020, unless extended by mutual consent of the parties (the &ldquo;<U>Exclusive
Term</U>&rdquo;). Notwithstanding anything to the contrary contained herein, any provision in this Agreement concerning or relating
to confidentiality, indemnification, contribution, advancement, the Company&rsquo;s representations and warranties and the Company&rsquo;s
obligations to pay fees and reimburse expenses will survive any expiration or termination of this Agreement. If any condition
specified in Section 8 is not satisfied when and as required to be satisfied, this Agreement may be terminated by the Placement
Agent by notice to the Company at any time on or prior to a Closing Date, which termination shall be without liability on the
part of any party to any other party, except that those portions of this Agreement specified in Section 19 shall at all times
be effective and shall survive such termination. Notwithstanding anything to the contrary in this Agreement, in the event that
this Agreement shall not be carried out for any reason whatsoever, within the time specified herein or any extensions thereof
pursuant to the terms herein, the Company shall be obligated to pay to the Placement Agent their actual and accountable out-of-pocket
expenses related to the transactions contemplated herein, in an amount not exceeding $25,000, then due and payable and upon demand
the Company shall pay the full amount thereof to the Placement Agent; and provided, however, that such expense cap in no way limits
or impairs the indemnification and contribution provisions of this Agreement. The Company will issue a press release acceptable
to the Placement Agent announcing the Closing of the Offering and identifying Dawson as the sole placement agent in the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Permitted Acts. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
in this Agreement shall be construed to limit the ability of the Placement Agent, its officers, directors, employees, agents,
associated persons and any individual or entity &ldquo;controlling,&rdquo; controlled by,&rdquo; or &ldquo;under common control&rdquo;
with the Placement Agent (as those terms are defined in Rule 405 under the Securities Act) to conduct its business including without
limitation the ability to pursue, investigate, analyze, invest in, or engage in investment banking, financial advisory or any
other business relationship with any individual or corporation, partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity
of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Representations, Warranties and Covenants of the Company.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date and time of the execution of this Agreement and each Closing Date, the Company represents, warrants and covenants
to the Placement Agent that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
<U>Blue Sky Qualifications</U>. The Company shall use its best efforts, in cooperation with the Placement Agent, if necessary,
to qualify the Securities for offering and sale under the applicable securities laws of such states and other jurisdictions (domestic
or foreign) as the Placement Agent may designate and to maintain such qualifications in effect so long as required to complete
the distribution of the Securities; provided, however, that the Company shall not be obligated to file any general consent to
service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not
so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so
subject.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
<U>No General Solicitation</U>. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf,
has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with
the offer or sale of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
<U>No Integrated Offering</U>. None of the Company or any of its affiliates, nor any Person acting on their behalf has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that
would require registration of the issuance of any of the Securities under the Securities Act, whether through integration with
prior offerings or otherwise, or cause this offering of the Securities to require approval of stockholders of the Company under
any applicable stockholder approval provisions. None of the Company, its affiliates, nor any person acting on their behalf will
take any action or steps that would require registration of the issuance of any of the Securities under the Securities Act or
cause the offering of any of the Securities to be integrated with other offerings of securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
<U>Regulation D Compliance</U>. None of the Company or the Company&rsquo;s directors, executive officers or, to the Company&rsquo;s
knowledge, its affiliates is a &ldquo;bad actor&rdquo; as defined in Rule 506(d) of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.
<U>Independent Accountants</U>. To the knowledge of the Company, the Company&rsquo;s independent auditor (the &ldquo;Auditor&rdquo;),
is an independent registered public accounting firm as required by the Securities Act and the regulations thereunder (&ldquo;<U>Securities
Act Regulations</U>&rdquo;) and the Public Company Accounting Oversight Board. The Auditor has not, during the periods covered
by the financial statements included in the Subscription Documents, provided to the Company any non-audit services, as such term
is used in Section 10A(g) of the Securities Exchange Act of 1934, as amended (&ldquo;<U>Exchange Act</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.
<U>Financial Statements</U>. The financial statements, including the notes thereto and supporting schedules included in the Subscription
Documents, fairly present in all material respects the financial position and the results of operations of the Company at the
dates and for the periods to which they apply; and such financial statements have been prepared in conformity with United States
generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;),
consistently applied throughout the periods involved (provided that unaudited interim financial statements are subject to year-end
audit adjustments that are not expected to be material in the aggregate and do not contain all footnotes required by GAAP). Except
as disclosed in the Subscription Documents, (a) the Company has not incurred any material liabilities or obligations, direct or
contingent, or entered into any material transactions other than in the ordinary course of business, (b) the Company has not declared
or paid any dividends or made any distribution of any kind with respect to its capital stock, (c) there has not been any change
in the capital stock of the Company (other than (i) grants under any stock compensation plan and (ii) shares of common stock issued
upon exercise or conversion of option, warrants or convertible securities described in the Subscription Documents), and (d) there
has not been any Material Adverse Change in the Company&rsquo;s long-term or short-term debt. &ldquo;<U>Material Adverse Change</U>&rdquo;
means a material adverse change in the financial position or results of operations of the Company, or any change or development
that, singularly or in the aggregate, would involve a material adverse change, in or affecting the condition (financial or otherwise),
results of operations, business, assets or prospects of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.
<U>Authorized Capital; Options, etc</U>. The Company had, at the date or dates indicated in the Subscription Documents the duly
authorized, issued and outstanding capitalization as set forth therein. Except as set forth in, or contemplated by, the Subscription
Documents or the Company&rsquo;s filings with the SEC (the &ldquo;<U>SEC Reports</U>&rdquo;), on the Closing Date there will be
no stock options, warrants, or other rights to purchase or otherwise acquire any authorized, but unissued shares of Common Stock
of the Company or any security convertible or exercisable into shares of Common Stock of the Company, or any contracts or commitments
to issue or sell shares of Common Stock or any such options, warrants, rights or convertible securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.
<U>Valid Issuance of Securities, etc.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Outstanding
    Securities</U>. All issued and outstanding securities of the Company issued prior to the transactions contemplated by this
    Agreement have been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have no
    rights of rescission with respect thereto, and are not subject to personal liability by reason of being such holders; and
    none of such securities were issued in violation of the preemptive rights of any holders of any security of the Company or
    similar contractual rights granted by the Company. The offers and sales of the outstanding shares of Common Stock were at
    all relevant times either registered under the Securities Act and the applicable state securities or &ldquo;blue sky&rdquo;
    laws or, based in part on the representations and warranties of the purchasers of such shares, exempt from such registration
    requirements.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Securities
    Sold Pursuant to this Agreement</U>. The Securities have been duly authorized for issuance and sale and, when issued and paid
    for, will be validly issued, fully paid and non-assessable; the holders thereof are not and will not be subject to personal
    liability by reason of being such holders; the Securities are not and will not be subject to the preemptive rights of any
    holders of any security of the Company or similar contractual rights granted by the Company; and all corporate action required
    to be taken for the authorization, issuance and sale of the Securities has been duly and validly taken.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1.3in; text-align: justify; text-indent: -0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.
<U>Validity and Binding Effect of Agreements</U>. This Agreement has been duly and validly authorized by the Company, and, when
executed and delivered, will constitute, the valid and binding agreement of the Company, enforceable against the Company in accordance
with its respective terms, except: (i) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar
laws affecting creditors&rsquo; rights generally; (ii) as enforceability of any indemnification or contribution provision may
be limited under the federal and state securities laws; and (iii) that the remedy of specific performance and injunctive and other
forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding
therefor may be brought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.
<U>No Conflicts, etc</U>. The execution, delivery and performance by the Company of this Agreement, and all ancillary documents,
the consummation by the Company of the transactions herein and therein contemplated and the compliance by the Company with the
terms hereof and thereof do not and will not, with or without the giving of notice or the lapse of time or both: (i) result in
a breach of, or conflict with any of the terms and provisions of, or constitute a material default under, or result in the creation,
modification, termination or imposition of any lien, charge or encumbrance upon any property or assets of the Company pursuant
to the terms of any agreement or instrument to which the Company is a party; (ii) result in any violation of the provisions of
the Company&rsquo;s Articles of Incorporation (as the same may be amended or restated from time to time, the &ldquo;<U>Charter</U>&rdquo;)
or the by-laws of the Company (as the same may be amended or restated from time to time, the &ldquo;<U>Bylaws</U>&rdquo;); or
(iii) violate any existing applicable law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic
or foreign, having jurisdiction over the Company or any of its assets or business (each, a &ldquo;<U>Governmental Entity</U>&rdquo;),
as of the date hereof, except in the cases of clauses (i) and (iii) for such breaches, conflicts or violations which would not
reasonably be expected to have a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">K.
<U>Regulatory</U>. Except as described in the SEC Reports or as would not reasonably be expected to result, individually or in
the aggregate, in a Material Adverse Change, the Company: (A) is and at all times has been in compliance with all statutes, rules,
or regulations applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing,
labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product manufactured or distributed by the
Company (&ldquo;<U>Applicable Laws</U>&rdquo;), except as would not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Change; (B) has not received any notice of adverse finding, warning letter, or other similar correspondence
or notice from any other Governmental Entity alleging or asserting noncompliance with any Applicable Laws or any licenses, certificates,
approvals, clearances, authorizations, permits and supplements or amendments thereto required by any such Applicable Laws (&ldquo;<U>Authorizations</U>&rdquo;);
(C) possesses all material Authorizations and such Authorizations are valid and in full force and effect and the Company is not
in material violation of any term of any such Authorizations, in each case except as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Change; (D) has not received written notice of any claim, action, suit, proceeding,
hearing, enforcement, investigation, arbitration or other action from any Governmental Entity or third party alleging that any
product operation or activity is in violation of any Applicable Laws or Authorizations and has no knowledge that any such Governmental
Entity or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding; (E) has
not received written notice that any Governmental Entity has taken, is taking or intends to take action to limit, suspend, modify
or revoke any Authorizations; (F) has filed, obtained, maintained or submitted all material reports, documents, forms, notices,
applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations
and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments
were complete and correct on the date filed (or were corrected or supplemented by a subsequent submission); and (G) has not, either
voluntarily or involuntarily, initiated, conducted, or issued or caused to be initiated, conducted or issued, any recall, market
withdrawal or replacement, safety alert, or other notice or action relating to the alleged lack of safety of any product or any
alleged product defect or violation and, to the Company&rsquo;s knowledge, no third party has initiated, conducted or intends
to initiate any such notice or action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.
<U>No Defaults; Violations</U>. No material default exists in the due performance and observance of any term, covenant or condition
of any material license, contract, indenture, mortgage, deed of trust, note, loan or credit agreement, or any other agreement
or instrument evidencing an obligation for borrowed money, or any other material agreement or instrument to which the Company
is a party or by which the Company may be bound or to which any of the properties or assets of the Company is subject. The Company
is not (i) in violation of any term or provision of its Charter or Bylaws, or (ii) in violation of any franchise, license, permit,
applicable law, rule, regulation, judgment or decree of any Governmental Entity applicable to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">M.
<U>Corporate Power; Licenses; Consents.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Conduct
    of Business</U>. The Company has all requisite corporate power and authority, and has all necessary authorizations, approvals,
    orders, licenses, certificates and permits of and from all governmental regulatory officials and bodies that it needs as of
    the date hereof to conduct its business purpose as described in the Subscription Documents. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Transactions
    Contemplated Herein</U>. The Company has all corporate power and authority to enter into this Agreement and to carry out the
    provisions and conditions hereof, and all consents, authorizations, approvals and orders required in connection therewith
    have been obtained. No consent, authorization or order of, and no filing with, any court, government agency or other body
    is required for the valid issuance, sale and delivery of the Securities and the consummation of the transactions and agreements
    contemplated by this Agreement, except for any notice filings that may be required under applicable securities law and except
    as otherwise disclosed in the Subscription Documents.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1.3in; text-align: justify; text-indent: -0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N.
<U>Litigation; Governmental Proceedings</U>. There is no material action, suit, proceeding, inquiry, arbitration, investigation,
litigation or governmental proceeding pending or, to the Company&rsquo;s knowledge, threatened against, or involving the Company
or, to the Company&rsquo;s knowledge, any executive officer or director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">O.
<U>Good Standing</U>. The Company has been duly organized and is validly existing as a corporation and is in good standing under
the laws of the State of Nevada as of the date hereof, and is duly qualified to do business and is in good standing in each other
jurisdiction in which its ownership or lease of property or the conduct of business requires such qualification, except where
the failure to qualify, singularly or in the aggregate, would not have or reasonably be expected to result in a Material Adverse
Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">P.
<U>Insurance</U>. The Company carries or is entitled to the benefits of insurance, with, to the Company&rsquo;s knowledge, reputable
insurers, and in such amounts and covering such risks which the Company believes are reasonably adequate, and all such insurance
is in full force and effect. The Company has no reason to believe that it will not be able (i) to renew its existing insurance
coverage as and when such policies expire or (ii) to obtain comparable coverage from similar institutions as may be necessary
or appropriate to conduct its business as now conducted and at a cost that would not result in a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.
<U>Finder&rsquo;s Fees</U>. There are no claims, payments, arrangements, agreements or understandings relating to the payment
of a finder&rsquo;s, consulting or origination fee by the Company or any Insider with respect to the sale of the Securities hereunder
or any other arrangements, agreements or understandings of the Company or, to the Company&rsquo;s knowledge, any of its stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">R.
<U>Foreign Corrupt Practices Act</U>. Neither the Company nor, to the Company&rsquo;s knowledge, any director, officer, agent,
employee or affiliate of the Company or any other person acting on behalf of the Company, has, directly or indirectly, given or
agreed to give any money, gift or similar benefit (other than legal price concessions to customers in the ordinary course of business)
to any customer, supplier, employee or agent of a customer or supplier, or official or employee of any governmental agency or
instrumentality of any government (domestic or foreign) or any political party or candidate for office (domestic or foreign) or
other person who was, is, or may be in a position to help or hinder the business of the Company (or assist it in connection with
any actual or proposed transaction) that (i) might subject the Company to any damage or penalty in any civil, criminal or governmental
litigation or proceeding, (ii) if not given in the past, might have had a Material Adverse Change or (iii) if not continued in
the future, might adversely affect the assets, business, operations or prospects of the Company. The Company has taken reasonable
steps to ensure that its accounting controls and procedures are sufficient to cause the Company to comply in all material respects
with the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S.
<U>Compliance with OFAC</U>. Neither the Company nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee
or affiliate of the Company or any other person acting on behalf of the Company, is currently subject to any U.S. sanctions administered
by the Office of Foreign Assets Control of the U.S. Department of the Treasury (&ldquo;<U>OFAC</U>&rdquo;), and the Company will
not, directly or indirectly, use the proceeds of the Offering hereunder, or lend, contribute or otherwise make available such
proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any
person currently subject to any U.S. sanctions administered by OFAC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">T.
<U>Money Laundering Laws</U>. The operations of the Company are and have been conducted at all times in compliance with applicable
financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
the money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar
rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the &ldquo;<U>Money
Laundering Laws</U>&rdquo;); and no action, suit or proceeding by or before any Governmental Entity involving the Company with
respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.
<U>Officers&rsquo; Certificate</U>. Any certificate signed by any duly authorized officer of the Company and delivered to you
or to your counsel shall be deemed a representation and warranty by the Company to the Placement Agent as to the matters covered
thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">V.
<U>No Labor Disputes</U>. No labor dispute with the employees of the Company exists or, to the knowledge of the Company, is imminent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">W.
<U>Intellectual Property Rights</U>. To the Company&rsquo;s knowledge, the Company has, or can acquire on reasonable terms, ownership
of and/or license to, or otherwise has the right to use, all inventions, know-how (including trade secrets and other unpatented
and/or unpatentable proprietary or confidential information, systems or procedures), patents and patent rights trademarks, service
marks and trade names, copyrights, (collectively &ldquo;<U>Intellectual Property</U>&rdquo;) material to carrying on its businesses
as described in the SEC Reports or Subscription Documents. The Company has not received any correspondence relating to any Intellectual
Property, including notice of: (A) infringement or misappropriation of, or conflict with, any Intellectual Property of a third
party; (B) asserted rights of others with respect to any Intellectual Property of the Company; (C) assertions that any Intellectual
Property of the Company is invalid or otherwise inadequate to protect the interest of the Company, that in each case (if the subject
of any unfavorable decision, ruling or finding), individually or in the aggregate, would have or would reasonably be expected
to have a Material Adverse Change. There are no third parties who have been able to establish any material rights to any Intellectual
Property, except for the retained rights of the owners or licensors of any Intellectual Property that is licensed to the Company.
There is no pending or, to the Company&rsquo;s knowledge, threatened action, suit, proceeding or claim by others: (A) challenging
the validity, enforceability or scope of any Intellectual Property of the Company or (B) challenging the Company&rsquo;s rights
in or to any Intellectual Property or (C) that the Company materially infringes, misappropriates or otherwise violates or conflicts
with any Intellectual Property or other proprietary rights of others. All patents issued in the name of, or assigned to, the Company,
and all patent applications made by or on behalf of the Company (collectively, the &ldquo;<U>Company Patents</U>&rdquo;) have
been duly and properly filed. The Company is not aware of any material information that was required to be disclosed to the United
States Patent and Trademark Office (the &ldquo;<U>PTO</U>&rdquo;) but that was not disclosed to the PTO with respect to any issued
Company Patent, or that is required to be disclosed and has not yet been disclosed in any pending application in the Company Patents
and that would preclude the grant of a patent on such application. To the Company&rsquo;s knowledge, the Company is the sole owner
of the Company Patents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X.
<U>Taxes</U>. The Company has filed all returns (as hereinafter defined) required to be filed with taxing authorities prior to
the date hereof or has duly obtained extensions of time for the filing thereof. The Company has paid all taxes (as hereinafter
defined) shown as due on such returns that were filed and has paid all taxes imposed on or assessed against the Company, except
for such exceptions as would not be expected, individually or in the aggregate, to have a Material Adverse Change. The provisions
for taxes payable, if any, shown on the financial statements included in the Subscription Documents are sufficient for all accrued
and unpaid taxes, whether or not disputed, and for all periods to and including the dates of such consolidated financial statements.
Except as disclosed in writing to the Placement Agents, (i) no issues have been raised (and are currently pending) by any taxing
authority in connection with any of the returns or taxes asserted as due from the Company, and (ii) no waivers of statutes of
limitation with respect to the returns or collection of taxes have been given by or requested from the Company. The term &ldquo;taxes&rdquo;
mean all federal, state, local, foreign and other net income, gross income, gross receipts, sales, use, ad valorem, transfer,
franchise, profits, license, lease, service, service use, withholding, payroll, employment, excise, severance, stamp, occupation,
premium, property, windfall profits, customs, duties or other taxes, fees, assessments or charges of any kind whatever, together
with any interest and any penalties, additions to tax or additional amounts with respect thereto. The term &ldquo;returns&rdquo;
means all returns, declarations, reports, statements and other documents required to be filed in respect to taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y.
<U>Employee Benefit Laws</U>. To the extent applicable, the operations of the Company are and have been conducted at all times
in material compliance with the Employee Retirement Income Security Act of 1974, as amended, the rules and regulations thereunder
and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively,
the &ldquo;<U>Employee Benefit Laws</U>&rdquo;). No action, suit or proceeding by or before any court or governmental agency,
authority or body or any arbitrator involving the Company or its subsidiaries with respect to the Employee Benefit Laws is pending
or, to the knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Z.
<U>Compliance with Laws</U>. Except as disclosed in the SEC Reports, the Company: (A) is and at all times has been in compliance
with all Applicable Laws, except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Change; (B) has not received any correspondence from any Governmental Entity alleging or asserting noncompliance with any Applicable
Laws or any Authorizations; (C) possesses all material Authorizations and such Authorizations are valid and in full force and
effect and the Company is not in material violation of any term of any such Authorizations, in each case except as would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Change; (D) has not received written notice
of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any Governmental
Entity or third party alleging that any product operation or activity is in violation of any Applicable Laws or Authorizations
and has no knowledge that any such Governmental Entity or third party is considering any such claim, litigation, arbitration,
action, suit, investigation or proceeding; (E) has not received written notice that any Governmental Entity has taken, is taking
or intends to take action to limit, suspend, modify or revoke any Authorizations; and (F) has filed, obtained, maintained or submitted
all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required
by any Applicable Laws or Authorizations and that all such reports, documents, forms, notices, applications, records, claims,
submissions and supplements or amendments were complete and correct in all material respects on the date filed (or were corrected
or supplemented by a subsequent submission).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AA.
<U>Integration</U>. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that
would cause the Offering to be integrated with prior offerings by the Company for purposes of the Securities Act that would require
the registration of the Securities or any such other securities under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Conditions of the Obligations of the Placement Agent.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of the Placement Agent hereunder shall be subject to the accuracy of the representations and warranties on the part
of the Company set forth in Section 7 hereof, in each case as of the date hereof and as of each Closing Date as though then made,
to the timely performance by each of the Company of its covenants and other obligations hereunder on and as of such dates, and
to each of the following additional conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
<U>Form D and Blue Sky</U>. The Company shall file a Form D with respect to the Securities as required under Regulation D and
to provide a copy thereof to Placement Agent promptly after such filing. The Company shall, on or before the Closing Date, take
such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to, qualify the Securities
for sale to the Investors at the Closing pursuant to this Agreement under applicable securities or &ldquo;blue sky&rdquo; laws
of the states of the United States (or to obtain an exemption from such qualification), and shall provide evidence of any such
action so taken to the Placement Agent on or prior to the Closing Date. Without limiting any other obligation of the Company under
this Agreement, the Company shall timely make all filings and reports relating to the offer and sale of the Securities required
under all applicable securities laws (including, without limitation, all applicable federal securities laws and all applicable
&ldquo;blue sky&rdquo; laws), and the Company shall comply with all applicable federal, state, local and foreign laws, statutes,
rules, regulations and the like relating to the offering and sale of the Securities to the Investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
<U>Officers&rsquo; Certificates</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Officers&rsquo;
    Certificate</U>. The Company shall have furnished to the Placement Agent a certificate, dated the Closing Date, of its Chief
    Executive Officer, as provided under the Subscription Documents.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Secretary&rsquo;s
    Certificate</U>. At of the Closing Date the Placement Agent shall have received a certificate of the Company signed by the
    Secretary of the Company, dated the Closing Date, certifying: (i) that each of the Charter and Bylaws is true and complete,
    has not been modified and is in full force and effect; (ii) that the resolutions of the Company&rsquo;s Board of Directors
    relating to the Offering are in full force and effect and have not been modified; and (iii) the good standing of the Company
    and its subsidiaries. The documents referred to in such certificate shall be attached to such certificate.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1.3in; text-align: justify; text-indent: -0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
<U>No Material Changes</U>. Since the date of the Subscription Documents, no event or series of events shall have occurred that
reasonably would have or result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
<U>Additional Documents</U>. At the Closing Date, Placement Agent Counsel shall have been furnished with such documents and certificates
letter from the Company&rsquo;s counsel allowing the Placement Agent to rely on the opinions issued to the Investors in the Offering;
a letter from the Company allowing the Placement Agent to rely on all representations and warranties of the Company set forth
in the Subscription Documents; such documents and opinions as they may require in order to evidence the accuracy of any of the
representations or warranties, or the fulfillment of any of the conditions, herein contained; and all proceedings taken by the
Company in connection with the issuance and sale of the Securities as herein contemplated shall be satisfactory in form and substance
to the Placement Agent and Placement Agent Counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Indemnification and Contribution; Procedures.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
<U>Indemnification of the Placement Agent</U>. The Company agrees to indemnify and hold harmless the Placement Agent, its affiliates
and each person controlling such Placement Agent (within the meaning of Section 15 of the Securities Act), and the directors,
officers, agents and employees of the Placement Agent, its affiliates and each such controlling person (the Placement Agent, and
each such entity or person hereafter is referred to as an &ldquo;<U>Indemnified Person</U>&rdquo;) from and against any losses,
claims, damages, judgments, assessments, costs and other liabilities (collectively, the &ldquo;<U>Liabilities</U>&rdquo;), and
shall reimburse each Indemnified Person for all fees and expenses (including the reasonable fees and expenses of counsel for the
Indemnified Persons, except as otherwise expressly provided in this Agreement) (collectively, the &ldquo;<U>Expenses</U>&rdquo;)
and agrees to advance payment of such Expenses as they are incurred by an Indemnified Person in investigating, preparing, pursuing
or defending any actions, whether or not any Indemnified Person is a party thereto, arising out of or based upon any untrue statement
or alleged untrue statement of a material fact contained in (i) the Subscription Documents (as from time to time each may be amended
and supplemented); (ii) any materials or information provided to investors by, or with the approval of, the Company in connection
with the marketing of the Offering, including any term sheets or &ldquo;road show&rdquo; or investor presentations made to investors
by the Company (whether in person or electronically); or (iii) any application or other document or written communication (in
this Section 9, collectively called &ldquo;application&rdquo;) executed by the Company or based upon written information furnished
by the Company in any jurisdiction in order to qualify the Securities under the securities laws thereof or to file for an exemption
from such requirement or filed with the Commission, any state securities commission or agency, any national securities exchange;
or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading, unless such statement or omission was made
in reliance upon, and in conformity with, information provided to the Company in writing specifically for use in an application
or in the Subscription Documents (the &ldquo;<U>Placement Agent&rsquo;s Information</U>&rdquo;) or unless such Liabilities are
determined by a final order of a court of appropriate jurisdiction to have resulted solely from the gross negligence or willful
misconduct of the person or persons seeking indemnification for such Liabilities. The Company also agrees to reimburse each Indemnified
Person for all Expenses as they are incurred in connection with such Indemnified Person&rsquo;s enforcement of his or its rights
under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
<U>Procedure</U>. Upon receipt by an Indemnified Person of actual notice of an action against such Indemnified Person with respect
to which indemnity may reasonably be expected to be sought under this Agreement, such Indemnified Person shall promptly notify
the Company in writing; provided that failure by any Indemnified Person so to notify the Company shall not relieve the Company
from any obligation or liability which the Company may have on account of this Section 9 or otherwise to such Indemnified Person
unless such failure to notify the Company materially and adversely affects the Company&rsquo;s ability to defend such action.
The Company shall, if requested by the Placement Agent, assume the defense of any such action (including the employment of counsel
designated by the Placement Agent and reasonably satisfactory to the Company). Any Indemnified Person shall have the right to
employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall
be at the expense of such Indemnified Person unless: (i) the Company has failed promptly to assume the defense and employ separate
counsel designated by the Placement Agent for the benefit of the Placement Agent and the other Indemnified Persons or (ii) such
Indemnified Person shall have been advised that in the opinion of counsel that there is an actual or potential conflict of interest
that prevents (or makes it imprudent for) the counsel designated by the Placement Agent and engaged by the Company for the purpose
of representing the Indemnified Person, to represent both such Indemnified Person and any other person represented or proposed
to be represented by such counsel. In either case described in clause (i) or (ii) of the preceding sentence in which the Indemnified
Persons employ separate counsel, the Company shall not be obligated to provide reimbursement for the fees and expenses of more
than one law firm. The Company shall not be liable for any settlement of any action effected without its written consent (which
shall not be unreasonably withheld). In addition, the Company shall not, without the prior written consent of the Placement Agent,
settle, compromise or consent to the entry of any judgment in or otherwise seek to terminate any pending or threatened action
in respect of which advancement, reimbursement, indemnification or contribution may be sought hereunder (whether or not such Indemnified
Person is a party thereto) unless such settlement, compromise, consent or termination (i) includes an unconditional release of
each Indemnified Person, acceptable to such Indemnified Party, from all Liabilities arising out of such action for which indemnification
or contribution may be sought hereunder and (ii) does not include a statement as to or an admission of fault, culpability or a
failure to act, by or on behalf of any Indemnified Person. The advancement, reimbursement, indemnification and contribution obligations
of the Company required hereby shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, as every Liability and Expense is incurred and is due and payable, and in such amounts as fully satisfy each and every
Liability and Expense as it is incurred (and in no event later than 30 days following the date of any invoice therefore).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
<U>Indemnification of the Company</U>. The Placement Agent agrees to indemnify and hold harmless the Company, its directors, its
executive officers and persons who control the Company within the meaning of Section 15 of the Securities Act or Section 20 of
the Exchange Act against any and all Liabilities, but only with respect to (a) untrue statements or omissions, or alleged untrue
statements or omissions made in the Subscription Documents or any amendment or supplement thereto, in reliance upon, and in strict
conformity with, the Placement Agent&rsquo;s Information, or (b) Liabilities that are determined by a final order of a court of
appropriate jurisdiction to have resulted solely from the gross negligence or willful misconduct of the Placement Agent. In case
any action shall be brought against the Company or any other person so indemnified based on the Subscription Documents or any
amendment or supplement thereto, and in respect of which indemnity may be sought against the Placement Agent, the Placement Agent
shall have the rights and duties given to the Company, and the Company and each other person so indemnified shall have the rights
and duties given to the Placement Agent by the provisions of Section 9.B. The Company agrees promptly to notify the Placement
Agent of the commencement of any litigation or proceedings against the Company or any of its executive officers, directors or
any person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act, in connection with the issuance and sale of the Securities or in connection with the Subscription Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
<U>Contribution</U>. In the event that a court of competent jurisdiction makes a finding that indemnity is unavailable to an Indemnified
Person, the Company shall contribute to the Liabilities and Expenses paid or payable by such Indemnified Person in such proportion
as is appropriate to reflect (i) the relative benefits to the Company, on the one hand, and to the Placement Agent and any other
Indemnified Person, on the other hand, of the matters contemplated by this Agreement or (ii) if the allocation provided by the
immediately preceding clause is not permitted by applicable law, not only such relative benefits but also the relative fault of
the Company, on the one hand, and the Placement Agent and any other Indemnified Person, on the other hand, in connection with
the matters as to which such Liabilities or Expenses relate, as well as any other relevant equitable considerations; provided
that in no event shall the Company contribute less than the amount necessary to ensure that all Indemnified Persons, in the aggregate,
are not liable for any Liabilities and Expenses in excess of the amount of commissions actually received by the Placement Agent
pursuant to this Agreement. The relative fault shall be determined by reference to, among other things, whether the untrue or
alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information
supplied by the Company on the one hand or the Placement Agent on the other and the parties&rsquo; relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or omission. The Company and the Placement Agent agree
that it would not be just and equitable if contributions pursuant to this subsection (D) were determined by pro rata allocation
or by any other method of allocation which does not take account of the equitable considerations referred to above in this subsection
(D). For purposes of this paragraph, the relative benefits to the Company, on the one hand, and to the Placement Agent on the
other hand, of the matters contemplated by this Agreement shall be deemed to be in the same proportion as: (a) the total value
received by the Company in the Offering, whether or not such Offering is consummated, bears to (b) the commissions paid to the
Placement Agent under this Agreement. Notwithstanding the above, no person guilty of fraudulent misrepresentation within the meaning
of Section 11(f) of the Securities Act shall be entitled to contribution from a party who was not guilty of fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.
<U>Limitation</U>. The Company also agrees that no Indemnified Person shall have any liability (whether direct or indirect, in
contract or tort or otherwise) to the Company for or in connection with advice or services rendered or to be rendered by any Indemnified
Person pursuant to this Agreement, the transactions contemplated thereby or any Indemnified Person&rsquo;s actions or inactions
in connection with any such advice, services or transactions, except to the extent that a court of competent jurisdiction has
made a finding that Liabilities (and related Expenses) of the Company have resulted exclusively from such Indemnified Person&rsquo;s
gross negligence or willful misconduct in connection with any such advice, actions, inactions or services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.
<U>Survival</U>. The advancement, reimbursement, indemnity and contribution obligations set forth in this Section 9 shall remain
in full force and effect regardless of any termination of, or the completion of any Indemnified Person&rsquo;s services under
or in connection with, this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>Limitation of Dawson&rsquo;s Liability to the Company.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dawson
and the Company further agree that neither Dawson nor any of its affiliates or any of their respective officers, directors, controlling
persons (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act), employees or agents shall
have any liability to the Company, its security holders or creditors, or any person asserting claims on behalf of or in the right
of the Company (whether direct or indirect, in contract or tort, for an act of negligence or otherwise) for any losses, fees,
damages, liabilities, costs, expenses or equitable relief arising out of or relating to this Agreement or the Services rendered
hereunder, except for losses, fees, damages, liabilities, costs or expenses that arise out of or are based on any action of or
failure to act by Dawson and that are finally judicially determined to have resulted solely from the gross negligence or willful
misconduct of Dawson.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>Limitation of Engagement to the Company. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges that Dawson has been retained only by the Company, that Dawson is providing services hereunder as an independent
contractor (and not in any fiduciary or agency capacity) and that the Company&rsquo;s engagement of Dawson is not deemed to be
on behalf of, and is not intended to confer rights upon, any shareholder, owner or partner of the Company or any other person
not a party hereto as against Dawson or any of its affiliates, or any of its or their respective officers, directors, controlling
persons (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act), employees or agents. Unless
otherwise expressly agreed in writing by Dawson, no one other than the Company is authorized to rely upon any statement or conduct
of Dawson in connection with this Agreement. The Company acknowledges that any recommendation or advice, written or oral, given
by Dawson to the Company in connection with Dawson&rsquo;s engagement is intended solely for the benefit and use of the Company&rsquo;s
management and directors in considering a possible Offering, and any such recommendation or advice is not on behalf of, and shall
not confer any rights or remedies upon, any other person or be used or relied upon for any other purpose. Dawson shall not have
the authority to make any commitment binding on the Company. The Company, in its sole discretion, shall have the right to reject
any investor introduced to it by Dawson. The Company agrees that it will perform and comply with the covenants and other obligations
set forth in any purchase agreement and related transaction documents between the Company and the Investors in the Offering, if
any, and that Dawson will be entitled to rely on the representations, warranties, agreements and covenants of the Company contained
in any such purchase agreement and related transaction documents as if such representations, warranties, agreements and covenants
were made directly to Dawson by the Company, provided that no such representations, warranties, agreements and covenants shall
in any way limit or modify the representations, warranties, agreements and covenants set forth in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<U>Amendments and Waivers. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
supplement, modification or waiver of this Agreement shall be binding unless executed in writing by the party to be bound thereby.
The failure of a party to exercise any right or remedy shall not be deemed or constitute a waiver of such right or remedy in the
future. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provision
hereof (regardless of whether similar), nor shall any such waiver be deemed or constitute a continuing waiver unless otherwise
expressly provided.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<U>Confidentiality.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of the consummation or public announcement of any Offering, Dawson shall have the right to disclose its participation
in such Offering, including, without limitation, the placement at its cost of &ldquo;tombstone&rdquo; advertisements in financial
and other newspapers and journals. Dawson agrees not to use any confidential information concerning the Company provided to Dawson
by the Company for any purposes other than those contemplated under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<U>Headings. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
headings of the various sections of this Agreement have been inserted for convenience of reference only and will not be deemed
to be part of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<U>Counterparts. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement may be executed in one or more counterparts and, if executed in more than one counterpart, the executed counterparts
shall each be deemed to be an original and all such counterparts shall together constitute one and the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.
<U>Severability. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
case any provision contained in this Agreement should be invalid, illegal or unenforceable in any respect, the validity, legality
and enforceability of the remaining provisions contained herein will not in any way be affected or impaired thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.
<U>Use of Information. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will furnish Dawson such written information as Dawson reasonably requests in connection with the performance of its services
hereunder. The Company understands, acknowledges and agrees that, in performing its services hereunder, Dawson will use and rely
entirely upon such information as well as publicly available information regarding the Company and other potential parties to
an Offering and that Dawson does not assume responsibility for independent verification of the accuracy or completeness of any
information, whether publicly available or otherwise furnished to it, concerning the Company or otherwise relevant to an Offering,
including, without limitation, any financial information, forecasts or projections considered by Dawson in connection with the
provision of its services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.
<U>Absence of Fiduciary Relationship. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that: (a) the Placement Agent has been retained solely to act as Placement Agent in connection
with the sale of the Securities and that no fiduciary, advisory or agency relationship between the Company and the Placement Agent
has been created in respect of any of the transactions contemplated by this Agreement, irrespective of whether the Placement Agent
has advised or is advising the Company on other matters; (b) the price and other terms of the Securities set forth in this Agreement
were established by the Company following discussions and arms-length negotiations with the Placement Agent and the Company is
capable of evaluating and understanding and understands and accepts the terms, risks and conditions of the transactions contemplated
by this Agreement; (c) it has been advised that the Placement Agent and its affiliates are engaged in a broad range of transactions
that may involve interests that differ from those of the Company and that the Placement Agent has no obligation to disclose such
interest and transactions to the Company by virtue of any fiduciary, advisory or agency relationship; and (d) it has been advised
that the Placement Agent is acting, in respect of the transactions contemplated by this Agreement, solely for the benefit of the
Placement Agent, and not on behalf of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.
<U>Survival Of Indemnities, Representations, Warranties, Etc.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
respective indemnities, covenants, agreements, representations, warranties and other statements of the Company and Placement Agent,
as set forth in this Agreement or made by them respectively, pursuant to this Agreement, shall remain in full force and effect,
regardless of any investigation made by or on behalf of the Placement Agents, the Company, the Purchasers or any person controlling
any of them and shall survive delivery of and payment for the Securities. Notwithstanding any termination of this Agreement, including
without limitation any termination pursuant to Section 5, the payment, reimbursement, indemnity, contribution and advancement
agreements contained in Sections 2, 5, 9, and 10, respectively, and the Company&rsquo;s covenants, representations, and warranties
set forth in this Agreement shall not terminate and shall remain in full force and effect at all times. The indemnity and contribution
provisions contained in Section 9 and the covenants, warranties and representations of the Company contained in this Agreement
shall remain operative and in full force and effect regardless of (i) any termination of this Agreement, (ii) any investigation
made by or on behalf of any Placement Agent, any person who controls any Placement Agent within the meaning of either Section
15 of the Securities Act or Section 20 of the Exchange Act or any affiliate of any Placement Agent, or by or on behalf of the
Company, its directors or officers or any person who controls the Company within the meaning of either Section 15 of the Securities
Act or Section 20 of the Exchange Act, and (iii) the issuance and delivery of the Securities. The Company and Placement Agent
agree to notify each other of the commencement of any Proceeding against either of them promptly, and, in the case of the Company,
against any of the Company&rsquo;s officers or directors in connection with the issuance and sale of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.
<U>Governing Law. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable to agreements made
and to be fully performed therein. Any disputes that arise under this Agreement, even after the termination of this Agreement,
will be heard only in the state or federal courts located in the City of New York, State of New York. The parties hereto expressly
agree to submit themselves to the jurisdiction of the foregoing courts in the City of New York, State of New York. The parties
hereto expressly waive any rights they may have to contest the jurisdiction, venue or authority of any court sitting in the City
and State of New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.
<U>Notices. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
communications hereunder shall be in writing and shall be mailed, hand delivered or faxed and confirmed to the parties hereto
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sigma
Labs, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3900
Paseo del Sol</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Santa
Fe, New Mexico 87507</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Placement Agent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dawson
James Securities, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
North Federal Highway &ndash; 5th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boca
Raton, FL 33432</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
party hereto may change the address for receipt of communications by giving written notice to the others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.
<U>Miscellaneous. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement shall not be modified or amended except in writing signed by Dawson and the Company. This Agreement shall be binding
upon and inure to the benefit of both Dawson and the Company and their respective assigns, successors, and legal representatives.
This Agreement constitutes the entire agreement of Dawson and the Company, and supersedes any prior agreements, with respect to
the subject matter hereof. If any provision of this Agreement is determined to be invalid or unenforceable in any respect, such
determination will not affect such provision in any other respect, and the remainder of this Agreement shall remain in full force
and effect. This Agreement may be executed in counterparts (including facsimile or .pdf counterparts), each of which shall be
deemed an original but all of which together shall constitute one and the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.
<U>Successors. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees, officers and
directors and controlling persons referred to in Section 9 hereof, and to their respective successors, and personal representative,
and, except as set forth in Section 9 of this Agreement, no other person will have any right or obligation hereunder or be considered
a third-party beneficiary hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.
<U>Partial Unenforceability. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not affect the validity or enforceability
of any other section, paragraph or provision hereof. If any Section, paragraph or provision of this Agreement is for any reason
determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as
are necessary to make it valid and enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.
<U>General Provisions. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges that in connection with the Offering of the Securities the Placement Agent: (i) has acted at arms-length,
are not agents of, and owe no fiduciary duties to the Company or any other person, (ii) owes the Company only those duties and
obligations set forth in this Agreement and (iii) may have interests that differ from those of the Company. The Company waives
to the full extent permitted by applicable law any claims it may have against the Placement Agent arising from an alleged breach
of fiduciary duty in connection with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Balance
of the Page Intentionally Left Blank]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
acknowledgment that the foregoing correctly sets forth the understanding reached by Dawson and the Company, and intending to be
legally bound, please sign in the space provided below, whereupon this letter shall constitute a binding Agreement as of the date
executed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGMA
    LABS, INC.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    John Rice</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    Rice</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreed
    and accepted as of the date first above written.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DAWSON
    JAMES SECURITIES, INC.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Robert D. Keyser</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    D. Keyser, Jr.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
